{"id": "BioInfer.d430.s0_BioInfer.d430.s0.p0", "text": "Molecular cloning and primary structure analysis demonstrated that alpha-catenin is homologous to vinculin and the beta-catenin is homologous to human plakoglobin and the Drosophila gene product armadillo.", "text_with_entity_marker": "Molecular cloning and primary structure analysis demonstrated that alpha-catenin is homologous to vinculin and the beta-catenin is homologous to human [E1]plakoglobin[/E1] and the Drosophila gene product [E2]armadillo[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "plakoglobin", "entity_1_idx": [[151, 162]], "entity_1_idx_in_text_with_entity_marker": [155, 166], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "armadillo", "entity_2_idx": [[195, 204]], "entity_2_idx_in_text_with_entity_marker": [208, 217], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d430.s0_BioInfer.d430.s0.p1", "text": "Molecular cloning and primary structure analysis demonstrated that alpha-catenin is homologous to vinculin and the beta-catenin is homologous to human plakoglobin and the Drosophila gene product armadillo.", "text_with_entity_marker": "Molecular cloning and primary structure analysis demonstrated that alpha-catenin is homologous to [E1]vinculin[/E1] and the beta-catenin is homologous to human [E2]plakoglobin[/E2] and the Drosophila gene product armadillo.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "vinculin", "entity_1_idx": [[98, 106]], "entity_1_idx_in_text_with_entity_marker": [102, 110], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[151, 162]], "entity_2_idx_in_text_with_entity_marker": [164, 175], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d430.s0_BioInfer.d430.s0.p2", "text": "Molecular cloning and primary structure analysis demonstrated that alpha-catenin is homologous to vinculin and the beta-catenin is homologous to human plakoglobin and the Drosophila gene product armadillo.", "text_with_entity_marker": "Molecular cloning and primary structure analysis demonstrated that alpha-catenin is homologous to vinculin and the [E1]beta-catenin[/E1] is homologous to human [E2]plakoglobin[/E2] and the Drosophila gene product armadillo.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "beta-catenin", "entity_1_idx": [[115, 127]], "entity_1_idx_in_text_with_entity_marker": [119, 131], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[151, 162]], "entity_2_idx_in_text_with_entity_marker": [164, 175], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d430.s0_BioInfer.d430.s0.p3", "text": "Molecular cloning and primary structure analysis demonstrated that alpha-catenin is homologous to vinculin and the beta-catenin is homologous to human plakoglobin and the Drosophila gene product armadillo.", "text_with_entity_marker": "Molecular cloning and primary structure analysis demonstrated that [E1]alpha-catenin[/E1] is homologous to vinculin and the beta-catenin is homologous to human [E2]plakoglobin[/E2] and the Drosophila gene product armadillo.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[67, 80]], "entity_1_idx_in_text_with_entity_marker": [71, 84], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[151, 162]], "entity_2_idx_in_text_with_entity_marker": [164, 175], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d430.s0_BioInfer.d430.s0.p4", "text": "Molecular cloning and primary structure analysis demonstrated that alpha-catenin is homologous to vinculin and the beta-catenin is homologous to human plakoglobin and the Drosophila gene product armadillo.", "text_with_entity_marker": "Molecular cloning and primary structure analysis demonstrated that alpha-catenin is homologous to [E1]vinculin[/E1] and the beta-catenin is homologous to human plakoglobin and the Drosophila gene product [E2]armadillo[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "vinculin", "entity_1_idx": [[98, 106]], "entity_1_idx_in_text_with_entity_marker": [102, 110], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "armadillo", "entity_2_idx": [[195, 204]], "entity_2_idx_in_text_with_entity_marker": [208, 217], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d430.s0_BioInfer.d430.s0.p5", "text": "Molecular cloning and primary structure analysis demonstrated that alpha-catenin is homologous to vinculin and the beta-catenin is homologous to human plakoglobin and the Drosophila gene product armadillo.", "text_with_entity_marker": "Molecular cloning and primary structure analysis demonstrated that alpha-catenin is homologous to vinculin and the [E1]beta-catenin[/E1] is homologous to human plakoglobin and the Drosophila gene product [E2]armadillo[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "beta-catenin", "entity_1_idx": [[115, 127]], "entity_1_idx_in_text_with_entity_marker": [119, 131], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "armadillo", "entity_2_idx": [[195, 204]], "entity_2_idx_in_text_with_entity_marker": [208, 217], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d430.s0_BioInfer.d430.s0.p6", "text": "Molecular cloning and primary structure analysis demonstrated that alpha-catenin is homologous to vinculin and the beta-catenin is homologous to human plakoglobin and the Drosophila gene product armadillo.", "text_with_entity_marker": "Molecular cloning and primary structure analysis demonstrated that [E1]alpha-catenin[/E1] is homologous to vinculin and the beta-catenin is homologous to human plakoglobin and the Drosophila gene product [E2]armadillo[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[67, 80]], "entity_1_idx_in_text_with_entity_marker": [71, 84], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "armadillo", "entity_2_idx": [[195, 204]], "entity_2_idx_in_text_with_entity_marker": [208, 217], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d430.s0_BioInfer.d430.s0.p7", "text": "Molecular cloning and primary structure analysis demonstrated that alpha-catenin is homologous to vinculin and the beta-catenin is homologous to human plakoglobin and the Drosophila gene product armadillo.", "text_with_entity_marker": "Molecular cloning and primary structure analysis demonstrated that alpha-catenin is homologous to [E1]vinculin[/E1] and the [E2]beta-catenin[/E2] is homologous to human plakoglobin and the Drosophila gene product armadillo.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "vinculin", "entity_1_idx": [[98, 106]], "entity_1_idx_in_text_with_entity_marker": [102, 110], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[115, 127]], "entity_2_idx_in_text_with_entity_marker": [128, 140], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d430.s0_BioInfer.d430.s0.p8", "text": "Molecular cloning and primary structure analysis demonstrated that alpha-catenin is homologous to vinculin and the beta-catenin is homologous to human plakoglobin and the Drosophila gene product armadillo.", "text_with_entity_marker": "Molecular cloning and primary structure analysis demonstrated that [E1]alpha-catenin[/E1] is homologous to [E2]vinculin[/E2] and the beta-catenin is homologous to human plakoglobin and the Drosophila gene product armadillo.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-catenin", "entity_1_idx": [[67, 80]], "entity_1_idx_in_text_with_entity_marker": [71, 84], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vinculin", "entity_2_idx": [[98, 106]], "entity_2_idx_in_text_with_entity_marker": [111, 119], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d430.s0_BioInfer.d430.s0.p9", "text": "Molecular cloning and primary structure analysis demonstrated that alpha-catenin is homologous to vinculin and the beta-catenin is homologous to human plakoglobin and the Drosophila gene product armadillo.", "text_with_entity_marker": "Molecular cloning and primary structure analysis demonstrated that [E1]alpha-catenin[/E1] is homologous to vinculin and the [E2]beta-catenin[/E2] is homologous to human plakoglobin and the Drosophila gene product armadillo.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[67, 80]], "entity_1_idx_in_text_with_entity_marker": [71, 84], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[115, 127]], "entity_2_idx_in_text_with_entity_marker": [128, 140], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d430.s1_BioInfer.d430.s1.p10", "text": "One complex is composed of E-cadherin, alpha- and beta-catenin, the other of E-cadherin, alpha-catenin and plakoglobin.", "text_with_entity_marker": "One complex is composed of [E1]E-cadherin[/E1], [E2]alpha-[/E2] and beta-catenin, the other of E-cadherin, alpha-catenin and plakoglobin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "E-cadherin", "entity_1_idx": [[27, 37]], "entity_1_idx_in_text_with_entity_marker": [31, 41], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-", "entity_2_idx": [[39, 45], [55, 62]], "entity_2_idx_in_text_with_entity_marker": [52, 58], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d430.s1_BioInfer.d430.s1.p11", "text": "One complex is composed of E-cadherin, alpha- and beta-catenin, the other of E-cadherin, alpha-catenin and plakoglobin.", "text_with_entity_marker": "One complex is composed of E-cadherin, [E1]alpha-[/E1] and [E2]beta-catenin[/E2], the other of E-cadherin, alpha-catenin and plakoglobin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-", "entity_1_idx": [[39, 45], [55, 62]], "entity_1_idx_in_text_with_entity_marker": [43, 49], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[50, 62]], "entity_2_idx_in_text_with_entity_marker": [63, 75], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d430.s1_BioInfer.d430.s1.p12", "text": "One complex is composed of E-cadherin, alpha- and beta-catenin, the other of E-cadherin, alpha-catenin and plakoglobin.", "text_with_entity_marker": "One complex is composed of [E1]E-cadherin[/E1], alpha- and beta-catenin, the other of E-cadherin, [E2]alpha-catenin[/E2] and plakoglobin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[27, 37]], "entity_1_idx_in_text_with_entity_marker": [31, 41], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[89, 102]], "entity_2_idx_in_text_with_entity_marker": [102, 115], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d430.s1_BioInfer.d430.s1.p13", "text": "One complex is composed of E-cadherin, alpha- and beta-catenin, the other of E-cadherin, alpha-catenin and plakoglobin.", "text_with_entity_marker": "One complex is composed of E-cadherin, alpha- and [E1]beta-catenin[/E1], the other of E-cadherin, [E2]alpha-catenin[/E2] and plakoglobin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[50, 62]], "entity_1_idx_in_text_with_entity_marker": [54, 66], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[89, 102]], "entity_2_idx_in_text_with_entity_marker": [102, 115], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d430.s1_BioInfer.d430.s1.p14", "text": "One complex is composed of E-cadherin, alpha- and beta-catenin, the other of E-cadherin, alpha-catenin and plakoglobin.", "text_with_entity_marker": "One complex is composed of [E1]E-cadherin[/E1], alpha- and [E2]beta-catenin[/E2], the other of E-cadherin, alpha-catenin and plakoglobin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "E-cadherin", "entity_1_idx": [[27, 37]], "entity_1_idx_in_text_with_entity_marker": [31, 41], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[50, 62]], "entity_2_idx_in_text_with_entity_marker": [63, 75], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d267.s0_BioInfer.d267.s0.p10", "text": "However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (XPD), mouse RAD51, and the HHR23B/p58 and HHR23A subunits of XPC.", "text_with_entity_marker": "However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include [E1]ERCC1[/E1], ERCC2 ([E2]XPD[/E2]), mouse RAD51, and the HHR23B/p58 and HHR23A subunits of XPC.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ERCC1", "entity_1_idx": [[93, 98]], "entity_1_idx_in_text_with_entity_marker": [97, 102], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "XPD", "entity_2_idx": [[107, 110]], "entity_2_idx_in_text_with_entity_marker": [120, 123], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d267.s0_BioInfer.d267.s0.p11", "text": "However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (XPD), mouse RAD51, and the HHR23B/p58 and HHR23A subunits of XPC.", "text_with_entity_marker": "However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, [E1]ERCC2[/E1] ([E2]XPD[/E2]), mouse RAD51, and the HHR23B/p58 and HHR23A subunits of XPC.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ERCC2", "entity_1_idx": [[100, 105]], "entity_1_idx_in_text_with_entity_marker": [104, 109], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "XPD", "entity_2_idx": [[107, 110]], "entity_2_idx_in_text_with_entity_marker": [120, 123], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d267.s0_BioInfer.d267.s0.p12", "text": "However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (XPD), mouse RAD51, and the HHR23B/p58 and HHR23A subunits of XPC.", "text_with_entity_marker": "However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 ([E1]XPD[/E1]), mouse [E2]RAD51[/E2], and the HHR23B/p58 and HHR23A subunits of XPC.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "XPD", "entity_1_idx": [[107, 110]], "entity_1_idx_in_text_with_entity_marker": [111, 114], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RAD51", "entity_2_idx": [[119, 124]], "entity_2_idx_in_text_with_entity_marker": [132, 137], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d267.s0_BioInfer.d267.s0.p13", "text": "However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (XPD), mouse RAD51, and the HHR23B/p58 and HHR23A subunits of XPC.", "text_with_entity_marker": "However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (XPD), mouse RAD51, and the [E1]HHR23B[/E1]/[E2]p58[/E2] and HHR23A subunits of XPC.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "HHR23B", "entity_1_idx": [[134, 140]], "entity_1_idx_in_text_with_entity_marker": [138, 144], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p58", "entity_2_idx": [[141, 144]], "entity_2_idx_in_text_with_entity_marker": [154, 157], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d267.s0_BioInfer.d267.s0.p14", "text": "However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (XPD), mouse RAD51, and the HHR23B/p58 and HHR23A subunits of XPC.", "text_with_entity_marker": "However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (XPD), mouse RAD51, and the [E1]HHR23B[/E1]/p58 and [E2]HHR23A[/E2] subunits of XPC.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "HHR23B", "entity_1_idx": [[134, 140]], "entity_1_idx_in_text_with_entity_marker": [138, 144], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "HHR23A", "entity_2_idx": [[149, 155]], "entity_2_idx_in_text_with_entity_marker": [162, 168], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d267.s0_BioInfer.d267.s0.p15", "text": "However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (XPD), mouse RAD51, and the HHR23B/p58 and HHR23A subunits of XPC.", "text_with_entity_marker": "However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include [E1]ERCC1[/E1], ERCC2 (XPD), mouse RAD51, and the [E2]HHR23B[/E2]/p58 and HHR23A subunits of XPC.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ERCC1", "entity_1_idx": [[93, 98]], "entity_1_idx_in_text_with_entity_marker": [97, 102], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "HHR23B", "entity_2_idx": [[134, 140]], "entity_2_idx_in_text_with_entity_marker": [147, 153], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d267.s0_BioInfer.d267.s0.p16", "text": "However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (XPD), mouse RAD51, and the HHR23B/p58 and HHR23A subunits of XPC.", "text_with_entity_marker": "However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, [E1]ERCC2[/E1] (XPD), mouse RAD51, and the [E2]HHR23B[/E2]/p58 and HHR23A subunits of XPC.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ERCC2", "entity_1_idx": [[100, 105]], "entity_1_idx_in_text_with_entity_marker": [104, 109], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "HHR23B", "entity_2_idx": [[134, 140]], "entity_2_idx_in_text_with_entity_marker": [147, 153], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d267.s0_BioInfer.d267.s0.p17", "text": "However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (XPD), mouse RAD51, and the HHR23B/p58 and HHR23A subunits of XPC.", "text_with_entity_marker": "However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (XPD), mouse [E1]RAD51[/E1], and the [E2]HHR23B[/E2]/p58 and HHR23A subunits of XPC.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD51", "entity_1_idx": [[119, 124]], "entity_1_idx_in_text_with_entity_marker": [123, 128], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "HHR23B", "entity_2_idx": [[134, 140]], "entity_2_idx_in_text_with_entity_marker": [147, 153], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d267.s0_BioInfer.d267.s0.p18", "text": "However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (XPD), mouse RAD51, and the HHR23B/p58 and HHR23A subunits of XPC.", "text_with_entity_marker": "However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (XPD), mouse RAD51, and the HHR23B/[E1]p58[/E1] and [E2]HHR23A[/E2] subunits of XPC.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "p58", "entity_1_idx": [[141, 144]], "entity_1_idx_in_text_with_entity_marker": [145, 148], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "HHR23A", "entity_2_idx": [[149, 155]], "entity_2_idx_in_text_with_entity_marker": [162, 168], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d267.s0_BioInfer.d267.s0.p19", "text": "However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (XPD), mouse RAD51, and the HHR23B/p58 and HHR23A subunits of XPC.", "text_with_entity_marker": "However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include [E1]ERCC1[/E1], ERCC2 (XPD), mouse RAD51, and the HHR23B/[E2]p58[/E2] and HHR23A subunits of XPC.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ERCC1", "entity_1_idx": [[93, 98]], "entity_1_idx_in_text_with_entity_marker": [97, 102], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "p58", "entity_2_idx": [[141, 144]], "entity_2_idx_in_text_with_entity_marker": [154, 157], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d773.s0_BioInfer.d773.s0.p0", "text": "Transcriptional regulation in the galactose regulon of yeast is determined by an interplay between a positive regulatory protein, GAL4, and a negative regulatory protein, GAL80.", "text_with_entity_marker": "Transcriptional regulation in the galactose regulon of yeast is determined by an interplay between a positive regulatory protein, [E1]GAL4[/E1], and a negative regulatory protein, [E2]GAL80[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "GAL4", "entity_1_idx": [[130, 134]], "entity_1_idx_in_text_with_entity_marker": [134, 138], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "GAL80", "entity_2_idx": [[171, 176]], "entity_2_idx_in_text_with_entity_marker": [184, 189], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d613.s0_BioInfer.d613.s0.p10", "text": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "text_with_entity_marker": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of [E1]IL-2[/E1] production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via [E2]p38[/E2] MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "IL-2", "entity_1_idx": [[110, 114]], "entity_1_idx_in_text_with_entity_marker": [114, 118], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p38", "entity_2_idx": [[325, 328]], "entity_2_idx_in_text_with_entity_marker": [338, 341], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d613.s0_BioInfer.d613.s0.p11", "text": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "text_with_entity_marker": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of [E1]IL-2[/E1] production in Jurkat cells and that the transcription factor AP-1 and pathways via [E2]mitogen-activated protein kinase[/E2] (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "IL-2", "entity_1_idx": [[110, 114]], "entity_1_idx_in_text_with_entity_marker": [114, 118], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "mitogen-activated protein kinase", "entity_2_idx": [[198, 230]], "entity_2_idx_in_text_with_entity_marker": [211, 243], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d613.s0_BioInfer.d613.s0.p12", "text": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "text_with_entity_marker": "The findings suggest that [E1]M1[/E1] [E2]muscarinic receptors[/E2] are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "M1", "entity_1_idx": [[26, 28]], "entity_1_idx_in_text_with_entity_marker": [30, 32], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "muscarinic receptors", "entity_2_idx": [[29, 49]], "entity_2_idx_in_text_with_entity_marker": [42, 62], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d613.s0_BioInfer.d613.s0.p13", "text": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "text_with_entity_marker": "The findings suggest that [E1]M1[/E1] muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and [E2]c-Jun N-terminal kinase[/E2], but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "M1", "entity_1_idx": [[26, 28]], "entity_1_idx_in_text_with_entity_marker": [30, 32], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "c-Jun N-terminal kinase", "entity_2_idx": [[288, 311]], "entity_2_idx_in_text_with_entity_marker": [301, 324], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d613.s0_BioInfer.d613.s0.p14", "text": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "text_with_entity_marker": "The findings suggest that [E1]M1[/E1] muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of [E2]IL-2[/E2] production.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "M1", "entity_1_idx": [[26, 28]], "entity_1_idx_in_text_with_entity_marker": [30, 32], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "IL-2", "entity_2_idx": [[402, 406]], "entity_2_idx_in_text_with_entity_marker": [415, 419], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d613.s0_BioInfer.d613.s0.p15", "text": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "text_with_entity_marker": "The findings suggest that [E1]M1[/E1] muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the [E2]muscarinic receptor[/E2]-mediated enhancement of IL-2 production.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "M1", "entity_1_idx": [[26, 28]], "entity_1_idx_in_text_with_entity_marker": [30, 32], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "muscarinic receptor", "entity_2_idx": [[358, 377]], "entity_2_idx_in_text_with_entity_marker": [371, 390], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d613.s0_BioInfer.d613.s0.p16", "text": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "text_with_entity_marker": "The findings suggest that [E1]M1[/E1] muscarinic receptors are involved in [E2]muscarinic receptor[/E2]-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "M1", "entity_1_idx": [[26, 28]], "entity_1_idx_in_text_with_entity_marker": [30, 32], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "muscarinic receptor", "entity_2_idx": [[66, 85]], "entity_2_idx_in_text_with_entity_marker": [79, 98], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d613.s0_BioInfer.d613.s0.p17", "text": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "text_with_entity_marker": "The findings suggest that [E1]M1[/E1] muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 [E2]MAPK[/E2], may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "M1", "entity_1_idx": [[26, 28]], "entity_1_idx_in_text_with_entity_marker": [30, 32], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "MAPK", "entity_2_idx": [[329, 333]], "entity_2_idx_in_text_with_entity_marker": [342, 346], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d613.s0_BioInfer.d613.s0.p18", "text": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "text_with_entity_marker": "The findings suggest that [E1]M1[/E1] muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/[E2]extracellular signal regulated protein kinase[/E2] and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "M1", "entity_1_idx": [[26, 28]], "entity_1_idx_in_text_with_entity_marker": [30, 32], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "extracellular signal regulated protein kinase", "entity_2_idx": [[238, 283]], "entity_2_idx_in_text_with_entity_marker": [251, 296], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d613.s0_BioInfer.d613.s0.p19", "text": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "text_with_entity_marker": "The findings suggest that [E1]M1[/E1] muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase ([E2]MAPK[/E2])/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "M1", "entity_1_idx": [[26, 28]], "entity_1_idx_in_text_with_entity_marker": [30, 32], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "MAPK", "entity_2_idx": [[232, 236]], "entity_2_idx_in_text_with_entity_marker": [245, 249], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d281.s0_BioInfer.d281.s0.p0", "text": "Human profilins are multifunctional, single-domain proteins which directly link the actin microfilament system to a variety of signalling pathways via two spatially distinct binding sites.", "text_with_entity_marker": "Human [E1]profilins[/E1] are multifunctional, single-domain proteins which directly link the [E2]actin[/E2] microfilament system to a variety of signalling pathways via two spatially distinct binding sites.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilins", "entity_1_idx": [[6, 15]], "entity_1_idx_in_text_with_entity_marker": [10, 19], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[84, 89]], "entity_2_idx_in_text_with_entity_marker": [97, 102], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d270.s0_BioInfer.d270.s0.p0", "text": "However, increases were also selective in nature, with increases in certain individual proteins, including actin (twofold to threefold), vimentin (2.5-fold to sevenfold), tropomyosin (threefold to sixfold), and myosin heavy chain, far exceeding overall increases in cellular protein content (20-40%).", "text_with_entity_marker": "However, increases were also selective in nature, with increases in certain individual proteins, including [E1]actin[/E1] (twofold to threefold), vimentin (2.5-fold to sevenfold), [E2]tropomyosin[/E2] (threefold to sixfold), and myosin heavy chain, far exceeding overall increases in cellular protein content (20-40%).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[107, 112]], "entity_1_idx_in_text_with_entity_marker": [111, 116], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "tropomyosin", "entity_2_idx": [[171, 182]], "entity_2_idx_in_text_with_entity_marker": [184, 195], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d270.s0_BioInfer.d270.s0.p1", "text": "However, increases were also selective in nature, with increases in certain individual proteins, including actin (twofold to threefold), vimentin (2.5-fold to sevenfold), tropomyosin (threefold to sixfold), and myosin heavy chain, far exceeding overall increases in cellular protein content (20-40%).", "text_with_entity_marker": "However, increases were also selective in nature, with increases in certain individual proteins, including [E1]actin[/E1] (twofold to threefold), [E2]vimentin[/E2] (2.5-fold to sevenfold), tropomyosin (threefold to sixfold), and myosin heavy chain, far exceeding overall increases in cellular protein content (20-40%).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[107, 112]], "entity_1_idx_in_text_with_entity_marker": [111, 116], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "vimentin", "entity_2_idx": [[137, 145]], "entity_2_idx_in_text_with_entity_marker": [150, 158], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d270.s0_BioInfer.d270.s0.p2", "text": "However, increases were also selective in nature, with increases in certain individual proteins, including actin (twofold to threefold), vimentin (2.5-fold to sevenfold), tropomyosin (threefold to sixfold), and myosin heavy chain, far exceeding overall increases in cellular protein content (20-40%).", "text_with_entity_marker": "However, increases were also selective in nature, with increases in certain individual proteins, including [E1]actin[/E1] (twofold to threefold), vimentin (2.5-fold to sevenfold), tropomyosin (threefold to sixfold), and [E2]myosin heavy chain[/E2], far exceeding overall increases in cellular protein content (20-40%).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[107, 112]], "entity_1_idx_in_text_with_entity_marker": [111, 116], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin heavy chain", "entity_2_idx": [[211, 229]], "entity_2_idx_in_text_with_entity_marker": [224, 242], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d270.s0_BioInfer.d270.s0.p3", "text": "However, increases were also selective in nature, with increases in certain individual proteins, including actin (twofold to threefold), vimentin (2.5-fold to sevenfold), tropomyosin (threefold to sixfold), and myosin heavy chain, far exceeding overall increases in cellular protein content (20-40%).", "text_with_entity_marker": "However, increases were also selective in nature, with increases in certain individual proteins, including actin (twofold to threefold), [E1]vimentin[/E1] (2.5-fold to sevenfold), [E2]tropomyosin[/E2] (threefold to sixfold), and myosin heavy chain, far exceeding overall increases in cellular protein content (20-40%).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "vimentin", "entity_1_idx": [[137, 145]], "entity_1_idx_in_text_with_entity_marker": [141, 149], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "tropomyosin", "entity_2_idx": [[171, 182]], "entity_2_idx_in_text_with_entity_marker": [184, 195], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d270.s0_BioInfer.d270.s0.p4", "text": "However, increases were also selective in nature, with increases in certain individual proteins, including actin (twofold to threefold), vimentin (2.5-fold to sevenfold), tropomyosin (threefold to sixfold), and myosin heavy chain, far exceeding overall increases in cellular protein content (20-40%).", "text_with_entity_marker": "However, increases were also selective in nature, with increases in certain individual proteins, including actin (twofold to threefold), vimentin (2.5-fold to sevenfold), [E1]tropomyosin[/E1] (threefold to sixfold), and [E2]myosin heavy chain[/E2], far exceeding overall increases in cellular protein content (20-40%).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "tropomyosin", "entity_1_idx": [[171, 182]], "entity_1_idx_in_text_with_entity_marker": [175, 186], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin heavy chain", "entity_2_idx": [[211, 229]], "entity_2_idx_in_text_with_entity_marker": [224, 242], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d270.s0_BioInfer.d270.s0.p5", "text": "However, increases were also selective in nature, with increases in certain individual proteins, including actin (twofold to threefold), vimentin (2.5-fold to sevenfold), tropomyosin (threefold to sixfold), and myosin heavy chain, far exceeding overall increases in cellular protein content (20-40%).", "text_with_entity_marker": "However, increases were also selective in nature, with increases in certain individual proteins, including actin (twofold to threefold), [E1]vimentin[/E1] (2.5-fold to sevenfold), tropomyosin (threefold to sixfold), and [E2]myosin heavy chain[/E2], far exceeding overall increases in cellular protein content (20-40%).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "vimentin", "entity_1_idx": [[137, 145]], "entity_1_idx_in_text_with_entity_marker": [141, 149], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin heavy chain", "entity_2_idx": [[211, 229]], "entity_2_idx_in_text_with_entity_marker": [224, 242], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p60", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen ([E1]EMA[/E1]), S-100 protein, [E2]vimentin[/E2] CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "EMA", "entity_1_idx": [[111, 114]], "entity_1_idx_in_text_with_entity_marker": [115, 118], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vimentin", "entity_2_idx": [[132, 140]], "entity_2_idx_in_text_with_entity_marker": [145, 153], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p61", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen ([E1]EMA[/E1]), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, [E2]smooth muscle myosin heavy chain[/E2], calponin, and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "EMA", "entity_1_idx": [[111, 114]], "entity_1_idx_in_text_with_entity_marker": [115, 118], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "smooth muscle myosin heavy chain", "entity_2_idx": [[186, 218]], "entity_2_idx_in_text_with_entity_marker": [199, 231], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p62", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen ([E1]EMA[/E1]), S-100 protein, vimentin CD34, type IV collagen, [E2]smooth muscle actin[/E2], smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "EMA", "entity_1_idx": [[111, 114]], "entity_1_idx_in_text_with_entity_marker": [115, 118], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "smooth muscle actin", "entity_2_idx": [[165, 184]], "entity_2_idx_in_text_with_entity_marker": [178, 197], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p63", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen ([E1]EMA[/E1]), S-100 protein, vimentin [E2]CD34[/E2], type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "EMA", "entity_1_idx": [[111, 114]], "entity_1_idx_in_text_with_entity_marker": [115, 118], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CD34", "entity_2_idx": [[141, 145]], "entity_2_idx_in_text_with_entity_marker": [154, 158], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p64", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of [E1]cytokeratins[/E1] (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen ([E2]EMA[/E2]), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cytokeratins", "entity_1_idx": [[38, 50], [77, 79]], "entity_1_idx_in_text_with_entity_marker": [42, 54], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "EMA", "entity_2_idx": [[111, 114]], "entity_2_idx_in_text_with_entity_marker": [124, 127], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p65", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of [E1]cytokeratins[/E1] (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen ([E2]EMA[/E2]), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cytokeratins", "entity_1_idx": [[38, 50], [70, 71]], "entity_1_idx_in_text_with_entity_marker": [42, 54], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "EMA", "entity_2_idx": [[111, 114]], "entity_2_idx_in_text_with_entity_marker": [124, 127], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p66", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen ([E1]EMA[/E1]), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, [E2]calponin[/E2], and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "EMA", "entity_1_idx": [[111, 114]], "entity_1_idx_in_text_with_entity_marker": [115, 118], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "calponin", "entity_2_idx": [[220, 228]], "entity_2_idx_in_text_with_entity_marker": [233, 241], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p67", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of cytokeratins ([E1]CKs[/E1]) (8/18, 1/10, 7, and 20), epithelial membrane antigen ([E2]EMA[/E2]), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CKs", "entity_1_idx": [[52, 55]], "entity_1_idx_in_text_with_entity_marker": [56, 59], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "EMA", "entity_2_idx": [[111, 114]], "entity_2_idx_in_text_with_entity_marker": [124, 127], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p68", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of [E1]cytokeratins[/E1] (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen ([E2]EMA[/E2]), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cytokeratins", "entity_1_idx": [[38, 50], [66, 68]], "entity_1_idx_in_text_with_entity_marker": [42, 54], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "EMA", "entity_2_idx": [[111, 114]], "entity_2_idx_in_text_with_entity_marker": [124, 127], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p69", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of [E1]cytokeratins[/E1] (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen ([E2]EMA[/E2]), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cytokeratins", "entity_1_idx": [[38, 50], [60, 62]], "entity_1_idx_in_text_with_entity_marker": [42, 54], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "EMA", "entity_2_idx": [[111, 114]], "entity_2_idx_in_text_with_entity_marker": [124, 127], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p120", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of [E1]cytokeratins[/E1] (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin [E2]CD34[/E2], type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cytokeratins", "entity_1_idx": [[38, 50], [60, 62]], "entity_1_idx_in_text_with_entity_marker": [42, 54], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CD34", "entity_2_idx": [[141, 145]], "entity_2_idx_in_text_with_entity_marker": [154, 158], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p121", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of [E1-E2]cytokeratins[/E1-E2] (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cytokeratins", "entity_1_idx": [[38, 50], [70, 71]], "entity_1_idx_in_text_with_entity_marker": [45, 57], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "cytokeratins", "entity_2_idx": [[38, 50], [77, 79]], "entity_2_idx_in_text_with_entity_marker": [45, 57], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p122", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of [E1]cytokeratins[/E1] (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, [E2]calponin[/E2], and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cytokeratins", "entity_1_idx": [[38, 50], [77, 79]], "entity_1_idx_in_text_with_entity_marker": [42, 54], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "calponin", "entity_2_idx": [[220, 228]], "entity_2_idx_in_text_with_entity_marker": [233, 241], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p123", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of [E1]cytokeratins[/E1] ([E2]CKs[/E2]) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cytokeratins", "entity_1_idx": [[38, 50], [77, 79]], "entity_1_idx_in_text_with_entity_marker": [42, 54], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "CKs", "entity_2_idx": [[52, 55]], "entity_2_idx_in_text_with_entity_marker": [65, 68], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p124", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of [E1-E2]cytokeratins[/E1-E2] (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cytokeratins", "entity_1_idx": [[38, 50], [66, 68]], "entity_1_idx_in_text_with_entity_marker": [45, 57], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cytokeratins", "entity_2_idx": [[38, 50], [77, 79]], "entity_2_idx_in_text_with_entity_marker": [45, 57], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p125", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of [E1-E2]cytokeratins[/E1-E2] (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cytokeratins", "entity_1_idx": [[38, 50], [60, 62]], "entity_1_idx_in_text_with_entity_marker": [45, 57], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cytokeratins", "entity_2_idx": [[38, 50], [77, 79]], "entity_2_idx_in_text_with_entity_marker": [45, 57], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p126", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of [E1]cytokeratins[/E1] (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, [E2]calponin[/E2], and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cytokeratins", "entity_1_idx": [[38, 50], [70, 71]], "entity_1_idx_in_text_with_entity_marker": [42, 54], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "calponin", "entity_2_idx": [[220, 228]], "entity_2_idx_in_text_with_entity_marker": [233, 241], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p127", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of [E1]cytokeratins[/E1] ([E2]CKs[/E2]) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cytokeratins", "entity_1_idx": [[38, 50], [70, 71]], "entity_1_idx_in_text_with_entity_marker": [42, 54], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "CKs", "entity_2_idx": [[52, 55]], "entity_2_idx_in_text_with_entity_marker": [65, 68], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p128", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of [E1-E2]cytokeratins[/E1-E2] (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cytokeratins", "entity_1_idx": [[38, 50], [66, 68]], "entity_1_idx_in_text_with_entity_marker": [45, 57], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cytokeratins", "entity_2_idx": [[38, 50], [70, 71]], "entity_2_idx_in_text_with_entity_marker": [45, 57], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p129", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of [E1-E2]cytokeratins[/E1-E2] (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cytokeratins", "entity_1_idx": [[38, 50], [60, 62]], "entity_1_idx_in_text_with_entity_marker": [45, 57], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cytokeratins", "entity_2_idx": [[38, 50], [70, 71]], "entity_2_idx_in_text_with_entity_marker": [45, 57], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d692.s0_BioInfer.d692.s0.p0", "text": "The Schizosaccharomyces pombe rhp51+, rad22+ and rhp54+ genes are homologous to RAD51, RAD52 and RAD54 respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.", "text_with_entity_marker": "The Schizosaccharomyces pombe rhp51+, rad22+ and [E1]rhp54+[/E1] genes are homologous to RAD51, RAD52 and [E2]RAD54[/E2] respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "rhp54+", "entity_1_idx": [[49, 55]], "entity_1_idx_in_text_with_entity_marker": [53, 59], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "RAD54", "entity_2_idx": [[97, 102]], "entity_2_idx_in_text_with_entity_marker": [110, 115], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d692.s0_BioInfer.d692.s0.p1", "text": "The Schizosaccharomyces pombe rhp51+, rad22+ and rhp54+ genes are homologous to RAD51, RAD52 and RAD54 respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.", "text_with_entity_marker": "The Schizosaccharomyces pombe rhp51+, rad22+ and [E1]rhp54+[/E1] genes are homologous to [E2]RAD51[/E2], RAD52 and RAD54 respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "rhp54+", "entity_1_idx": [[49, 55]], "entity_1_idx_in_text_with_entity_marker": [53, 59], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "RAD51", "entity_2_idx": [[80, 85]], "entity_2_idx_in_text_with_entity_marker": [93, 98], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d692.s0_BioInfer.d692.s0.p2", "text": "The Schizosaccharomyces pombe rhp51+, rad22+ and rhp54+ genes are homologous to RAD51, RAD52 and RAD54 respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.", "text_with_entity_marker": "The Schizosaccharomyces pombe rhp51+, [E1]rad22+[/E1] and [E2]rhp54+[/E2] genes are homologous to RAD51, RAD52 and RAD54 respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "rad22+", "entity_1_idx": [[38, 44]], "entity_1_idx_in_text_with_entity_marker": [42, 48], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "rhp54+", "entity_2_idx": [[49, 55]], "entity_2_idx_in_text_with_entity_marker": [62, 68], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d692.s0_BioInfer.d692.s0.p3", "text": "The Schizosaccharomyces pombe rhp51+, rad22+ and rhp54+ genes are homologous to RAD51, RAD52 and RAD54 respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.", "text_with_entity_marker": "The Schizosaccharomyces pombe [E1]rhp51+[/E1], rad22+ and [E2]rhp54+[/E2] genes are homologous to RAD51, RAD52 and RAD54 respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "rhp51+", "entity_1_idx": [[30, 36]], "entity_1_idx_in_text_with_entity_marker": [34, 40], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "rhp54+", "entity_2_idx": [[49, 55]], "entity_2_idx_in_text_with_entity_marker": [62, 68], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d692.s0_BioInfer.d692.s0.p4", "text": "The Schizosaccharomyces pombe rhp51+, rad22+ and rhp54+ genes are homologous to RAD51, RAD52 and RAD54 respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.", "text_with_entity_marker": "The Schizosaccharomyces pombe rhp51+, rad22+ and [E1]rhp54+[/E1] genes are homologous to RAD51, [E2]RAD52[/E2] and RAD54 respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "rhp54+", "entity_1_idx": [[49, 55]], "entity_1_idx_in_text_with_entity_marker": [53, 59], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "RAD52", "entity_2_idx": [[87, 92]], "entity_2_idx_in_text_with_entity_marker": [100, 105], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d692.s0_BioInfer.d692.s0.p5", "text": "The Schizosaccharomyces pombe rhp51+, rad22+ and rhp54+ genes are homologous to RAD51, RAD52 and RAD54 respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.", "text_with_entity_marker": "The Schizosaccharomyces pombe rhp51+, rad22+ and rhp54+ genes are homologous to [E1]RAD51[/E1], RAD52 and [E2]RAD54[/E2] respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD51", "entity_1_idx": [[80, 85]], "entity_1_idx_in_text_with_entity_marker": [84, 89], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "RAD54", "entity_2_idx": [[97, 102]], "entity_2_idx_in_text_with_entity_marker": [110, 115], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d692.s0_BioInfer.d692.s0.p6", "text": "The Schizosaccharomyces pombe rhp51+, rad22+ and rhp54+ genes are homologous to RAD51, RAD52 and RAD54 respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.", "text_with_entity_marker": "The Schizosaccharomyces pombe rhp51+, [E1]rad22+[/E1] and rhp54+ genes are homologous to RAD51, RAD52 and [E2]RAD54[/E2] respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "rad22+", "entity_1_idx": [[38, 44]], "entity_1_idx_in_text_with_entity_marker": [42, 48], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "RAD54", "entity_2_idx": [[97, 102]], "entity_2_idx_in_text_with_entity_marker": [110, 115], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d692.s0_BioInfer.d692.s0.p7", "text": "The Schizosaccharomyces pombe rhp51+, rad22+ and rhp54+ genes are homologous to RAD51, RAD52 and RAD54 respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.", "text_with_entity_marker": "The Schizosaccharomyces pombe [E1]rhp51+[/E1], rad22+ and rhp54+ genes are homologous to RAD51, RAD52 and [E2]RAD54[/E2] respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "rhp51+", "entity_1_idx": [[30, 36]], "entity_1_idx_in_text_with_entity_marker": [34, 40], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "RAD54", "entity_2_idx": [[97, 102]], "entity_2_idx_in_text_with_entity_marker": [110, 115], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d692.s0_BioInfer.d692.s0.p8", "text": "The Schizosaccharomyces pombe rhp51+, rad22+ and rhp54+ genes are homologous to RAD51, RAD52 and RAD54 respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.", "text_with_entity_marker": "The Schizosaccharomyces pombe rhp51+, rad22+ and rhp54+ genes are homologous to RAD51, [E1]RAD52[/E1] and [E2]RAD54[/E2] respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD52", "entity_1_idx": [[87, 92]], "entity_1_idx_in_text_with_entity_marker": [91, 96], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "RAD54", "entity_2_idx": [[97, 102]], "entity_2_idx_in_text_with_entity_marker": [110, 115], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d692.s0_BioInfer.d692.s0.p9", "text": "The Schizosaccharomyces pombe rhp51+, rad22+ and rhp54+ genes are homologous to RAD51, RAD52 and RAD54 respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.", "text_with_entity_marker": "The Schizosaccharomyces pombe rhp51+, [E1]rad22+[/E1] and rhp54+ genes are homologous to [E2]RAD51[/E2], RAD52 and RAD54 respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "rad22+", "entity_1_idx": [[38, 44]], "entity_1_idx_in_text_with_entity_marker": [42, 48], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "RAD51", "entity_2_idx": [[80, 85]], "entity_2_idx_in_text_with_entity_marker": [93, 98], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d692.s0_BioInfer.d692.s0.p10", "text": "The Schizosaccharomyces pombe rhp51+, rad22+ and rhp54+ genes are homologous to RAD51, RAD52 and RAD54 respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.", "text_with_entity_marker": "The Schizosaccharomyces pombe [E1]rhp51+[/E1], rad22+ and rhp54+ genes are homologous to [E2]RAD51[/E2], RAD52 and RAD54 respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "rhp51+", "entity_1_idx": [[30, 36]], "entity_1_idx_in_text_with_entity_marker": [34, 40], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "RAD51", "entity_2_idx": [[80, 85]], "entity_2_idx_in_text_with_entity_marker": [93, 98], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d692.s0_BioInfer.d692.s0.p11", "text": "The Schizosaccharomyces pombe rhp51+, rad22+ and rhp54+ genes are homologous to RAD51, RAD52 and RAD54 respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.", "text_with_entity_marker": "The Schizosaccharomyces pombe rhp51+, rad22+ and rhp54+ genes are homologous to [E1]RAD51[/E1], [E2]RAD52[/E2] and RAD54 respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD51", "entity_1_idx": [[80, 85]], "entity_1_idx_in_text_with_entity_marker": [84, 89], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "RAD52", "entity_2_idx": [[87, 92]], "entity_2_idx_in_text_with_entity_marker": [100, 105], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d692.s0_BioInfer.d692.s0.p12", "text": "The Schizosaccharomyces pombe rhp51+, rad22+ and rhp54+ genes are homologous to RAD51, RAD52 and RAD54 respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.", "text_with_entity_marker": "The Schizosaccharomyces pombe [E1]rhp51+[/E1], [E2]rad22+[/E2] and rhp54+ genes are homologous to RAD51, RAD52 and RAD54 respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "rhp51+", "entity_1_idx": [[30, 36]], "entity_1_idx_in_text_with_entity_marker": [34, 40], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "rad22+", "entity_2_idx": [[38, 44]], "entity_2_idx_in_text_with_entity_marker": [51, 57], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d692.s0_BioInfer.d692.s0.p13", "text": "The Schizosaccharomyces pombe rhp51+, rad22+ and rhp54+ genes are homologous to RAD51, RAD52 and RAD54 respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.", "text_with_entity_marker": "The Schizosaccharomyces pombe rhp51+, [E1]rad22+[/E1] and rhp54+ genes are homologous to RAD51, [E2]RAD52[/E2] and RAD54 respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "rad22+", "entity_1_idx": [[38, 44]], "entity_1_idx_in_text_with_entity_marker": [42, 48], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "RAD52", "entity_2_idx": [[87, 92]], "entity_2_idx_in_text_with_entity_marker": [100, 105], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d692.s0_BioInfer.d692.s0.p14", "text": "The Schizosaccharomyces pombe rhp51+, rad22+ and rhp54+ genes are homologous to RAD51, RAD52 and RAD54 respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.", "text_with_entity_marker": "The Schizosaccharomyces pombe [E1]rhp51+[/E1], rad22+ and rhp54+ genes are homologous to RAD51, [E2]RAD52[/E2] and RAD54 respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "rhp51+", "entity_1_idx": [[30, 36]], "entity_1_idx_in_text_with_entity_marker": [34, 40], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "RAD52", "entity_2_idx": [[87, 92]], "entity_2_idx_in_text_with_entity_marker": [100, 105], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d834.s0_BioInfer.d834.s0.p0", "text": "Within the sieve-tube exudate, profilin was present in 15-fold molar excess to actin.", "text_with_entity_marker": "Within the sieve-tube exudate, [E1]profilin[/E1] was present in 15-fold molar excess to [E2]actin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[31, 39]], "entity_1_idx_in_text_with_entity_marker": [35, 43], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[79, 84]], "entity_2_idx_in_text_with_entity_marker": [92, 97], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d770.s0_BioInfer.d770.s0.p0", "text": "Total actin and myosin heavy chain mRNAs, and polyadenylated RNA, were determined using slot-blot assays.", "text_with_entity_marker": "Total [E1]actin[/E1] and [E2]myosin heavy chain[/E2] mRNAs, and polyadenylated RNA, were determined using slot-blot assays.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[6, 11]], "entity_1_idx_in_text_with_entity_marker": [10, 15], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin heavy chain", "entity_2_idx": [[16, 34]], "entity_2_idx_in_text_with_entity_marker": [29, 47], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d404.s0_BioInfer.d404.s0.p0", "text": "Like the spectrin alpha-chain, the major central part of the spectrin beta-chain is made up of repeat units of 106 amino-acids.", "text_with_entity_marker": "Like the [E1]spectrin alpha-chain[/E1], the major central part of the [E2]spectrin beta-chain[/E2] is made up of repeat units of 106 amino-acids.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "spectrin alpha-chain", "entity_1_idx": [[9, 29]], "entity_1_idx_in_text_with_entity_marker": [13, 33], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "spectrin beta-chain", "entity_2_idx": [[61, 80]], "entity_2_idx_in_text_with_entity_marker": [74, 93], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d744.s0_BioInfer.d744.s0.p0", "text": "This process involves other actin-binding proteins, such as cofilin and coronin.", "text_with_entity_marker": "This process involves other [E1]actin-binding proteins[/E1], such as cofilin and [E2]coronin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin-binding proteins", "entity_1_idx": [[28, 50]], "entity_1_idx_in_text_with_entity_marker": [32, 54], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "coronin", "entity_2_idx": [[72, 79]], "entity_2_idx_in_text_with_entity_marker": [85, 92], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d744.s0_BioInfer.d744.s0.p1", "text": "This process involves other actin-binding proteins, such as cofilin and coronin.", "text_with_entity_marker": "This process involves other actin-binding proteins, such as [E1]cofilin[/E1] and [E2]coronin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[60, 67]], "entity_1_idx_in_text_with_entity_marker": [64, 71], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "coronin", "entity_2_idx": [[72, 79]], "entity_2_idx_in_text_with_entity_marker": [85, 92], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d744.s0_BioInfer.d744.s0.p2", "text": "This process involves other actin-binding proteins, such as cofilin and coronin.", "text_with_entity_marker": "This process involves other [E1]actin-binding proteins[/E1], such as [E2]cofilin[/E2] and coronin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin-binding proteins", "entity_1_idx": [[28, 50]], "entity_1_idx_in_text_with_entity_marker": [32, 54], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "cofilin", "entity_2_idx": [[60, 67]], "entity_2_idx_in_text_with_entity_marker": [73, 80], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p60", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein ([E1]M[/E1]) gene sequences; another, M and [E2]fusion protein[/E2] (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "M", "entity_1_idx": [[252, 253]], "entity_1_idx_in_text_with_entity_marker": [256, 257], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "fusion protein", "entity_2_idx": [[286, 300]], "entity_2_idx_in_text_with_entity_marker": [299, 313], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p61", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein ([E1]M[/E1]) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein ([E2]HN[/E2]) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "M", "entity_1_idx": [[252, 253]], "entity_1_idx_in_text_with_entity_marker": [256, 257], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "HN", "entity_2_idx": [[379, 381]], "entity_2_idx_in_text_with_entity_marker": [392, 394], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p62", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein ([E1]M[/E1]) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and [E2]hemagglutinin-neuraminidase protein[/E2] (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "M", "entity_1_idx": [[252, 253]], "entity_1_idx_in_text_with_entity_marker": [256, 257], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "hemagglutinin-neuraminidase protein", "entity_2_idx": [[342, 377]], "entity_2_idx_in_text_with_entity_marker": [355, 390], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p63", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein ([E1]P[/E1]) gene sequences; another, P and [E2]membrane protein[/E2] (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "P", "entity_1_idx": [[200, 201]], "entity_1_idx_in_text_with_entity_marker": [204, 205], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "membrane protein", "entity_2_idx": [[234, 250]], "entity_2_idx_in_text_with_entity_marker": [247, 263], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p64", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein ([E1]P[/E1]) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein ([E2]F0[/E2]) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "P", "entity_1_idx": [[200, 201]], "entity_1_idx_in_text_with_entity_marker": [204, 205], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "F0", "entity_2_idx": [[302, 304]], "entity_2_idx_in_text_with_entity_marker": [315, 317], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p65", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein ([E1]P[/E1]) gene sequences; another, P and membrane protein (M) gene sequences; another, M and [E2]fusion protein[/E2] (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "P", "entity_1_idx": [[200, 201]], "entity_1_idx_in_text_with_entity_marker": [204, 205], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "fusion protein", "entity_2_idx": [[286, 300]], "entity_2_idx_in_text_with_entity_marker": [299, 313], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p66", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein ([E1]P[/E1]) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein ([E2]HN[/E2]) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "P", "entity_1_idx": [[200, 201]], "entity_1_idx_in_text_with_entity_marker": [204, 205], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "HN", "entity_2_idx": [[379, 381]], "entity_2_idx_in_text_with_entity_marker": [392, 394], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p67", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein ([E1]P[/E1]) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and [E2]hemagglutinin-neuraminidase protein[/E2] (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "P", "entity_1_idx": [[200, 201]], "entity_1_idx_in_text_with_entity_marker": [204, 205], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "hemagglutinin-neuraminidase protein", "entity_2_idx": [[342, 377]], "entity_2_idx_in_text_with_entity_marker": [355, 390], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p68", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and [E1]membrane protein[/E1] (M) gene sequences; another, M and fusion protein ([E2]F0[/E2]) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "membrane protein", "entity_1_idx": [[234, 250]], "entity_1_idx_in_text_with_entity_marker": [238, 254], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "F0", "entity_2_idx": [[302, 304]], "entity_2_idx_in_text_with_entity_marker": [315, 317], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p69", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and [E1]membrane protein[/E1] (M) gene sequences; another, M and [E2]fusion protein[/E2] (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "membrane protein", "entity_1_idx": [[234, 250]], "entity_1_idx_in_text_with_entity_marker": [238, 254], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "fusion protein", "entity_2_idx": [[286, 300]], "entity_2_idx_in_text_with_entity_marker": [299, 313], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d563.s0_BioInfer.d563.s0.p0", "text": "The actin cytoskeleton-associated protein talin binds to integrins, vinculin, and actin.", "text_with_entity_marker": "The [E1]actin[/E1] cytoskeleton-associated protein [E2]talin[/E2] binds to integrins, vinculin, and actin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[4, 9]], "entity_1_idx_in_text_with_entity_marker": [8, 13], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[42, 47]], "entity_2_idx_in_text_with_entity_marker": [55, 60], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d563.s0_BioInfer.d563.s0.p1", "text": "The actin cytoskeleton-associated protein talin binds to integrins, vinculin, and actin.", "text_with_entity_marker": "The [E1]actin[/E1] cytoskeleton-associated protein talin binds to [E2]integrins[/E2], vinculin, and actin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[4, 9]], "entity_1_idx_in_text_with_entity_marker": [8, 13], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "integrins", "entity_2_idx": [[57, 66]], "entity_2_idx_in_text_with_entity_marker": [70, 79], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d563.s0_BioInfer.d563.s0.p2", "text": "The actin cytoskeleton-associated protein talin binds to integrins, vinculin, and actin.", "text_with_entity_marker": "The [E1]actin[/E1] cytoskeleton-associated protein talin binds to integrins, [E2]vinculin[/E2], and actin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[4, 9]], "entity_1_idx_in_text_with_entity_marker": [8, 13], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vinculin", "entity_2_idx": [[68, 76]], "entity_2_idx_in_text_with_entity_marker": [81, 89], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d563.s0_BioInfer.d563.s0.p3", "text": "The actin cytoskeleton-associated protein talin binds to integrins, vinculin, and actin.", "text_with_entity_marker": "The [E1]actin[/E1] cytoskeleton-associated protein talin binds to integrins, vinculin, and [E2]actin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[4, 9]], "entity_1_idx_in_text_with_entity_marker": [8, 13], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[82, 87]], "entity_2_idx_in_text_with_entity_marker": [95, 100], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d563.s0_BioInfer.d563.s0.p4", "text": "The actin cytoskeleton-associated protein talin binds to integrins, vinculin, and actin.", "text_with_entity_marker": "The actin cytoskeleton-associated protein [E1]talin[/E1] binds to [E2]integrins[/E2], vinculin, and actin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "talin", "entity_1_idx": [[42, 47]], "entity_1_idx_in_text_with_entity_marker": [46, 51], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "integrins", "entity_2_idx": [[57, 66]], "entity_2_idx_in_text_with_entity_marker": [70, 79], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d563.s0_BioInfer.d563.s0.p5", "text": "The actin cytoskeleton-associated protein talin binds to integrins, vinculin, and actin.", "text_with_entity_marker": "The actin cytoskeleton-associated protein [E1]talin[/E1] binds to integrins, [E2]vinculin[/E2], and actin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "talin", "entity_1_idx": [[42, 47]], "entity_1_idx_in_text_with_entity_marker": [46, 51], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vinculin", "entity_2_idx": [[68, 76]], "entity_2_idx_in_text_with_entity_marker": [81, 89], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d563.s0_BioInfer.d563.s0.p6", "text": "The actin cytoskeleton-associated protein talin binds to integrins, vinculin, and actin.", "text_with_entity_marker": "The actin cytoskeleton-associated protein [E1]talin[/E1] binds to integrins, vinculin, and [E2]actin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "talin", "entity_1_idx": [[42, 47]], "entity_1_idx_in_text_with_entity_marker": [46, 51], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[82, 87]], "entity_2_idx_in_text_with_entity_marker": [95, 100], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d563.s0_BioInfer.d563.s0.p7", "text": "The actin cytoskeleton-associated protein talin binds to integrins, vinculin, and actin.", "text_with_entity_marker": "The actin cytoskeleton-associated protein talin binds to [E1]integrins[/E1], [E2]vinculin[/E2], and actin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "integrins", "entity_1_idx": [[57, 66]], "entity_1_idx_in_text_with_entity_marker": [61, 70], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vinculin", "entity_2_idx": [[68, 76]], "entity_2_idx_in_text_with_entity_marker": [81, 89], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d563.s0_BioInfer.d563.s0.p8", "text": "The actin cytoskeleton-associated protein talin binds to integrins, vinculin, and actin.", "text_with_entity_marker": "The actin cytoskeleton-associated protein talin binds to [E1]integrins[/E1], vinculin, and [E2]actin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "integrins", "entity_1_idx": [[57, 66]], "entity_1_idx_in_text_with_entity_marker": [61, 70], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[82, 87]], "entity_2_idx_in_text_with_entity_marker": [95, 100], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d563.s0_BioInfer.d563.s0.p9", "text": "The actin cytoskeleton-associated protein talin binds to integrins, vinculin, and actin.", "text_with_entity_marker": "The actin cytoskeleton-associated protein talin binds to integrins, [E1]vinculin[/E1], and [E2]actin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "vinculin", "entity_1_idx": [[68, 76]], "entity_1_idx_in_text_with_entity_marker": [72, 80], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[82, 87]], "entity_2_idx_in_text_with_entity_marker": [95, 100], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d525.s2_BioInfer.d525.s2.p11", "text": "To investigate the role of cofilin in EGF-stimulated actin polymerization and lamellipod extension in MTLn3 cells, we examined in detail the temporal and spatial distribution of cofilin relative to free barbed ends and characterized the actin dynamics by measuring the changes in the number of actin filaments.", "text_with_entity_marker": "To investigate the role of cofilin in [E1]EGF[/E1]-stimulated [E2]actin[/E2] polymerization and lamellipod extension in MTLn3 cells, we examined in detail the temporal and spatial distribution of cofilin relative to free barbed ends and characterized the actin dynamics by measuring the changes in the number of actin filaments.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "EGF", "entity_1_idx": [[38, 41]], "entity_1_idx_in_text_with_entity_marker": [42, 45], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[53, 58]], "entity_2_idx_in_text_with_entity_marker": [66, 71], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d525.s2_BioInfer.d525.s2.p12", "text": "To investigate the role of cofilin in EGF-stimulated actin polymerization and lamellipod extension in MTLn3 cells, we examined in detail the temporal and spatial distribution of cofilin relative to free barbed ends and characterized the actin dynamics by measuring the changes in the number of actin filaments.", "text_with_entity_marker": "To investigate the role of cofilin in EGF-stimulated actin polymerization and lamellipod extension in MTLn3 cells, we examined in detail the temporal and spatial distribution of [E1]cofilin[/E1] relative to free barbed ends and characterized the actin dynamics by measuring the changes in the number of [E2]actin[/E2] filaments.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[178, 185]], "entity_1_idx_in_text_with_entity_marker": [182, 189], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[294, 299]], "entity_2_idx_in_text_with_entity_marker": [307, 312], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d525.s2_BioInfer.d525.s2.p13", "text": "To investigate the role of cofilin in EGF-stimulated actin polymerization and lamellipod extension in MTLn3 cells, we examined in detail the temporal and spatial distribution of cofilin relative to free barbed ends and characterized the actin dynamics by measuring the changes in the number of actin filaments.", "text_with_entity_marker": "To investigate the role of cofilin in EGF-stimulated [E1]actin[/E1] polymerization and lamellipod extension in MTLn3 cells, we examined in detail the temporal and spatial distribution of cofilin relative to free barbed ends and characterized the actin dynamics by measuring the changes in the number of [E2]actin[/E2] filaments.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[53, 58]], "entity_1_idx_in_text_with_entity_marker": [57, 62], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[294, 299]], "entity_2_idx_in_text_with_entity_marker": [307, 312], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d525.s2_BioInfer.d525.s2.p14", "text": "To investigate the role of cofilin in EGF-stimulated actin polymerization and lamellipod extension in MTLn3 cells, we examined in detail the temporal and spatial distribution of cofilin relative to free barbed ends and characterized the actin dynamics by measuring the changes in the number of actin filaments.", "text_with_entity_marker": "To investigate the role of cofilin in EGF-stimulated [E1]actin[/E1] polymerization and lamellipod extension in MTLn3 cells, we examined in detail the temporal and spatial distribution of [E2]cofilin[/E2] relative to free barbed ends and characterized the actin dynamics by measuring the changes in the number of actin filaments.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[53, 58]], "entity_1_idx_in_text_with_entity_marker": [57, 62], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[178, 185]], "entity_2_idx_in_text_with_entity_marker": [191, 198], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d107.s0_BioInfer.d107.s0.p0", "text": "Neuropilin-1 mediates collapsin-1/semaphorin III inhibition of endothelial cell motility: functional competition of collapsin-1 and vascular endothelial growth factor-165.", "text_with_entity_marker": "Neuropilin-1 mediates [E1]collapsin-1[/E1]/semaphorin III inhibition of endothelial cell motility: functional competition of collapsin-1 and [E2]vascular endothelial growth factor-165[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "collapsin-1", "entity_1_idx": [[22, 33]], "entity_1_idx_in_text_with_entity_marker": [26, 37], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vascular endothelial growth factor-165", "entity_2_idx": [[132, 170]], "entity_2_idx_in_text_with_entity_marker": [145, 183], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d107.s0_BioInfer.d107.s0.p1", "text": "Neuropilin-1 mediates collapsin-1/semaphorin III inhibition of endothelial cell motility: functional competition of collapsin-1 and vascular endothelial growth factor-165.", "text_with_entity_marker": "Neuropilin-1 mediates [E1]collapsin-1[/E1]/[E2]semaphorin III[/E2] inhibition of endothelial cell motility: functional competition of collapsin-1 and vascular endothelial growth factor-165.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "collapsin-1", "entity_1_idx": [[22, 33]], "entity_1_idx_in_text_with_entity_marker": [26, 37], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "semaphorin III", "entity_2_idx": [[34, 48]], "entity_2_idx_in_text_with_entity_marker": [47, 61], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d107.s0_BioInfer.d107.s0.p2", "text": "Neuropilin-1 mediates collapsin-1/semaphorin III inhibition of endothelial cell motility: functional competition of collapsin-1 and vascular endothelial growth factor-165.", "text_with_entity_marker": "[E1]Neuropilin-1[/E1] mediates [E2]collapsin-1[/E2]/semaphorin III inhibition of endothelial cell motility: functional competition of collapsin-1 and vascular endothelial growth factor-165.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Neuropilin-1", "entity_1_idx": [[0, 12]], "entity_1_idx_in_text_with_entity_marker": [4, 16], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "collapsin-1", "entity_2_idx": [[22, 33]], "entity_2_idx_in_text_with_entity_marker": [35, 46], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d107.s0_BioInfer.d107.s0.p3", "text": "Neuropilin-1 mediates collapsin-1/semaphorin III inhibition of endothelial cell motility: functional competition of collapsin-1 and vascular endothelial growth factor-165.", "text_with_entity_marker": "Neuropilin-1 mediates [E1]collapsin-1[/E1]/semaphorin III inhibition of endothelial cell motility: functional competition of [E2]collapsin-1[/E2] and vascular endothelial growth factor-165.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "collapsin-1", "entity_1_idx": [[22, 33]], "entity_1_idx_in_text_with_entity_marker": [26, 37], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "collapsin-1", "entity_2_idx": [[116, 127]], "entity_2_idx_in_text_with_entity_marker": [129, 140], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d107.s0_BioInfer.d107.s0.p4", "text": "Neuropilin-1 mediates collapsin-1/semaphorin III inhibition of endothelial cell motility: functional competition of collapsin-1 and vascular endothelial growth factor-165.", "text_with_entity_marker": "Neuropilin-1 mediates collapsin-1/[E1]semaphorin III[/E1] inhibition of endothelial cell motility: functional competition of collapsin-1 and [E2]vascular endothelial growth factor-165[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "semaphorin III", "entity_1_idx": [[34, 48]], "entity_1_idx_in_text_with_entity_marker": [38, 52], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vascular endothelial growth factor-165", "entity_2_idx": [[132, 170]], "entity_2_idx_in_text_with_entity_marker": [145, 183], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d107.s0_BioInfer.d107.s0.p5", "text": "Neuropilin-1 mediates collapsin-1/semaphorin III inhibition of endothelial cell motility: functional competition of collapsin-1 and vascular endothelial growth factor-165.", "text_with_entity_marker": "[E1]Neuropilin-1[/E1] mediates collapsin-1/semaphorin III inhibition of endothelial cell motility: functional competition of collapsin-1 and [E2]vascular endothelial growth factor-165[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Neuropilin-1", "entity_1_idx": [[0, 12]], "entity_1_idx_in_text_with_entity_marker": [4, 16], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vascular endothelial growth factor-165", "entity_2_idx": [[132, 170]], "entity_2_idx_in_text_with_entity_marker": [145, 183], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d107.s0_BioInfer.d107.s0.p6", "text": "Neuropilin-1 mediates collapsin-1/semaphorin III inhibition of endothelial cell motility: functional competition of collapsin-1 and vascular endothelial growth factor-165.", "text_with_entity_marker": "Neuropilin-1 mediates collapsin-1/semaphorin III inhibition of endothelial cell motility: functional competition of [E1]collapsin-1[/E1] and [E2]vascular endothelial growth factor-165[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "collapsin-1", "entity_1_idx": [[116, 127]], "entity_1_idx_in_text_with_entity_marker": [120, 131], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vascular endothelial growth factor-165", "entity_2_idx": [[132, 170]], "entity_2_idx_in_text_with_entity_marker": [145, 183], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d107.s0_BioInfer.d107.s0.p7", "text": "Neuropilin-1 mediates collapsin-1/semaphorin III inhibition of endothelial cell motility: functional competition of collapsin-1 and vascular endothelial growth factor-165.", "text_with_entity_marker": "[E1]Neuropilin-1[/E1] mediates collapsin-1/[E2]semaphorin III[/E2] inhibition of endothelial cell motility: functional competition of collapsin-1 and vascular endothelial growth factor-165.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Neuropilin-1", "entity_1_idx": [[0, 12]], "entity_1_idx_in_text_with_entity_marker": [4, 16], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "semaphorin III", "entity_2_idx": [[34, 48]], "entity_2_idx_in_text_with_entity_marker": [47, 61], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d107.s0_BioInfer.d107.s0.p8", "text": "Neuropilin-1 mediates collapsin-1/semaphorin III inhibition of endothelial cell motility: functional competition of collapsin-1 and vascular endothelial growth factor-165.", "text_with_entity_marker": "Neuropilin-1 mediates collapsin-1/[E1]semaphorin III[/E1] inhibition of endothelial cell motility: functional competition of [E2]collapsin-1[/E2] and vascular endothelial growth factor-165.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "semaphorin III", "entity_1_idx": [[34, 48]], "entity_1_idx_in_text_with_entity_marker": [38, 52], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "collapsin-1", "entity_2_idx": [[116, 127]], "entity_2_idx_in_text_with_entity_marker": [129, 140], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d107.s0_BioInfer.d107.s0.p9", "text": "Neuropilin-1 mediates collapsin-1/semaphorin III inhibition of endothelial cell motility: functional competition of collapsin-1 and vascular endothelial growth factor-165.", "text_with_entity_marker": "[E1]Neuropilin-1[/E1] mediates collapsin-1/semaphorin III inhibition of endothelial cell motility: functional competition of [E2]collapsin-1[/E2] and vascular endothelial growth factor-165.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Neuropilin-1", "entity_1_idx": [[0, 12]], "entity_1_idx_in_text_with_entity_marker": [4, 16], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "collapsin-1", "entity_2_idx": [[116, 127]], "entity_2_idx_in_text_with_entity_marker": [129, 140], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d620.s0_BioInfer.d620.s0.p0", "text": "The herpes simplex virus type-1 DNA helicase-primase is a heterotrimer encoded by the UL5, UL8, and UL52 genes.", "text_with_entity_marker": "The herpes simplex virus type-1 DNA helicase-primase is a heterotrimer encoded by the UL5, [E1]UL8[/E1], and [E2]UL52[/E2] genes.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL8", "entity_1_idx": [[91, 94]], "entity_1_idx_in_text_with_entity_marker": [95, 98], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "UL52", "entity_2_idx": [[100, 104]], "entity_2_idx_in_text_with_entity_marker": [113, 117], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d620.s0_BioInfer.d620.s0.p1", "text": "The herpes simplex virus type-1 DNA helicase-primase is a heterotrimer encoded by the UL5, UL8, and UL52 genes.", "text_with_entity_marker": "The herpes simplex virus type-1 [E1]DNA helicase-primase[/E1] is a heterotrimer encoded by the UL5, [E2]UL8[/E2], and UL52 genes.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "DNA helicase-primase", "entity_1_idx": [[32, 52]], "entity_1_idx_in_text_with_entity_marker": [36, 56], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "UL8", "entity_2_idx": [[91, 94]], "entity_2_idx_in_text_with_entity_marker": [104, 107], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d620.s0_BioInfer.d620.s0.p2", "text": "The herpes simplex virus type-1 DNA helicase-primase is a heterotrimer encoded by the UL5, UL8, and UL52 genes.", "text_with_entity_marker": "The herpes simplex virus type-1 DNA helicase-primase is a heterotrimer encoded by the [E1]UL5[/E1], [E2]UL8[/E2], and UL52 genes.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL5", "entity_1_idx": [[86, 89]], "entity_1_idx_in_text_with_entity_marker": [90, 93], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "UL8", "entity_2_idx": [[91, 94]], "entity_2_idx_in_text_with_entity_marker": [104, 107], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d620.s0_BioInfer.d620.s0.p3", "text": "The herpes simplex virus type-1 DNA helicase-primase is a heterotrimer encoded by the UL5, UL8, and UL52 genes.", "text_with_entity_marker": "The herpes simplex virus type-1 [E1]DNA helicase-primase[/E1] is a heterotrimer encoded by the UL5, UL8, and [E2]UL52[/E2] genes.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "DNA helicase-primase", "entity_1_idx": [[32, 52]], "entity_1_idx_in_text_with_entity_marker": [36, 56], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "UL52", "entity_2_idx": [[100, 104]], "entity_2_idx_in_text_with_entity_marker": [113, 117], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d620.s0_BioInfer.d620.s0.p4", "text": "The herpes simplex virus type-1 DNA helicase-primase is a heterotrimer encoded by the UL5, UL8, and UL52 genes.", "text_with_entity_marker": "The herpes simplex virus type-1 DNA helicase-primase is a heterotrimer encoded by the [E1]UL5[/E1], UL8, and [E2]UL52[/E2] genes.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL5", "entity_1_idx": [[86, 89]], "entity_1_idx_in_text_with_entity_marker": [90, 93], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "UL52", "entity_2_idx": [[100, 104]], "entity_2_idx_in_text_with_entity_marker": [113, 117], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d620.s0_BioInfer.d620.s0.p5", "text": "The herpes simplex virus type-1 DNA helicase-primase is a heterotrimer encoded by the UL5, UL8, and UL52 genes.", "text_with_entity_marker": "The herpes simplex virus type-1 [E1]DNA helicase-primase[/E1] is a heterotrimer encoded by the [E2]UL5[/E2], UL8, and UL52 genes.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "DNA helicase-primase", "entity_1_idx": [[32, 52]], "entity_1_idx_in_text_with_entity_marker": [36, 56], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "UL5", "entity_2_idx": [[86, 89]], "entity_2_idx_in_text_with_entity_marker": [99, 102], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p20", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: [E1]histone[/E1] H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three [E2]histone[/E2] H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[158, 165]], "entity_1_idx_in_text_with_entity_marker": [162, 169], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "histone", "entity_2_idx": [[306, 313]], "entity_2_idx_in_text_with_entity_marker": [319, 326], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p21", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, [E1]histone[/E1] H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three [E2]histone[/E2] H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[218, 225]], "entity_1_idx_in_text_with_entity_marker": [222, 229], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "histone", "entity_2_idx": [[306, 313]], "entity_2_idx_in_text_with_entity_marker": [319, 326], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p22", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, [E1]histone[/E1] H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three [E2]histone[/E2] H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[203, 210]], "entity_1_idx_in_text_with_entity_marker": [207, 214], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "histone", "entity_2_idx": [[306, 313]], "entity_2_idx_in_text_with_entity_marker": [319, 326], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p23", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four [E1]histone[/E1] H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three [E2]histone[/E2] H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[178, 185]], "entity_1_idx_in_text_with_entity_marker": [182, 189], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "histone", "entity_2_idx": [[306, 313]], "entity_2_idx_in_text_with_entity_marker": [319, 326], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p24", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, [E1]histone[/E1] H2A.X, histone H2A.Z, histone H2B, three [E2]histone[/E2] H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[257, 264]], "entity_1_idx_in_text_with_entity_marker": [261, 268], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "histone", "entity_2_idx": [[306, 313]], "entity_2_idx_in_text_with_entity_marker": [319, 326], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p25", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, [E1]histone[/E1] H2B, three [E2]histone[/E2] H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[287, 294]], "entity_1_idx_in_text_with_entity_marker": [291, 298], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "histone", "entity_2_idx": [[306, 313]], "entity_2_idx_in_text_with_entity_marker": [319, 326], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p26", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, [E1]histone[/E1] H2A.Z, histone H2B, three [E2]histone[/E2] H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[272, 279]], "entity_1_idx_in_text_with_entity_marker": [276, 283], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "histone", "entity_2_idx": [[306, 313]], "entity_2_idx_in_text_with_entity_marker": [319, 326], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p27", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three [E1]histone[/E1] [E2]H3[/E2] variants and histone H4.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "histone", "entity_1_idx": [[306, 313]], "entity_1_idx_in_text_with_entity_marker": [310, 317], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H3", "entity_2_idx": [[314, 316]], "entity_2_idx_in_text_with_entity_marker": [327, 329], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p28", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone [E1]H2B[/E1], three [E2]histone[/E2] H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H2B", "entity_1_idx": [[295, 298]], "entity_1_idx_in_text_with_entity_marker": [299, 302], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[306, 313]], "entity_2_idx_in_text_with_entity_marker": [319, 326], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p29", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three [E1]histone[/E1] H3 variants and histone [E2]H4[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[306, 313]], "entity_1_idx_in_text_with_entity_marker": [310, 317], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H4", "entity_2_idx": [[338, 340]], "entity_2_idx_in_text_with_entity_marker": [351, 353], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p90", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four [E1]histone[/E1] H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, [E2]histone[/E2] H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[178, 185]], "entity_1_idx_in_text_with_entity_marker": [182, 189], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "histone", "entity_2_idx": [[257, 264]], "entity_2_idx_in_text_with_entity_marker": [270, 277], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p91", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four [E1]histone[/E1] H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, [E2]histone[/E2] H2B, three histone H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[178, 185]], "entity_1_idx_in_text_with_entity_marker": [182, 189], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "histone", "entity_2_idx": [[287, 294]], "entity_2_idx_in_text_with_entity_marker": [300, 307], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p92", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four [E1]histone[/E1] H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, [E2]histone[/E2] H2A.Z, histone H2B, three histone H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[178, 185]], "entity_1_idx_in_text_with_entity_marker": [182, 189], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "histone", "entity_2_idx": [[272, 279]], "entity_2_idx_in_text_with_entity_marker": [285, 292], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p93", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four [E1]histone[/E1] H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone [E2]H3[/E2] variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[178, 185]], "entity_1_idx_in_text_with_entity_marker": [182, 189], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H3", "entity_2_idx": [[314, 316]], "entity_2_idx_in_text_with_entity_marker": [327, 329], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p94", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four [E1]histone[/E1] H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone [E2]H2B[/E2], three histone H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[178, 185]], "entity_1_idx_in_text_with_entity_marker": [182, 189], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H2B", "entity_2_idx": [[295, 298]], "entity_2_idx_in_text_with_entity_marker": [308, 311], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p95", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four [E1]histone[/E1] H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone [E2]H4[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[178, 185]], "entity_1_idx_in_text_with_entity_marker": [182, 189], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H4", "entity_2_idx": [[338, 340]], "entity_2_idx_in_text_with_entity_marker": [351, 353], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p96", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four [E1]histone[/E1] H1 subfractions, histone H2A.1, histone H2A.2, oxidized [E2]histone[/E2] H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[178, 185]], "entity_1_idx_in_text_with_entity_marker": [182, 189], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "histone", "entity_2_idx": [[242, 249]], "entity_2_idx_in_text_with_entity_marker": [255, 262], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p97", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four [E1]histone[/E1] H1 subfractions, histone [E2]H2A.1[/E2], histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[178, 185]], "entity_1_idx_in_text_with_entity_marker": [182, 189], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H2A.1", "entity_2_idx": [[211, 216]], "entity_2_idx_in_text_with_entity_marker": [224, 229], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p98", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four [E1]histone[/E1] [E2]H1[/E2] subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "histone", "entity_1_idx": [[178, 185]], "entity_1_idx_in_text_with_entity_marker": [182, 189], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H1", "entity_2_idx": [[186, 188]], "entity_2_idx_in_text_with_entity_marker": [199, 201], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p99", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone [E1]H1(0)[/E1], four [E2]histone[/E2] H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H1(0)", "entity_1_idx": [[166, 171]], "entity_1_idx_in_text_with_entity_marker": [170, 175], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[178, 185]], "entity_2_idx_in_text_with_entity_marker": [191, 198], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p110", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized [E1]histone[/E1] H2A.2, [E2]histone[/E2] H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[242, 249]], "entity_1_idx_in_text_with_entity_marker": [246, 253], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "histone", "entity_2_idx": [[257, 264]], "entity_2_idx_in_text_with_entity_marker": [270, 277], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p111", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone [E1]H2A.1[/E1], histone H2A.2, oxidized histone H2A.2, [E2]histone[/E2] H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H2A.1", "entity_1_idx": [[211, 216]], "entity_1_idx_in_text_with_entity_marker": [215, 220], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[257, 264]], "entity_2_idx_in_text_with_entity_marker": [270, 277], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p112", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone [E1]H1[/E1] subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, [E2]histone[/E2] H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H1", "entity_1_idx": [[186, 188]], "entity_1_idx_in_text_with_entity_marker": [190, 192], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[257, 264]], "entity_2_idx_in_text_with_entity_marker": [270, 277], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p113", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone [E1]H1(0)[/E1], four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, [E2]histone[/E2] H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H1(0)", "entity_1_idx": [[166, 171]], "entity_1_idx_in_text_with_entity_marker": [170, 175], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[257, 264]], "entity_2_idx_in_text_with_entity_marker": [270, 277], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p114", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified [E1]histones[/E1] were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, [E2]histone[/E2] H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histones", "entity_1_idx": [[100, 108]], "entity_1_idx_in_text_with_entity_marker": [104, 112], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "histone", "entity_2_idx": [[257, 264]], "entity_2_idx_in_text_with_entity_marker": [270, 277], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p115", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, [E1]histone[/E1] H2A.X, histone [E2]H2A.Z[/E2], histone H2B, three histone H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[257, 264]], "entity_1_idx_in_text_with_entity_marker": [261, 268], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H2A.Z", "entity_2_idx": [[280, 285]], "entity_2_idx_in_text_with_entity_marker": [293, 298], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p116", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, [E1]histone[/E1] [E2]H2A.X[/E2], histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "histone", "entity_1_idx": [[257, 264]], "entity_1_idx_in_text_with_entity_marker": [261, 268], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H2A.X", "entity_2_idx": [[265, 270]], "entity_2_idx_in_text_with_entity_marker": [278, 283], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p117", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone [E1]H2A.2[/E1], [E2]histone[/E2] H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H2A.2", "entity_1_idx": [[250, 255]], "entity_1_idx_in_text_with_entity_marker": [254, 259], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[257, 264]], "entity_2_idx_in_text_with_entity_marker": [270, 277], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p118", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone [E1]H2A.2[/E1], oxidized histone H2A.2, [E2]histone[/E2] H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H2A.2", "entity_1_idx": [[226, 231]], "entity_1_idx_in_text_with_entity_marker": [230, 235], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[257, 264]], "entity_2_idx_in_text_with_entity_marker": [270, 277], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p119", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, [E1]histone[/E1] H2A.Z, [E2]histone[/E2] H2B, three histone H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[272, 279]], "entity_1_idx_in_text_with_entity_marker": [276, 283], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "histone", "entity_2_idx": [[287, 294]], "entity_2_idx_in_text_with_entity_marker": [300, 307], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d282.s0_BioInfer.d282.s0.p0", "text": "Human platelet P-235, a talin-like actin binding protein, binds selectively to mixed lipid bilayers.", "text_with_entity_marker": "Human [E1]platelet P-235[/E1], a talin-like [E2]actin binding protein[/E2], binds selectively to mixed lipid bilayers.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "platelet P-235", "entity_1_idx": [[6, 20]], "entity_1_idx_in_text_with_entity_marker": [10, 24], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin binding protein", "entity_2_idx": [[35, 56]], "entity_2_idx_in_text_with_entity_marker": [48, 69], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d282.s0_BioInfer.d282.s0.p1", "text": "Human platelet P-235, a talin-like actin binding protein, binds selectively to mixed lipid bilayers.", "text_with_entity_marker": "Human platelet P-235, a [E1]talin[/E1]-like [E2]actin binding protein[/E2], binds selectively to mixed lipid bilayers.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "talin", "entity_1_idx": [[24, 29]], "entity_1_idx_in_text_with_entity_marker": [28, 33], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin binding protein", "entity_2_idx": [[35, 56]], "entity_2_idx_in_text_with_entity_marker": [48, 69], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d282.s0_BioInfer.d282.s0.p2", "text": "Human platelet P-235, a talin-like actin binding protein, binds selectively to mixed lipid bilayers.", "text_with_entity_marker": "Human [E1]platelet P-235[/E1], a [E2]talin[/E2]-like actin binding protein, binds selectively to mixed lipid bilayers.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "platelet P-235", "entity_1_idx": [[6, 20]], "entity_1_idx_in_text_with_entity_marker": [10, 24], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[24, 29]], "entity_2_idx_in_text_with_entity_marker": [37, 42], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d424.s0_BioInfer.d424.s0.p0", "text": "METHODS: We immunohistochemically investigated the expression of E-cadherin (E-Cad), alpha-catenin (A-Cat) and beta-catenin (B-Cat) during human intrahepatic bile duct development, using 31 fetal livers of various gestational ages.", "text_with_entity_marker": "METHODS: We immunohistochemically investigated the expression of [E1]E-cadherin[/E1] (E-Cad), alpha-catenin (A-Cat) and [E2]beta-catenin[/E2] (B-Cat) during human intrahepatic bile duct development, using 31 fetal livers of various gestational ages.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[65, 75]], "entity_1_idx_in_text_with_entity_marker": [69, 79], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[111, 123]], "entity_2_idx_in_text_with_entity_marker": [124, 136], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d424.s0_BioInfer.d424.s0.p1", "text": "METHODS: We immunohistochemically investigated the expression of E-cadherin (E-Cad), alpha-catenin (A-Cat) and beta-catenin (B-Cat) during human intrahepatic bile duct development, using 31 fetal livers of various gestational ages.", "text_with_entity_marker": "METHODS: We immunohistochemically investigated the expression of E-cadherin (E-Cad), alpha-catenin ([E1]A-Cat[/E1]) and [E2]beta-catenin[/E2] (B-Cat) during human intrahepatic bile duct development, using 31 fetal livers of various gestational ages.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "A-Cat", "entity_1_idx": [[100, 105]], "entity_1_idx_in_text_with_entity_marker": [104, 109], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[111, 123]], "entity_2_idx_in_text_with_entity_marker": [124, 136], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d424.s0_BioInfer.d424.s0.p2", "text": "METHODS: We immunohistochemically investigated the expression of E-cadherin (E-Cad), alpha-catenin (A-Cat) and beta-catenin (B-Cat) during human intrahepatic bile duct development, using 31 fetal livers of various gestational ages.", "text_with_entity_marker": "METHODS: We immunohistochemically investigated the expression of E-cadherin (E-Cad), [E1]alpha-catenin[/E1] (A-Cat) and [E2]beta-catenin[/E2] (B-Cat) during human intrahepatic bile duct development, using 31 fetal livers of various gestational ages.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[85, 98]], "entity_1_idx_in_text_with_entity_marker": [89, 102], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[111, 123]], "entity_2_idx_in_text_with_entity_marker": [124, 136], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d424.s0_BioInfer.d424.s0.p3", "text": "METHODS: We immunohistochemically investigated the expression of E-cadherin (E-Cad), alpha-catenin (A-Cat) and beta-catenin (B-Cat) during human intrahepatic bile duct development, using 31 fetal livers of various gestational ages.", "text_with_entity_marker": "METHODS: We immunohistochemically investigated the expression of E-cadherin (E-Cad), alpha-catenin (A-Cat) and [E1]beta-catenin[/E1] ([E2]B-Cat[/E2]) during human intrahepatic bile duct development, using 31 fetal livers of various gestational ages.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[111, 123]], "entity_1_idx_in_text_with_entity_marker": [115, 127], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "B-Cat", "entity_2_idx": [[125, 130]], "entity_2_idx_in_text_with_entity_marker": [138, 143], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d424.s0_BioInfer.d424.s0.p4", "text": "METHODS: We immunohistochemically investigated the expression of E-cadherin (E-Cad), alpha-catenin (A-Cat) and beta-catenin (B-Cat) during human intrahepatic bile duct development, using 31 fetal livers of various gestational ages.", "text_with_entity_marker": "METHODS: We immunohistochemically investigated the expression of E-cadherin ([E1]E-Cad[/E1]), alpha-catenin (A-Cat) and [E2]beta-catenin[/E2] (B-Cat) during human intrahepatic bile duct development, using 31 fetal livers of various gestational ages.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-Cad", "entity_1_idx": [[77, 82]], "entity_1_idx_in_text_with_entity_marker": [81, 86], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[111, 123]], "entity_2_idx_in_text_with_entity_marker": [124, 136], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d424.s0_BioInfer.d424.s0.p5", "text": "METHODS: We immunohistochemically investigated the expression of E-cadherin (E-Cad), alpha-catenin (A-Cat) and beta-catenin (B-Cat) during human intrahepatic bile duct development, using 31 fetal livers of various gestational ages.", "text_with_entity_marker": "METHODS: We immunohistochemically investigated the expression of [E1]E-cadherin[/E1] (E-Cad), alpha-catenin ([E2]A-Cat[/E2]) and beta-catenin (B-Cat) during human intrahepatic bile duct development, using 31 fetal livers of various gestational ages.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[65, 75]], "entity_1_idx_in_text_with_entity_marker": [69, 79], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "A-Cat", "entity_2_idx": [[100, 105]], "entity_2_idx_in_text_with_entity_marker": [113, 118], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d424.s0_BioInfer.d424.s0.p6", "text": "METHODS: We immunohistochemically investigated the expression of E-cadherin (E-Cad), alpha-catenin (A-Cat) and beta-catenin (B-Cat) during human intrahepatic bile duct development, using 31 fetal livers of various gestational ages.", "text_with_entity_marker": "METHODS: We immunohistochemically investigated the expression of [E1]E-cadherin[/E1] (E-Cad), [E2]alpha-catenin[/E2] (A-Cat) and beta-catenin (B-Cat) during human intrahepatic bile duct development, using 31 fetal livers of various gestational ages.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[65, 75]], "entity_1_idx_in_text_with_entity_marker": [69, 79], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[85, 98]], "entity_2_idx_in_text_with_entity_marker": [98, 111], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d424.s0_BioInfer.d424.s0.p7", "text": "METHODS: We immunohistochemically investigated the expression of E-cadherin (E-Cad), alpha-catenin (A-Cat) and beta-catenin (B-Cat) during human intrahepatic bile duct development, using 31 fetal livers of various gestational ages.", "text_with_entity_marker": "METHODS: We immunohistochemically investigated the expression of [E1]E-cadherin[/E1] (E-Cad), alpha-catenin (A-Cat) and beta-catenin ([E2]B-Cat[/E2]) during human intrahepatic bile duct development, using 31 fetal livers of various gestational ages.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[65, 75]], "entity_1_idx_in_text_with_entity_marker": [69, 79], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "B-Cat", "entity_2_idx": [[125, 130]], "entity_2_idx_in_text_with_entity_marker": [138, 143], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d424.s0_BioInfer.d424.s0.p8", "text": "METHODS: We immunohistochemically investigated the expression of E-cadherin (E-Cad), alpha-catenin (A-Cat) and beta-catenin (B-Cat) during human intrahepatic bile duct development, using 31 fetal livers of various gestational ages.", "text_with_entity_marker": "METHODS: We immunohistochemically investigated the expression of [E1]E-cadherin[/E1] ([E2]E-Cad[/E2]), alpha-catenin (A-Cat) and beta-catenin (B-Cat) during human intrahepatic bile duct development, using 31 fetal livers of various gestational ages.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[65, 75]], "entity_1_idx_in_text_with_entity_marker": [69, 79], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "E-Cad", "entity_2_idx": [[77, 82]], "entity_2_idx_in_text_with_entity_marker": [90, 95], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d424.s0_BioInfer.d424.s0.p9", "text": "METHODS: We immunohistochemically investigated the expression of E-cadherin (E-Cad), alpha-catenin (A-Cat) and beta-catenin (B-Cat) during human intrahepatic bile duct development, using 31 fetal livers of various gestational ages.", "text_with_entity_marker": "METHODS: We immunohistochemically investigated the expression of E-cadherin (E-Cad), [E1]alpha-catenin[/E1] ([E2]A-Cat[/E2]) and beta-catenin (B-Cat) during human intrahepatic bile duct development, using 31 fetal livers of various gestational ages.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[85, 98]], "entity_1_idx_in_text_with_entity_marker": [89, 102], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "A-Cat", "entity_2_idx": [[100, 105]], "entity_2_idx_in_text_with_entity_marker": [113, 118], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d424.s0_BioInfer.d424.s0.p10", "text": "METHODS: We immunohistochemically investigated the expression of E-cadherin (E-Cad), alpha-catenin (A-Cat) and beta-catenin (B-Cat) during human intrahepatic bile duct development, using 31 fetal livers of various gestational ages.", "text_with_entity_marker": "METHODS: We immunohistochemically investigated the expression of E-cadherin (E-Cad), alpha-catenin ([E1]A-Cat[/E1]) and beta-catenin ([E2]B-Cat[/E2]) during human intrahepatic bile duct development, using 31 fetal livers of various gestational ages.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "A-Cat", "entity_1_idx": [[100, 105]], "entity_1_idx_in_text_with_entity_marker": [104, 109], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "B-Cat", "entity_2_idx": [[125, 130]], "entity_2_idx_in_text_with_entity_marker": [138, 143], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d424.s0_BioInfer.d424.s0.p11", "text": "METHODS: We immunohistochemically investigated the expression of E-cadherin (E-Cad), alpha-catenin (A-Cat) and beta-catenin (B-Cat) during human intrahepatic bile duct development, using 31 fetal livers of various gestational ages.", "text_with_entity_marker": "METHODS: We immunohistochemically investigated the expression of E-cadherin ([E1]E-Cad[/E1]), alpha-catenin ([E2]A-Cat[/E2]) and beta-catenin (B-Cat) during human intrahepatic bile duct development, using 31 fetal livers of various gestational ages.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-Cad", "entity_1_idx": [[77, 82]], "entity_1_idx_in_text_with_entity_marker": [81, 86], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "A-Cat", "entity_2_idx": [[100, 105]], "entity_2_idx_in_text_with_entity_marker": [113, 118], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d424.s0_BioInfer.d424.s0.p12", "text": "METHODS: We immunohistochemically investigated the expression of E-cadherin (E-Cad), alpha-catenin (A-Cat) and beta-catenin (B-Cat) during human intrahepatic bile duct development, using 31 fetal livers of various gestational ages.", "text_with_entity_marker": "METHODS: We immunohistochemically investigated the expression of E-cadherin (E-Cad), [E1]alpha-catenin[/E1] (A-Cat) and beta-catenin ([E2]B-Cat[/E2]) during human intrahepatic bile duct development, using 31 fetal livers of various gestational ages.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[85, 98]], "entity_1_idx_in_text_with_entity_marker": [89, 102], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "B-Cat", "entity_2_idx": [[125, 130]], "entity_2_idx_in_text_with_entity_marker": [138, 143], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d424.s0_BioInfer.d424.s0.p13", "text": "METHODS: We immunohistochemically investigated the expression of E-cadherin (E-Cad), alpha-catenin (A-Cat) and beta-catenin (B-Cat) during human intrahepatic bile duct development, using 31 fetal livers of various gestational ages.", "text_with_entity_marker": "METHODS: We immunohistochemically investigated the expression of E-cadherin ([E1]E-Cad[/E1]), [E2]alpha-catenin[/E2] (A-Cat) and beta-catenin (B-Cat) during human intrahepatic bile duct development, using 31 fetal livers of various gestational ages.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-Cad", "entity_1_idx": [[77, 82]], "entity_1_idx_in_text_with_entity_marker": [81, 86], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[85, 98]], "entity_2_idx_in_text_with_entity_marker": [98, 111], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d424.s0_BioInfer.d424.s0.p14", "text": "METHODS: We immunohistochemically investigated the expression of E-cadherin (E-Cad), alpha-catenin (A-Cat) and beta-catenin (B-Cat) during human intrahepatic bile duct development, using 31 fetal livers of various gestational ages.", "text_with_entity_marker": "METHODS: We immunohistochemically investigated the expression of E-cadherin ([E1]E-Cad[/E1]), alpha-catenin (A-Cat) and beta-catenin ([E2]B-Cat[/E2]) during human intrahepatic bile duct development, using 31 fetal livers of various gestational ages.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-Cad", "entity_1_idx": [[77, 82]], "entity_1_idx_in_text_with_entity_marker": [81, 86], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "B-Cat", "entity_2_idx": [[125, 130]], "entity_2_idx_in_text_with_entity_marker": [138, 143], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d330.s0_BioInfer.d330.s0.p0", "text": "In COS-7 cells overexpressing a N-WASP mutant lacking the proline-rich domain (Deltap) unable to interact with profilin, the actin tail formation of intracellular Shigella was inhibited.", "text_with_entity_marker": "In COS-7 cells overexpressing a N-WASP mutant lacking the proline-rich domain (Deltap) unable to interact with [E1]profilin[/E1], the [E2]actin[/E2] tail formation of intracellular Shigella was inhibited.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[111, 119]], "entity_1_idx_in_text_with_entity_marker": [115, 123], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[125, 130]], "entity_2_idx_in_text_with_entity_marker": [138, 143], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d330.s0_BioInfer.d330.s0.p1", "text": "In COS-7 cells overexpressing a N-WASP mutant lacking the proline-rich domain (Deltap) unable to interact with profilin, the actin tail formation of intracellular Shigella was inhibited.", "text_with_entity_marker": "In COS-7 cells overexpressing a [E1]N-WASP[/E1] mutant lacking the proline-rich domain (Deltap) unable to interact with profilin, the [E2]actin[/E2] tail formation of intracellular Shigella was inhibited.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "N-WASP", "entity_1_idx": [[32, 38], [79, 85]], "entity_1_idx_in_text_with_entity_marker": [36, 42], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[125, 130]], "entity_2_idx_in_text_with_entity_marker": [138, 143], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d330.s0_BioInfer.d330.s0.p2", "text": "In COS-7 cells overexpressing a N-WASP mutant lacking the proline-rich domain (Deltap) unable to interact with profilin, the actin tail formation of intracellular Shigella was inhibited.", "text_with_entity_marker": "In COS-7 cells overexpressing a [E1]N-WASP[/E1] mutant lacking the proline-rich domain (Deltap) unable to interact with [E2]profilin[/E2], the actin tail formation of intracellular Shigella was inhibited.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "N-WASP", "entity_1_idx": [[32, 38], [79, 85]], "entity_1_idx_in_text_with_entity_marker": [36, 42], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[111, 119]], "entity_2_idx_in_text_with_entity_marker": [124, 132], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d224.s0_BioInfer.d224.s0.p0", "text": "Furthermore, this inactivating effect of calmodulin can be prevented by coexpressing a region of the cytoskeletal protein alpha-actinin2 known to interact with the CO region of NR1.", "text_with_entity_marker": "Furthermore, this inactivating effect of [E1]calmodulin[/E1] can be prevented by coexpressing a region of the cytoskeletal protein [E2]alpha-actinin2[/E2] known to interact with the CO region of NR1.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "calmodulin", "entity_1_idx": [[41, 51]], "entity_1_idx_in_text_with_entity_marker": [45, 55], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-actinin2", "entity_2_idx": [[122, 136]], "entity_2_idx_in_text_with_entity_marker": [135, 149], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d224.s0_BioInfer.d224.s0.p1", "text": "Furthermore, this inactivating effect of calmodulin can be prevented by coexpressing a region of the cytoskeletal protein alpha-actinin2 known to interact with the CO region of NR1.", "text_with_entity_marker": "Furthermore, this inactivating effect of [E1]calmodulin[/E1] can be prevented by coexpressing a region of the cytoskeletal protein alpha-actinin2 known to interact with the CO region of [E2]NR1[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "calmodulin", "entity_1_idx": [[41, 51]], "entity_1_idx_in_text_with_entity_marker": [45, 55], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "NR1", "entity_2_idx": [[177, 180]], "entity_2_idx_in_text_with_entity_marker": [190, 193], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d224.s0_BioInfer.d224.s0.p2", "text": "Furthermore, this inactivating effect of calmodulin can be prevented by coexpressing a region of the cytoskeletal protein alpha-actinin2 known to interact with the CO region of NR1.", "text_with_entity_marker": "Furthermore, this inactivating effect of calmodulin can be prevented by coexpressing a region of the cytoskeletal protein [E1]alpha-actinin2[/E1] known to interact with the CO region of [E2]NR1[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-actinin2", "entity_1_idx": [[122, 136]], "entity_1_idx_in_text_with_entity_marker": [126, 140], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "NR1", "entity_2_idx": [[177, 180]], "entity_2_idx_in_text_with_entity_marker": [190, 193], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p70", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-N-4a-4b-[E1]M[/E1]-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed [E2]glycoprotein[/E2] gene; and L is the proposed transcriptase gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "M", "entity_1_idx": [[44, 45]], "entity_1_idx_in_text_with_entity_marker": [48, 49], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "glycoprotein", "entity_2_idx": [[289, 301]], "entity_2_idx_in_text_with_entity_marker": [302, 314], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p71", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-N-4a-4b-[E1]M[/E1]-G-L-5', where N is the [E2]nucleocapsid protein[/E2] gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "M", "entity_1_idx": [[44, 45]], "entity_1_idx_in_text_with_entity_marker": [48, 49], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "nucleocapsid protein", "entity_2_idx": [[69, 89]], "entity_2_idx_in_text_with_entity_marker": [82, 102], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p72", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-N-4a-4b-[E1]M[/E1]-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed [E2]phosphoprotein[/E2] P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "M", "entity_1_idx": [[44, 45]], "entity_1_idx_in_text_with_entity_marker": [48, 49], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "phosphoprotein", "entity_2_idx": [[157, 171]], "entity_2_idx_in_text_with_entity_marker": [170, 184], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p73", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-N-4a-4b-[E1]M[/E1]-G-L-5', where N is the nucleocapsid protein gene; [E2]4a[/E2] and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "M", "entity_1_idx": [[44, 45]], "entity_1_idx_in_text_with_entity_marker": [48, 49], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "4a", "entity_2_idx": [[96, 98]], "entity_2_idx_in_text_with_entity_marker": [109, 111], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p74", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-N-4a-4b-[E1]M[/E1]-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed [E2]matrix protein[/E2] gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "M", "entity_1_idx": [[44, 45]], "entity_1_idx_in_text_with_entity_marker": [48, 49], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "matrix protein", "entity_2_idx": [[250, 264]], "entity_2_idx_in_text_with_entity_marker": [263, 277], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p75", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-[E1]N[/E1]-[E2]4a[/E2]-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "N", "entity_1_idx": [[36, 37]], "entity_1_idx_in_text_with_entity_marker": [40, 41], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "4a", "entity_2_idx": [[38, 40]], "entity_2_idx_in_text_with_entity_marker": [51, 53], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p76", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-[E1]N[/E1]-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; [E2]G[/E2] is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "N", "entity_1_idx": [[36, 37]], "entity_1_idx_in_text_with_entity_marker": [40, 41], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "G", "entity_2_idx": [[271, 272]], "entity_2_idx_in_text_with_entity_marker": [284, 285], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p77", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-[E1]N[/E1]-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and [E2]L[/E2] is the proposed transcriptase gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "N", "entity_1_idx": [[36, 37]], "entity_1_idx_in_text_with_entity_marker": [40, 41], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "L", "entity_2_idx": [[312, 313]], "entity_2_idx_in_text_with_entity_marker": [325, 326], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p78", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-[E1]N[/E1]-4a-4b-M-G-L-5', where [E2]N[/E2] is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "N", "entity_1_idx": [[36, 37]], "entity_1_idx_in_text_with_entity_marker": [40, 41], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "N", "entity_2_idx": [[60, 61]], "entity_2_idx_in_text_with_entity_marker": [73, 74], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p79", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-[E1]N[/E1]-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein [E2]P[/E2] and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "N", "entity_1_idx": [[36, 37]], "entity_1_idx_in_text_with_entity_marker": [40, 41], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "P", "entity_2_idx": [[172, 173]], "entity_2_idx_in_text_with_entity_marker": [185, 186], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p110", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; [E1]M[/E1] is the proposed matrix protein gene; G is the proposed glycoprotein gene; and [E2]L[/E2] is the proposed transcriptase gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "M", "entity_1_idx": [[232, 233]], "entity_1_idx_in_text_with_entity_marker": [236, 237], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "L", "entity_2_idx": [[312, 313]], "entity_2_idx_in_text_with_entity_marker": [325, 326], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p111", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and [E1]L[/E1] is the proposed [E2]transcriptase[/E2] gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "L", "entity_1_idx": [[312, 313]], "entity_1_idx_in_text_with_entity_marker": [316, 317], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "transcriptase", "entity_2_idx": [[330, 343]], "entity_2_idx_in_text_with_entity_marker": [343, 356], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p112", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed [E1]glycoprotein[/E1] gene; and [E2]L[/E2] is the proposed transcriptase gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "glycoprotein", "entity_1_idx": [[289, 301]], "entity_1_idx_in_text_with_entity_marker": [293, 305], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "L", "entity_2_idx": [[312, 313]], "entity_2_idx_in_text_with_entity_marker": [325, 326], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p113", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the [E1]nucleocapsid protein[/E1] gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and [E2]L[/E2] is the proposed transcriptase gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nucleocapsid protein", "entity_1_idx": [[69, 89]], "entity_1_idx_in_text_with_entity_marker": [73, 93], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "L", "entity_2_idx": [[312, 313]], "entity_2_idx_in_text_with_entity_marker": [325, 326], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p114", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed [E1]phosphoprotein[/E1] P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and [E2]L[/E2] is the proposed transcriptase gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "phosphoprotein", "entity_1_idx": [[157, 171]], "entity_1_idx_in_text_with_entity_marker": [161, 175], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "L", "entity_2_idx": [[312, 313]], "entity_2_idx_in_text_with_entity_marker": [325, 326], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p115", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; [E1]4a[/E1] and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and [E2]L[/E2] is the proposed transcriptase gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "4a", "entity_1_idx": [[96, 98]], "entity_1_idx_in_text_with_entity_marker": [100, 102], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "L", "entity_2_idx": [[312, 313]], "entity_2_idx_in_text_with_entity_marker": [325, 326], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p116", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed [E1]matrix protein[/E1] gene; G is the proposed glycoprotein gene; and [E2]L[/E2] is the proposed transcriptase gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "matrix protein", "entity_1_idx": [[250, 264]], "entity_1_idx_in_text_with_entity_marker": [254, 268], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "L", "entity_2_idx": [[312, 313]], "entity_2_idx_in_text_with_entity_marker": [325, 326], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p117", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where [E1]N[/E1] is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein [E2]P[/E2] and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "N", "entity_1_idx": [[60, 61]], "entity_1_idx_in_text_with_entity_marker": [64, 65], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "P", "entity_2_idx": [[172, 173]], "entity_2_idx_in_text_with_entity_marker": [185, 186], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p118", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where [E1]N[/E1] is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; [E2]M[/E2] is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "N", "entity_1_idx": [[60, 61]], "entity_1_idx_in_text_with_entity_marker": [64, 65], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "M", "entity_2_idx": [[232, 233]], "entity_2_idx_in_text_with_entity_marker": [245, 246], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p119", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where [E1]N[/E1] is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed [E2]transcriptase[/E2] gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "N", "entity_1_idx": [[60, 61]], "entity_1_idx_in_text_with_entity_marker": [64, 65], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "transcriptase", "entity_2_idx": [[330, 343]], "entity_2_idx_in_text_with_entity_marker": [343, 356], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d814.s0_BioInfer.d814.s0.p0", "text": "We have shown that the FH proteins Bni1p and Bnr1p are potential targets of the Rho family small GTP-binding proteins and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.", "text_with_entity_marker": "We have shown that the FH proteins Bni1p and Bnr1p are potential targets of the [E1]Rho[/E1] family small GTP-binding proteins and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the [E2]actin[/E2] cytoskeleton in the yeast Saccharomyces cerevisiae.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Rho", "entity_1_idx": [[80, 83]], "entity_1_idx_in_text_with_entity_marker": [84, 87], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[234, 239]], "entity_2_idx_in_text_with_entity_marker": [247, 252], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d814.s0_BioInfer.d814.s0.p1", "text": "We have shown that the FH proteins Bni1p and Bnr1p are potential targets of the Rho family small GTP-binding proteins and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.", "text_with_entity_marker": "We have shown that the FH proteins Bni1p and [E1]Bnr1p[/E1] are potential targets of the Rho family small GTP-binding proteins and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the [E2]actin[/E2] cytoskeleton in the yeast Saccharomyces cerevisiae.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Bnr1p", "entity_1_idx": [[45, 50]], "entity_1_idx_in_text_with_entity_marker": [49, 54], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[234, 239]], "entity_2_idx_in_text_with_entity_marker": [247, 252], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d814.s0_BioInfer.d814.s0.p2", "text": "We have shown that the FH proteins Bni1p and Bnr1p are potential targets of the Rho family small GTP-binding proteins and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.", "text_with_entity_marker": "We have shown that the FH proteins Bni1p and Bnr1p are potential targets of the Rho family [E1]small GTP-binding proteins[/E1] and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the [E2]actin[/E2] cytoskeleton in the yeast Saccharomyces cerevisiae.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "small GTP-binding proteins", "entity_1_idx": [[91, 117]], "entity_1_idx_in_text_with_entity_marker": [95, 121], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "actin", "entity_2_idx": [[234, 239]], "entity_2_idx_in_text_with_entity_marker": [247, 252], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d814.s0_BioInfer.d814.s0.p3", "text": "We have shown that the FH proteins Bni1p and Bnr1p are potential targets of the Rho family small GTP-binding proteins and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.", "text_with_entity_marker": "We have shown that the FH proteins [E1]Bni1p[/E1] and Bnr1p are potential targets of the Rho family small GTP-binding proteins and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the [E2]actin[/E2] cytoskeleton in the yeast Saccharomyces cerevisiae.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Bni1p", "entity_1_idx": [[35, 40]], "entity_1_idx_in_text_with_entity_marker": [39, 44], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[234, 239]], "entity_2_idx_in_text_with_entity_marker": [247, 252], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d814.s0_BioInfer.d814.s0.p4", "text": "We have shown that the FH proteins Bni1p and Bnr1p are potential targets of the Rho family small GTP-binding proteins and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.", "text_with_entity_marker": "We have shown that the FH proteins Bni1p and Bnr1p are potential targets of the Rho family small GTP-binding proteins and bind to an actin-binding protein, [E1]profilin[/E1], at their proline-rich FH1 domains to regulate reorganization of the [E2]actin[/E2] cytoskeleton in the yeast Saccharomyces cerevisiae.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[156, 164]], "entity_1_idx_in_text_with_entity_marker": [160, 168], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[234, 239]], "entity_2_idx_in_text_with_entity_marker": [247, 252], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d814.s0_BioInfer.d814.s0.p5", "text": "We have shown that the FH proteins Bni1p and Bnr1p are potential targets of the Rho family small GTP-binding proteins and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.", "text_with_entity_marker": "We have shown that the FH proteins Bni1p and Bnr1p are potential targets of the Rho family small GTP-binding proteins and bind to an [E1]actin-binding protein[/E1], profilin, at their proline-rich FH1 domains to regulate reorganization of the [E2]actin[/E2] cytoskeleton in the yeast Saccharomyces cerevisiae.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin-binding protein", "entity_1_idx": [[133, 154]], "entity_1_idx_in_text_with_entity_marker": [137, 158], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "actin", "entity_2_idx": [[234, 239]], "entity_2_idx_in_text_with_entity_marker": [247, 252], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d814.s0_BioInfer.d814.s0.p6", "text": "We have shown that the FH proteins Bni1p and Bnr1p are potential targets of the Rho family small GTP-binding proteins and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.", "text_with_entity_marker": "We have shown that the [E1]FH proteins[/E1] Bni1p and Bnr1p are potential targets of the Rho family small GTP-binding proteins and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the [E2]actin[/E2] cytoskeleton in the yeast Saccharomyces cerevisiae.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "FH proteins", "entity_1_idx": [[23, 34]], "entity_1_idx_in_text_with_entity_marker": [27, 38], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "actin", "entity_2_idx": [[234, 239]], "entity_2_idx_in_text_with_entity_marker": [247, 252], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d814.s0_BioInfer.d814.s0.p7", "text": "We have shown that the FH proteins Bni1p and Bnr1p are potential targets of the Rho family small GTP-binding proteins and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.", "text_with_entity_marker": "We have shown that the FH proteins Bni1p and [E1]Bnr1p[/E1] are potential targets of the [E2]Rho[/E2] family small GTP-binding proteins and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Bnr1p", "entity_1_idx": [[45, 50]], "entity_1_idx_in_text_with_entity_marker": [49, 54], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Rho", "entity_2_idx": [[80, 83]], "entity_2_idx_in_text_with_entity_marker": [93, 96], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d814.s0_BioInfer.d814.s0.p8", "text": "We have shown that the FH proteins Bni1p and Bnr1p are potential targets of the Rho family small GTP-binding proteins and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.", "text_with_entity_marker": "We have shown that the FH proteins Bni1p and Bnr1p are potential targets of the [E1]Rho[/E1] family [E2]small GTP-binding proteins[/E2] and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Rho", "entity_1_idx": [[80, 83]], "entity_1_idx_in_text_with_entity_marker": [84, 87], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "small GTP-binding proteins", "entity_2_idx": [[91, 117]], "entity_2_idx_in_text_with_entity_marker": [104, 130], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d814.s0_BioInfer.d814.s0.p9", "text": "We have shown that the FH proteins Bni1p and Bnr1p are potential targets of the Rho family small GTP-binding proteins and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.", "text_with_entity_marker": "We have shown that the FH proteins [E1]Bni1p[/E1] and Bnr1p are potential targets of the [E2]Rho[/E2] family small GTP-binding proteins and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Bni1p", "entity_1_idx": [[35, 40]], "entity_1_idx_in_text_with_entity_marker": [39, 44], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Rho", "entity_2_idx": [[80, 83]], "entity_2_idx_in_text_with_entity_marker": [93, 96], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d814.s0_BioInfer.d814.s0.p20", "text": "We have shown that the FH proteins Bni1p and Bnr1p are potential targets of the Rho family small GTP-binding proteins and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.", "text_with_entity_marker": "We have shown that the FH proteins Bni1p and Bnr1p are potential targets of the Rho family [E1]small GTP-binding proteins[/E1] and bind to an [E2]actin-binding protein[/E2], profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "small GTP-binding proteins", "entity_1_idx": [[91, 117]], "entity_1_idx_in_text_with_entity_marker": [95, 121], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "actin-binding protein", "entity_2_idx": [[133, 154]], "entity_2_idx_in_text_with_entity_marker": [146, 167], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d814.s0_BioInfer.d814.s0.p21", "text": "We have shown that the FH proteins Bni1p and Bnr1p are potential targets of the Rho family small GTP-binding proteins and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.", "text_with_entity_marker": "We have shown that the [E1]FH proteins[/E1] Bni1p and Bnr1p are potential targets of the Rho family [E2]small GTP-binding proteins[/E2] and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "FH proteins", "entity_1_idx": [[23, 34]], "entity_1_idx_in_text_with_entity_marker": [27, 38], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "small GTP-binding proteins", "entity_2_idx": [[91, 117]], "entity_2_idx_in_text_with_entity_marker": [104, 130], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d814.s0_BioInfer.d814.s0.p22", "text": "We have shown that the FH proteins Bni1p and Bnr1p are potential targets of the Rho family small GTP-binding proteins and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.", "text_with_entity_marker": "We have shown that the FH proteins [E1]Bni1p[/E1] and Bnr1p are potential targets of the Rho family small GTP-binding proteins and bind to an actin-binding protein, [E2]profilin[/E2], at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Bni1p", "entity_1_idx": [[35, 40]], "entity_1_idx_in_text_with_entity_marker": [39, 44], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[156, 164]], "entity_2_idx_in_text_with_entity_marker": [169, 177], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d814.s0_BioInfer.d814.s0.p23", "text": "We have shown that the FH proteins Bni1p and Bnr1p are potential targets of the Rho family small GTP-binding proteins and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.", "text_with_entity_marker": "We have shown that the FH proteins [E1]Bni1p[/E1] and Bnr1p are potential targets of the Rho family small GTP-binding proteins and bind to an [E2]actin-binding protein[/E2], profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Bni1p", "entity_1_idx": [[35, 40]], "entity_1_idx_in_text_with_entity_marker": [39, 44], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin-binding protein", "entity_2_idx": [[133, 154]], "entity_2_idx_in_text_with_entity_marker": [146, 167], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d814.s0_BioInfer.d814.s0.p24", "text": "We have shown that the FH proteins Bni1p and Bnr1p are potential targets of the Rho family small GTP-binding proteins and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.", "text_with_entity_marker": "We have shown that the [E1]FH proteins[/E1] [E2]Bni1p[/E2] and Bnr1p are potential targets of the Rho family small GTP-binding proteins and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "FH proteins", "entity_1_idx": [[23, 34]], "entity_1_idx_in_text_with_entity_marker": [27, 38], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "Bni1p", "entity_2_idx": [[35, 40]], "entity_2_idx_in_text_with_entity_marker": [48, 53], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d814.s0_BioInfer.d814.s0.p25", "text": "We have shown that the FH proteins Bni1p and Bnr1p are potential targets of the Rho family small GTP-binding proteins and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.", "text_with_entity_marker": "We have shown that the FH proteins Bni1p and Bnr1p are potential targets of the Rho family small GTP-binding proteins and bind to an [E1]actin-binding protein[/E1], [E2]profilin[/E2], at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin-binding protein", "entity_1_idx": [[133, 154]], "entity_1_idx_in_text_with_entity_marker": [137, 158], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "profilin", "entity_2_idx": [[156, 164]], "entity_2_idx_in_text_with_entity_marker": [169, 177], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d814.s0_BioInfer.d814.s0.p26", "text": "We have shown that the FH proteins Bni1p and Bnr1p are potential targets of the Rho family small GTP-binding proteins and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.", "text_with_entity_marker": "We have shown that the [E1]FH proteins[/E1] Bni1p and Bnr1p are potential targets of the Rho family small GTP-binding proteins and bind to an actin-binding protein, [E2]profilin[/E2], at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "FH proteins", "entity_1_idx": [[23, 34]], "entity_1_idx_in_text_with_entity_marker": [27, 38], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "profilin", "entity_2_idx": [[156, 164]], "entity_2_idx_in_text_with_entity_marker": [169, 177], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d814.s0_BioInfer.d814.s0.p27", "text": "We have shown that the FH proteins Bni1p and Bnr1p are potential targets of the Rho family small GTP-binding proteins and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.", "text_with_entity_marker": "We have shown that the [E1]FH proteins[/E1] Bni1p and Bnr1p are potential targets of the Rho family small GTP-binding proteins and bind to an [E2]actin-binding protein[/E2], profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "FH proteins", "entity_1_idx": [[23, 34]], "entity_1_idx_in_text_with_entity_marker": [27, 38], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "actin-binding protein", "entity_2_idx": [[133, 154]], "entity_2_idx_in_text_with_entity_marker": [146, 167], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d538.s0_BioInfer.d538.s0.p0", "text": "Significantly, those actin mutants exhibiting the most severe phenotypes in all three processes have altered residues that cluster to a small region of the actin crystal structure previously defined as the fimbrin (Sac6p)-binding site.", "text_with_entity_marker": "Significantly, those actin mutants exhibiting the most severe phenotypes in all three processes have altered residues that cluster to a small region of the [E1]actin[/E1] crystal structure previously defined as the [E2]fimbrin[/E2] (Sac6p)-binding site.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[156, 161]], "entity_1_idx_in_text_with_entity_marker": [160, 165], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "fimbrin", "entity_2_idx": [[206, 213]], "entity_2_idx_in_text_with_entity_marker": [219, 226], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d538.s0_BioInfer.d538.s0.p1", "text": "Significantly, those actin mutants exhibiting the most severe phenotypes in all three processes have altered residues that cluster to a small region of the actin crystal structure previously defined as the fimbrin (Sac6p)-binding site.", "text_with_entity_marker": "Significantly, those actin mutants exhibiting the most severe phenotypes in all three processes have altered residues that cluster to a small region of the [E1]actin[/E1] crystal structure previously defined as the fimbrin ([E2]Sac6p[/E2])-binding site.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[156, 161]], "entity_1_idx_in_text_with_entity_marker": [160, 165], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Sac6p", "entity_2_idx": [[215, 220]], "entity_2_idx_in_text_with_entity_marker": [228, 233], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d538.s0_BioInfer.d538.s0.p2", "text": "Significantly, those actin mutants exhibiting the most severe phenotypes in all three processes have altered residues that cluster to a small region of the actin crystal structure previously defined as the fimbrin (Sac6p)-binding site.", "text_with_entity_marker": "Significantly, those [E1]actin[/E1] mutants exhibiting the most severe phenotypes in all three processes have altered residues that cluster to a small region of the [E2]actin[/E2] crystal structure previously defined as the fimbrin (Sac6p)-binding site.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[21, 26]], "entity_1_idx_in_text_with_entity_marker": [25, 30], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[156, 161]], "entity_2_idx_in_text_with_entity_marker": [169, 174], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d538.s0_BioInfer.d538.s0.p3", "text": "Significantly, those actin mutants exhibiting the most severe phenotypes in all three processes have altered residues that cluster to a small region of the actin crystal structure previously defined as the fimbrin (Sac6p)-binding site.", "text_with_entity_marker": "Significantly, those actin mutants exhibiting the most severe phenotypes in all three processes have altered residues that cluster to a small region of the actin crystal structure previously defined as the [E1]fimbrin[/E1] ([E2]Sac6p[/E2])-binding site.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "fimbrin", "entity_1_idx": [[206, 213]], "entity_1_idx_in_text_with_entity_marker": [210, 217], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Sac6p", "entity_2_idx": [[215, 220]], "entity_2_idx_in_text_with_entity_marker": [228, 233], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d538.s0_BioInfer.d538.s0.p4", "text": "Significantly, those actin mutants exhibiting the most severe phenotypes in all three processes have altered residues that cluster to a small region of the actin crystal structure previously defined as the fimbrin (Sac6p)-binding site.", "text_with_entity_marker": "Significantly, those [E1]actin[/E1] mutants exhibiting the most severe phenotypes in all three processes have altered residues that cluster to a small region of the actin crystal structure previously defined as the [E2]fimbrin[/E2] (Sac6p)-binding site.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[21, 26]], "entity_1_idx_in_text_with_entity_marker": [25, 30], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "fimbrin", "entity_2_idx": [[206, 213]], "entity_2_idx_in_text_with_entity_marker": [219, 226], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d538.s0_BioInfer.d538.s0.p5", "text": "Significantly, those actin mutants exhibiting the most severe phenotypes in all three processes have altered residues that cluster to a small region of the actin crystal structure previously defined as the fimbrin (Sac6p)-binding site.", "text_with_entity_marker": "Significantly, those [E1]actin[/E1] mutants exhibiting the most severe phenotypes in all three processes have altered residues that cluster to a small region of the actin crystal structure previously defined as the fimbrin ([E2]Sac6p[/E2])-binding site.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[21, 26]], "entity_1_idx_in_text_with_entity_marker": [25, 30], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "Sac6p", "entity_2_idx": [[215, 220]], "entity_2_idx_in_text_with_entity_marker": [228, 233], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d664.s0_BioInfer.d664.s0.p0", "text": "The predicted sequence of AtFim1 shares ca. 40% identity with nonplant fimbrins and contains two tandem repeats, each possessing a 27 amino acid region identified as a putative actin-binding domain in fimbrins and in a larger family of actin cross-linking proteins.", "text_with_entity_marker": "The predicted sequence of AtFim1 shares ca. 40% identity with nonplant fimbrins and contains two tandem repeats, each possessing a 27 amino acid region identified as a putative [E1]actin[/E1]-binding domain in fimbrins and in a larger family of [E2]actin[/E2] cross-linking proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[177, 182]], "entity_1_idx_in_text_with_entity_marker": [181, 186], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[236, 241]], "entity_2_idx_in_text_with_entity_marker": [249, 254], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d664.s0_BioInfer.d664.s0.p1", "text": "The predicted sequence of AtFim1 shares ca. 40% identity with nonplant fimbrins and contains two tandem repeats, each possessing a 27 amino acid region identified as a putative actin-binding domain in fimbrins and in a larger family of actin cross-linking proteins.", "text_with_entity_marker": "The predicted sequence of AtFim1 shares ca. 40% identity with nonplant fimbrins and contains two tandem repeats, each possessing a 27 amino acid region identified as a putative actin-binding domain in [E1]fimbrins[/E1] and in a larger family of [E2]actin[/E2] cross-linking proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "fimbrins", "entity_1_idx": [[201, 209]], "entity_1_idx_in_text_with_entity_marker": [205, 213], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[236, 241]], "entity_2_idx_in_text_with_entity_marker": [249, 254], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d664.s0_BioInfer.d664.s0.p2", "text": "The predicted sequence of AtFim1 shares ca. 40% identity with nonplant fimbrins and contains two tandem repeats, each possessing a 27 amino acid region identified as a putative actin-binding domain in fimbrins and in a larger family of actin cross-linking proteins.", "text_with_entity_marker": "The predicted sequence of AtFim1 shares ca. 40% identity with nonplant [E1]fimbrins[/E1] and contains two tandem repeats, each possessing a 27 amino acid region identified as a putative actin-binding domain in fimbrins and in a larger family of [E2]actin[/E2] cross-linking proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "fimbrins", "entity_1_idx": [[71, 79]], "entity_1_idx_in_text_with_entity_marker": [75, 83], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[236, 241]], "entity_2_idx_in_text_with_entity_marker": [249, 254], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d664.s0_BioInfer.d664.s0.p3", "text": "The predicted sequence of AtFim1 shares ca. 40% identity with nonplant fimbrins and contains two tandem repeats, each possessing a 27 amino acid region identified as a putative actin-binding domain in fimbrins and in a larger family of actin cross-linking proteins.", "text_with_entity_marker": "The predicted sequence of [E1]AtFim1[/E1] shares ca. 40% identity with nonplant fimbrins and contains two tandem repeats, each possessing a 27 amino acid region identified as a putative actin-binding domain in fimbrins and in a larger family of [E2]actin[/E2] cross-linking proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "AtFim1", "entity_1_idx": [[26, 32]], "entity_1_idx_in_text_with_entity_marker": [30, 36], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[236, 241]], "entity_2_idx_in_text_with_entity_marker": [249, 254], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d664.s0_BioInfer.d664.s0.p4", "text": "The predicted sequence of AtFim1 shares ca. 40% identity with nonplant fimbrins and contains two tandem repeats, each possessing a 27 amino acid region identified as a putative actin-binding domain in fimbrins and in a larger family of actin cross-linking proteins.", "text_with_entity_marker": "The predicted sequence of AtFim1 shares ca. 40% identity with nonplant fimbrins and contains two tandem repeats, each possessing a 27 amino acid region identified as a putative [E1]actin[/E1]-binding domain in [E2]fimbrins[/E2] and in a larger family of actin cross-linking proteins.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[177, 182]], "entity_1_idx_in_text_with_entity_marker": [181, 186], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "fimbrins", "entity_2_idx": [[201, 209]], "entity_2_idx_in_text_with_entity_marker": [214, 222], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d664.s0_BioInfer.d664.s0.p5", "text": "The predicted sequence of AtFim1 shares ca. 40% identity with nonplant fimbrins and contains two tandem repeats, each possessing a 27 amino acid region identified as a putative actin-binding domain in fimbrins and in a larger family of actin cross-linking proteins.", "text_with_entity_marker": "The predicted sequence of AtFim1 shares ca. 40% identity with nonplant [E1]fimbrins[/E1] and contains two tandem repeats, each possessing a 27 amino acid region identified as a putative [E2]actin[/E2]-binding domain in fimbrins and in a larger family of actin cross-linking proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "fimbrins", "entity_1_idx": [[71, 79]], "entity_1_idx_in_text_with_entity_marker": [75, 83], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[177, 182]], "entity_2_idx_in_text_with_entity_marker": [190, 195], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d664.s0_BioInfer.d664.s0.p6", "text": "The predicted sequence of AtFim1 shares ca. 40% identity with nonplant fimbrins and contains two tandem repeats, each possessing a 27 amino acid region identified as a putative actin-binding domain in fimbrins and in a larger family of actin cross-linking proteins.", "text_with_entity_marker": "The predicted sequence of [E1]AtFim1[/E1] shares ca. 40% identity with nonplant fimbrins and contains two tandem repeats, each possessing a 27 amino acid region identified as a putative [E2]actin[/E2]-binding domain in fimbrins and in a larger family of actin cross-linking proteins.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "AtFim1", "entity_1_idx": [[26, 32]], "entity_1_idx_in_text_with_entity_marker": [30, 36], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[177, 182]], "entity_2_idx_in_text_with_entity_marker": [190, 195], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d664.s0_BioInfer.d664.s0.p7", "text": "The predicted sequence of AtFim1 shares ca. 40% identity with nonplant fimbrins and contains two tandem repeats, each possessing a 27 amino acid region identified as a putative actin-binding domain in fimbrins and in a larger family of actin cross-linking proteins.", "text_with_entity_marker": "The predicted sequence of AtFim1 shares ca. 40% identity with nonplant [E1]fimbrins[/E1] and contains two tandem repeats, each possessing a 27 amino acid region identified as a putative actin-binding domain in [E2]fimbrins[/E2] and in a larger family of actin cross-linking proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "fimbrins", "entity_1_idx": [[71, 79]], "entity_1_idx_in_text_with_entity_marker": [75, 83], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "fimbrins", "entity_2_idx": [[201, 209]], "entity_2_idx_in_text_with_entity_marker": [214, 222], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d664.s0_BioInfer.d664.s0.p8", "text": "The predicted sequence of AtFim1 shares ca. 40% identity with nonplant fimbrins and contains two tandem repeats, each possessing a 27 amino acid region identified as a putative actin-binding domain in fimbrins and in a larger family of actin cross-linking proteins.", "text_with_entity_marker": "The predicted sequence of [E1]AtFim1[/E1] shares ca. 40% identity with nonplant fimbrins and contains two tandem repeats, each possessing a 27 amino acid region identified as a putative actin-binding domain in [E2]fimbrins[/E2] and in a larger family of actin cross-linking proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "AtFim1", "entity_1_idx": [[26, 32]], "entity_1_idx_in_text_with_entity_marker": [30, 36], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "fimbrins", "entity_2_idx": [[201, 209]], "entity_2_idx_in_text_with_entity_marker": [214, 222], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d664.s0_BioInfer.d664.s0.p9", "text": "The predicted sequence of AtFim1 shares ca. 40% identity with nonplant fimbrins and contains two tandem repeats, each possessing a 27 amino acid region identified as a putative actin-binding domain in fimbrins and in a larger family of actin cross-linking proteins.", "text_with_entity_marker": "The predicted sequence of [E1]AtFim1[/E1] shares ca. 40% identity with nonplant [E2]fimbrins[/E2] and contains two tandem repeats, each possessing a 27 amino acid region identified as a putative actin-binding domain in fimbrins and in a larger family of actin cross-linking proteins.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "AtFim1", "entity_1_idx": [[26, 32]], "entity_1_idx_in_text_with_entity_marker": [30, 36], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "fimbrins", "entity_2_idx": [[71, 79]], "entity_2_idx_in_text_with_entity_marker": [84, 92], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d113.s0_BioInfer.d113.s0.p0", "text": "Both tyrosine phosphorylation and association of beta-catenin with EGFR were inhibited by tyrphostin, a specific inhibitor of the EGFR tyrosine kinase, whereas dissociation of alpha-catenin from E-cadherin was not.", "text_with_entity_marker": "Both tyrosine phosphorylation and association of beta-catenin with [E1]EGFR[/E1] were inhibited by tyrphostin, a specific inhibitor of the EGFR tyrosine kinase, whereas dissociation of alpha-catenin from [E2]E-cadherin[/E2] was not.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "EGFR", "entity_1_idx": [[67, 71]], "entity_1_idx_in_text_with_entity_marker": [71, 75], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "E-cadherin", "entity_2_idx": [[195, 205]], "entity_2_idx_in_text_with_entity_marker": [208, 218], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d113.s0_BioInfer.d113.s0.p1", "text": "Both tyrosine phosphorylation and association of beta-catenin with EGFR were inhibited by tyrphostin, a specific inhibitor of the EGFR tyrosine kinase, whereas dissociation of alpha-catenin from E-cadherin was not.", "text_with_entity_marker": "Both tyrosine phosphorylation and association of beta-catenin with [E1]EGFR[/E1] were inhibited by tyrphostin, a specific inhibitor of the [E2]EGFR[/E2] tyrosine kinase, whereas dissociation of alpha-catenin from E-cadherin was not.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "EGFR", "entity_1_idx": [[67, 71]], "entity_1_idx_in_text_with_entity_marker": [71, 75], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "EGFR", "entity_2_idx": [[130, 134]], "entity_2_idx_in_text_with_entity_marker": [143, 147], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d113.s0_BioInfer.d113.s0.p2", "text": "Both tyrosine phosphorylation and association of beta-catenin with EGFR were inhibited by tyrphostin, a specific inhibitor of the EGFR tyrosine kinase, whereas dissociation of alpha-catenin from E-cadherin was not.", "text_with_entity_marker": "Both tyrosine phosphorylation and association of beta-catenin with [E1]EGFR[/E1] were inhibited by tyrphostin, a specific inhibitor of the EGFR [E2]tyrosine kinase[/E2], whereas dissociation of alpha-catenin from E-cadherin was not.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "EGFR", "entity_1_idx": [[67, 71]], "entity_1_idx_in_text_with_entity_marker": [71, 75], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "tyrosine kinase", "entity_2_idx": [[135, 150]], "entity_2_idx_in_text_with_entity_marker": [148, 163], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d113.s0_BioInfer.d113.s0.p3", "text": "Both tyrosine phosphorylation and association of beta-catenin with EGFR were inhibited by tyrphostin, a specific inhibitor of the EGFR tyrosine kinase, whereas dissociation of alpha-catenin from E-cadherin was not.", "text_with_entity_marker": "Both tyrosine phosphorylation and association of beta-catenin with [E1]EGFR[/E1] were inhibited by tyrphostin, a specific inhibitor of the EGFR tyrosine kinase, whereas dissociation of [E2]alpha-catenin[/E2] from E-cadherin was not.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "EGFR", "entity_1_idx": [[67, 71]], "entity_1_idx_in_text_with_entity_marker": [71, 75], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[176, 189]], "entity_2_idx_in_text_with_entity_marker": [189, 202], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d113.s0_BioInfer.d113.s0.p4", "text": "Both tyrosine phosphorylation and association of beta-catenin with EGFR were inhibited by tyrphostin, a specific inhibitor of the EGFR tyrosine kinase, whereas dissociation of alpha-catenin from E-cadherin was not.", "text_with_entity_marker": "Both tyrosine phosphorylation and association of [E1]beta-catenin[/E1] with [E2]EGFR[/E2] were inhibited by tyrphostin, a specific inhibitor of the EGFR tyrosine kinase, whereas dissociation of alpha-catenin from E-cadherin was not.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "beta-catenin", "entity_1_idx": [[49, 61]], "entity_1_idx_in_text_with_entity_marker": [53, 65], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "EGFR", "entity_2_idx": [[67, 71]], "entity_2_idx_in_text_with_entity_marker": [80, 84], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d113.s0_BioInfer.d113.s0.p5", "text": "Both tyrosine phosphorylation and association of beta-catenin with EGFR were inhibited by tyrphostin, a specific inhibitor of the EGFR tyrosine kinase, whereas dissociation of alpha-catenin from E-cadherin was not.", "text_with_entity_marker": "Both tyrosine phosphorylation and association of beta-catenin with EGFR were inhibited by tyrphostin, a specific inhibitor of the [E1]EGFR[/E1] tyrosine kinase, whereas dissociation of alpha-catenin from [E2]E-cadherin[/E2] was not.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "EGFR", "entity_1_idx": [[130, 134]], "entity_1_idx_in_text_with_entity_marker": [134, 138], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "E-cadherin", "entity_2_idx": [[195, 205]], "entity_2_idx_in_text_with_entity_marker": [208, 218], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d113.s0_BioInfer.d113.s0.p6", "text": "Both tyrosine phosphorylation and association of beta-catenin with EGFR were inhibited by tyrphostin, a specific inhibitor of the EGFR tyrosine kinase, whereas dissociation of alpha-catenin from E-cadherin was not.", "text_with_entity_marker": "Both tyrosine phosphorylation and association of beta-catenin with EGFR were inhibited by tyrphostin, a specific inhibitor of the EGFR [E1]tyrosine kinase[/E1], whereas dissociation of alpha-catenin from [E2]E-cadherin[/E2] was not.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "tyrosine kinase", "entity_1_idx": [[135, 150]], "entity_1_idx_in_text_with_entity_marker": [139, 154], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "E-cadherin", "entity_2_idx": [[195, 205]], "entity_2_idx_in_text_with_entity_marker": [208, 218], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d113.s0_BioInfer.d113.s0.p7", "text": "Both tyrosine phosphorylation and association of beta-catenin with EGFR were inhibited by tyrphostin, a specific inhibitor of the EGFR tyrosine kinase, whereas dissociation of alpha-catenin from E-cadherin was not.", "text_with_entity_marker": "Both tyrosine phosphorylation and association of beta-catenin with EGFR were inhibited by tyrphostin, a specific inhibitor of the EGFR tyrosine kinase, whereas dissociation of [E1]alpha-catenin[/E1] from [E2]E-cadherin[/E2] was not.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-catenin", "entity_1_idx": [[176, 189]], "entity_1_idx_in_text_with_entity_marker": [180, 193], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "E-cadherin", "entity_2_idx": [[195, 205]], "entity_2_idx_in_text_with_entity_marker": [208, 218], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d113.s0_BioInfer.d113.s0.p8", "text": "Both tyrosine phosphorylation and association of beta-catenin with EGFR were inhibited by tyrphostin, a specific inhibitor of the EGFR tyrosine kinase, whereas dissociation of alpha-catenin from E-cadherin was not.", "text_with_entity_marker": "Both tyrosine phosphorylation and association of [E1]beta-catenin[/E1] with EGFR were inhibited by tyrphostin, a specific inhibitor of the EGFR tyrosine kinase, whereas dissociation of alpha-catenin from [E2]E-cadherin[/E2] was not.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[49, 61]], "entity_1_idx_in_text_with_entity_marker": [53, 65], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "E-cadherin", "entity_2_idx": [[195, 205]], "entity_2_idx_in_text_with_entity_marker": [208, 218], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d113.s0_BioInfer.d113.s0.p9", "text": "Both tyrosine phosphorylation and association of beta-catenin with EGFR were inhibited by tyrphostin, a specific inhibitor of the EGFR tyrosine kinase, whereas dissociation of alpha-catenin from E-cadherin was not.", "text_with_entity_marker": "Both tyrosine phosphorylation and association of beta-catenin with EGFR were inhibited by tyrphostin, a specific inhibitor of the [E1]EGFR[/E1] [E2]tyrosine kinase[/E2], whereas dissociation of alpha-catenin from E-cadherin was not.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "EGFR", "entity_1_idx": [[130, 134]], "entity_1_idx_in_text_with_entity_marker": [134, 138], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "tyrosine kinase", "entity_2_idx": [[135, 150]], "entity_2_idx_in_text_with_entity_marker": [148, 163], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d99.s0_BioInfer.d99.s0.p0", "text": "Biochemical analyses revealed a strong induction of VEGF-receptor-2 (flk-1/KDR) tyrosine-autophosphorylation by VEGF which was maximal after 5 minutes and was followed by receptor downregulation.", "text_with_entity_marker": "Biochemical analyses revealed a strong induction of [E1]VEGF-receptor-2[/E1] (flk-1/KDR) tyrosine-autophosphorylation by [E2]VEGF[/E2] which was maximal after 5 minutes and was followed by receptor downregulation.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "VEGF-receptor-2", "entity_1_idx": [[52, 67]], "entity_1_idx_in_text_with_entity_marker": [56, 71], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "VEGF", "entity_2_idx": [[112, 116]], "entity_2_idx_in_text_with_entity_marker": [125, 129], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d99.s0_BioInfer.d99.s0.p1", "text": "Biochemical analyses revealed a strong induction of VEGF-receptor-2 (flk-1/KDR) tyrosine-autophosphorylation by VEGF which was maximal after 5 minutes and was followed by receptor downregulation.", "text_with_entity_marker": "Biochemical analyses revealed a strong induction of [E1]VEGF-receptor-2[/E1] (flk-1/[E2]KDR[/E2]) tyrosine-autophosphorylation by VEGF which was maximal after 5 minutes and was followed by receptor downregulation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "VEGF-receptor-2", "entity_1_idx": [[52, 67]], "entity_1_idx_in_text_with_entity_marker": [56, 71], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "KDR", "entity_2_idx": [[75, 78]], "entity_2_idx_in_text_with_entity_marker": [88, 91], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d99.s0_BioInfer.d99.s0.p2", "text": "Biochemical analyses revealed a strong induction of VEGF-receptor-2 (flk-1/KDR) tyrosine-autophosphorylation by VEGF which was maximal after 5 minutes and was followed by receptor downregulation.", "text_with_entity_marker": "Biochemical analyses revealed a strong induction of [E1]VEGF-receptor-2[/E1] ([E2]flk-1[/E2]/KDR) tyrosine-autophosphorylation by VEGF which was maximal after 5 minutes and was followed by receptor downregulation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "VEGF-receptor-2", "entity_1_idx": [[52, 67]], "entity_1_idx_in_text_with_entity_marker": [56, 71], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "flk-1", "entity_2_idx": [[69, 74]], "entity_2_idx_in_text_with_entity_marker": [82, 87], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d99.s0_BioInfer.d99.s0.p3", "text": "Biochemical analyses revealed a strong induction of VEGF-receptor-2 (flk-1/KDR) tyrosine-autophosphorylation by VEGF which was maximal after 5 minutes and was followed by receptor downregulation.", "text_with_entity_marker": "Biochemical analyses revealed a strong induction of VEGF-receptor-2 (flk-1/[E1]KDR[/E1]) tyrosine-autophosphorylation by [E2]VEGF[/E2] which was maximal after 5 minutes and was followed by receptor downregulation.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "KDR", "entity_1_idx": [[75, 78]], "entity_1_idx_in_text_with_entity_marker": [79, 82], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "VEGF", "entity_2_idx": [[112, 116]], "entity_2_idx_in_text_with_entity_marker": [125, 129], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d99.s0_BioInfer.d99.s0.p4", "text": "Biochemical analyses revealed a strong induction of VEGF-receptor-2 (flk-1/KDR) tyrosine-autophosphorylation by VEGF which was maximal after 5 minutes and was followed by receptor downregulation.", "text_with_entity_marker": "Biochemical analyses revealed a strong induction of VEGF-receptor-2 ([E1]flk-1[/E1]/KDR) tyrosine-autophosphorylation by [E2]VEGF[/E2] which was maximal after 5 minutes and was followed by receptor downregulation.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "flk-1", "entity_1_idx": [[69, 74]], "entity_1_idx_in_text_with_entity_marker": [73, 78], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "VEGF", "entity_2_idx": [[112, 116]], "entity_2_idx_in_text_with_entity_marker": [125, 129], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d99.s0_BioInfer.d99.s0.p5", "text": "Biochemical analyses revealed a strong induction of VEGF-receptor-2 (flk-1/KDR) tyrosine-autophosphorylation by VEGF which was maximal after 5 minutes and was followed by receptor downregulation.", "text_with_entity_marker": "Biochemical analyses revealed a strong induction of VEGF-receptor-2 ([E1]flk-1[/E1]/[E2]KDR[/E2]) tyrosine-autophosphorylation by VEGF which was maximal after 5 minutes and was followed by receptor downregulation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "flk-1", "entity_1_idx": [[69, 74]], "entity_1_idx_in_text_with_entity_marker": [73, 78], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "KDR", "entity_2_idx": [[75, 78]], "entity_2_idx_in_text_with_entity_marker": [88, 91], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d393.s0_BioInfer.d393.s0.p0", "text": "Isolation of human skeletal muscle myosin heavy chain and actin for measurement of fractional synthesis rates.", "text_with_entity_marker": "Isolation of human [E1]skeletal muscle myosin heavy chain[/E1] and [E2]actin[/E2] for measurement of fractional synthesis rates.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "skeletal muscle myosin heavy chain", "entity_1_idx": [[19, 53]], "entity_1_idx_in_text_with_entity_marker": [23, 57], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[58, 63]], "entity_2_idx_in_text_with_entity_marker": [71, 76], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d393.s1_BioInfer.d393.s1.p0", "text": "Using sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), we have developed a simple method to isolate myosin heavy chain (MHC) and actin from small (60-80 mg) human skeletal muscle samples for the determination of their fractional synthesis rates.", "text_with_entity_marker": "Using sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), we have developed a simple method to isolate [E1]myosin heavy chain[/E1] (MHC) and [E2]actin[/E2] from small (60-80 mg) human skeletal muscle samples for the determination of their fractional synthesis rates.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin heavy chain", "entity_1_idx": [[121, 139]], "entity_1_idx_in_text_with_entity_marker": [125, 143], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[150, 155]], "entity_2_idx_in_text_with_entity_marker": [163, 168], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d393.s1_BioInfer.d393.s1.p1", "text": "Using sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), we have developed a simple method to isolate myosin heavy chain (MHC) and actin from small (60-80 mg) human skeletal muscle samples for the determination of their fractional synthesis rates.", "text_with_entity_marker": "Using sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), we have developed a simple method to isolate myosin heavy chain ([E1]MHC[/E1]) and [E2]actin[/E2] from small (60-80 mg) human skeletal muscle samples for the determination of their fractional synthesis rates.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MHC", "entity_1_idx": [[141, 144]], "entity_1_idx_in_text_with_entity_marker": [145, 148], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[150, 155]], "entity_2_idx_in_text_with_entity_marker": [163, 168], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d393.s1_BioInfer.d393.s1.p2", "text": "Using sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), we have developed a simple method to isolate myosin heavy chain (MHC) and actin from small (60-80 mg) human skeletal muscle samples for the determination of their fractional synthesis rates.", "text_with_entity_marker": "Using sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), we have developed a simple method to isolate [E1]myosin heavy chain[/E1] ([E2]MHC[/E2]) and actin from small (60-80 mg) human skeletal muscle samples for the determination of their fractional synthesis rates.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin heavy chain", "entity_1_idx": [[121, 139]], "entity_1_idx_in_text_with_entity_marker": [125, 143], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "MHC", "entity_2_idx": [[141, 144]], "entity_2_idx_in_text_with_entity_marker": [154, 157], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d389.s0_BioInfer.d389.s0.p0", "text": "Involvement of profilin in the actin-based motility of L. monocytogenes in cells and in cell-free extracts.", "text_with_entity_marker": "Involvement of [E1]profilin[/E1] in the [E2]actin[/E2]-based motility of L. monocytogenes in cells and in cell-free extracts.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[15, 23]], "entity_1_idx_in_text_with_entity_marker": [19, 27], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[31, 36]], "entity_2_idx_in_text_with_entity_marker": [44, 49], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d422.s0_BioInfer.d422.s0.p50", "text": "METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of cyclin D1, Rb, p16INK4, p27KIP1, and PCNA; the cell-cell adhesion molecules of E-cadherin, alpha-catenin, and beta-catenin; and the heat shock proteins of HSP27 and HSP70.", "text_with_entity_marker": "METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of cyclin D1, [E1]Rb[/E1], p16INK4, p27KIP1, and PCNA; the cell-cell adhesion molecules of E-cadherin, [E2]alpha-catenin[/E2], and beta-catenin; and the heat shock proteins of HSP27 and HSP70.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Rb", "entity_1_idx": [[206, 208]], "entity_1_idx_in_text_with_entity_marker": [210, 212], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[286, 299]], "entity_2_idx_in_text_with_entity_marker": [299, 312], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d422.s0_BioInfer.d422.s0.p51", "text": "METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of cyclin D1, Rb, p16INK4, p27KIP1, and PCNA; the cell-cell adhesion molecules of E-cadherin, alpha-catenin, and beta-catenin; and the heat shock proteins of HSP27 and HSP70.", "text_with_entity_marker": "METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of cyclin D1, Rb, p16INK4, p27KIP1, and PCNA; the cell-cell adhesion molecules of E-cadherin, [E1]alpha-catenin[/E1], and beta-catenin; and the heat shock proteins of HSP27 and [E2]HSP70[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[286, 299]], "entity_1_idx_in_text_with_entity_marker": [290, 303], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "HSP70", "entity_2_idx": [[360, 365]], "entity_2_idx_in_text_with_entity_marker": [373, 378], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d422.s0_BioInfer.d422.s0.p52", "text": "METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of cyclin D1, Rb, p16INK4, p27KIP1, and PCNA; the cell-cell adhesion molecules of E-cadherin, alpha-catenin, and beta-catenin; and the heat shock proteins of HSP27 and HSP70.", "text_with_entity_marker": "METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of cyclin D1, [E1]Rb[/E1], p16INK4, [E2]p27KIP1[/E2], and PCNA; the cell-cell adhesion molecules of E-cadherin, alpha-catenin, and beta-catenin; and the heat shock proteins of HSP27 and HSP70.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Rb", "entity_1_idx": [[206, 208]], "entity_1_idx_in_text_with_entity_marker": [210, 212], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "p27KIP1", "entity_2_idx": [[219, 226]], "entity_2_idx_in_text_with_entity_marker": [232, 239], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d422.s0_BioInfer.d422.s0.p53", "text": "METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of cyclin D1, Rb, p16INK4, p27KIP1, and PCNA; the cell-cell adhesion molecules of E-cadherin, alpha-catenin, and beta-catenin; and the heat shock proteins of HSP27 and HSP70.", "text_with_entity_marker": "METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of cyclin D1, Rb, p16INK4, [E1]p27KIP1[/E1], and PCNA; the cell-cell adhesion molecules of E-cadherin, alpha-catenin, and beta-catenin; and the heat shock proteins of HSP27 and [E2]HSP70[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p27KIP1", "entity_1_idx": [[219, 226]], "entity_1_idx_in_text_with_entity_marker": [223, 230], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "HSP70", "entity_2_idx": [[360, 365]], "entity_2_idx_in_text_with_entity_marker": [373, 378], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d422.s0_BioInfer.d422.s0.p54", "text": "METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of cyclin D1, Rb, p16INK4, p27KIP1, and PCNA; the cell-cell adhesion molecules of E-cadherin, alpha-catenin, and beta-catenin; and the heat shock proteins of HSP27 and HSP70.", "text_with_entity_marker": "METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of cyclin D1, [E1]Rb[/E1], p16INK4, p27KIP1, and PCNA; the cell-cell adhesion molecules of E-cadherin, alpha-catenin, and beta-catenin; and the heat shock proteins of HSP27 and [E2]HSP70[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Rb", "entity_1_idx": [[206, 208]], "entity_1_idx_in_text_with_entity_marker": [210, 212], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "HSP70", "entity_2_idx": [[360, 365]], "entity_2_idx_in_text_with_entity_marker": [373, 378], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d108.s0_BioInfer.d108.s0.p20", "text": "Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).", "text_with_entity_marker": "Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase [E1]VEGF receptor 2[/E1] ([E2]VEGFR-2[/E2]).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "VEGF receptor 2", "entity_1_idx": [[174, 189]], "entity_1_idx_in_text_with_entity_marker": [178, 193], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "VEGFR-2", "entity_2_idx": [[191, 198]], "entity_2_idx_in_text_with_entity_marker": [204, 211], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d108.s0_BioInfer.d108.s0.p21", "text": "Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).", "text_with_entity_marker": "Neuropilin 1 (NP-1) is a receptor for [E1]vascular endothelial growth factor[/E1] (VEGF) 165 ([E2]VEGF165[/E2]) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "vascular endothelial growth factor", "entity_1_idx": [[38, 72], [80, 83]], "entity_1_idx_in_text_with_entity_marker": [42, 76], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "VEGF165", "entity_2_idx": [[85, 92]], "entity_2_idx_in_text_with_entity_marker": [98, 105], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d108.s0_BioInfer.d108.s0.p22", "text": "Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).", "text_with_entity_marker": "Neuropilin 1 (NP-1) is a receptor for [E1]vascular endothelial growth factor[/E1] (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances [E2]VEGF165[/E2] function through tyrosine kinase VEGF receptor 2 (VEGFR-2).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "vascular endothelial growth factor", "entity_1_idx": [[38, 72], [80, 83]], "entity_1_idx_in_text_with_entity_marker": [42, 76], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "VEGF165", "entity_2_idx": [[133, 140]], "entity_2_idx_in_text_with_entity_marker": [146, 153], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d108.s0_BioInfer.d108.s0.p23", "text": "Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).", "text_with_entity_marker": "Neuropilin 1 (NP-1) is a receptor for [E1]vascular endothelial growth factor[/E1] ([E2]VEGF[/E2]) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "vascular endothelial growth factor", "entity_1_idx": [[38, 72], [80, 83]], "entity_1_idx_in_text_with_entity_marker": [42, 76], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "VEGF", "entity_2_idx": [[74, 78]], "entity_2_idx_in_text_with_entity_marker": [87, 91], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d108.s0_BioInfer.d108.s0.p24", "text": "Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).", "text_with_entity_marker": "Neuropilin 1 (NP-1) is a receptor for [E1]vascular endothelial growth factor[/E1] (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through [E2]tyrosine kinase[/E2] VEGF receptor 2 (VEGFR-2).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "vascular endothelial growth factor", "entity_1_idx": [[38, 72], [80, 83]], "entity_1_idx_in_text_with_entity_marker": [42, 76], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "tyrosine kinase", "entity_2_idx": [[158, 173]], "entity_2_idx_in_text_with_entity_marker": [171, 186], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d108.s0_BioInfer.d108.s0.p25", "text": "Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).", "text_with_entity_marker": "Neuropilin 1 (NP-1) is a receptor for [E1]vascular endothelial growth factor[/E1] (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase [E2]VEGF receptor 2[/E2] (VEGFR-2).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "vascular endothelial growth factor", "entity_1_idx": [[38, 72], [80, 83]], "entity_1_idx_in_text_with_entity_marker": [42, 76], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "VEGF receptor 2", "entity_2_idx": [[174, 189]], "entity_2_idx_in_text_with_entity_marker": [187, 202], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d108.s0_BioInfer.d108.s0.p26", "text": "Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).", "text_with_entity_marker": "Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) 165 ([E1]VEGF165[/E1]) and acts as a coreceptor that enhances [E2]VEGF165[/E2] function through tyrosine kinase VEGF receptor 2 (VEGFR-2).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "VEGF165", "entity_1_idx": [[85, 92]], "entity_1_idx_in_text_with_entity_marker": [89, 96], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "VEGF165", "entity_2_idx": [[133, 140]], "entity_2_idx_in_text_with_entity_marker": [146, 153], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d108.s0_BioInfer.d108.s0.p27", "text": "Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).", "text_with_entity_marker": "Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor ([E1]VEGF[/E1]) 165 ([E2]VEGF165[/E2]) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "VEGF", "entity_1_idx": [[74, 78]], "entity_1_idx_in_text_with_entity_marker": [78, 82], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "VEGF165", "entity_2_idx": [[85, 92]], "entity_2_idx_in_text_with_entity_marker": [98, 105], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d108.s0_BioInfer.d108.s0.p28", "text": "Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).", "text_with_entity_marker": "Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) 165 ([E1]VEGF165[/E1]) and acts as a coreceptor that enhances VEGF165 function through [E2]tyrosine kinase[/E2] VEGF receptor 2 (VEGFR-2).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "VEGF165", "entity_1_idx": [[85, 92]], "entity_1_idx_in_text_with_entity_marker": [89, 96], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "tyrosine kinase", "entity_2_idx": [[158, 173]], "entity_2_idx_in_text_with_entity_marker": [171, 186], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d108.s0_BioInfer.d108.s0.p29", "text": "Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).", "text_with_entity_marker": "Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) 165 ([E1]VEGF165[/E1]) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase [E2]VEGF receptor 2[/E2] (VEGFR-2).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "VEGF165", "entity_1_idx": [[85, 92]], "entity_1_idx_in_text_with_entity_marker": [89, 96], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "VEGF receptor 2", "entity_2_idx": [[174, 189]], "entity_2_idx_in_text_with_entity_marker": [187, 202], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d237.s0_BioInfer.d237.s0.p0", "text": "Here, specific interactions between human RAD51 and RAD52 proteins are demonstrated both in vivo, using the yeast two-hybrid system and immunoprecipitation of insect cells co-infected with RAD51 and RAD52 recombinant viruses, and in vitro, using affinity chromatography with purified recombinant proteins.", "text_with_entity_marker": "Here, specific interactions between human RAD51 and RAD52 proteins are demonstrated both in vivo, using the yeast two-hybrid system and immunoprecipitation of insect cells co-infected with [E1]RAD51[/E1] and [E2]RAD52[/E2] recombinant viruses, and in vitro, using affinity chromatography with purified recombinant proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD51", "entity_1_idx": [[189, 194]], "entity_1_idx_in_text_with_entity_marker": [193, 198], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD52", "entity_2_idx": [[199, 204]], "entity_2_idx_in_text_with_entity_marker": [212, 217], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d237.s0_BioInfer.d237.s0.p1", "text": "Here, specific interactions between human RAD51 and RAD52 proteins are demonstrated both in vivo, using the yeast two-hybrid system and immunoprecipitation of insect cells co-infected with RAD51 and RAD52 recombinant viruses, and in vitro, using affinity chromatography with purified recombinant proteins.", "text_with_entity_marker": "Here, specific interactions between human RAD51 and [E1]RAD52[/E1] proteins are demonstrated both in vivo, using the yeast two-hybrid system and immunoprecipitation of insect cells co-infected with RAD51 and [E2]RAD52[/E2] recombinant viruses, and in vitro, using affinity chromatography with purified recombinant proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD52", "entity_1_idx": [[52, 57]], "entity_1_idx_in_text_with_entity_marker": [56, 61], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "RAD52", "entity_2_idx": [[199, 204]], "entity_2_idx_in_text_with_entity_marker": [212, 217], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d237.s0_BioInfer.d237.s0.p2", "text": "Here, specific interactions between human RAD51 and RAD52 proteins are demonstrated both in vivo, using the yeast two-hybrid system and immunoprecipitation of insect cells co-infected with RAD51 and RAD52 recombinant viruses, and in vitro, using affinity chromatography with purified recombinant proteins.", "text_with_entity_marker": "Here, specific interactions between human [E1]RAD51[/E1] and RAD52 proteins are demonstrated both in vivo, using the yeast two-hybrid system and immunoprecipitation of insect cells co-infected with RAD51 and [E2]RAD52[/E2] recombinant viruses, and in vitro, using affinity chromatography with purified recombinant proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD51", "entity_1_idx": [[42, 47]], "entity_1_idx_in_text_with_entity_marker": [46, 51], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "RAD52", "entity_2_idx": [[199, 204]], "entity_2_idx_in_text_with_entity_marker": [212, 217], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d237.s0_BioInfer.d237.s0.p3", "text": "Here, specific interactions between human RAD51 and RAD52 proteins are demonstrated both in vivo, using the yeast two-hybrid system and immunoprecipitation of insect cells co-infected with RAD51 and RAD52 recombinant viruses, and in vitro, using affinity chromatography with purified recombinant proteins.", "text_with_entity_marker": "Here, specific interactions between human RAD51 and [E1]RAD52[/E1] proteins are demonstrated both in vivo, using the yeast two-hybrid system and immunoprecipitation of insect cells co-infected with [E2]RAD51[/E2] and RAD52 recombinant viruses, and in vitro, using affinity chromatography with purified recombinant proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD52", "entity_1_idx": [[52, 57]], "entity_1_idx_in_text_with_entity_marker": [56, 61], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "RAD51", "entity_2_idx": [[189, 194]], "entity_2_idx_in_text_with_entity_marker": [202, 207], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d237.s0_BioInfer.d237.s0.p4", "text": "Here, specific interactions between human RAD51 and RAD52 proteins are demonstrated both in vivo, using the yeast two-hybrid system and immunoprecipitation of insect cells co-infected with RAD51 and RAD52 recombinant viruses, and in vitro, using affinity chromatography with purified recombinant proteins.", "text_with_entity_marker": "Here, specific interactions between human [E1]RAD51[/E1] and RAD52 proteins are demonstrated both in vivo, using the yeast two-hybrid system and immunoprecipitation of insect cells co-infected with [E2]RAD51[/E2] and RAD52 recombinant viruses, and in vitro, using affinity chromatography with purified recombinant proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD51", "entity_1_idx": [[42, 47]], "entity_1_idx_in_text_with_entity_marker": [46, 51], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "RAD51", "entity_2_idx": [[189, 194]], "entity_2_idx_in_text_with_entity_marker": [202, 207], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d237.s0_BioInfer.d237.s0.p5", "text": "Here, specific interactions between human RAD51 and RAD52 proteins are demonstrated both in vivo, using the yeast two-hybrid system and immunoprecipitation of insect cells co-infected with RAD51 and RAD52 recombinant viruses, and in vitro, using affinity chromatography with purified recombinant proteins.", "text_with_entity_marker": "Here, specific interactions between human [E1]RAD51[/E1] and [E2]RAD52[/E2] proteins are demonstrated both in vivo, using the yeast two-hybrid system and immunoprecipitation of insect cells co-infected with RAD51 and RAD52 recombinant viruses, and in vitro, using affinity chromatography with purified recombinant proteins.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "RAD51", "entity_1_idx": [[42, 47]], "entity_1_idx_in_text_with_entity_marker": [46, 51], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "RAD52", "entity_2_idx": [[52, 57]], "entity_2_idx_in_text_with_entity_marker": [65, 70], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d237.s1_BioInfer.d237.s1.p0", "text": "Interaction of the yeast RAD51 and RAD52 proteins plays a crucial role in yeast DNA homologous recombination and DNA double-strand break repair.", "text_with_entity_marker": "Interaction of the yeast [E1]RAD51[/E1] and [E2]RAD52[/E2] proteins plays a crucial role in yeast DNA homologous recombination and DNA double-strand break repair.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "RAD51", "entity_1_idx": [[25, 30]], "entity_1_idx_in_text_with_entity_marker": [29, 34], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RAD52", "entity_2_idx": [[35, 40]], "entity_2_idx_in_text_with_entity_marker": [48, 53], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d237.s2_BioInfer.d237.s2.p0", "text": "Specific interactions between the human RAD51 and RAD52 proteins.", "text_with_entity_marker": "Specific interactions between the human [E1]RAD51[/E1] and [E2]RAD52[/E2] proteins.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "RAD51", "entity_1_idx": [[40, 45]], "entity_1_idx_in_text_with_entity_marker": [44, 49], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RAD52", "entity_2_idx": [[50, 55]], "entity_2_idx_in_text_with_entity_marker": [63, 68], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d237.s3_BioInfer.d237.s3.p0", "text": "The RAD51-interacting region (amino acids 291-330) of the human RAD52 protein shows no homology with the yeast RAD52 protein, indicating that the interaction between RAD51 and RAD52 is species-specific.", "text_with_entity_marker": "The RAD51-interacting region (amino acids 291-330) of the human [E1]RAD52[/E1] protein shows no homology with the yeast [E2]RAD52[/E2] protein, indicating that the interaction between RAD51 and RAD52 is species-specific.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "RAD52", "entity_1_idx": [[64, 69]], "entity_1_idx_in_text_with_entity_marker": [68, 73], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RAD52", "entity_2_idx": [[111, 116]], "entity_2_idx_in_text_with_entity_marker": [124, 129], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d237.s3_BioInfer.d237.s3.p1", "text": "The RAD51-interacting region (amino acids 291-330) of the human RAD52 protein shows no homology with the yeast RAD52 protein, indicating that the interaction between RAD51 and RAD52 is species-specific.", "text_with_entity_marker": "The RAD51-interacting region (amino acids 291-330) of the human RAD52 protein shows no homology with the yeast [E1]RAD52[/E1] protein, indicating that the interaction between [E2]RAD51[/E2] and RAD52 is species-specific.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD52", "entity_1_idx": [[111, 116]], "entity_1_idx_in_text_with_entity_marker": [115, 120], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RAD51", "entity_2_idx": [[166, 171]], "entity_2_idx_in_text_with_entity_marker": [179, 184], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d237.s3_BioInfer.d237.s3.p2", "text": "The RAD51-interacting region (amino acids 291-330) of the human RAD52 protein shows no homology with the yeast RAD52 protein, indicating that the interaction between RAD51 and RAD52 is species-specific.", "text_with_entity_marker": "The RAD51-interacting region (amino acids 291-330) of the human RAD52 protein shows no homology with the yeast [E1]RAD52[/E1] protein, indicating that the interaction between RAD51 and [E2]RAD52[/E2] is species-specific.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD52", "entity_1_idx": [[111, 116]], "entity_1_idx_in_text_with_entity_marker": [115, 120], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RAD52", "entity_2_idx": [[176, 181]], "entity_2_idx_in_text_with_entity_marker": [189, 194], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d237.s3_BioInfer.d237.s3.p3", "text": "The RAD51-interacting region (amino acids 291-330) of the human RAD52 protein shows no homology with the yeast RAD52 protein, indicating that the interaction between RAD51 and RAD52 is species-specific.", "text_with_entity_marker": "The [E1]RAD51[/E1]-interacting region (amino acids 291-330) of the human RAD52 protein shows no homology with the yeast [E2]RAD52[/E2] protein, indicating that the interaction between RAD51 and RAD52 is species-specific.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD51", "entity_1_idx": [[4, 9]], "entity_1_idx_in_text_with_entity_marker": [8, 13], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RAD52", "entity_2_idx": [[111, 116]], "entity_2_idx_in_text_with_entity_marker": [124, 129], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d237.s3_BioInfer.d237.s3.p4", "text": "The RAD51-interacting region (amino acids 291-330) of the human RAD52 protein shows no homology with the yeast RAD52 protein, indicating that the interaction between RAD51 and RAD52 is species-specific.", "text_with_entity_marker": "The RAD51-interacting region (amino acids 291-330) of the human [E1]RAD52[/E1] protein shows no homology with the yeast RAD52 protein, indicating that the interaction between [E2]RAD51[/E2] and RAD52 is species-specific.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD52", "entity_1_idx": [[64, 69]], "entity_1_idx_in_text_with_entity_marker": [68, 73], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RAD51", "entity_2_idx": [[166, 171]], "entity_2_idx_in_text_with_entity_marker": [179, 184], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d237.s3_BioInfer.d237.s3.p5", "text": "The RAD51-interacting region (amino acids 291-330) of the human RAD52 protein shows no homology with the yeast RAD52 protein, indicating that the interaction between RAD51 and RAD52 is species-specific.", "text_with_entity_marker": "The RAD51-interacting region (amino acids 291-330) of the human [E1]RAD52[/E1] protein shows no homology with the yeast RAD52 protein, indicating that the interaction between RAD51 and [E2]RAD52[/E2] is species-specific.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD52", "entity_1_idx": [[64, 69]], "entity_1_idx_in_text_with_entity_marker": [68, 73], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RAD52", "entity_2_idx": [[176, 181]], "entity_2_idx_in_text_with_entity_marker": [189, 194], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d237.s3_BioInfer.d237.s3.p6", "text": "The RAD51-interacting region (amino acids 291-330) of the human RAD52 protein shows no homology with the yeast RAD52 protein, indicating that the interaction between RAD51 and RAD52 is species-specific.", "text_with_entity_marker": "The [E1]RAD51[/E1]-interacting region (amino acids 291-330) of the human [E2]RAD52[/E2] protein shows no homology with the yeast RAD52 protein, indicating that the interaction between RAD51 and RAD52 is species-specific.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "RAD51", "entity_1_idx": [[4, 9]], "entity_1_idx_in_text_with_entity_marker": [8, 13], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RAD52", "entity_2_idx": [[64, 69]], "entity_2_idx_in_text_with_entity_marker": [77, 82], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d237.s3_BioInfer.d237.s3.p7", "text": "The RAD51-interacting region (amino acids 291-330) of the human RAD52 protein shows no homology with the yeast RAD52 protein, indicating that the interaction between RAD51 and RAD52 is species-specific.", "text_with_entity_marker": "The RAD51-interacting region (amino acids 291-330) of the human RAD52 protein shows no homology with the yeast RAD52 protein, indicating that the interaction between [E1]RAD51[/E1] and [E2]RAD52[/E2] is species-specific.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "RAD51", "entity_1_idx": [[166, 171]], "entity_1_idx_in_text_with_entity_marker": [170, 175], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RAD52", "entity_2_idx": [[176, 181]], "entity_2_idx_in_text_with_entity_marker": [189, 194], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d237.s3_BioInfer.d237.s3.p8", "text": "The RAD51-interacting region (amino acids 291-330) of the human RAD52 protein shows no homology with the yeast RAD52 protein, indicating that the interaction between RAD51 and RAD52 is species-specific.", "text_with_entity_marker": "The [E1]RAD51[/E1]-interacting region (amino acids 291-330) of the human RAD52 protein shows no homology with the yeast RAD52 protein, indicating that the interaction between [E2]RAD51[/E2] and RAD52 is species-specific.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD51", "entity_1_idx": [[4, 9]], "entity_1_idx_in_text_with_entity_marker": [8, 13], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RAD51", "entity_2_idx": [[166, 171]], "entity_2_idx_in_text_with_entity_marker": [179, 184], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d237.s3_BioInfer.d237.s3.p9", "text": "The RAD51-interacting region (amino acids 291-330) of the human RAD52 protein shows no homology with the yeast RAD52 protein, indicating that the interaction between RAD51 and RAD52 is species-specific.", "text_with_entity_marker": "The [E1]RAD51[/E1]-interacting region (amino acids 291-330) of the human RAD52 protein shows no homology with the yeast RAD52 protein, indicating that the interaction between RAD51 and [E2]RAD52[/E2] is species-specific.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD51", "entity_1_idx": [[4, 9]], "entity_1_idx_in_text_with_entity_marker": [8, 13], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RAD52", "entity_2_idx": [[176, 181]], "entity_2_idx_in_text_with_entity_marker": [189, 194], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d237.s4_BioInfer.d237.s4.p0", "text": "These results suggest that RAD52 may modulate the catalytic activities of RAD51 protein such as homologous pairing and strand exchange through a direct physical interaction.", "text_with_entity_marker": "These results suggest that [E1]RAD52[/E1] may modulate the catalytic activities of [E2]RAD51[/E2] protein such as homologous pairing and strand exchange through a direct physical interaction.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "RAD52", "entity_1_idx": [[27, 32]], "entity_1_idx_in_text_with_entity_marker": [31, 36], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "RAD51", "entity_2_idx": [[74, 79]], "entity_2_idx_in_text_with_entity_marker": [87, 92], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d465.s1_BioInfer.d465.s1.p12", "text": "We observed that four replication proteins, UL5, UL8 UL52, and UL9, are necessary for the localization of ICP8 (UL29) to prereplicative sites natural infection conditions.", "text_with_entity_marker": "We observed that four replication proteins, UL5, [E1]UL8[/E1] [E2]UL52[/E2], and UL9, are necessary for the localization of ICP8 (UL29) to prereplicative sites natural infection conditions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL8", "entity_1_idx": [[49, 52]], "entity_1_idx_in_text_with_entity_marker": [53, 56], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "UL52", "entity_2_idx": [[53, 57]], "entity_2_idx_in_text_with_entity_marker": [66, 70], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d465.s1_BioInfer.d465.s1.p13", "text": "We observed that four replication proteins, UL5, UL8 UL52, and UL9, are necessary for the localization of ICP8 (UL29) to prereplicative sites natural infection conditions.", "text_with_entity_marker": "We observed that four replication proteins, [E1]UL5[/E1], UL8 [E2]UL52[/E2], and UL9, are necessary for the localization of ICP8 (UL29) to prereplicative sites natural infection conditions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL5", "entity_1_idx": [[44, 47]], "entity_1_idx_in_text_with_entity_marker": [48, 51], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "UL52", "entity_2_idx": [[53, 57]], "entity_2_idx_in_text_with_entity_marker": [66, 70], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d465.s1_BioInfer.d465.s1.p14", "text": "We observed that four replication proteins, UL5, UL8 UL52, and UL9, are necessary for the localization of ICP8 (UL29) to prereplicative sites natural infection conditions.", "text_with_entity_marker": "We observed that four replication proteins, [E1]UL5[/E1], [E2]UL8[/E2] UL52, and UL9, are necessary for the localization of ICP8 (UL29) to prereplicative sites natural infection conditions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL5", "entity_1_idx": [[44, 47]], "entity_1_idx_in_text_with_entity_marker": [48, 51], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "UL8", "entity_2_idx": [[49, 52]], "entity_2_idx_in_text_with_entity_marker": [62, 65], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d651.s0_BioInfer.d651.s0.p20", "text": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "text_with_entity_marker": "The neoplastic cells were positive for [E1]vimentin[/E1], [E2]Factor-XIIIa[/E2], alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "vimentin", "entity_1_idx": [[39, 47]], "entity_1_idx_in_text_with_entity_marker": [43, 51], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "Factor-XIIIa", "entity_2_idx": [[49, 61]], "entity_2_idx_in_text_with_entity_marker": [62, 74], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d651.s0_BioInfer.d651.s0.p21", "text": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "text_with_entity_marker": "The neoplastic cells were positive for [E1]vimentin[/E1], Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for [E2]desmin[/E2], calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "vimentin", "entity_1_idx": [[39, 47]], "entity_1_idx_in_text_with_entity_marker": [43, 51], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "desmin", "entity_2_idx": [[116, 122]], "entity_2_idx_in_text_with_entity_marker": [129, 135], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d651.s0_BioInfer.d651.s0.p22", "text": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "text_with_entity_marker": "The neoplastic cells were positive for [E1]vimentin[/E1], Factor-XIIIa, alpha-smooth muscle actin and [E2]CD34[/E2], but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "vimentin", "entity_1_idx": [[39, 47]], "entity_1_idx_in_text_with_entity_marker": [43, 51], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "CD34", "entity_2_idx": [[93, 97]], "entity_2_idx_in_text_with_entity_marker": [106, 110], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d651.s0_BioInfer.d651.s0.p23", "text": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "text_with_entity_marker": "The neoplastic cells were positive for [E1]vimentin[/E1], Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, [E2]high molecular weight caldesmon[/E2], smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "vimentin", "entity_1_idx": [[39, 47]], "entity_1_idx_in_text_with_entity_marker": [43, 51], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "high molecular weight caldesmon", "entity_2_idx": [[134, 165]], "entity_2_idx_in_text_with_entity_marker": [147, 178], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d651.s0_BioInfer.d651.s0.p24", "text": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "text_with_entity_marker": "The neoplastic cells were positive for [E1]vimentin[/E1], Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, [E2]calponin[/E2], high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "vimentin", "entity_1_idx": [[39, 47]], "entity_1_idx_in_text_with_entity_marker": [43, 51], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "calponin", "entity_2_idx": [[124, 132]], "entity_2_idx_in_text_with_entity_marker": [137, 145], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d651.s0_BioInfer.d651.s0.p25", "text": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "text_with_entity_marker": "The neoplastic cells were positive for [E1]vimentin[/E1], Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, [E2]collagen type IV[/E2], laminin and S-100 protein.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "vimentin", "entity_1_idx": [[39, 47]], "entity_1_idx_in_text_with_entity_marker": [43, 51], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "collagen type IV", "entity_2_idx": [[201, 217]], "entity_2_idx_in_text_with_entity_marker": [214, 230], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d651.s0_BioInfer.d651.s0.p26", "text": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "text_with_entity_marker": "The neoplastic cells were positive for [E1]vimentin[/E1], Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, [E2]laminin[/E2] and S-100 protein.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "vimentin", "entity_1_idx": [[39, 47]], "entity_1_idx_in_text_with_entity_marker": [43, 51], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "laminin", "entity_2_idx": [[219, 226]], "entity_2_idx_in_text_with_entity_marker": [232, 239], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d651.s0_BioInfer.d651.s0.p27", "text": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "text_with_entity_marker": "The neoplastic cells were positive for vimentin, [E1]Factor-XIIIa[/E1], [E2]alpha-smooth muscle actin[/E2] and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Factor-XIIIa", "entity_1_idx": [[49, 61]], "entity_1_idx_in_text_with_entity_marker": [53, 65], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-smooth muscle actin", "entity_2_idx": [[63, 88]], "entity_2_idx_in_text_with_entity_marker": [76, 101], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d651.s0_BioInfer.d651.s0.p28", "text": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "text_with_entity_marker": "The neoplastic cells were positive for vimentin, Factor-XIIIa, [E1]alpha-smooth muscle actin[/E1] and CD34, but negative for [E2]desmin[/E2], calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-smooth muscle actin", "entity_1_idx": [[63, 88]], "entity_1_idx_in_text_with_entity_marker": [67, 92], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "desmin", "entity_2_idx": [[116, 122]], "entity_2_idx_in_text_with_entity_marker": [129, 135], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d651.s0_BioInfer.d651.s0.p29", "text": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "text_with_entity_marker": "The neoplastic cells were positive for vimentin, Factor-XIIIa, [E1]alpha-smooth muscle actin[/E1] and [E2]CD34[/E2], but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-smooth muscle actin", "entity_1_idx": [[63, 88]], "entity_1_idx_in_text_with_entity_marker": [67, 92], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "CD34", "entity_2_idx": [[93, 97]], "entity_2_idx_in_text_with_entity_marker": [106, 110], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d704.s0_BioInfer.d704.s0.p0", "text": "These proteins each have a verprolin-homology (V) domain, cofilin-homology (C) domain and an acidic (A) region at the C-terminus, through which they activate the Arp2/3 complex, leading to rapid actin polymerization.", "text_with_entity_marker": "These proteins each have a [E1]verprolin[/E1]-homology (V) domain, cofilin-homology (C) domain and an acidic (A) region at the C-terminus, through which they activate the [E2]Arp2[/E2]/3 complex, leading to rapid actin polymerization.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "verprolin", "entity_1_idx": [[27, 36]], "entity_1_idx_in_text_with_entity_marker": [31, 40], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "Arp2", "entity_2_idx": [[162, 166]], "entity_2_idx_in_text_with_entity_marker": [175, 179], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d704.s0_BioInfer.d704.s0.p1", "text": "These proteins each have a verprolin-homology (V) domain, cofilin-homology (C) domain and an acidic (A) region at the C-terminus, through which they activate the Arp2/3 complex, leading to rapid actin polymerization.", "text_with_entity_marker": "These proteins each have a [E1]verprolin[/E1]-homology (V) domain, cofilin-homology (C) domain and an acidic (A) region at the C-terminus, through which they activate the Arp2/3 complex, leading to rapid [E2]actin[/E2] polymerization.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "verprolin", "entity_1_idx": [[27, 36]], "entity_1_idx_in_text_with_entity_marker": [31, 40], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[195, 200]], "entity_2_idx_in_text_with_entity_marker": [208, 213], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d704.s0_BioInfer.d704.s0.p2", "text": "These proteins each have a verprolin-homology (V) domain, cofilin-homology (C) domain and an acidic (A) region at the C-terminus, through which they activate the Arp2/3 complex, leading to rapid actin polymerization.", "text_with_entity_marker": "These proteins each have a [E1]verprolin[/E1]-homology (V) domain, [E2]cofilin[/E2]-homology (C) domain and an acidic (A) region at the C-terminus, through which they activate the Arp2/3 complex, leading to rapid actin polymerization.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "verprolin", "entity_1_idx": [[27, 36]], "entity_1_idx_in_text_with_entity_marker": [31, 40], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "cofilin", "entity_2_idx": [[58, 65]], "entity_2_idx_in_text_with_entity_marker": [71, 78], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d704.s0_BioInfer.d704.s0.p3", "text": "These proteins each have a verprolin-homology (V) domain, cofilin-homology (C) domain and an acidic (A) region at the C-terminus, through which they activate the Arp2/3 complex, leading to rapid actin polymerization.", "text_with_entity_marker": "These proteins each have a [E1]verprolin[/E1]-homology (V) domain, cofilin-homology (C) domain and an acidic (A) region at the C-terminus, through which they activate the [E2]Arp[/E2]2/3 complex, leading to rapid actin polymerization.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "verprolin", "entity_1_idx": [[27, 36]], "entity_1_idx_in_text_with_entity_marker": [31, 40], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "Arp", "entity_2_idx": [[162, 165], [167, 168]], "entity_2_idx_in_text_with_entity_marker": [175, 178], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d704.s0_BioInfer.d704.s0.p4", "text": "These proteins each have a verprolin-homology (V) domain, cofilin-homology (C) domain and an acidic (A) region at the C-terminus, through which they activate the Arp2/3 complex, leading to rapid actin polymerization.", "text_with_entity_marker": "These proteins each have a verprolin-homology (V) domain, cofilin-homology (C) domain and an acidic (A) region at the C-terminus, through which they activate the [E1]Arp2[/E1]/3 complex, leading to rapid [E2]actin[/E2] polymerization.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Arp2", "entity_1_idx": [[162, 166]], "entity_1_idx_in_text_with_entity_marker": [166, 170], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[195, 200]], "entity_2_idx_in_text_with_entity_marker": [208, 213], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d704.s0_BioInfer.d704.s0.p5", "text": "These proteins each have a verprolin-homology (V) domain, cofilin-homology (C) domain and an acidic (A) region at the C-terminus, through which they activate the Arp2/3 complex, leading to rapid actin polymerization.", "text_with_entity_marker": "These proteins each have a verprolin-homology (V) domain, [E1]cofilin[/E1]-homology (C) domain and an acidic (A) region at the C-terminus, through which they activate the [E2]Arp2[/E2]/3 complex, leading to rapid actin polymerization.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[58, 65]], "entity_1_idx_in_text_with_entity_marker": [62, 69], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "Arp2", "entity_2_idx": [[162, 166]], "entity_2_idx_in_text_with_entity_marker": [175, 179], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d704.s0_BioInfer.d704.s0.p6", "text": "These proteins each have a verprolin-homology (V) domain, cofilin-homology (C) domain and an acidic (A) region at the C-terminus, through which they activate the Arp2/3 complex, leading to rapid actin polymerization.", "text_with_entity_marker": "These proteins each have a verprolin-homology (V) domain, cofilin-homology (C) domain and an acidic (A) region at the C-terminus, through which they activate the [E1-E2]Arp[/E1]2[/E2]/3 complex, leading to rapid actin polymerization.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Arp", "entity_1_idx": [[162, 165], [167, 168]], "entity_1_idx_in_text_with_entity_marker": [169, 172], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Arp[/E1]2", "entity_2_idx": [[162, 166]], "entity_2_idx_in_text_with_entity_marker": [169, 178], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d704.s0_BioInfer.d704.s0.p7", "text": "These proteins each have a verprolin-homology (V) domain, cofilin-homology (C) domain and an acidic (A) region at the C-terminus, through which they activate the Arp2/3 complex, leading to rapid actin polymerization.", "text_with_entity_marker": "These proteins each have a verprolin-homology (V) domain, [E1]cofilin[/E1]-homology (C) domain and an acidic (A) region at the C-terminus, through which they activate the Arp2/3 complex, leading to rapid [E2]actin[/E2] polymerization.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[58, 65]], "entity_1_idx_in_text_with_entity_marker": [62, 69], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[195, 200]], "entity_2_idx_in_text_with_entity_marker": [208, 213], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d704.s0_BioInfer.d704.s0.p8", "text": "These proteins each have a verprolin-homology (V) domain, cofilin-homology (C) domain and an acidic (A) region at the C-terminus, through which they activate the Arp2/3 complex, leading to rapid actin polymerization.", "text_with_entity_marker": "These proteins each have a verprolin-homology (V) domain, cofilin-homology (C) domain and an acidic (A) region at the C-terminus, through which they activate the [E1]Arp[/E1]2/3 complex, leading to rapid [E2]actin[/E2] polymerization.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Arp", "entity_1_idx": [[162, 165], [167, 168]], "entity_1_idx_in_text_with_entity_marker": [166, 169], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[195, 200]], "entity_2_idx_in_text_with_entity_marker": [208, 213], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d704.s0_BioInfer.d704.s0.p9", "text": "These proteins each have a verprolin-homology (V) domain, cofilin-homology (C) domain and an acidic (A) region at the C-terminus, through which they activate the Arp2/3 complex, leading to rapid actin polymerization.", "text_with_entity_marker": "These proteins each have a verprolin-homology (V) domain, [E1]cofilin[/E1]-homology (C) domain and an acidic (A) region at the C-terminus, through which they activate the [E2]Arp[/E2]2/3 complex, leading to rapid actin polymerization.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[58, 65]], "entity_1_idx_in_text_with_entity_marker": [62, 69], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "Arp", "entity_2_idx": [[162, 165], [167, 168]], "entity_2_idx_in_text_with_entity_marker": [175, 178], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d93.s0_BioInfer.d93.s0.p0", "text": "Because histone H3 shares many structural features with histone H4 and is intimately associated with H4 in the assembled nucleosome, we asked whether H3 has similar functions.", "text_with_entity_marker": "Because histone H3 shares many structural features with histone [E1]H4[/E1] and is intimately associated with H4 in the assembled nucleosome, we asked whether [E2]H3[/E2] has similar functions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H4", "entity_1_idx": [[64, 66]], "entity_1_idx_in_text_with_entity_marker": [68, 70], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H3", "entity_2_idx": [[150, 152]], "entity_2_idx_in_text_with_entity_marker": [163, 165], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d93.s0_BioInfer.d93.s0.p1", "text": "Because histone H3 shares many structural features with histone H4 and is intimately associated with H4 in the assembled nucleosome, we asked whether H3 has similar functions.", "text_with_entity_marker": "Because [E1]histone[/E1] H3 shares many structural features with histone H4 and is intimately associated with H4 in the assembled nucleosome, we asked whether [E2]H3[/E2] has similar functions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[8, 15]], "entity_1_idx_in_text_with_entity_marker": [12, 19], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H3", "entity_2_idx": [[150, 152]], "entity_2_idx_in_text_with_entity_marker": [163, 165], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d93.s0_BioInfer.d93.s0.p2", "text": "Because histone H3 shares many structural features with histone H4 and is intimately associated with H4 in the assembled nucleosome, we asked whether H3 has similar functions.", "text_with_entity_marker": "Because histone H3 shares many structural features with histone H4 and is intimately associated with [E1]H4[/E1] in the assembled nucleosome, we asked whether [E2]H3[/E2] has similar functions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H4", "entity_1_idx": [[101, 103]], "entity_1_idx_in_text_with_entity_marker": [105, 107], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H3", "entity_2_idx": [[150, 152]], "entity_2_idx_in_text_with_entity_marker": [163, 165], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d93.s0_BioInfer.d93.s0.p3", "text": "Because histone H3 shares many structural features with histone H4 and is intimately associated with H4 in the assembled nucleosome, we asked whether H3 has similar functions.", "text_with_entity_marker": "Because histone H3 shares many structural features with [E1]histone[/E1] H4 and is intimately associated with H4 in the assembled nucleosome, we asked whether [E2]H3[/E2] has similar functions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[56, 63]], "entity_1_idx_in_text_with_entity_marker": [60, 67], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H3", "entity_2_idx": [[150, 152]], "entity_2_idx_in_text_with_entity_marker": [163, 165], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d93.s0_BioInfer.d93.s0.p4", "text": "Because histone H3 shares many structural features with histone H4 and is intimately associated with H4 in the assembled nucleosome, we asked whether H3 has similar functions.", "text_with_entity_marker": "Because histone [E1]H3[/E1] shares many structural features with histone H4 and is intimately associated with H4 in the assembled nucleosome, we asked whether [E2]H3[/E2] has similar functions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H3", "entity_1_idx": [[16, 18]], "entity_1_idx_in_text_with_entity_marker": [20, 22], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H3", "entity_2_idx": [[150, 152]], "entity_2_idx_in_text_with_entity_marker": [163, 165], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d93.s0_BioInfer.d93.s0.p5", "text": "Because histone H3 shares many structural features with histone H4 and is intimately associated with H4 in the assembled nucleosome, we asked whether H3 has similar functions.", "text_with_entity_marker": "Because [E1]histone[/E1] H3 shares many structural features with histone [E2]H4[/E2] and is intimately associated with H4 in the assembled nucleosome, we asked whether H3 has similar functions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[8, 15]], "entity_1_idx_in_text_with_entity_marker": [12, 19], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H4", "entity_2_idx": [[64, 66]], "entity_2_idx_in_text_with_entity_marker": [77, 79], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d93.s0_BioInfer.d93.s0.p6", "text": "Because histone H3 shares many structural features with histone H4 and is intimately associated with H4 in the assembled nucleosome, we asked whether H3 has similar functions.", "text_with_entity_marker": "Because histone H3 shares many structural features with histone [E1]H4[/E1] and is intimately associated with [E2]H4[/E2] in the assembled nucleosome, we asked whether H3 has similar functions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H4", "entity_1_idx": [[64, 66]], "entity_1_idx_in_text_with_entity_marker": [68, 70], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H4", "entity_2_idx": [[101, 103]], "entity_2_idx_in_text_with_entity_marker": [114, 116], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d93.s0_BioInfer.d93.s0.p7", "text": "Because histone H3 shares many structural features with histone H4 and is intimately associated with H4 in the assembled nucleosome, we asked whether H3 has similar functions.", "text_with_entity_marker": "Because histone H3 shares many structural features with [E1]histone[/E1] [E2]H4[/E2] and is intimately associated with H4 in the assembled nucleosome, we asked whether H3 has similar functions.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "histone", "entity_1_idx": [[56, 63]], "entity_1_idx_in_text_with_entity_marker": [60, 67], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H4", "entity_2_idx": [[64, 66]], "entity_2_idx_in_text_with_entity_marker": [77, 79], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d93.s0_BioInfer.d93.s0.p8", "text": "Because histone H3 shares many structural features with histone H4 and is intimately associated with H4 in the assembled nucleosome, we asked whether H3 has similar functions.", "text_with_entity_marker": "Because histone [E1]H3[/E1] shares many structural features with histone [E2]H4[/E2] and is intimately associated with H4 in the assembled nucleosome, we asked whether H3 has similar functions.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "H3", "entity_1_idx": [[16, 18]], "entity_1_idx_in_text_with_entity_marker": [20, 22], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H4", "entity_2_idx": [[64, 66]], "entity_2_idx_in_text_with_entity_marker": [77, 79], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d93.s0_BioInfer.d93.s0.p9", "text": "Because histone H3 shares many structural features with histone H4 and is intimately associated with H4 in the assembled nucleosome, we asked whether H3 has similar functions.", "text_with_entity_marker": "Because [E1]histone[/E1] H3 shares many structural features with histone H4 and is intimately associated with [E2]H4[/E2] in the assembled nucleosome, we asked whether H3 has similar functions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[8, 15]], "entity_1_idx_in_text_with_entity_marker": [12, 19], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H4", "entity_2_idx": [[101, 103]], "entity_2_idx_in_text_with_entity_marker": [114, 116], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d93.s0_BioInfer.d93.s0.p10", "text": "Because histone H3 shares many structural features with histone H4 and is intimately associated with H4 in the assembled nucleosome, we asked whether H3 has similar functions.", "text_with_entity_marker": "Because [E1]histone[/E1] H3 shares many structural features with [E2]histone[/E2] H4 and is intimately associated with H4 in the assembled nucleosome, we asked whether H3 has similar functions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[8, 15]], "entity_1_idx_in_text_with_entity_marker": [12, 19], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "histone", "entity_2_idx": [[56, 63]], "entity_2_idx_in_text_with_entity_marker": [69, 76], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d93.s0_BioInfer.d93.s0.p11", "text": "Because histone H3 shares many structural features with histone H4 and is intimately associated with H4 in the assembled nucleosome, we asked whether H3 has similar functions.", "text_with_entity_marker": "Because [E1]histone[/E1] [E2]H3[/E2] shares many structural features with histone H4 and is intimately associated with H4 in the assembled nucleosome, we asked whether H3 has similar functions.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "histone", "entity_1_idx": [[8, 15]], "entity_1_idx_in_text_with_entity_marker": [12, 19], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H3", "entity_2_idx": [[16, 18]], "entity_2_idx_in_text_with_entity_marker": [29, 31], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d93.s0_BioInfer.d93.s0.p12", "text": "Because histone H3 shares many structural features with histone H4 and is intimately associated with H4 in the assembled nucleosome, we asked whether H3 has similar functions.", "text_with_entity_marker": "Because histone H3 shares many structural features with [E1]histone[/E1] H4 and is intimately associated with [E2]H4[/E2] in the assembled nucleosome, we asked whether H3 has similar functions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[56, 63]], "entity_1_idx_in_text_with_entity_marker": [60, 67], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H4", "entity_2_idx": [[101, 103]], "entity_2_idx_in_text_with_entity_marker": [114, 116], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d93.s0_BioInfer.d93.s0.p13", "text": "Because histone H3 shares many structural features with histone H4 and is intimately associated with H4 in the assembled nucleosome, we asked whether H3 has similar functions.", "text_with_entity_marker": "Because histone [E1]H3[/E1] shares many structural features with histone H4 and is intimately associated with [E2]H4[/E2] in the assembled nucleosome, we asked whether H3 has similar functions.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "H3", "entity_1_idx": [[16, 18]], "entity_1_idx_in_text_with_entity_marker": [20, 22], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H4", "entity_2_idx": [[101, 103]], "entity_2_idx_in_text_with_entity_marker": [114, 116], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d93.s0_BioInfer.d93.s0.p14", "text": "Because histone H3 shares many structural features with histone H4 and is intimately associated with H4 in the assembled nucleosome, we asked whether H3 has similar functions.", "text_with_entity_marker": "Because histone [E1]H3[/E1] shares many structural features with [E2]histone[/E2] H4 and is intimately associated with H4 in the assembled nucleosome, we asked whether H3 has similar functions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H3", "entity_1_idx": [[16, 18]], "entity_1_idx_in_text_with_entity_marker": [20, 22], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[56, 63]], "entity_2_idx_in_text_with_entity_marker": [69, 76], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d555.s0_BioInfer.d555.s0.p0", "text": "Such motifs are known to bind to profilins (PFNs), small proteins engaged in the control of actin dynamics.", "text_with_entity_marker": "Such motifs are known to bind to [E1]profilins[/E1] ([E2]PFNs[/E2]), small proteins engaged in the control of actin dynamics.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilins", "entity_1_idx": [[33, 42]], "entity_1_idx_in_text_with_entity_marker": [37, 46], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "PFNs", "entity_2_idx": [[44, 48]], "entity_2_idx_in_text_with_entity_marker": [57, 61], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d555.s0_BioInfer.d555.s0.p1", "text": "Such motifs are known to bind to profilins (PFNs), small proteins engaged in the control of actin dynamics.", "text_with_entity_marker": "Such motifs are known to bind to profilins ([E1]PFNs[/E1]), small proteins engaged in the control of [E2]actin[/E2] dynamics.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "PFNs", "entity_1_idx": [[44, 48]], "entity_1_idx_in_text_with_entity_marker": [48, 52], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "actin", "entity_2_idx": [[92, 97]], "entity_2_idx_in_text_with_entity_marker": [105, 110], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d555.s0_BioInfer.d555.s0.p2", "text": "Such motifs are known to bind to profilins (PFNs), small proteins engaged in the control of actin dynamics.", "text_with_entity_marker": "Such motifs are known to bind to [E1]profilins[/E1] (PFNs), small proteins engaged in the control of [E2]actin[/E2] dynamics.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilins", "entity_1_idx": [[33, 42]], "entity_1_idx_in_text_with_entity_marker": [37, 46], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "actin", "entity_2_idx": [[92, 97]], "entity_2_idx_in_text_with_entity_marker": [105, 110], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d746.s0_BioInfer.d746.s0.p0", "text": "This shows that structural changes in the poly(L-proline)-binding region of profilin can affect the distantly located actin-binding site.", "text_with_entity_marker": "This shows that structural changes in the poly(L-proline)-binding region of [E1]profilin[/E1] can affect the distantly located [E2]actin[/E2]-binding site.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[76, 84]], "entity_1_idx_in_text_with_entity_marker": [80, 88], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[118, 123]], "entity_2_idx_in_text_with_entity_marker": [131, 136], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d118.s0_BioInfer.d118.s0.p0", "text": "By indirect immunofluorescence, both R. rickettsii and Listeria monocytogenes actin tails were shown to contain the cytoskeletal proteins vasodilator-stimulated phosphoprotein profilin, vinculin, and filamin.", "text_with_entity_marker": "By indirect immunofluorescence, both R. rickettsii and Listeria monocytogenes [E1]actin[/E1] tails were shown to contain the cytoskeletal proteins vasodilator-stimulated phosphoprotein profilin, vinculin, and [E2]filamin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[78, 83]], "entity_1_idx_in_text_with_entity_marker": [82, 87], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "filamin", "entity_2_idx": [[200, 207]], "entity_2_idx_in_text_with_entity_marker": [213, 220], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d118.s0_BioInfer.d118.s0.p1", "text": "By indirect immunofluorescence, both R. rickettsii and Listeria monocytogenes actin tails were shown to contain the cytoskeletal proteins vasodilator-stimulated phosphoprotein profilin, vinculin, and filamin.", "text_with_entity_marker": "By indirect immunofluorescence, both R. rickettsii and Listeria monocytogenes [E1]actin[/E1] tails were shown to contain the cytoskeletal proteins vasodilator-stimulated phosphoprotein profilin, [E2]vinculin[/E2], and filamin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[78, 83]], "entity_1_idx_in_text_with_entity_marker": [82, 87], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vinculin", "entity_2_idx": [[186, 194]], "entity_2_idx_in_text_with_entity_marker": [199, 207], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d118.s0_BioInfer.d118.s0.p2", "text": "By indirect immunofluorescence, both R. rickettsii and Listeria monocytogenes actin tails were shown to contain the cytoskeletal proteins vasodilator-stimulated phosphoprotein profilin, vinculin, and filamin.", "text_with_entity_marker": "By indirect immunofluorescence, both R. rickettsii and Listeria monocytogenes [E1]actin[/E1] tails were shown to contain the cytoskeletal proteins [E2]vasodilator-stimulated phosphoprotein[/E2] profilin, vinculin, and filamin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[78, 83]], "entity_1_idx_in_text_with_entity_marker": [82, 87], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vasodilator-stimulated phosphoprotein", "entity_2_idx": [[138, 175]], "entity_2_idx_in_text_with_entity_marker": [151, 188], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d118.s0_BioInfer.d118.s0.p3", "text": "By indirect immunofluorescence, both R. rickettsii and Listeria monocytogenes actin tails were shown to contain the cytoskeletal proteins vasodilator-stimulated phosphoprotein profilin, vinculin, and filamin.", "text_with_entity_marker": "By indirect immunofluorescence, both R. rickettsii and Listeria monocytogenes [E1]actin[/E1] tails were shown to contain the cytoskeletal proteins vasodilator-stimulated phosphoprotein [E2]profilin[/E2], vinculin, and filamin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[78, 83]], "entity_1_idx_in_text_with_entity_marker": [82, 87], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[176, 184]], "entity_2_idx_in_text_with_entity_marker": [189, 197], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d118.s0_BioInfer.d118.s0.p4", "text": "By indirect immunofluorescence, both R. rickettsii and Listeria monocytogenes actin tails were shown to contain the cytoskeletal proteins vasodilator-stimulated phosphoprotein profilin, vinculin, and filamin.", "text_with_entity_marker": "By indirect immunofluorescence, both R. rickettsii and Listeria monocytogenes actin tails were shown to contain the cytoskeletal proteins vasodilator-stimulated phosphoprotein profilin, [E1]vinculin[/E1], and [E2]filamin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "vinculin", "entity_1_idx": [[186, 194]], "entity_1_idx_in_text_with_entity_marker": [190, 198], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "filamin", "entity_2_idx": [[200, 207]], "entity_2_idx_in_text_with_entity_marker": [213, 220], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d118.s0_BioInfer.d118.s0.p5", "text": "By indirect immunofluorescence, both R. rickettsii and Listeria monocytogenes actin tails were shown to contain the cytoskeletal proteins vasodilator-stimulated phosphoprotein profilin, vinculin, and filamin.", "text_with_entity_marker": "By indirect immunofluorescence, both R. rickettsii and Listeria monocytogenes actin tails were shown to contain the cytoskeletal proteins [E1]vasodilator-stimulated phosphoprotein[/E1] profilin, vinculin, and [E2]filamin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "vasodilator-stimulated phosphoprotein", "entity_1_idx": [[138, 175]], "entity_1_idx_in_text_with_entity_marker": [142, 179], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "filamin", "entity_2_idx": [[200, 207]], "entity_2_idx_in_text_with_entity_marker": [213, 220], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d118.s0_BioInfer.d118.s0.p6", "text": "By indirect immunofluorescence, both R. rickettsii and Listeria monocytogenes actin tails were shown to contain the cytoskeletal proteins vasodilator-stimulated phosphoprotein profilin, vinculin, and filamin.", "text_with_entity_marker": "By indirect immunofluorescence, both R. rickettsii and Listeria monocytogenes actin tails were shown to contain the cytoskeletal proteins vasodilator-stimulated phosphoprotein [E1]profilin[/E1], vinculin, and [E2]filamin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[176, 184]], "entity_1_idx_in_text_with_entity_marker": [180, 188], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "filamin", "entity_2_idx": [[200, 207]], "entity_2_idx_in_text_with_entity_marker": [213, 220], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d118.s0_BioInfer.d118.s0.p7", "text": "By indirect immunofluorescence, both R. rickettsii and Listeria monocytogenes actin tails were shown to contain the cytoskeletal proteins vasodilator-stimulated phosphoprotein profilin, vinculin, and filamin.", "text_with_entity_marker": "By indirect immunofluorescence, both R. rickettsii and Listeria monocytogenes actin tails were shown to contain the cytoskeletal proteins [E1]vasodilator-stimulated phosphoprotein[/E1] profilin, [E2]vinculin[/E2], and filamin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "vasodilator-stimulated phosphoprotein", "entity_1_idx": [[138, 175]], "entity_1_idx_in_text_with_entity_marker": [142, 179], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vinculin", "entity_2_idx": [[186, 194]], "entity_2_idx_in_text_with_entity_marker": [199, 207], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d118.s0_BioInfer.d118.s0.p8", "text": "By indirect immunofluorescence, both R. rickettsii and Listeria monocytogenes actin tails were shown to contain the cytoskeletal proteins vasodilator-stimulated phosphoprotein profilin, vinculin, and filamin.", "text_with_entity_marker": "By indirect immunofluorescence, both R. rickettsii and Listeria monocytogenes actin tails were shown to contain the cytoskeletal proteins vasodilator-stimulated phosphoprotein [E1]profilin[/E1], [E2]vinculin[/E2], and filamin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[176, 184]], "entity_1_idx_in_text_with_entity_marker": [180, 188], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vinculin", "entity_2_idx": [[186, 194]], "entity_2_idx_in_text_with_entity_marker": [199, 207], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d118.s0_BioInfer.d118.s0.p9", "text": "By indirect immunofluorescence, both R. rickettsii and Listeria monocytogenes actin tails were shown to contain the cytoskeletal proteins vasodilator-stimulated phosphoprotein profilin, vinculin, and filamin.", "text_with_entity_marker": "By indirect immunofluorescence, both R. rickettsii and Listeria monocytogenes actin tails were shown to contain the cytoskeletal proteins [E1]vasodilator-stimulated phosphoprotein[/E1] [E2]profilin[/E2], vinculin, and filamin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "vasodilator-stimulated phosphoprotein", "entity_1_idx": [[138, 175]], "entity_1_idx_in_text_with_entity_marker": [142, 179], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[176, 184]], "entity_2_idx_in_text_with_entity_marker": [189, 197], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d217.s0_BioInfer.d217.s0.p0", "text": "From previous work, the BNI1, GIC1, and GIC2 gene products also appear to be involved in linking Cdc42p to the actin cytoskeleton.", "text_with_entity_marker": "From previous work, the [E1]BNI1[/E1], GIC1, and GIC2 gene products also appear to be involved in linking Cdc42p to the [E2]actin[/E2] cytoskeleton.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "BNI1", "entity_1_idx": [[24, 28]], "entity_1_idx_in_text_with_entity_marker": [28, 32], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "actin", "entity_2_idx": [[111, 116]], "entity_2_idx_in_text_with_entity_marker": [124, 129], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d217.s0_BioInfer.d217.s0.p1", "text": "From previous work, the BNI1, GIC1, and GIC2 gene products also appear to be involved in linking Cdc42p to the actin cytoskeleton.", "text_with_entity_marker": "From previous work, the BNI1, GIC1, and GIC2 gene products also appear to be involved in linking [E1]Cdc42p[/E1] to the [E2]actin[/E2] cytoskeleton.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Cdc42p", "entity_1_idx": [[97, 103]], "entity_1_idx_in_text_with_entity_marker": [101, 107], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[111, 116]], "entity_2_idx_in_text_with_entity_marker": [124, 129], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d217.s0_BioInfer.d217.s0.p2", "text": "From previous work, the BNI1, GIC1, and GIC2 gene products also appear to be involved in linking Cdc42p to the actin cytoskeleton.", "text_with_entity_marker": "From previous work, the BNI1, GIC1, and [E1]GIC2[/E1] gene products also appear to be involved in linking Cdc42p to the [E2]actin[/E2] cytoskeleton.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "GIC2", "entity_1_idx": [[40, 44]], "entity_1_idx_in_text_with_entity_marker": [44, 48], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "actin", "entity_2_idx": [[111, 116]], "entity_2_idx_in_text_with_entity_marker": [124, 129], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d217.s0_BioInfer.d217.s0.p3", "text": "From previous work, the BNI1, GIC1, and GIC2 gene products also appear to be involved in linking Cdc42p to the actin cytoskeleton.", "text_with_entity_marker": "From previous work, the BNI1, [E1]GIC1[/E1], and GIC2 gene products also appear to be involved in linking Cdc42p to the [E2]actin[/E2] cytoskeleton.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "GIC1", "entity_1_idx": [[30, 34]], "entity_1_idx_in_text_with_entity_marker": [34, 38], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "actin", "entity_2_idx": [[111, 116]], "entity_2_idx_in_text_with_entity_marker": [124, 129], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d217.s0_BioInfer.d217.s0.p4", "text": "From previous work, the BNI1, GIC1, and GIC2 gene products also appear to be involved in linking Cdc42p to the actin cytoskeleton.", "text_with_entity_marker": "From previous work, the [E1]BNI1[/E1], GIC1, and GIC2 gene products also appear to be involved in linking [E2]Cdc42p[/E2] to the actin cytoskeleton.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "BNI1", "entity_1_idx": [[24, 28]], "entity_1_idx_in_text_with_entity_marker": [28, 32], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "Cdc42p", "entity_2_idx": [[97, 103]], "entity_2_idx_in_text_with_entity_marker": [110, 116], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d217.s0_BioInfer.d217.s0.p5", "text": "From previous work, the BNI1, GIC1, and GIC2 gene products also appear to be involved in linking Cdc42p to the actin cytoskeleton.", "text_with_entity_marker": "From previous work, the [E1]BNI1[/E1], GIC1, and [E2]GIC2[/E2] gene products also appear to be involved in linking Cdc42p to the actin cytoskeleton.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "BNI1", "entity_1_idx": [[24, 28]], "entity_1_idx_in_text_with_entity_marker": [28, 32], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "GIC2", "entity_2_idx": [[40, 44]], "entity_2_idx_in_text_with_entity_marker": [53, 57], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d217.s0_BioInfer.d217.s0.p6", "text": "From previous work, the BNI1, GIC1, and GIC2 gene products also appear to be involved in linking Cdc42p to the actin cytoskeleton.", "text_with_entity_marker": "From previous work, the [E1]BNI1[/E1], [E2]GIC1[/E2], and GIC2 gene products also appear to be involved in linking Cdc42p to the actin cytoskeleton.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "BNI1", "entity_1_idx": [[24, 28]], "entity_1_idx_in_text_with_entity_marker": [28, 32], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "GIC1", "entity_2_idx": [[30, 34]], "entity_2_idx_in_text_with_entity_marker": [43, 47], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d217.s0_BioInfer.d217.s0.p7", "text": "From previous work, the BNI1, GIC1, and GIC2 gene products also appear to be involved in linking Cdc42p to the actin cytoskeleton.", "text_with_entity_marker": "From previous work, the BNI1, GIC1, and [E1]GIC2[/E1] gene products also appear to be involved in linking [E2]Cdc42p[/E2] to the actin cytoskeleton.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "GIC2", "entity_1_idx": [[40, 44]], "entity_1_idx_in_text_with_entity_marker": [44, 48], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "Cdc42p", "entity_2_idx": [[97, 103]], "entity_2_idx_in_text_with_entity_marker": [110, 116], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d217.s0_BioInfer.d217.s0.p8", "text": "From previous work, the BNI1, GIC1, and GIC2 gene products also appear to be involved in linking Cdc42p to the actin cytoskeleton.", "text_with_entity_marker": "From previous work, the BNI1, [E1]GIC1[/E1], and GIC2 gene products also appear to be involved in linking [E2]Cdc42p[/E2] to the actin cytoskeleton.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "GIC1", "entity_1_idx": [[30, 34]], "entity_1_idx_in_text_with_entity_marker": [34, 38], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "Cdc42p", "entity_2_idx": [[97, 103]], "entity_2_idx_in_text_with_entity_marker": [110, 116], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d217.s0_BioInfer.d217.s0.p9", "text": "From previous work, the BNI1, GIC1, and GIC2 gene products also appear to be involved in linking Cdc42p to the actin cytoskeleton.", "text_with_entity_marker": "From previous work, the BNI1, [E1]GIC1[/E1], and [E2]GIC2[/E2] gene products also appear to be involved in linking Cdc42p to the actin cytoskeleton.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "GIC1", "entity_1_idx": [[30, 34]], "entity_1_idx_in_text_with_entity_marker": [34, 38], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "GIC2", "entity_2_idx": [[40, 44]], "entity_2_idx_in_text_with_entity_marker": [53, 57], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p0", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian [E1]histone[/E1] H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; [E2]histones[/E2] H2A and H2B show less heterogeneity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[172, 179]], "entity_1_idx_in_text_with_entity_marker": [176, 183], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "histones", "entity_2_idx": [[387, 395]], "entity_2_idx_in_text_with_entity_marker": [400, 408], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p1", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core [E1]histones[/E1] from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; [E2]histones[/E2] H2A and H2B show less heterogeneity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histones", "entity_1_idx": [[9, 17]], "entity_1_idx_in_text_with_entity_marker": [13, 21], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histones", "entity_2_idx": [[387, 395]], "entity_2_idx_in_text_with_entity_marker": [400, 408], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p2", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of [E1]histone[/E1] H3; [E2]histones[/E2] H2A and H2B show less heterogeneity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[375, 382]], "entity_1_idx_in_text_with_entity_marker": [379, 386], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "histones", "entity_2_idx": [[387, 395]], "entity_2_idx_in_text_with_entity_marker": [400, 408], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p3", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; [E1]histone[/E1] H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; [E2]histones[/E2] H2A and H2B show less heterogeneity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[88, 95]], "entity_1_idx_in_text_with_entity_marker": [92, 99], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "histones", "entity_2_idx": [[387, 395]], "entity_2_idx_in_text_with_entity_marker": [400, 408], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p4", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; [E1]histones[/E1] H2A and [E2]H2B[/E2] show less heterogeneity.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "histones", "entity_1_idx": [[387, 395]], "entity_1_idx_in_text_with_entity_marker": [391, 399], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H2B", "entity_2_idx": [[404, 407]], "entity_2_idx_in_text_with_entity_marker": [417, 420], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p5", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); [E1]histone[/E1] H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; [E2]histones[/E2] H2A and H2B show less heterogeneity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[245, 252]], "entity_1_idx_in_text_with_entity_marker": [249, 256], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "histones", "entity_2_idx": [[387, 395]], "entity_2_idx_in_text_with_entity_marker": [400, 408], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p6", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core histones from Physarum, [E1]histones[/E1] H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; [E2]histones[/E2] H2A and H2B show less heterogeneity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histones", "entity_1_idx": [[33, 41]], "entity_1_idx_in_text_with_entity_marker": [37, 45], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histones", "entity_2_idx": [[387, 395]], "entity_2_idx_in_text_with_entity_marker": [400, 408], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p7", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone [E1]H4[/E1] shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; [E2]histones[/E2] H2A and H2B show less heterogeneity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H4", "entity_1_idx": [[96, 98]], "entity_1_idx_in_text_with_entity_marker": [100, 102], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histones", "entity_2_idx": [[387, 395]], "entity_2_idx_in_text_with_entity_marker": [400, 408], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p8", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core histones from Physarum, histones H2A, H2B, H3, and [E1]H4[/E1], are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; [E2]histones[/E2] H2A and H2B show less heterogeneity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H4", "entity_1_idx": [[60, 62]], "entity_1_idx_in_text_with_entity_marker": [64, 66], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histones", "entity_2_idx": [[387, 395]], "entity_2_idx_in_text_with_entity_marker": [400, 408], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p9", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone [E1]H3[/E1] has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; [E2]histones[/E2] H2A and H2B show less heterogeneity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H3", "entity_1_idx": [[253, 255]], "entity_1_idx_in_text_with_entity_marker": [257, 259], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histones", "entity_2_idx": [[387, 395]], "entity_2_idx_in_text_with_entity_marker": [400, 408], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p100", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core histones from Physarum, histones H2A, H2B, H3, and [E1]H4[/E1], are rapidly acetylated; histone [E2]H4[/E2] shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H4", "entity_1_idx": [[60, 62]], "entity_1_idx_in_text_with_entity_marker": [64, 66], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H4", "entity_2_idx": [[96, 98]], "entity_2_idx_in_text_with_entity_marker": [109, 111], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p101", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone [E1]H4[/E1] shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone [E2]H3[/E2] has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H4", "entity_1_idx": [[96, 98]], "entity_1_idx_in_text_with_entity_marker": [100, 102], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H3", "entity_2_idx": [[253, 255]], "entity_2_idx_in_text_with_entity_marker": [266, 268], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p102", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone [E1]H4[/E1] shows five subfractions, analogous to the five subfractions of mammalian histone [E2]H4[/E2] (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H4", "entity_1_idx": [[96, 98]], "entity_1_idx_in_text_with_entity_marker": [100, 102], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H4", "entity_2_idx": [[180, 182]], "entity_2_idx_in_text_with_entity_marker": [193, 195], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p103", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core histones from Physarum, histones [E1]H2A[/E1], H2B, H3, and H4, are rapidly acetylated; histone [E2]H4[/E2] shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H2A", "entity_1_idx": [[42, 45]], "entity_1_idx_in_text_with_entity_marker": [46, 49], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H4", "entity_2_idx": [[96, 98]], "entity_2_idx_in_text_with_entity_marker": [109, 111], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p104", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core histones from Physarum, histones H2A, H2B, [E1]H3[/E1], and H4, are rapidly acetylated; histone [E2]H4[/E2] shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H3", "entity_1_idx": [[52, 54]], "entity_1_idx_in_text_with_entity_marker": [56, 58], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H4", "entity_2_idx": [[96, 98]], "entity_2_idx_in_text_with_entity_marker": [109, 111], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p105", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core histones from Physarum, histones H2A, [E1]H2B[/E1], H3, and H4, are rapidly acetylated; histone [E2]H4[/E2] shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H2B", "entity_1_idx": [[47, 50]], "entity_1_idx_in_text_with_entity_marker": [51, 54], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H4", "entity_2_idx": [[96, 98]], "entity_2_idx_in_text_with_entity_marker": [109, 111], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p106", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone [E1]H4[/E1] shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones [E2]H2A[/E2] and H2B show less heterogeneity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H4", "entity_1_idx": [[96, 98]], "entity_1_idx_in_text_with_entity_marker": [100, 102], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H2A", "entity_2_idx": [[396, 399]], "entity_2_idx_in_text_with_entity_marker": [409, 412], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p107", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone [E1]H4[/E1] shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone [E2]H3[/E2]; histones H2A and H2B show less heterogeneity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H4", "entity_1_idx": [[96, 98]], "entity_1_idx_in_text_with_entity_marker": [100, 102], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H3", "entity_2_idx": [[383, 385]], "entity_2_idx_in_text_with_entity_marker": [396, 398], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p108", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core histones from Physarum, histones H2A, H2B, H3, and [E1]H4[/E1], are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone [E2]H3[/E2] has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H4", "entity_1_idx": [[60, 62]], "entity_1_idx_in_text_with_entity_marker": [64, 66], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H3", "entity_2_idx": [[253, 255]], "entity_2_idx_in_text_with_entity_marker": [266, 268], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p109", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core histones from Physarum, histones H2A, H2B, H3, and [E1]H4[/E1], are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone [E2]H4[/E2] (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H4", "entity_1_idx": [[60, 62]], "entity_1_idx_in_text_with_entity_marker": [64, 66], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H4", "entity_2_idx": [[180, 182]], "entity_2_idx_in_text_with_entity_marker": [193, 195], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d824.s0_BioInfer.d824.s0.p0", "text": "We studied the roles of cofilin, an actin-binding phosphoprotein, in superoxide production of neutrophil-like HL-60 cells triggered by opsonized zymosan (OZ).", "text_with_entity_marker": "We studied the roles of [E1]cofilin[/E1], an [E2]actin[/E2]-binding phosphoprotein, in superoxide production of neutrophil-like HL-60 cells triggered by opsonized zymosan (OZ).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cofilin", "entity_1_idx": [[24, 31]], "entity_1_idx_in_text_with_entity_marker": [28, 35], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[36, 41]], "entity_2_idx_in_text_with_entity_marker": [49, 54], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d827.s0_BioInfer.d827.s0.p0", "text": "We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in MSH2 or MLH1 to assess the involvement of mononucleotide repeats contained in the coding regions of MSH3, MSH6, BAX, and TGFbeta RII.", "text_with_entity_marker": "We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in [E1]MSH2[/E1] or MLH1 to assess the involvement of mononucleotide repeats contained in the coding regions of [E2]MSH3[/E2], MSH6, BAX, and TGFbeta RII.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MSH2", "entity_1_idx": [[148, 152]], "entity_1_idx_in_text_with_entity_marker": [152, 156], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MSH3", "entity_2_idx": [[248, 252]], "entity_2_idx_in_text_with_entity_marker": [261, 265], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d827.s0_BioInfer.d827.s0.p1", "text": "We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in MSH2 or MLH1 to assess the involvement of mononucleotide repeats contained in the coding regions of MSH3, MSH6, BAX, and TGFbeta RII.", "text_with_entity_marker": "We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in [E1]MSH2[/E1] or [E2]MLH1[/E2] to assess the involvement of mononucleotide repeats contained in the coding regions of MSH3, MSH6, BAX, and TGFbeta RII.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MSH2", "entity_1_idx": [[148, 152]], "entity_1_idx_in_text_with_entity_marker": [152, 156], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MLH1", "entity_2_idx": [[156, 160]], "entity_2_idx_in_text_with_entity_marker": [169, 173], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d827.s0_BioInfer.d827.s0.p2", "text": "We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in MSH2 or MLH1 to assess the involvement of mononucleotide repeats contained in the coding regions of MSH3, MSH6, BAX, and TGFbeta RII.", "text_with_entity_marker": "We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in [E1]MSH2[/E1] or MLH1 to assess the involvement of mononucleotide repeats contained in the coding regions of MSH3, MSH6, [E2]BAX[/E2], and TGFbeta RII.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MSH2", "entity_1_idx": [[148, 152]], "entity_1_idx_in_text_with_entity_marker": [152, 156], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "BAX", "entity_2_idx": [[260, 263]], "entity_2_idx_in_text_with_entity_marker": [273, 276], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d827.s0_BioInfer.d827.s0.p3", "text": "We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in MSH2 or MLH1 to assess the involvement of mononucleotide repeats contained in the coding regions of MSH3, MSH6, BAX, and TGFbeta RII.", "text_with_entity_marker": "We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in [E1]MSH2[/E1] or MLH1 to assess the involvement of mononucleotide repeats contained in the coding regions of MSH3, [E2]MSH6[/E2], BAX, and TGFbeta RII.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MSH2", "entity_1_idx": [[148, 152]], "entity_1_idx_in_text_with_entity_marker": [152, 156], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MSH6", "entity_2_idx": [[254, 258]], "entity_2_idx_in_text_with_entity_marker": [267, 271], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d827.s0_BioInfer.d827.s0.p4", "text": "We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in MSH2 or MLH1 to assess the involvement of mononucleotide repeats contained in the coding regions of MSH3, MSH6, BAX, and TGFbeta RII.", "text_with_entity_marker": "We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in [E1]MSH2[/E1] or MLH1 to assess the involvement of mononucleotide repeats contained in the coding regions of MSH3, MSH6, BAX, and [E2]TGFbeta RII[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MSH2", "entity_1_idx": [[148, 152]], "entity_1_idx_in_text_with_entity_marker": [152, 156], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "TGFbeta RII", "entity_2_idx": [[269, 280]], "entity_2_idx_in_text_with_entity_marker": [282, 293], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d827.s0_BioInfer.d827.s0.p5", "text": "We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in MSH2 or MLH1 to assess the involvement of mononucleotide repeats contained in the coding regions of MSH3, MSH6, BAX, and TGFbeta RII.", "text_with_entity_marker": "We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in MSH2 or [E1]MLH1[/E1] to assess the involvement of mononucleotide repeats contained in the coding regions of [E2]MSH3[/E2], MSH6, BAX, and TGFbeta RII.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MLH1", "entity_1_idx": [[156, 160]], "entity_1_idx_in_text_with_entity_marker": [160, 164], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MSH3", "entity_2_idx": [[248, 252]], "entity_2_idx_in_text_with_entity_marker": [261, 265], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d827.s0_BioInfer.d827.s0.p6", "text": "We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in MSH2 or MLH1 to assess the involvement of mononucleotide repeats contained in the coding regions of MSH3, MSH6, BAX, and TGFbeta RII.", "text_with_entity_marker": "We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in MSH2 or MLH1 to assess the involvement of mononucleotide repeats contained in the coding regions of [E1]MSH3[/E1], MSH6, [E2]BAX[/E2], and TGFbeta RII.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MSH3", "entity_1_idx": [[248, 252]], "entity_1_idx_in_text_with_entity_marker": [252, 256], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "BAX", "entity_2_idx": [[260, 263]], "entity_2_idx_in_text_with_entity_marker": [273, 276], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d827.s0_BioInfer.d827.s0.p7", "text": "We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in MSH2 or MLH1 to assess the involvement of mononucleotide repeats contained in the coding regions of MSH3, MSH6, BAX, and TGFbeta RII.", "text_with_entity_marker": "We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in MSH2 or MLH1 to assess the involvement of mononucleotide repeats contained in the coding regions of [E1]MSH3[/E1], [E2]MSH6[/E2], BAX, and TGFbeta RII.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MSH3", "entity_1_idx": [[248, 252]], "entity_1_idx_in_text_with_entity_marker": [252, 256], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MSH6", "entity_2_idx": [[254, 258]], "entity_2_idx_in_text_with_entity_marker": [267, 271], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d827.s0_BioInfer.d827.s0.p8", "text": "We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in MSH2 or MLH1 to assess the involvement of mononucleotide repeats contained in the coding regions of MSH3, MSH6, BAX, and TGFbeta RII.", "text_with_entity_marker": "We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in MSH2 or MLH1 to assess the involvement of mononucleotide repeats contained in the coding regions of [E1]MSH3[/E1], MSH6, BAX, and [E2]TGFbeta RII[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MSH3", "entity_1_idx": [[248, 252]], "entity_1_idx_in_text_with_entity_marker": [252, 256], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "TGFbeta RII", "entity_2_idx": [[269, 280]], "entity_2_idx_in_text_with_entity_marker": [282, 293], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d827.s0_BioInfer.d827.s0.p9", "text": "We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in MSH2 or MLH1 to assess the involvement of mononucleotide repeats contained in the coding regions of MSH3, MSH6, BAX, and TGFbeta RII.", "text_with_entity_marker": "We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in MSH2 or [E1]MLH1[/E1] to assess the involvement of mononucleotide repeats contained in the coding regions of MSH3, MSH6, [E2]BAX[/E2], and TGFbeta RII.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MLH1", "entity_1_idx": [[156, 160]], "entity_1_idx_in_text_with_entity_marker": [160, 164], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "BAX", "entity_2_idx": [[260, 263]], "entity_2_idx_in_text_with_entity_marker": [273, 276], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d827.s0_BioInfer.d827.s0.p10", "text": "We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in MSH2 or MLH1 to assess the involvement of mononucleotide repeats contained in the coding regions of MSH3, MSH6, BAX, and TGFbeta RII.", "text_with_entity_marker": "We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in MSH2 or [E1]MLH1[/E1] to assess the involvement of mononucleotide repeats contained in the coding regions of MSH3, [E2]MSH6[/E2], BAX, and TGFbeta RII.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MLH1", "entity_1_idx": [[156, 160]], "entity_1_idx_in_text_with_entity_marker": [160, 164], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MSH6", "entity_2_idx": [[254, 258]], "entity_2_idx_in_text_with_entity_marker": [267, 271], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d827.s0_BioInfer.d827.s0.p11", "text": "We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in MSH2 or MLH1 to assess the involvement of mononucleotide repeats contained in the coding regions of MSH3, MSH6, BAX, and TGFbeta RII.", "text_with_entity_marker": "We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in MSH2 or [E1]MLH1[/E1] to assess the involvement of mononucleotide repeats contained in the coding regions of MSH3, MSH6, BAX, and [E2]TGFbeta RII[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MLH1", "entity_1_idx": [[156, 160]], "entity_1_idx_in_text_with_entity_marker": [160, 164], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "TGFbeta RII", "entity_2_idx": [[269, 280]], "entity_2_idx_in_text_with_entity_marker": [282, 293], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d827.s0_BioInfer.d827.s0.p12", "text": "We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in MSH2 or MLH1 to assess the involvement of mononucleotide repeats contained in the coding regions of MSH3, MSH6, BAX, and TGFbeta RII.", "text_with_entity_marker": "We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in MSH2 or MLH1 to assess the involvement of mononucleotide repeats contained in the coding regions of MSH3, [E1]MSH6[/E1], [E2]BAX[/E2], and TGFbeta RII.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MSH6", "entity_1_idx": [[254, 258]], "entity_1_idx_in_text_with_entity_marker": [258, 262], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "BAX", "entity_2_idx": [[260, 263]], "entity_2_idx_in_text_with_entity_marker": [273, 276], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d827.s0_BioInfer.d827.s0.p13", "text": "We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in MSH2 or MLH1 to assess the involvement of mononucleotide repeats contained in the coding regions of MSH3, MSH6, BAX, and TGFbeta RII.", "text_with_entity_marker": "We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in MSH2 or MLH1 to assess the involvement of mononucleotide repeats contained in the coding regions of MSH3, MSH6, [E1]BAX[/E1], and [E2]TGFbeta RII[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "BAX", "entity_1_idx": [[260, 263]], "entity_1_idx_in_text_with_entity_marker": [264, 267], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "TGFbeta RII", "entity_2_idx": [[269, 280]], "entity_2_idx_in_text_with_entity_marker": [282, 293], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d827.s0_BioInfer.d827.s0.p14", "text": "We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in MSH2 or MLH1 to assess the involvement of mononucleotide repeats contained in the coding regions of MSH3, MSH6, BAX, and TGFbeta RII.", "text_with_entity_marker": "We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in MSH2 or MLH1 to assess the involvement of mononucleotide repeats contained in the coding regions of MSH3, [E1]MSH6[/E1], BAX, and [E2]TGFbeta RII[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MSH6", "entity_1_idx": [[254, 258]], "entity_1_idx_in_text_with_entity_marker": [258, 262], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "TGFbeta RII", "entity_2_idx": [[269, 280]], "entity_2_idx_in_text_with_entity_marker": [282, 293], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d243.s0_BioInfer.d243.s0.p30", "text": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "text_with_entity_marker": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, [E1]CDC39[/E1], [E2]STE12[/E2], TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CDC39", "entity_1_idx": [[205, 210]], "entity_1_idx_in_text_with_entity_marker": [209, 214], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "STE12", "entity_2_idx": [[212, 217]], "entity_2_idx_in_text_with_entity_marker": [225, 230], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d243.s0_BioInfer.d243.s0.p31", "text": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "text_with_entity_marker": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, [E1]CDC39[/E1], STE12, TEC1, WHI3, NAB1, DBR1, [E2]CDC55[/E2], SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CDC39", "entity_1_idx": [[205, 210]], "entity_1_idx_in_text_with_entity_marker": [209, 214], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "CDC55", "entity_2_idx": [[243, 248]], "entity_2_idx_in_text_with_entity_marker": [256, 261], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d243.s0_BioInfer.d243.s0.p32", "text": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "text_with_entity_marker": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, [E1]CDC39[/E1], STE12, TEC1, [E2]WHI3[/E2], NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CDC39", "entity_1_idx": [[205, 210]], "entity_1_idx_in_text_with_entity_marker": [209, 214], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "WHI3", "entity_2_idx": [[225, 229]], "entity_2_idx_in_text_with_entity_marker": [238, 242], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d243.s0_BioInfer.d243.s0.p33", "text": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "text_with_entity_marker": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, [E1]CDC39[/E1], STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, [E2]TPM1[/E2], SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CDC39", "entity_1_idx": [[205, 210]], "entity_1_idx_in_text_with_entity_marker": [209, 214], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "TPM1", "entity_2_idx": [[256, 260]], "entity_2_idx_in_text_with_entity_marker": [269, 273], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d243.s0_BioInfer.d243.s0.p34", "text": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "text_with_entity_marker": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, [E1]CDC39[/E1], STE12, TEC1, WHI3, NAB1, [E2]DBR1[/E2], CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CDC39", "entity_1_idx": [[205, 210]], "entity_1_idx_in_text_with_entity_marker": [209, 214], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "DBR1", "entity_2_idx": [[237, 241]], "entity_2_idx_in_text_with_entity_marker": [250, 254], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d243.s0_BioInfer.d243.s0.p35", "text": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "text_with_entity_marker": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, [E1]CDC39[/E1], STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, [E2]BNI1[/E2], DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CDC39", "entity_1_idx": [[205, 210]], "entity_1_idx_in_text_with_entity_marker": [209, 214], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "BNI1", "entity_2_idx": [[268, 272]], "entity_2_idx_in_text_with_entity_marker": [281, 285], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d243.s0_BioInfer.d243.s0.p36", "text": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "text_with_entity_marker": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, [E1]CDC39[/E1], STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, [E2]DFG10[/E2], BUD8 and DFG16, mutations that block filamentous growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CDC39", "entity_1_idx": [[205, 210]], "entity_1_idx_in_text_with_entity_marker": [209, 214], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "DFG10", "entity_2_idx": [[286, 291]], "entity_2_idx_in_text_with_entity_marker": [299, 304], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d243.s0_BioInfer.d243.s0.p37", "text": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "text_with_entity_marker": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, [E1]CDC39[/E1], STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and [E2]DFG16[/E2], mutations that block filamentous growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CDC39", "entity_1_idx": [[205, 210]], "entity_1_idx_in_text_with_entity_marker": [209, 214], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "DFG16", "entity_2_idx": [[302, 307]], "entity_2_idx_in_text_with_entity_marker": [315, 320], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d243.s0_BioInfer.d243.s0.p38", "text": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "text_with_entity_marker": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, [E1]CDC39[/E1], STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, [E2]DFG9[/E2], DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CDC39", "entity_1_idx": [[205, 210]], "entity_1_idx_in_text_with_entity_marker": [209, 214], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "DFG9", "entity_2_idx": [[280, 284]], "entity_2_idx_in_text_with_entity_marker": [293, 297], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d243.s0_BioInfer.d243.s0.p39", "text": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "text_with_entity_marker": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, [E1]CDC39[/E1], STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, [E2]SPA2[/E2], BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CDC39", "entity_1_idx": [[205, 210]], "entity_1_idx_in_text_with_entity_marker": [209, 214], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "SPA2", "entity_2_idx": [[262, 266]], "entity_2_idx_in_text_with_entity_marker": [275, 279], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d218.s0_BioInfer.d218.s0.p0", "text": "From these observations it is concluded that (i) RAD52 is required for high levels of both gene conversions and reciprocal crossovers, (ii) that RAD51 is not required for intrachromosomal crossovers, and (iii) that RAD51 and RAD52 have different functions, or that RAD52 has functions in addition to those of the Rad51/Rad52 protein complex.", "text_with_entity_marker": "From these observations it is concluded that (i) [E1]RAD52[/E1] is required for high levels of both gene conversions and reciprocal crossovers, (ii) that RAD51 is not required for intrachromosomal crossovers, and (iii) that [E2]RAD51[/E2] and RAD52 have different functions, or that RAD52 has functions in addition to those of the Rad51/Rad52 protein complex.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD52", "entity_1_idx": [[49, 54]], "entity_1_idx_in_text_with_entity_marker": [53, 58], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD51", "entity_2_idx": [[215, 220]], "entity_2_idx_in_text_with_entity_marker": [228, 233], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d218.s0_BioInfer.d218.s0.p1", "text": "From these observations it is concluded that (i) RAD52 is required for high levels of both gene conversions and reciprocal crossovers, (ii) that RAD51 is not required for intrachromosomal crossovers, and (iii) that RAD51 and RAD52 have different functions, or that RAD52 has functions in addition to those of the Rad51/Rad52 protein complex.", "text_with_entity_marker": "From these observations it is concluded that (i) [E1]RAD52[/E1] is required for high levels of both gene conversions and reciprocal crossovers, (ii) that [E2]RAD51[/E2] is not required for intrachromosomal crossovers, and (iii) that RAD51 and RAD52 have different functions, or that RAD52 has functions in addition to those of the Rad51/Rad52 protein complex.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD52", "entity_1_idx": [[49, 54]], "entity_1_idx_in_text_with_entity_marker": [53, 58], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD51", "entity_2_idx": [[145, 150]], "entity_2_idx_in_text_with_entity_marker": [158, 163], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d218.s0_BioInfer.d218.s0.p2", "text": "From these observations it is concluded that (i) RAD52 is required for high levels of both gene conversions and reciprocal crossovers, (ii) that RAD51 is not required for intrachromosomal crossovers, and (iii) that RAD51 and RAD52 have different functions, or that RAD52 has functions in addition to those of the Rad51/Rad52 protein complex.", "text_with_entity_marker": "From these observations it is concluded that (i) [E1]RAD52[/E1] is required for high levels of both gene conversions and reciprocal crossovers, (ii) that RAD51 is not required for intrachromosomal crossovers, and (iii) that RAD51 and [E2]RAD52[/E2] have different functions, or that RAD52 has functions in addition to those of the Rad51/Rad52 protein complex.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD52", "entity_1_idx": [[49, 54]], "entity_1_idx_in_text_with_entity_marker": [53, 58], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD52", "entity_2_idx": [[225, 230]], "entity_2_idx_in_text_with_entity_marker": [238, 243], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d218.s0_BioInfer.d218.s0.p3", "text": "From these observations it is concluded that (i) RAD52 is required for high levels of both gene conversions and reciprocal crossovers, (ii) that RAD51 is not required for intrachromosomal crossovers, and (iii) that RAD51 and RAD52 have different functions, or that RAD52 has functions in addition to those of the Rad51/Rad52 protein complex.", "text_with_entity_marker": "From these observations it is concluded that (i) [E1]RAD52[/E1] is required for high levels of both gene conversions and reciprocal crossovers, (ii) that RAD51 is not required for intrachromosomal crossovers, and (iii) that RAD51 and RAD52 have different functions, or that RAD52 has functions in addition to those of the Rad51/[E2]Rad52[/E2] protein complex.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD52", "entity_1_idx": [[49, 54]], "entity_1_idx_in_text_with_entity_marker": [53, 58], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "Rad52", "entity_2_idx": [[319, 324]], "entity_2_idx_in_text_with_entity_marker": [332, 337], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d218.s0_BioInfer.d218.s0.p4", "text": "From these observations it is concluded that (i) RAD52 is required for high levels of both gene conversions and reciprocal crossovers, (ii) that RAD51 is not required for intrachromosomal crossovers, and (iii) that RAD51 and RAD52 have different functions, or that RAD52 has functions in addition to those of the Rad51/Rad52 protein complex.", "text_with_entity_marker": "From these observations it is concluded that (i) [E1]RAD52[/E1] is required for high levels of both gene conversions and reciprocal crossovers, (ii) that RAD51 is not required for intrachromosomal crossovers, and (iii) that RAD51 and RAD52 have different functions, or that [E2]RAD52[/E2] has functions in addition to those of the Rad51/Rad52 protein complex.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD52", "entity_1_idx": [[49, 54]], "entity_1_idx_in_text_with_entity_marker": [53, 58], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD52", "entity_2_idx": [[265, 270]], "entity_2_idx_in_text_with_entity_marker": [278, 283], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d218.s0_BioInfer.d218.s0.p5", "text": "From these observations it is concluded that (i) RAD52 is required for high levels of both gene conversions and reciprocal crossovers, (ii) that RAD51 is not required for intrachromosomal crossovers, and (iii) that RAD51 and RAD52 have different functions, or that RAD52 has functions in addition to those of the Rad51/Rad52 protein complex.", "text_with_entity_marker": "From these observations it is concluded that (i) [E1]RAD52[/E1] is required for high levels of both gene conversions and reciprocal crossovers, (ii) that RAD51 is not required for intrachromosomal crossovers, and (iii) that RAD51 and RAD52 have different functions, or that RAD52 has functions in addition to those of the [E2]Rad51[/E2]/Rad52 protein complex.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD52", "entity_1_idx": [[49, 54]], "entity_1_idx_in_text_with_entity_marker": [53, 58], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "Rad51", "entity_2_idx": [[313, 318]], "entity_2_idx_in_text_with_entity_marker": [326, 331], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d218.s0_BioInfer.d218.s0.p6", "text": "From these observations it is concluded that (i) RAD52 is required for high levels of both gene conversions and reciprocal crossovers, (ii) that RAD51 is not required for intrachromosomal crossovers, and (iii) that RAD51 and RAD52 have different functions, or that RAD52 has functions in addition to those of the Rad51/Rad52 protein complex.", "text_with_entity_marker": "From these observations it is concluded that (i) RAD52 is required for high levels of both gene conversions and reciprocal crossovers, (ii) that [E1]RAD51[/E1] is not required for intrachromosomal crossovers, and (iii) that [E2]RAD51[/E2] and RAD52 have different functions, or that RAD52 has functions in addition to those of the Rad51/Rad52 protein complex.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD51", "entity_1_idx": [[145, 150]], "entity_1_idx_in_text_with_entity_marker": [149, 154], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD51", "entity_2_idx": [[215, 220]], "entity_2_idx_in_text_with_entity_marker": [228, 233], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d218.s0_BioInfer.d218.s0.p7", "text": "From these observations it is concluded that (i) RAD52 is required for high levels of both gene conversions and reciprocal crossovers, (ii) that RAD51 is not required for intrachromosomal crossovers, and (iii) that RAD51 and RAD52 have different functions, or that RAD52 has functions in addition to those of the Rad51/Rad52 protein complex.", "text_with_entity_marker": "From these observations it is concluded that (i) RAD52 is required for high levels of both gene conversions and reciprocal crossovers, (ii) that RAD51 is not required for intrachromosomal crossovers, and (iii) that [E1]RAD51[/E1] and [E2]RAD52[/E2] have different functions, or that RAD52 has functions in addition to those of the Rad51/Rad52 protein complex.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "RAD51", "entity_1_idx": [[215, 220]], "entity_1_idx_in_text_with_entity_marker": [219, 224], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "RAD52", "entity_2_idx": [[225, 230]], "entity_2_idx_in_text_with_entity_marker": [238, 243], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d218.s0_BioInfer.d218.s0.p8", "text": "From these observations it is concluded that (i) RAD52 is required for high levels of both gene conversions and reciprocal crossovers, (ii) that RAD51 is not required for intrachromosomal crossovers, and (iii) that RAD51 and RAD52 have different functions, or that RAD52 has functions in addition to those of the Rad51/Rad52 protein complex.", "text_with_entity_marker": "From these observations it is concluded that (i) RAD52 is required for high levels of both gene conversions and reciprocal crossovers, (ii) that RAD51 is not required for intrachromosomal crossovers, and (iii) that [E1]RAD51[/E1] and RAD52 have different functions, or that RAD52 has functions in addition to those of the Rad51/[E2]Rad52[/E2] protein complex.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD51", "entity_1_idx": [[215, 220]], "entity_1_idx_in_text_with_entity_marker": [219, 224], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "Rad52", "entity_2_idx": [[319, 324]], "entity_2_idx_in_text_with_entity_marker": [332, 337], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d218.s0_BioInfer.d218.s0.p9", "text": "From these observations it is concluded that (i) RAD52 is required for high levels of both gene conversions and reciprocal crossovers, (ii) that RAD51 is not required for intrachromosomal crossovers, and (iii) that RAD51 and RAD52 have different functions, or that RAD52 has functions in addition to those of the Rad51/Rad52 protein complex.", "text_with_entity_marker": "From these observations it is concluded that (i) RAD52 is required for high levels of both gene conversions and reciprocal crossovers, (ii) that RAD51 is not required for intrachromosomal crossovers, and (iii) that [E1]RAD51[/E1] and RAD52 have different functions, or that [E2]RAD52[/E2] has functions in addition to those of the Rad51/Rad52 protein complex.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD51", "entity_1_idx": [[215, 220]], "entity_1_idx_in_text_with_entity_marker": [219, 224], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "RAD52", "entity_2_idx": [[265, 270]], "entity_2_idx_in_text_with_entity_marker": [278, 283], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d218.s0_BioInfer.d218.s0.p10", "text": "From these observations it is concluded that (i) RAD52 is required for high levels of both gene conversions and reciprocal crossovers, (ii) that RAD51 is not required for intrachromosomal crossovers, and (iii) that RAD51 and RAD52 have different functions, or that RAD52 has functions in addition to those of the Rad51/Rad52 protein complex.", "text_with_entity_marker": "From these observations it is concluded that (i) RAD52 is required for high levels of both gene conversions and reciprocal crossovers, (ii) that RAD51 is not required for intrachromosomal crossovers, and (iii) that [E1]RAD51[/E1] and RAD52 have different functions, or that RAD52 has functions in addition to those of the [E2]Rad51[/E2]/Rad52 protein complex.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD51", "entity_1_idx": [[215, 220]], "entity_1_idx_in_text_with_entity_marker": [219, 224], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "Rad51", "entity_2_idx": [[313, 318]], "entity_2_idx_in_text_with_entity_marker": [326, 331], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d218.s0_BioInfer.d218.s0.p11", "text": "From these observations it is concluded that (i) RAD52 is required for high levels of both gene conversions and reciprocal crossovers, (ii) that RAD51 is not required for intrachromosomal crossovers, and (iii) that RAD51 and RAD52 have different functions, or that RAD52 has functions in addition to those of the Rad51/Rad52 protein complex.", "text_with_entity_marker": "From these observations it is concluded that (i) RAD52 is required for high levels of both gene conversions and reciprocal crossovers, (ii) that [E1]RAD51[/E1] is not required for intrachromosomal crossovers, and (iii) that RAD51 and [E2]RAD52[/E2] have different functions, or that RAD52 has functions in addition to those of the Rad51/Rad52 protein complex.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD51", "entity_1_idx": [[145, 150]], "entity_1_idx_in_text_with_entity_marker": [149, 154], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD52", "entity_2_idx": [[225, 230]], "entity_2_idx_in_text_with_entity_marker": [238, 243], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d218.s0_BioInfer.d218.s0.p12", "text": "From these observations it is concluded that (i) RAD52 is required for high levels of both gene conversions and reciprocal crossovers, (ii) that RAD51 is not required for intrachromosomal crossovers, and (iii) that RAD51 and RAD52 have different functions, or that RAD52 has functions in addition to those of the Rad51/Rad52 protein complex.", "text_with_entity_marker": "From these observations it is concluded that (i) RAD52 is required for high levels of both gene conversions and reciprocal crossovers, (ii) that [E1]RAD51[/E1] is not required for intrachromosomal crossovers, and (iii) that RAD51 and RAD52 have different functions, or that RAD52 has functions in addition to those of the Rad51/[E2]Rad52[/E2] protein complex.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD51", "entity_1_idx": [[145, 150]], "entity_1_idx_in_text_with_entity_marker": [149, 154], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "Rad52", "entity_2_idx": [[319, 324]], "entity_2_idx_in_text_with_entity_marker": [332, 337], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d218.s0_BioInfer.d218.s0.p13", "text": "From these observations it is concluded that (i) RAD52 is required for high levels of both gene conversions and reciprocal crossovers, (ii) that RAD51 is not required for intrachromosomal crossovers, and (iii) that RAD51 and RAD52 have different functions, or that RAD52 has functions in addition to those of the Rad51/Rad52 protein complex.", "text_with_entity_marker": "From these observations it is concluded that (i) RAD52 is required for high levels of both gene conversions and reciprocal crossovers, (ii) that [E1]RAD51[/E1] is not required for intrachromosomal crossovers, and (iii) that RAD51 and RAD52 have different functions, or that [E2]RAD52[/E2] has functions in addition to those of the Rad51/Rad52 protein complex.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD51", "entity_1_idx": [[145, 150]], "entity_1_idx_in_text_with_entity_marker": [149, 154], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD52", "entity_2_idx": [[265, 270]], "entity_2_idx_in_text_with_entity_marker": [278, 283], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d218.s0_BioInfer.d218.s0.p14", "text": "From these observations it is concluded that (i) RAD52 is required for high levels of both gene conversions and reciprocal crossovers, (ii) that RAD51 is not required for intrachromosomal crossovers, and (iii) that RAD51 and RAD52 have different functions, or that RAD52 has functions in addition to those of the Rad51/Rad52 protein complex.", "text_with_entity_marker": "From these observations it is concluded that (i) RAD52 is required for high levels of both gene conversions and reciprocal crossovers, (ii) that [E1]RAD51[/E1] is not required for intrachromosomal crossovers, and (iii) that RAD51 and RAD52 have different functions, or that RAD52 has functions in addition to those of the [E2]Rad51[/E2]/Rad52 protein complex.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD51", "entity_1_idx": [[145, 150]], "entity_1_idx_in_text_with_entity_marker": [149, 154], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "Rad51", "entity_2_idx": [[313, 318]], "entity_2_idx_in_text_with_entity_marker": [326, 331], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d218.s0_BioInfer.d218.s0.p15", "text": "From these observations it is concluded that (i) RAD52 is required for high levels of both gene conversions and reciprocal crossovers, (ii) that RAD51 is not required for intrachromosomal crossovers, and (iii) that RAD51 and RAD52 have different functions, or that RAD52 has functions in addition to those of the Rad51/Rad52 protein complex.", "text_with_entity_marker": "From these observations it is concluded that (i) RAD52 is required for high levels of both gene conversions and reciprocal crossovers, (ii) that RAD51 is not required for intrachromosomal crossovers, and (iii) that RAD51 and [E1]RAD52[/E1] have different functions, or that RAD52 has functions in addition to those of the Rad51/[E2]Rad52[/E2] protein complex.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD52", "entity_1_idx": [[225, 230]], "entity_1_idx_in_text_with_entity_marker": [229, 234], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "Rad52", "entity_2_idx": [[319, 324]], "entity_2_idx_in_text_with_entity_marker": [332, 337], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d218.s0_BioInfer.d218.s0.p16", "text": "From these observations it is concluded that (i) RAD52 is required for high levels of both gene conversions and reciprocal crossovers, (ii) that RAD51 is not required for intrachromosomal crossovers, and (iii) that RAD51 and RAD52 have different functions, or that RAD52 has functions in addition to those of the Rad51/Rad52 protein complex.", "text_with_entity_marker": "From these observations it is concluded that (i) RAD52 is required for high levels of both gene conversions and reciprocal crossovers, (ii) that RAD51 is not required for intrachromosomal crossovers, and (iii) that RAD51 and [E1]RAD52[/E1] have different functions, or that [E2]RAD52[/E2] has functions in addition to those of the Rad51/Rad52 protein complex.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD52", "entity_1_idx": [[225, 230]], "entity_1_idx_in_text_with_entity_marker": [229, 234], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "RAD52", "entity_2_idx": [[265, 270]], "entity_2_idx_in_text_with_entity_marker": [278, 283], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d218.s0_BioInfer.d218.s0.p17", "text": "From these observations it is concluded that (i) RAD52 is required for high levels of both gene conversions and reciprocal crossovers, (ii) that RAD51 is not required for intrachromosomal crossovers, and (iii) that RAD51 and RAD52 have different functions, or that RAD52 has functions in addition to those of the Rad51/Rad52 protein complex.", "text_with_entity_marker": "From these observations it is concluded that (i) RAD52 is required for high levels of both gene conversions and reciprocal crossovers, (ii) that RAD51 is not required for intrachromosomal crossovers, and (iii) that RAD51 and [E1]RAD52[/E1] have different functions, or that RAD52 has functions in addition to those of the [E2]Rad51[/E2]/Rad52 protein complex.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD52", "entity_1_idx": [[225, 230]], "entity_1_idx_in_text_with_entity_marker": [229, 234], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "Rad51", "entity_2_idx": [[313, 318]], "entity_2_idx_in_text_with_entity_marker": [326, 331], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d218.s0_BioInfer.d218.s0.p18", "text": "From these observations it is concluded that (i) RAD52 is required for high levels of both gene conversions and reciprocal crossovers, (ii) that RAD51 is not required for intrachromosomal crossovers, and (iii) that RAD51 and RAD52 have different functions, or that RAD52 has functions in addition to those of the Rad51/Rad52 protein complex.", "text_with_entity_marker": "From these observations it is concluded that (i) RAD52 is required for high levels of both gene conversions and reciprocal crossovers, (ii) that RAD51 is not required for intrachromosomal crossovers, and (iii) that RAD51 and RAD52 have different functions, or that [E1]RAD52[/E1] has functions in addition to those of the Rad51/[E2]Rad52[/E2] protein complex.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD52", "entity_1_idx": [[265, 270]], "entity_1_idx_in_text_with_entity_marker": [269, 274], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "Rad52", "entity_2_idx": [[319, 324]], "entity_2_idx_in_text_with_entity_marker": [332, 337], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d218.s0_BioInfer.d218.s0.p19", "text": "From these observations it is concluded that (i) RAD52 is required for high levels of both gene conversions and reciprocal crossovers, (ii) that RAD51 is not required for intrachromosomal crossovers, and (iii) that RAD51 and RAD52 have different functions, or that RAD52 has functions in addition to those of the Rad51/Rad52 protein complex.", "text_with_entity_marker": "From these observations it is concluded that (i) RAD52 is required for high levels of both gene conversions and reciprocal crossovers, (ii) that RAD51 is not required for intrachromosomal crossovers, and (iii) that RAD51 and RAD52 have different functions, or that RAD52 has functions in addition to those of the [E1]Rad51[/E1]/[E2]Rad52[/E2] protein complex.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Rad51", "entity_1_idx": [[313, 318]], "entity_1_idx_in_text_with_entity_marker": [317, 322], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Rad52", "entity_2_idx": [[319, 324]], "entity_2_idx_in_text_with_entity_marker": [332, 337], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d218.s0_BioInfer.d218.s0.p20", "text": "From these observations it is concluded that (i) RAD52 is required for high levels of both gene conversions and reciprocal crossovers, (ii) that RAD51 is not required for intrachromosomal crossovers, and (iii) that RAD51 and RAD52 have different functions, or that RAD52 has functions in addition to those of the Rad51/Rad52 protein complex.", "text_with_entity_marker": "From these observations it is concluded that (i) RAD52 is required for high levels of both gene conversions and reciprocal crossovers, (ii) that RAD51 is not required for intrachromosomal crossovers, and (iii) that RAD51 and RAD52 have different functions, or that [E1]RAD52[/E1] has functions in addition to those of the [E2]Rad51[/E2]/Rad52 protein complex.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD52", "entity_1_idx": [[265, 270]], "entity_1_idx_in_text_with_entity_marker": [269, 274], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "Rad51", "entity_2_idx": [[313, 318]], "entity_2_idx_in_text_with_entity_marker": [326, 331], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d279.s0_BioInfer.d279.s0.p0", "text": "However, upon treatment with DMSO, cytoplasmic actin filaments were disrupted and intranuclear rod structures containing cofilin and actin were apparently larger and thicker in cells overexpressing cofilin than in normal cells.", "text_with_entity_marker": "However, upon treatment with DMSO, cytoplasmic actin filaments were disrupted and intranuclear rod structures containing [E1]cofilin[/E1] and actin were apparently larger and thicker in cells overexpressing [E2]cofilin[/E2] than in normal cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[121, 128]], "entity_1_idx_in_text_with_entity_marker": [125, 132], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[198, 205]], "entity_2_idx_in_text_with_entity_marker": [211, 218], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d279.s0_BioInfer.d279.s0.p1", "text": "However, upon treatment with DMSO, cytoplasmic actin filaments were disrupted and intranuclear rod structures containing cofilin and actin were apparently larger and thicker in cells overexpressing cofilin than in normal cells.", "text_with_entity_marker": "However, upon treatment with DMSO, cytoplasmic actin filaments were disrupted and intranuclear rod structures containing cofilin and [E1]actin[/E1] were apparently larger and thicker in cells overexpressing [E2]cofilin[/E2] than in normal cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[133, 138]], "entity_1_idx_in_text_with_entity_marker": [137, 142], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[198, 205]], "entity_2_idx_in_text_with_entity_marker": [211, 218], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d279.s0_BioInfer.d279.s0.p2", "text": "However, upon treatment with DMSO, cytoplasmic actin filaments were disrupted and intranuclear rod structures containing cofilin and actin were apparently larger and thicker in cells overexpressing cofilin than in normal cells.", "text_with_entity_marker": "However, upon treatment with DMSO, cytoplasmic [E1]actin[/E1] filaments were disrupted and intranuclear rod structures containing cofilin and actin were apparently larger and thicker in cells overexpressing [E2]cofilin[/E2] than in normal cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[47, 52]], "entity_1_idx_in_text_with_entity_marker": [51, 56], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "cofilin", "entity_2_idx": [[198, 205]], "entity_2_idx_in_text_with_entity_marker": [211, 218], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d279.s0_BioInfer.d279.s0.p3", "text": "However, upon treatment with DMSO, cytoplasmic actin filaments were disrupted and intranuclear rod structures containing cofilin and actin were apparently larger and thicker in cells overexpressing cofilin than in normal cells.", "text_with_entity_marker": "However, upon treatment with DMSO, cytoplasmic actin filaments were disrupted and intranuclear rod structures containing [E1]cofilin[/E1] and [E2]actin[/E2] were apparently larger and thicker in cells overexpressing cofilin than in normal cells.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cofilin", "entity_1_idx": [[121, 128]], "entity_1_idx_in_text_with_entity_marker": [125, 132], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[133, 138]], "entity_2_idx_in_text_with_entity_marker": [146, 151], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d279.s0_BioInfer.d279.s0.p4", "text": "However, upon treatment with DMSO, cytoplasmic actin filaments were disrupted and intranuclear rod structures containing cofilin and actin were apparently larger and thicker in cells overexpressing cofilin than in normal cells.", "text_with_entity_marker": "However, upon treatment with DMSO, cytoplasmic [E1]actin[/E1] filaments were disrupted and intranuclear rod structures containing [E2]cofilin[/E2] and actin were apparently larger and thicker in cells overexpressing cofilin than in normal cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[47, 52]], "entity_1_idx_in_text_with_entity_marker": [51, 56], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "cofilin", "entity_2_idx": [[121, 128]], "entity_2_idx_in_text_with_entity_marker": [134, 141], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d279.s0_BioInfer.d279.s0.p5", "text": "However, upon treatment with DMSO, cytoplasmic actin filaments were disrupted and intranuclear rod structures containing cofilin and actin were apparently larger and thicker in cells overexpressing cofilin than in normal cells.", "text_with_entity_marker": "However, upon treatment with DMSO, cytoplasmic [E1]actin[/E1] filaments were disrupted and intranuclear rod structures containing cofilin and [E2]actin[/E2] were apparently larger and thicker in cells overexpressing cofilin than in normal cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[47, 52]], "entity_1_idx_in_text_with_entity_marker": [51, 56], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[133, 138]], "entity_2_idx_in_text_with_entity_marker": [146, 151], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d279.s1_BioInfer.d279.s1.p0", "text": "In cultured cells, cofilin, as well as ADF, translocates from the cytoplasm into the nucleus together with actin and forms rod-like structures in response to heat shock or dimethylsulfoxide (DMSO) treatment.", "text_with_entity_marker": "In cultured cells, cofilin, as well as [E1]ADF[/E1], translocates from the cytoplasm into the nucleus together with [E2]actin[/E2] and forms rod-like structures in response to heat shock or dimethylsulfoxide (DMSO) treatment.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "ADF", "entity_1_idx": [[39, 42]], "entity_1_idx_in_text_with_entity_marker": [43, 46], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[107, 112]], "entity_2_idx_in_text_with_entity_marker": [120, 125], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d279.s1_BioInfer.d279.s1.p1", "text": "In cultured cells, cofilin, as well as ADF, translocates from the cytoplasm into the nucleus together with actin and forms rod-like structures in response to heat shock or dimethylsulfoxide (DMSO) treatment.", "text_with_entity_marker": "In cultured cells, [E1]cofilin[/E1], as well as [E2]ADF[/E2], translocates from the cytoplasm into the nucleus together with actin and forms rod-like structures in response to heat shock or dimethylsulfoxide (DMSO) treatment.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[19, 26]], "entity_1_idx_in_text_with_entity_marker": [23, 30], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "ADF", "entity_2_idx": [[39, 42]], "entity_2_idx_in_text_with_entity_marker": [52, 55], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d279.s1_BioInfer.d279.s1.p2", "text": "In cultured cells, cofilin, as well as ADF, translocates from the cytoplasm into the nucleus together with actin and forms rod-like structures in response to heat shock or dimethylsulfoxide (DMSO) treatment.", "text_with_entity_marker": "In cultured cells, [E1]cofilin[/E1], as well as ADF, translocates from the cytoplasm into the nucleus together with [E2]actin[/E2] and forms rod-like structures in response to heat shock or dimethylsulfoxide (DMSO) treatment.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cofilin", "entity_1_idx": [[19, 26]], "entity_1_idx_in_text_with_entity_marker": [23, 30], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[107, 112]], "entity_2_idx_in_text_with_entity_marker": [120, 125], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d279.s2_BioInfer.d279.s2.p0", "text": "Stimulus-dependent disorganization of actin filaments induced by overexpression of cofilin in C2 myoblasts.", "text_with_entity_marker": "Stimulus-dependent disorganization of [E1]actin[/E1] filaments induced by overexpression of [E2]cofilin[/E2] in C2 myoblasts.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[38, 43]], "entity_1_idx_in_text_with_entity_marker": [42, 47], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[83, 90]], "entity_2_idx_in_text_with_entity_marker": [96, 103], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d699.s0_BioInfer.d699.s0.p0", "text": "These genes were designated UL5, UL8, UL9, UL42, and UL52 and were predicted to encode proteins with molecular weights of, respectively, 99,000, 80,000, 94,000, 51,000, and 114,000.", "text_with_entity_marker": "These genes were designated [E1]UL5[/E1], UL8, [E2]UL9[/E2], UL42, and UL52 and were predicted to encode proteins with molecular weights of, respectively, 99,000, 80,000, 94,000, 51,000, and 114,000.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL5", "entity_1_idx": [[28, 31]], "entity_1_idx_in_text_with_entity_marker": [32, 35], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL9", "entity_2_idx": [[38, 41]], "entity_2_idx_in_text_with_entity_marker": [51, 54], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d699.s0_BioInfer.d699.s0.p1", "text": "These genes were designated UL5, UL8, UL9, UL42, and UL52 and were predicted to encode proteins with molecular weights of, respectively, 99,000, 80,000, 94,000, 51,000, and 114,000.", "text_with_entity_marker": "These genes were designated [E1]UL5[/E1], [E2]UL8[/E2], UL9, UL42, and UL52 and were predicted to encode proteins with molecular weights of, respectively, 99,000, 80,000, 94,000, 51,000, and 114,000.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL5", "entity_1_idx": [[28, 31]], "entity_1_idx_in_text_with_entity_marker": [32, 35], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL8", "entity_2_idx": [[33, 36]], "entity_2_idx_in_text_with_entity_marker": [46, 49], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d699.s0_BioInfer.d699.s0.p2", "text": "These genes were designated UL5, UL8, UL9, UL42, and UL52 and were predicted to encode proteins with molecular weights of, respectively, 99,000, 80,000, 94,000, 51,000, and 114,000.", "text_with_entity_marker": "These genes were designated [E1]UL5[/E1], UL8, UL9, UL42, and [E2]UL52[/E2] and were predicted to encode proteins with molecular weights of, respectively, 99,000, 80,000, 94,000, 51,000, and 114,000.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL5", "entity_1_idx": [[28, 31]], "entity_1_idx_in_text_with_entity_marker": [32, 35], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL52", "entity_2_idx": [[53, 57]], "entity_2_idx_in_text_with_entity_marker": [66, 70], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d699.s0_BioInfer.d699.s0.p3", "text": "These genes were designated UL5, UL8, UL9, UL42, and UL52 and were predicted to encode proteins with molecular weights of, respectively, 99,000, 80,000, 94,000, 51,000, and 114,000.", "text_with_entity_marker": "These genes were designated [E1]UL5[/E1], UL8, UL9, [E2]UL42[/E2], and UL52 and were predicted to encode proteins with molecular weights of, respectively, 99,000, 80,000, 94,000, 51,000, and 114,000.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL5", "entity_1_idx": [[28, 31]], "entity_1_idx_in_text_with_entity_marker": [32, 35], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL42", "entity_2_idx": [[43, 47]], "entity_2_idx_in_text_with_entity_marker": [56, 60], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d699.s0_BioInfer.d699.s0.p4", "text": "These genes were designated UL5, UL8, UL9, UL42, and UL52 and were predicted to encode proteins with molecular weights of, respectively, 99,000, 80,000, 94,000, 51,000, and 114,000.", "text_with_entity_marker": "These genes were designated UL5, [E1]UL8[/E1], [E2]UL9[/E2], UL42, and UL52 and were predicted to encode proteins with molecular weights of, respectively, 99,000, 80,000, 94,000, 51,000, and 114,000.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL8", "entity_1_idx": [[33, 36]], "entity_1_idx_in_text_with_entity_marker": [37, 40], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL9", "entity_2_idx": [[38, 41]], "entity_2_idx_in_text_with_entity_marker": [51, 54], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d699.s0_BioInfer.d699.s0.p5", "text": "These genes were designated UL5, UL8, UL9, UL42, and UL52 and were predicted to encode proteins with molecular weights of, respectively, 99,000, 80,000, 94,000, 51,000, and 114,000.", "text_with_entity_marker": "These genes were designated UL5, UL8, [E1]UL9[/E1], UL42, and [E2]UL52[/E2] and were predicted to encode proteins with molecular weights of, respectively, 99,000, 80,000, 94,000, 51,000, and 114,000.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL9", "entity_1_idx": [[38, 41]], "entity_1_idx_in_text_with_entity_marker": [42, 45], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL52", "entity_2_idx": [[53, 57]], "entity_2_idx_in_text_with_entity_marker": [66, 70], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d699.s0_BioInfer.d699.s0.p6", "text": "These genes were designated UL5, UL8, UL9, UL42, and UL52 and were predicted to encode proteins with molecular weights of, respectively, 99,000, 80,000, 94,000, 51,000, and 114,000.", "text_with_entity_marker": "These genes were designated UL5, UL8, [E1]UL9[/E1], [E2]UL42[/E2], and UL52 and were predicted to encode proteins with molecular weights of, respectively, 99,000, 80,000, 94,000, 51,000, and 114,000.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL9", "entity_1_idx": [[38, 41]], "entity_1_idx_in_text_with_entity_marker": [42, 45], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL42", "entity_2_idx": [[43, 47]], "entity_2_idx_in_text_with_entity_marker": [56, 60], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d699.s0_BioInfer.d699.s0.p7", "text": "These genes were designated UL5, UL8, UL9, UL42, and UL52 and were predicted to encode proteins with molecular weights of, respectively, 99,000, 80,000, 94,000, 51,000, and 114,000.", "text_with_entity_marker": "These genes were designated UL5, [E1]UL8[/E1], UL9, UL42, and [E2]UL52[/E2] and were predicted to encode proteins with molecular weights of, respectively, 99,000, 80,000, 94,000, 51,000, and 114,000.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL8", "entity_1_idx": [[33, 36]], "entity_1_idx_in_text_with_entity_marker": [37, 40], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL52", "entity_2_idx": [[53, 57]], "entity_2_idx_in_text_with_entity_marker": [66, 70], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d699.s0_BioInfer.d699.s0.p8", "text": "These genes were designated UL5, UL8, UL9, UL42, and UL52 and were predicted to encode proteins with molecular weights of, respectively, 99,000, 80,000, 94,000, 51,000, and 114,000.", "text_with_entity_marker": "These genes were designated UL5, [E1]UL8[/E1], UL9, [E2]UL42[/E2], and UL52 and were predicted to encode proteins with molecular weights of, respectively, 99,000, 80,000, 94,000, 51,000, and 114,000.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL8", "entity_1_idx": [[33, 36]], "entity_1_idx_in_text_with_entity_marker": [37, 40], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL42", "entity_2_idx": [[43, 47]], "entity_2_idx_in_text_with_entity_marker": [56, 60], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d699.s0_BioInfer.d699.s0.p9", "text": "These genes were designated UL5, UL8, UL9, UL42, and UL52 and were predicted to encode proteins with molecular weights of, respectively, 99,000, 80,000, 94,000, 51,000, and 114,000.", "text_with_entity_marker": "These genes were designated UL5, UL8, UL9, [E1]UL42[/E1], and [E2]UL52[/E2] and were predicted to encode proteins with molecular weights of, respectively, 99,000, 80,000, 94,000, 51,000, and 114,000.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL42", "entity_1_idx": [[43, 47]], "entity_1_idx_in_text_with_entity_marker": [47, 51], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL52", "entity_2_idx": [[53, 57]], "entity_2_idx_in_text_with_entity_marker": [66, 70], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d568.s0_BioInfer.d568.s0.p0", "text": "The activation of the c-Raf-1-BxB-ER protein leads to an accumulation of high levels of cyclin D1 protein and a repression of the p27Kip1 cyclin-dependent kinase inhibitor under all culture conditions tested.", "text_with_entity_marker": "The activation of the [E1]c-Raf-1-BxB[/E1]-[E2]ER[/E2] protein leads to an accumulation of high levels of cyclin D1 protein and a repression of the p27Kip1 cyclin-dependent kinase inhibitor under all culture conditions tested.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "c-Raf-1-BxB", "entity_1_idx": [[22, 33]], "entity_1_idx_in_text_with_entity_marker": [26, 37], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "ER", "entity_2_idx": [[34, 36]], "entity_2_idx_in_text_with_entity_marker": [47, 49], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d568.s0_BioInfer.d568.s0.p1", "text": "The activation of the c-Raf-1-BxB-ER protein leads to an accumulation of high levels of cyclin D1 protein and a repression of the p27Kip1 cyclin-dependent kinase inhibitor under all culture conditions tested.", "text_with_entity_marker": "The activation of the [E1]c-Raf-1-BxB[/E1]-ER protein leads to an accumulation of high levels of [E2]cyclin D1[/E2] protein and a repression of the p27Kip1 cyclin-dependent kinase inhibitor under all culture conditions tested.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "c-Raf-1-BxB", "entity_1_idx": [[22, 33]], "entity_1_idx_in_text_with_entity_marker": [26, 37], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin D1", "entity_2_idx": [[88, 97]], "entity_2_idx_in_text_with_entity_marker": [101, 110], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d568.s0_BioInfer.d568.s0.p2", "text": "The activation of the c-Raf-1-BxB-ER protein leads to an accumulation of high levels of cyclin D1 protein and a repression of the p27Kip1 cyclin-dependent kinase inhibitor under all culture conditions tested.", "text_with_entity_marker": "The activation of the [E1]c-Raf-1-BxB[/E1]-ER protein leads to an accumulation of high levels of cyclin D1 protein and a repression of the p27Kip1 [E2]cyclin-dependent kinase inhibitor[/E2] under all culture conditions tested.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "c-Raf-1-BxB", "entity_1_idx": [[22, 33]], "entity_1_idx_in_text_with_entity_marker": [26, 37], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin-dependent kinase inhibitor", "entity_2_idx": [[138, 171]], "entity_2_idx_in_text_with_entity_marker": [151, 184], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d568.s0_BioInfer.d568.s0.p3", "text": "The activation of the c-Raf-1-BxB-ER protein leads to an accumulation of high levels of cyclin D1 protein and a repression of the p27Kip1 cyclin-dependent kinase inhibitor under all culture conditions tested.", "text_with_entity_marker": "The activation of the [E1]c-Raf-1-BxB[/E1]-ER protein leads to an accumulation of high levels of cyclin D1 protein and a repression of the [E2]p27Kip1[/E2] cyclin-dependent kinase inhibitor under all culture conditions tested.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "c-Raf-1-BxB", "entity_1_idx": [[22, 33]], "entity_1_idx_in_text_with_entity_marker": [26, 37], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p27Kip1", "entity_2_idx": [[130, 137]], "entity_2_idx_in_text_with_entity_marker": [143, 150], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d568.s0_BioInfer.d568.s0.p4", "text": "The activation of the c-Raf-1-BxB-ER protein leads to an accumulation of high levels of cyclin D1 protein and a repression of the p27Kip1 cyclin-dependent kinase inhibitor under all culture conditions tested.", "text_with_entity_marker": "The activation of the c-Raf-1-BxB-[E1]ER[/E1] protein leads to an accumulation of high levels of [E2]cyclin D1[/E2] protein and a repression of the p27Kip1 cyclin-dependent kinase inhibitor under all culture conditions tested.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "ER", "entity_1_idx": [[34, 36]], "entity_1_idx_in_text_with_entity_marker": [38, 40], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin D1", "entity_2_idx": [[88, 97]], "entity_2_idx_in_text_with_entity_marker": [101, 110], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d568.s0_BioInfer.d568.s0.p5", "text": "The activation of the c-Raf-1-BxB-ER protein leads to an accumulation of high levels of cyclin D1 protein and a repression of the p27Kip1 cyclin-dependent kinase inhibitor under all culture conditions tested.", "text_with_entity_marker": "The activation of the c-Raf-1-BxB-[E1]ER[/E1] protein leads to an accumulation of high levels of cyclin D1 protein and a repression of the p27Kip1 [E2]cyclin-dependent kinase inhibitor[/E2] under all culture conditions tested.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ER", "entity_1_idx": [[34, 36]], "entity_1_idx_in_text_with_entity_marker": [38, 40], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin-dependent kinase inhibitor", "entity_2_idx": [[138, 171]], "entity_2_idx_in_text_with_entity_marker": [151, 184], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d568.s0_BioInfer.d568.s0.p6", "text": "The activation of the c-Raf-1-BxB-ER protein leads to an accumulation of high levels of cyclin D1 protein and a repression of the p27Kip1 cyclin-dependent kinase inhibitor under all culture conditions tested.", "text_with_entity_marker": "The activation of the c-Raf-1-BxB-[E1]ER[/E1] protein leads to an accumulation of high levels of cyclin D1 protein and a repression of the [E2]p27Kip1[/E2] cyclin-dependent kinase inhibitor under all culture conditions tested.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "ER", "entity_1_idx": [[34, 36]], "entity_1_idx_in_text_with_entity_marker": [38, 40], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p27Kip1", "entity_2_idx": [[130, 137]], "entity_2_idx_in_text_with_entity_marker": [143, 150], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d568.s0_BioInfer.d568.s0.p7", "text": "The activation of the c-Raf-1-BxB-ER protein leads to an accumulation of high levels of cyclin D1 protein and a repression of the p27Kip1 cyclin-dependent kinase inhibitor under all culture conditions tested.", "text_with_entity_marker": "The activation of the c-Raf-1-BxB-ER protein leads to an accumulation of high levels of [E1]cyclin D1[/E1] protein and a repression of the p27Kip1 [E2]cyclin-dependent kinase inhibitor[/E2] under all culture conditions tested.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin D1", "entity_1_idx": [[88, 97]], "entity_1_idx_in_text_with_entity_marker": [92, 101], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin-dependent kinase inhibitor", "entity_2_idx": [[138, 171]], "entity_2_idx_in_text_with_entity_marker": [151, 184], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d568.s0_BioInfer.d568.s0.p8", "text": "The activation of the c-Raf-1-BxB-ER protein leads to an accumulation of high levels of cyclin D1 protein and a repression of the p27Kip1 cyclin-dependent kinase inhibitor under all culture conditions tested.", "text_with_entity_marker": "The activation of the c-Raf-1-BxB-ER protein leads to an accumulation of high levels of [E1]cyclin D1[/E1] protein and a repression of the [E2]p27Kip1[/E2] cyclin-dependent kinase inhibitor under all culture conditions tested.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin D1", "entity_1_idx": [[88, 97]], "entity_1_idx_in_text_with_entity_marker": [92, 101], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p27Kip1", "entity_2_idx": [[130, 137]], "entity_2_idx_in_text_with_entity_marker": [143, 150], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d568.s0_BioInfer.d568.s0.p9", "text": "The activation of the c-Raf-1-BxB-ER protein leads to an accumulation of high levels of cyclin D1 protein and a repression of the p27Kip1 cyclin-dependent kinase inhibitor under all culture conditions tested.", "text_with_entity_marker": "The activation of the c-Raf-1-BxB-ER protein leads to an accumulation of high levels of cyclin D1 protein and a repression of the [E1]p27Kip1[/E1] [E2]cyclin-dependent kinase inhibitor[/E2] under all culture conditions tested.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "p27Kip1", "entity_1_idx": [[130, 137]], "entity_1_idx_in_text_with_entity_marker": [134, 141], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin-dependent kinase inhibitor", "entity_2_idx": [[138, 171]], "entity_2_idx_in_text_with_entity_marker": [151, 184], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d77.s0_BioInfer.d77.s0.p0", "text": "Arp2/3 complex from Acanthamoeba binds profilin and cross-links actin filaments.", "text_with_entity_marker": "[E1]Arp2[/E1]/3 complex from Acanthamoeba binds [E2]profilin[/E2] and cross-links actin filaments.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Arp2", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[39, 47]], "entity_2_idx_in_text_with_entity_marker": [52, 60], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d77.s0_BioInfer.d77.s0.p1", "text": "Arp2/3 complex from Acanthamoeba binds profilin and cross-links actin filaments.", "text_with_entity_marker": "[E1]Arp[/E1]2/3 complex from Acanthamoeba binds [E2]profilin[/E2] and cross-links actin filaments.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Arp", "entity_1_idx": [[0, 3], [5, 6]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[39, 47]], "entity_2_idx_in_text_with_entity_marker": [52, 60], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d77.s0_BioInfer.d77.s0.p2", "text": "Arp2/3 complex from Acanthamoeba binds profilin and cross-links actin filaments.", "text_with_entity_marker": "Arp2/3 complex from Acanthamoeba binds [E1]profilin[/E1] and cross-links [E2]actin[/E2] filaments.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[39, 47]], "entity_1_idx_in_text_with_entity_marker": [43, 51], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[64, 69]], "entity_2_idx_in_text_with_entity_marker": [77, 82], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d77.s0_BioInfer.d77.s0.p3", "text": "Arp2/3 complex from Acanthamoeba binds profilin and cross-links actin filaments.", "text_with_entity_marker": "[E1-E2]Arp[/E1]2[/E2]/3 complex from Acanthamoeba binds profilin and cross-links actin filaments.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Arp", "entity_1_idx": [[0, 3], [5, 6]], "entity_1_idx_in_text_with_entity_marker": [7, 10], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Arp[/E1]2", "entity_2_idx": [[0, 4]], "entity_2_idx_in_text_with_entity_marker": [7, 16], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d77.s0_BioInfer.d77.s0.p4", "text": "Arp2/3 complex from Acanthamoeba binds profilin and cross-links actin filaments.", "text_with_entity_marker": "[E1]Arp2[/E1]/3 complex from Acanthamoeba binds profilin and cross-links [E2]actin[/E2] filaments.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Arp2", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[64, 69]], "entity_2_idx_in_text_with_entity_marker": [77, 82], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d77.s0_BioInfer.d77.s0.p5", "text": "Arp2/3 complex from Acanthamoeba binds profilin and cross-links actin filaments.", "text_with_entity_marker": "[E1]Arp[/E1]2/3 complex from Acanthamoeba binds profilin and cross-links [E2]actin[/E2] filaments.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Arp", "entity_1_idx": [[0, 3], [5, 6]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[64, 69]], "entity_2_idx_in_text_with_entity_marker": [77, 82], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d77.s1_BioInfer.d77.s1.p0", "text": "By analytical ultracentrifugation, rhodamine-labeled profilin binds Arp2/3 complex with a Kd of 7 microM, an affinity intermediate between the low affinity of profilin for barbed ends of actin filaments and its high affinity for actin monomers.", "text_with_entity_marker": "By analytical ultracentrifugation, rhodamine-labeled profilin binds Arp2/3 complex with a Kd of 7 microM, an affinity intermediate between the low affinity of [E1]profilin[/E1] for barbed ends of actin filaments and its high affinity for [E2]actin[/E2] monomers.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[159, 167]], "entity_1_idx_in_text_with_entity_marker": [163, 171], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[229, 234]], "entity_2_idx_in_text_with_entity_marker": [242, 247], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d77.s1_BioInfer.d77.s1.p1", "text": "By analytical ultracentrifugation, rhodamine-labeled profilin binds Arp2/3 complex with a Kd of 7 microM, an affinity intermediate between the low affinity of profilin for barbed ends of actin filaments and its high affinity for actin monomers.", "text_with_entity_marker": "By analytical ultracentrifugation, rhodamine-labeled profilin binds [E1]Arp2[/E1]/3 complex with a Kd of 7 microM, an affinity intermediate between the low affinity of profilin for barbed ends of actin filaments and its high affinity for [E2]actin[/E2] monomers.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Arp2", "entity_1_idx": [[68, 72]], "entity_1_idx_in_text_with_entity_marker": [72, 76], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[229, 234]], "entity_2_idx_in_text_with_entity_marker": [242, 247], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d77.s1_BioInfer.d77.s1.p2", "text": "By analytical ultracentrifugation, rhodamine-labeled profilin binds Arp2/3 complex with a Kd of 7 microM, an affinity intermediate between the low affinity of profilin for barbed ends of actin filaments and its high affinity for actin monomers.", "text_with_entity_marker": "By analytical ultracentrifugation, rhodamine-labeled [E1]profilin[/E1] binds Arp2/3 complex with a Kd of 7 microM, an affinity intermediate between the low affinity of profilin for barbed ends of actin filaments and its high affinity for [E2]actin[/E2] monomers.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[53, 61]], "entity_1_idx_in_text_with_entity_marker": [57, 65], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[229, 234]], "entity_2_idx_in_text_with_entity_marker": [242, 247], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d77.s1_BioInfer.d77.s1.p3", "text": "By analytical ultracentrifugation, rhodamine-labeled profilin binds Arp2/3 complex with a Kd of 7 microM, an affinity intermediate between the low affinity of profilin for barbed ends of actin filaments and its high affinity for actin monomers.", "text_with_entity_marker": "By analytical ultracentrifugation, rhodamine-labeled profilin binds Arp2/3 complex with a Kd of 7 microM, an affinity intermediate between the low affinity of profilin for barbed ends of [E1]actin[/E1] filaments and its high affinity for [E2]actin[/E2] monomers.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[187, 192]], "entity_1_idx_in_text_with_entity_marker": [191, 196], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[229, 234]], "entity_2_idx_in_text_with_entity_marker": [242, 247], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d167.s0_BioInfer.d167.s0.p0", "text": "Deletion of SIR4 enhanced mURA3 and MET15 silencing, but deletion of SIR1 or SIR3 did not affect silencing, indicating that the mechanism of silencing differs from that at telomeres and silent mating loci.", "text_with_entity_marker": "Deletion of [E1]SIR4[/E1] enhanced [E2]mURA3[/E2] and MET15 silencing, but deletion of SIR1 or SIR3 did not affect silencing, indicating that the mechanism of silencing differs from that at telomeres and silent mating loci.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "SIR4", "entity_1_idx": [[12, 16]], "entity_1_idx_in_text_with_entity_marker": [16, 20], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "mURA3", "entity_2_idx": [[26, 31]], "entity_2_idx_in_text_with_entity_marker": [39, 44], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d167.s0_BioInfer.d167.s0.p1", "text": "Deletion of SIR4 enhanced mURA3 and MET15 silencing, but deletion of SIR1 or SIR3 did not affect silencing, indicating that the mechanism of silencing differs from that at telomeres and silent mating loci.", "text_with_entity_marker": "Deletion of SIR4 enhanced [E1]mURA3[/E1] and MET15 silencing, but deletion of SIR1 or [E2]SIR3[/E2] did not affect silencing, indicating that the mechanism of silencing differs from that at telomeres and silent mating loci.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "mURA3", "entity_1_idx": [[26, 31]], "entity_1_idx_in_text_with_entity_marker": [30, 35], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "SIR3", "entity_2_idx": [[77, 81]], "entity_2_idx_in_text_with_entity_marker": [90, 94], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d167.s0_BioInfer.d167.s0.p2", "text": "Deletion of SIR4 enhanced mURA3 and MET15 silencing, but deletion of SIR1 or SIR3 did not affect silencing, indicating that the mechanism of silencing differs from that at telomeres and silent mating loci.", "text_with_entity_marker": "Deletion of SIR4 enhanced [E1]mURA3[/E1] and MET15 silencing, but deletion of [E2]SIR1[/E2] or SIR3 did not affect silencing, indicating that the mechanism of silencing differs from that at telomeres and silent mating loci.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "mURA3", "entity_1_idx": [[26, 31]], "entity_1_idx_in_text_with_entity_marker": [30, 35], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "SIR1", "entity_2_idx": [[69, 73]], "entity_2_idx_in_text_with_entity_marker": [82, 86], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d167.s0_BioInfer.d167.s0.p3", "text": "Deletion of SIR4 enhanced mURA3 and MET15 silencing, but deletion of SIR1 or SIR3 did not affect silencing, indicating that the mechanism of silencing differs from that at telomeres and silent mating loci.", "text_with_entity_marker": "Deletion of SIR4 enhanced [E1]mURA3[/E1] and [E2]MET15[/E2] silencing, but deletion of SIR1 or SIR3 did not affect silencing, indicating that the mechanism of silencing differs from that at telomeres and silent mating loci.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "mURA3", "entity_1_idx": [[26, 31]], "entity_1_idx_in_text_with_entity_marker": [30, 35], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MET15", "entity_2_idx": [[36, 41]], "entity_2_idx_in_text_with_entity_marker": [49, 54], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d167.s0_BioInfer.d167.s0.p4", "text": "Deletion of SIR4 enhanced mURA3 and MET15 silencing, but deletion of SIR1 or SIR3 did not affect silencing, indicating that the mechanism of silencing differs from that at telomeres and silent mating loci.", "text_with_entity_marker": "Deletion of [E1]SIR4[/E1] enhanced mURA3 and MET15 silencing, but deletion of SIR1 or [E2]SIR3[/E2] did not affect silencing, indicating that the mechanism of silencing differs from that at telomeres and silent mating loci.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SIR4", "entity_1_idx": [[12, 16]], "entity_1_idx_in_text_with_entity_marker": [16, 20], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "SIR3", "entity_2_idx": [[77, 81]], "entity_2_idx_in_text_with_entity_marker": [90, 94], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d167.s0_BioInfer.d167.s0.p5", "text": "Deletion of SIR4 enhanced mURA3 and MET15 silencing, but deletion of SIR1 or SIR3 did not affect silencing, indicating that the mechanism of silencing differs from that at telomeres and silent mating loci.", "text_with_entity_marker": "Deletion of [E1]SIR4[/E1] enhanced mURA3 and MET15 silencing, but deletion of [E2]SIR1[/E2] or SIR3 did not affect silencing, indicating that the mechanism of silencing differs from that at telomeres and silent mating loci.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SIR4", "entity_1_idx": [[12, 16]], "entity_1_idx_in_text_with_entity_marker": [16, 20], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "SIR1", "entity_2_idx": [[69, 73]], "entity_2_idx_in_text_with_entity_marker": [82, 86], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d167.s0_BioInfer.d167.s0.p6", "text": "Deletion of SIR4 enhanced mURA3 and MET15 silencing, but deletion of SIR1 or SIR3 did not affect silencing, indicating that the mechanism of silencing differs from that at telomeres and silent mating loci.", "text_with_entity_marker": "Deletion of [E1]SIR4[/E1] enhanced mURA3 and [E2]MET15[/E2] silencing, but deletion of SIR1 or SIR3 did not affect silencing, indicating that the mechanism of silencing differs from that at telomeres and silent mating loci.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "SIR4", "entity_1_idx": [[12, 16]], "entity_1_idx_in_text_with_entity_marker": [16, 20], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MET15", "entity_2_idx": [[36, 41]], "entity_2_idx_in_text_with_entity_marker": [49, 54], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d167.s0_BioInfer.d167.s0.p7", "text": "Deletion of SIR4 enhanced mURA3 and MET15 silencing, but deletion of SIR1 or SIR3 did not affect silencing, indicating that the mechanism of silencing differs from that at telomeres and silent mating loci.", "text_with_entity_marker": "Deletion of SIR4 enhanced mURA3 and MET15 silencing, but deletion of [E1]SIR1[/E1] or [E2]SIR3[/E2] did not affect silencing, indicating that the mechanism of silencing differs from that at telomeres and silent mating loci.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SIR1", "entity_1_idx": [[69, 73]], "entity_1_idx_in_text_with_entity_marker": [73, 77], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "SIR3", "entity_2_idx": [[77, 81]], "entity_2_idx_in_text_with_entity_marker": [90, 94], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d167.s0_BioInfer.d167.s0.p8", "text": "Deletion of SIR4 enhanced mURA3 and MET15 silencing, but deletion of SIR1 or SIR3 did not affect silencing, indicating that the mechanism of silencing differs from that at telomeres and silent mating loci.", "text_with_entity_marker": "Deletion of SIR4 enhanced mURA3 and [E1]MET15[/E1] silencing, but deletion of SIR1 or [E2]SIR3[/E2] did not affect silencing, indicating that the mechanism of silencing differs from that at telomeres and silent mating loci.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "MET15", "entity_1_idx": [[36, 41]], "entity_1_idx_in_text_with_entity_marker": [40, 45], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "SIR3", "entity_2_idx": [[77, 81]], "entity_2_idx_in_text_with_entity_marker": [90, 94], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d167.s0_BioInfer.d167.s0.p9", "text": "Deletion of SIR4 enhanced mURA3 and MET15 silencing, but deletion of SIR1 or SIR3 did not affect silencing, indicating that the mechanism of silencing differs from that at telomeres and silent mating loci.", "text_with_entity_marker": "Deletion of SIR4 enhanced mURA3 and [E1]MET15[/E1] silencing, but deletion of [E2]SIR1[/E2] or SIR3 did not affect silencing, indicating that the mechanism of silencing differs from that at telomeres and silent mating loci.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "MET15", "entity_1_idx": [[36, 41]], "entity_1_idx_in_text_with_entity_marker": [40, 45], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "SIR1", "entity_2_idx": [[69, 73]], "entity_2_idx_in_text_with_entity_marker": [82, 86], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p30", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), [E1]fusion[/E1] (F), nucleocapsid protein (NP), [E2]phosphoprotein[/E2] (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "fusion", "entity_1_idx": [[57, 63], [130, 138]], "entity_1_idx_in_text_with_entity_marker": [61, 67], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "phosphoprotein", "entity_2_idx": [[96, 110], [130, 138]], "entity_2_idx_in_text_with_entity_marker": [109, 123], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p31", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), [E1]fusion[/E1] (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, [E2]F[/E2], NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "fusion", "entity_1_idx": [[57, 63], [130, 138]], "entity_1_idx_in_text_with_entity_marker": [61, 67], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "F", "entity_2_idx": [[156, 157], [168, 176]], "entity_2_idx_in_text_with_entity_marker": [169, 170], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p32", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin ([E1]H[/E1]), [E2]fusion[/E2] (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H", "entity_1_idx": [[53, 54]], "entity_1_idx_in_text_with_entity_marker": [57, 58], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "fusion", "entity_2_idx": [[57, 63], [130, 138]], "entity_2_idx_in_text_with_entity_marker": [70, 76], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p33", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), [E1]fusion[/E1] (F), nucleocapsid protein (NP), phosphoprotein ([E2]P[/E2]) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "fusion", "entity_1_idx": [[57, 63], [130, 138]], "entity_1_idx_in_text_with_entity_marker": [61, 67], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P", "entity_2_idx": [[112, 113]], "entity_2_idx_in_text_with_entity_marker": [125, 126], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p34", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), [E1]fusion[/E1] (F), nucleocapsid protein ([E2]NP[/E2]), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "fusion", "entity_1_idx": [[57, 63], [130, 138]], "entity_1_idx_in_text_with_entity_marker": [61, 67], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "NP", "entity_2_idx": [[91, 93]], "entity_2_idx_in_text_with_entity_marker": [104, 106], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p35", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), [E1]fusion[/E1] (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix ([E2]M[/E2]) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "fusion", "entity_1_idx": [[57, 63], [130, 138]], "entity_1_idx_in_text_with_entity_marker": [61, 67], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "M", "entity_2_idx": [[127, 128]], "entity_2_idx_in_text_with_entity_marker": [140, 141], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p36", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the [E1]haemagglutinin[/E1] (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and [E2]matrix[/E2] (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "haemagglutinin", "entity_1_idx": [[37, 51], [130, 138]], "entity_1_idx_in_text_with_entity_marker": [41, 55], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "matrix", "entity_2_idx": [[119, 125], [130, 138]], "entity_2_idx_in_text_with_entity_marker": [132, 138], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p37", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), [E1]nucleocapsid protein[/E1] (NP), phosphoprotein (P) and [E2]matrix[/E2] (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nucleocapsid protein", "entity_1_idx": [[69, 89], [130, 138]], "entity_1_idx_in_text_with_entity_marker": [73, 93], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "matrix", "entity_2_idx": [[119, 125], [130, 138]], "entity_2_idx_in_text_with_entity_marker": [132, 138], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p38", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and [E1]matrix[/E1] (M) proteins of MV and the [E2]H[/E2], F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "matrix", "entity_1_idx": [[119, 125], [130, 138]], "entity_1_idx_in_text_with_entity_marker": [123, 129], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H", "entity_2_idx": [[153, 154], [168, 176]], "entity_2_idx_in_text_with_entity_marker": [166, 167], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p39", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and [E1]matrix[/E1] (M) proteins of MV and the H, F, NP and [E2]P proteins[/E2] of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "matrix", "entity_1_idx": [[119, 125], [130, 138]], "entity_1_idx_in_text_with_entity_marker": [123, 129], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P proteins", "entity_2_idx": [[166, 176]], "entity_2_idx_in_text_with_entity_marker": [179, 189], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p80", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), [E1]phosphoprotein[/E1] (P) and matrix ([E2]M[/E2]) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "phosphoprotein", "entity_1_idx": [[96, 110], [130, 138]], "entity_1_idx_in_text_with_entity_marker": [100, 114], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "M", "entity_2_idx": [[127, 128]], "entity_2_idx_in_text_with_entity_marker": [140, 141], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p81", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin ([E1]H[/E1]), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, [E2]F[/E2], NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H", "entity_1_idx": [[53, 54]], "entity_1_idx_in_text_with_entity_marker": [57, 58], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "F", "entity_2_idx": [[156, 157], [168, 176]], "entity_2_idx_in_text_with_entity_marker": [169, 170], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p82", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein ([E1]P[/E1]) and matrix (M) proteins of MV and the H, [E2]F[/E2], NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "P", "entity_1_idx": [[112, 113]], "entity_1_idx_in_text_with_entity_marker": [116, 117], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "F", "entity_2_idx": [[156, 157], [168, 176]], "entity_2_idx_in_text_with_entity_marker": [169, 170], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p83", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein ([E1]NP[/E1]), phosphoprotein (P) and matrix (M) proteins of MV and the H, [E2]F[/E2], NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "NP", "entity_1_idx": [[91, 93]], "entity_1_idx_in_text_with_entity_marker": [95, 97], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "F", "entity_2_idx": [[156, 157], [168, 176]], "entity_2_idx_in_text_with_entity_marker": [169, 170], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p84", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix ([E1]M[/E1]) proteins of MV and the H, [E2]F[/E2], NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "M", "entity_1_idx": [[127, 128]], "entity_1_idx_in_text_with_entity_marker": [131, 132], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "F", "entity_2_idx": [[156, 157], [168, 176]], "entity_2_idx_in_text_with_entity_marker": [169, 170], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p85", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin ([E1]H[/E1]), fusion (F), nucleocapsid protein (NP), phosphoprotein ([E2]P[/E2]) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H", "entity_1_idx": [[53, 54]], "entity_1_idx_in_text_with_entity_marker": [57, 58], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P", "entity_2_idx": [[112, 113]], "entity_2_idx_in_text_with_entity_marker": [125, 126], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p86", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin ([E1]H[/E1]), fusion (F), nucleocapsid protein ([E2]NP[/E2]), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H", "entity_1_idx": [[53, 54]], "entity_1_idx_in_text_with_entity_marker": [57, 58], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "NP", "entity_2_idx": [[91, 93]], "entity_2_idx_in_text_with_entity_marker": [104, 106], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p87", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin ([E1]H[/E1]), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix ([E2]M[/E2]) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H", "entity_1_idx": [[53, 54]], "entity_1_idx_in_text_with_entity_marker": [57, 58], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "M", "entity_2_idx": [[127, 128]], "entity_2_idx_in_text_with_entity_marker": [140, 141], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p88", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein ([E1]NP[/E1]), phosphoprotein ([E2]P[/E2]) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "NP", "entity_1_idx": [[91, 93]], "entity_1_idx_in_text_with_entity_marker": [95, 97], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P", "entity_2_idx": [[112, 113]], "entity_2_idx_in_text_with_entity_marker": [125, 126], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p89", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein ([E1]P[/E1]) and matrix ([E2]M[/E2]) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "P", "entity_1_idx": [[112, 113]], "entity_1_idx_in_text_with_entity_marker": [116, 117], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "M", "entity_2_idx": [[127, 128]], "entity_2_idx_in_text_with_entity_marker": [140, 141], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d199.s0_BioInfer.d199.s0.p0", "text": "Exposure of the cells to tumor promoter did, however, result in a loss of actin and talin-rich cell surface elaborations that resemble focal contact precursor structures.", "text_with_entity_marker": "Exposure of the cells to tumor promoter did, however, result in a loss of [E1]actin[/E1] and [E2]talin[/E2]-rich cell surface elaborations that resemble focal contact precursor structures.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[74, 79]], "entity_1_idx_in_text_with_entity_marker": [78, 83], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "talin", "entity_2_idx": [[84, 89]], "entity_2_idx_in_text_with_entity_marker": [97, 102], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d649.s0_BioInfer.d649.s0.p10", "text": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "text_with_entity_marker": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, [E1]calcium vector protein[/E1], [E2]creatine kinase[/E2], muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "calcium vector protein", "entity_1_idx": [[166, 188]], "entity_1_idx_in_text_with_entity_marker": [170, 192], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "creatine kinase", "entity_2_idx": [[190, 205]], "entity_2_idx_in_text_with_entity_marker": [203, 218], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d649.s0_BioInfer.d649.s0.p11", "text": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "text_with_entity_marker": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, [E1]myosin heavy chain[/E1], [E2]calmodulin[/E2], calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin heavy chain", "entity_1_idx": [[124, 142]], "entity_1_idx_in_text_with_entity_marker": [128, 146], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "calmodulin", "entity_2_idx": [[144, 154]], "entity_2_idx_in_text_with_entity_marker": [157, 167], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d649.s0_BioInfer.d649.s0.p12", "text": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "text_with_entity_marker": "The muscle-related genes included actin, tropomyosin, troponin I, [E1]myosin regulatory light chain[/E1], myosin light chain kinase, [E2]myosin heavy chain[/E2], calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin regulatory light chain", "entity_1_idx": [[66, 95]], "entity_1_idx_in_text_with_entity_marker": [70, 99], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin heavy chain", "entity_2_idx": [[124, 142]], "entity_2_idx_in_text_with_entity_marker": [137, 155], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d649.s0_BioInfer.d649.s0.p13", "text": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "text_with_entity_marker": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, [E1]myosin light chain kinase[/E1], [E2]myosin heavy chain[/E2], calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin light chain kinase", "entity_1_idx": [[97, 122]], "entity_1_idx_in_text_with_entity_marker": [101, 126], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin heavy chain", "entity_2_idx": [[124, 142]], "entity_2_idx_in_text_with_entity_marker": [137, 155], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d649.s0_BioInfer.d649.s0.p14", "text": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "text_with_entity_marker": "The muscle-related genes included actin, [E1]tropomyosin[/E1], troponin I, myosin regulatory light chain, myosin light chain kinase, [E2]myosin heavy chain[/E2], calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "tropomyosin", "entity_1_idx": [[41, 52]], "entity_1_idx_in_text_with_entity_marker": [45, 56], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin heavy chain", "entity_2_idx": [[124, 142]], "entity_2_idx_in_text_with_entity_marker": [137, 155], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d649.s0_BioInfer.d649.s0.p15", "text": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "text_with_entity_marker": "The muscle-related genes included actin, tropomyosin, [E1]troponin I[/E1], myosin regulatory light chain, myosin light chain kinase, [E2]myosin heavy chain[/E2], calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "troponin I", "entity_1_idx": [[54, 64]], "entity_1_idx_in_text_with_entity_marker": [58, 68], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin heavy chain", "entity_2_idx": [[124, 142]], "entity_2_idx_in_text_with_entity_marker": [137, 155], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d649.s0_BioInfer.d649.s0.p16", "text": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "text_with_entity_marker": "The muscle-related genes included [E1]actin[/E1], tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, [E2]myosin heavy chain[/E2], calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[34, 39]], "entity_1_idx_in_text_with_entity_marker": [38, 43], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin heavy chain", "entity_2_idx": [[124, 142]], "entity_2_idx_in_text_with_entity_marker": [137, 155], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d649.s0_BioInfer.d649.s0.p17", "text": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "text_with_entity_marker": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, [E1]myosin heavy chain[/E1], calmodulin, calponin, calcium vector protein, creatine kinase, [E2]muscle LIM[/E2] protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin heavy chain", "entity_1_idx": [[124, 142]], "entity_1_idx_in_text_with_entity_marker": [128, 146], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "muscle LIM", "entity_2_idx": [[207, 217]], "entity_2_idx_in_text_with_entity_marker": [220, 230], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d649.s0_BioInfer.d649.s0.p18", "text": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "text_with_entity_marker": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, [E1]myosin heavy chain[/E1], calmodulin, [E2]calponin[/E2], calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin heavy chain", "entity_1_idx": [[124, 142]], "entity_1_idx_in_text_with_entity_marker": [128, 146], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "calponin", "entity_2_idx": [[156, 164]], "entity_2_idx_in_text_with_entity_marker": [169, 177], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d649.s0_BioInfer.d649.s0.p19", "text": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "text_with_entity_marker": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, [E1]myosin heavy chain[/E1], calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and [E2]SH3-binding glutamate-rich protein[/E2], suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin heavy chain", "entity_1_idx": [[124, 142]], "entity_1_idx_in_text_with_entity_marker": [128, 146], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "SH3-binding glutamate-rich protein", "entity_2_idx": [[231, 265]], "entity_2_idx_in_text_with_entity_marker": [244, 278], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d772.s0_BioInfer.d772.s0.p20", "text": "Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.", "text_with_entity_marker": "Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, [E1]FADD[/E1], [E2]DR3[/E2], FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "FADD", "entity_1_idx": [[73, 77]], "entity_1_idx_in_text_with_entity_marker": [77, 81], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "DR3", "entity_2_idx": [[79, 82]], "entity_2_idx_in_text_with_entity_marker": [92, 95], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d772.s0_BioInfer.d772.s0.p21", "text": "Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.", "text_with_entity_marker": "Transcriptional expression of TNFR1(p55), as well as that of FLICE, [E1]Fas[/E1], [E2]FADD[/E2], DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Fas", "entity_1_idx": [[68, 71]], "entity_1_idx_in_text_with_entity_marker": [72, 75], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "FADD", "entity_2_idx": [[73, 77]], "entity_2_idx_in_text_with_entity_marker": [86, 90], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d772.s0_BioInfer.d772.s0.p22", "text": "Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.", "text_with_entity_marker": "Transcriptional expression of TNFR1([E1]p55[/E1]), as well as that of FLICE, Fas, [E2]FADD[/E2], DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p55", "entity_1_idx": [[36, 39]], "entity_1_idx_in_text_with_entity_marker": [40, 43], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "FADD", "entity_2_idx": [[73, 77]], "entity_2_idx_in_text_with_entity_marker": [86, 90], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d772.s0_BioInfer.d772.s0.p23", "text": "Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.", "text_with_entity_marker": "Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, [E1]FADD[/E1], DR3, FAF, TRADD, and [E2]RIP[/E2] was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "FADD", "entity_1_idx": [[73, 77]], "entity_1_idx_in_text_with_entity_marker": [77, 81], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RIP", "entity_2_idx": [[100, 103]], "entity_2_idx_in_text_with_entity_marker": [113, 116], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d772.s0_BioInfer.d772.s0.p24", "text": "Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.", "text_with_entity_marker": "Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, [E1]FAF[/E1], TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to [E2]TNFalpha[/E2]-induced apoptosis may not be determined by the constitutive expression level of these factors.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "FAF", "entity_1_idx": [[84, 87]], "entity_1_idx_in_text_with_entity_marker": [88, 91], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TNFalpha", "entity_2_idx": [[175, 183]], "entity_2_idx_in_text_with_entity_marker": [188, 196], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d772.s0_BioInfer.d772.s0.p25", "text": "Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.", "text_with_entity_marker": "Transcriptional expression of [E1]TNFR1[/E1](p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to [E2]TNFalpha[/E2]-induced apoptosis may not be determined by the constitutive expression level of these factors.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "TNFR1", "entity_1_idx": [[30, 35]], "entity_1_idx_in_text_with_entity_marker": [34, 39], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TNFalpha", "entity_2_idx": [[175, 183]], "entity_2_idx_in_text_with_entity_marker": [188, 196], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d772.s0_BioInfer.d772.s0.p26", "text": "Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.", "text_with_entity_marker": "Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, [E1]DR3[/E1], FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to [E2]TNFalpha[/E2]-induced apoptosis may not be determined by the constitutive expression level of these factors.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "DR3", "entity_1_idx": [[79, 82]], "entity_1_idx_in_text_with_entity_marker": [83, 86], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TNFalpha", "entity_2_idx": [[175, 183]], "entity_2_idx_in_text_with_entity_marker": [188, 196], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d772.s0_BioInfer.d772.s0.p27", "text": "Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.", "text_with_entity_marker": "Transcriptional expression of TNFR1(p55), as well as that of FLICE, [E1]Fas[/E1], FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to [E2]TNFalpha[/E2]-induced apoptosis may not be determined by the constitutive expression level of these factors.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Fas", "entity_1_idx": [[68, 71]], "entity_1_idx_in_text_with_entity_marker": [72, 75], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TNFalpha", "entity_2_idx": [[175, 183]], "entity_2_idx_in_text_with_entity_marker": [188, 196], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d772.s0_BioInfer.d772.s0.p28", "text": "Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.", "text_with_entity_marker": "Transcriptional expression of TNFR1([E1]p55[/E1]), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to [E2]TNFalpha[/E2]-induced apoptosis may not be determined by the constitutive expression level of these factors.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "p55", "entity_1_idx": [[36, 39]], "entity_1_idx_in_text_with_entity_marker": [40, 43], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TNFalpha", "entity_2_idx": [[175, 183]], "entity_2_idx_in_text_with_entity_marker": [188, 196], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d772.s0_BioInfer.d772.s0.p29", "text": "Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.", "text_with_entity_marker": "Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and [E1]RIP[/E1] was similar in these cell lines, indicating that the susceptibility to [E2]TNFalpha[/E2]-induced apoptosis may not be determined by the constitutive expression level of these factors.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "RIP", "entity_1_idx": [[100, 103]], "entity_1_idx_in_text_with_entity_marker": [104, 107], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TNFalpha", "entity_2_idx": [[175, 183]], "entity_2_idx_in_text_with_entity_marker": [188, 196], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d772.s0_BioInfer.d772.s0.p30", "text": "Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.", "text_with_entity_marker": "Transcriptional expression of [E1]TNFR1[/E1](p55), as well as that of FLICE, Fas, FADD, DR3, [E2]FAF[/E2], TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TNFR1", "entity_1_idx": [[30, 35]], "entity_1_idx_in_text_with_entity_marker": [34, 39], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "FAF", "entity_2_idx": [[84, 87]], "entity_2_idx_in_text_with_entity_marker": [97, 100], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d772.s0_BioInfer.d772.s0.p31", "text": "Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.", "text_with_entity_marker": "Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, [E1]DR3[/E1], [E2]FAF[/E2], TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "DR3", "entity_1_idx": [[79, 82]], "entity_1_idx_in_text_with_entity_marker": [83, 86], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "FAF", "entity_2_idx": [[84, 87]], "entity_2_idx_in_text_with_entity_marker": [97, 100], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d772.s0_BioInfer.d772.s0.p32", "text": "Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.", "text_with_entity_marker": "Transcriptional expression of TNFR1(p55), as well as that of FLICE, [E1]Fas[/E1], FADD, DR3, [E2]FAF[/E2], TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Fas", "entity_1_idx": [[68, 71]], "entity_1_idx_in_text_with_entity_marker": [72, 75], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "FAF", "entity_2_idx": [[84, 87]], "entity_2_idx_in_text_with_entity_marker": [97, 100], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d772.s0_BioInfer.d772.s0.p33", "text": "Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.", "text_with_entity_marker": "Transcriptional expression of TNFR1([E1]p55[/E1]), as well as that of FLICE, Fas, FADD, DR3, [E2]FAF[/E2], TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p55", "entity_1_idx": [[36, 39]], "entity_1_idx_in_text_with_entity_marker": [40, 43], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "FAF", "entity_2_idx": [[84, 87]], "entity_2_idx_in_text_with_entity_marker": [97, 100], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d772.s0_BioInfer.d772.s0.p34", "text": "Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.", "text_with_entity_marker": "Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, [E1]FAF[/E1], TRADD, and [E2]RIP[/E2] was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "FAF", "entity_1_idx": [[84, 87]], "entity_1_idx_in_text_with_entity_marker": [88, 91], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RIP", "entity_2_idx": [[100, 103]], "entity_2_idx_in_text_with_entity_marker": [113, 116], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d772.s0_BioInfer.d772.s0.p35", "text": "Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.", "text_with_entity_marker": "Transcriptional expression of [E1]TNFR1[/E1](p55), as well as that of FLICE, Fas, FADD, [E2]DR3[/E2], FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TNFR1", "entity_1_idx": [[30, 35]], "entity_1_idx_in_text_with_entity_marker": [34, 39], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "DR3", "entity_2_idx": [[79, 82]], "entity_2_idx_in_text_with_entity_marker": [92, 95], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d772.s0_BioInfer.d772.s0.p36", "text": "Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.", "text_with_entity_marker": "Transcriptional expression of [E1]TNFR1[/E1](p55), as well as that of FLICE, [E2]Fas[/E2], FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TNFR1", "entity_1_idx": [[30, 35]], "entity_1_idx_in_text_with_entity_marker": [34, 39], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Fas", "entity_2_idx": [[68, 71]], "entity_2_idx_in_text_with_entity_marker": [81, 84], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d772.s0_BioInfer.d772.s0.p37", "text": "Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.", "text_with_entity_marker": "Transcriptional expression of [E1]TNFR1[/E1]([E2]p55[/E2]), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TNFR1", "entity_1_idx": [[30, 35]], "entity_1_idx_in_text_with_entity_marker": [34, 39], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p55", "entity_2_idx": [[36, 39]], "entity_2_idx_in_text_with_entity_marker": [49, 52], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d772.s0_BioInfer.d772.s0.p38", "text": "Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.", "text_with_entity_marker": "Transcriptional expression of [E1]TNFR1[/E1](p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and [E2]RIP[/E2] was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TNFR1", "entity_1_idx": [[30, 35]], "entity_1_idx_in_text_with_entity_marker": [34, 39], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RIP", "entity_2_idx": [[100, 103]], "entity_2_idx_in_text_with_entity_marker": [113, 116], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d772.s0_BioInfer.d772.s0.p39", "text": "Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.", "text_with_entity_marker": "Transcriptional expression of TNFR1(p55), as well as that of FLICE, [E1]Fas[/E1], FADD, [E2]DR3[/E2], FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Fas", "entity_1_idx": [[68, 71]], "entity_1_idx_in_text_with_entity_marker": [72, 75], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "DR3", "entity_2_idx": [[79, 82]], "entity_2_idx_in_text_with_entity_marker": [92, 95], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d772.s0_BioInfer.d772.s0.p40", "text": "Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.", "text_with_entity_marker": "Transcriptional expression of TNFR1([E1]p55[/E1]), as well as that of FLICE, Fas, FADD, [E2]DR3[/E2], FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p55", "entity_1_idx": [[36, 39]], "entity_1_idx_in_text_with_entity_marker": [40, 43], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "DR3", "entity_2_idx": [[79, 82]], "entity_2_idx_in_text_with_entity_marker": [92, 95], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d772.s0_BioInfer.d772.s0.p41", "text": "Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.", "text_with_entity_marker": "Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, [E1]DR3[/E1], FAF, TRADD, and [E2]RIP[/E2] was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "DR3", "entity_1_idx": [[79, 82]], "entity_1_idx_in_text_with_entity_marker": [83, 86], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RIP", "entity_2_idx": [[100, 103]], "entity_2_idx_in_text_with_entity_marker": [113, 116], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d772.s0_BioInfer.d772.s0.p42", "text": "Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.", "text_with_entity_marker": "Transcriptional expression of TNFR1([E1]p55[/E1]), as well as that of FLICE, [E2]Fas[/E2], FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p55", "entity_1_idx": [[36, 39]], "entity_1_idx_in_text_with_entity_marker": [40, 43], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Fas", "entity_2_idx": [[68, 71]], "entity_2_idx_in_text_with_entity_marker": [81, 84], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d772.s0_BioInfer.d772.s0.p43", "text": "Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.", "text_with_entity_marker": "Transcriptional expression of TNFR1(p55), as well as that of FLICE, [E1]Fas[/E1], FADD, DR3, FAF, TRADD, and [E2]RIP[/E2] was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Fas", "entity_1_idx": [[68, 71]], "entity_1_idx_in_text_with_entity_marker": [72, 75], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RIP", "entity_2_idx": [[100, 103]], "entity_2_idx_in_text_with_entity_marker": [113, 116], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d772.s0_BioInfer.d772.s0.p44", "text": "Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.", "text_with_entity_marker": "Transcriptional expression of TNFR1([E1]p55[/E1]), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and [E2]RIP[/E2] was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p55", "entity_1_idx": [[36, 39]], "entity_1_idx_in_text_with_entity_marker": [40, 43], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RIP", "entity_2_idx": [[100, 103]], "entity_2_idx_in_text_with_entity_marker": [113, 116], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d342.s0_BioInfer.d342.s0.p0", "text": "Inhibition of the interactions of cofilin, destrin, and deoxyribonuclease I with actin by phosphoinositides.", "text_with_entity_marker": "Inhibition of the interactions of [E1]cofilin[/E1], destrin, and [E2]deoxyribonuclease I[/E2] with actin by phosphoinositides.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[34, 41]], "entity_1_idx_in_text_with_entity_marker": [38, 45], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "deoxyribonuclease I", "entity_2_idx": [[56, 75]], "entity_2_idx_in_text_with_entity_marker": [69, 88], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d342.s0_BioInfer.d342.s0.p1", "text": "Inhibition of the interactions of cofilin, destrin, and deoxyribonuclease I with actin by phosphoinositides.", "text_with_entity_marker": "Inhibition of the interactions of [E1]cofilin[/E1], destrin, and deoxyribonuclease I with [E2]actin[/E2] by phosphoinositides.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cofilin", "entity_1_idx": [[34, 41]], "entity_1_idx_in_text_with_entity_marker": [38, 45], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[81, 86]], "entity_2_idx_in_text_with_entity_marker": [94, 99], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d342.s0_BioInfer.d342.s0.p2", "text": "Inhibition of the interactions of cofilin, destrin, and deoxyribonuclease I with actin by phosphoinositides.", "text_with_entity_marker": "Inhibition of the interactions of [E1]cofilin[/E1], [E2]destrin[/E2], and deoxyribonuclease I with actin by phosphoinositides.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[34, 41]], "entity_1_idx_in_text_with_entity_marker": [38, 45], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "destrin", "entity_2_idx": [[43, 50]], "entity_2_idx_in_text_with_entity_marker": [56, 63], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d342.s0_BioInfer.d342.s0.p3", "text": "Inhibition of the interactions of cofilin, destrin, and deoxyribonuclease I with actin by phosphoinositides.", "text_with_entity_marker": "Inhibition of the interactions of cofilin, destrin, and [E1]deoxyribonuclease I[/E1] with [E2]actin[/E2] by phosphoinositides.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "deoxyribonuclease I", "entity_1_idx": [[56, 75]], "entity_1_idx_in_text_with_entity_marker": [60, 79], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[81, 86]], "entity_2_idx_in_text_with_entity_marker": [94, 99], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d342.s0_BioInfer.d342.s0.p4", "text": "Inhibition of the interactions of cofilin, destrin, and deoxyribonuclease I with actin by phosphoinositides.", "text_with_entity_marker": "Inhibition of the interactions of cofilin, [E1]destrin[/E1], and [E2]deoxyribonuclease I[/E2] with actin by phosphoinositides.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "destrin", "entity_1_idx": [[43, 50]], "entity_1_idx_in_text_with_entity_marker": [47, 54], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "deoxyribonuclease I", "entity_2_idx": [[56, 75]], "entity_2_idx_in_text_with_entity_marker": [69, 88], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d342.s0_BioInfer.d342.s0.p5", "text": "Inhibition of the interactions of cofilin, destrin, and deoxyribonuclease I with actin by phosphoinositides.", "text_with_entity_marker": "Inhibition of the interactions of cofilin, [E1]destrin[/E1], and deoxyribonuclease I with [E2]actin[/E2] by phosphoinositides.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "destrin", "entity_1_idx": [[43, 50]], "entity_1_idx_in_text_with_entity_marker": [47, 54], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[81, 86]], "entity_2_idx_in_text_with_entity_marker": [94, 99], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d240.s0_BioInfer.d240.s0.p0", "text": "Here we demonstrate that type XIII collagen is concentrated in cultured skin fibroblasts and several other human mesenchymal cell lines in the focal adhesions at the ends of actin stress fibers, co-localizing with the known focal adhesion components talin and vinculin.", "text_with_entity_marker": "Here we demonstrate that [E1]type XIII collagen[/E1] is concentrated in cultured skin fibroblasts and several other human mesenchymal cell lines in the focal adhesions at the ends of actin stress fibers, co-localizing with the known focal adhesion components [E2]talin[/E2] and vinculin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "type XIII collagen", "entity_1_idx": [[25, 43]], "entity_1_idx_in_text_with_entity_marker": [29, 47], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[250, 255]], "entity_2_idx_in_text_with_entity_marker": [263, 268], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d240.s0_BioInfer.d240.s0.p1", "text": "Here we demonstrate that type XIII collagen is concentrated in cultured skin fibroblasts and several other human mesenchymal cell lines in the focal adhesions at the ends of actin stress fibers, co-localizing with the known focal adhesion components talin and vinculin.", "text_with_entity_marker": "Here we demonstrate that [E1]type XIII collagen[/E1] is concentrated in cultured skin fibroblasts and several other human mesenchymal cell lines in the focal adhesions at the ends of actin stress fibers, co-localizing with the known focal adhesion components talin and [E2]vinculin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "type XIII collagen", "entity_1_idx": [[25, 43]], "entity_1_idx_in_text_with_entity_marker": [29, 47], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vinculin", "entity_2_idx": [[260, 268]], "entity_2_idx_in_text_with_entity_marker": [273, 281], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d240.s0_BioInfer.d240.s0.p2", "text": "Here we demonstrate that type XIII collagen is concentrated in cultured skin fibroblasts and several other human mesenchymal cell lines in the focal adhesions at the ends of actin stress fibers, co-localizing with the known focal adhesion components talin and vinculin.", "text_with_entity_marker": "Here we demonstrate that [E1]type XIII collagen[/E1] is concentrated in cultured skin fibroblasts and several other human mesenchymal cell lines in the focal adhesions at the ends of [E2]actin[/E2] stress fibers, co-localizing with the known focal adhesion components talin and vinculin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "type XIII collagen", "entity_1_idx": [[25, 43]], "entity_1_idx_in_text_with_entity_marker": [29, 47], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[174, 179]], "entity_2_idx_in_text_with_entity_marker": [187, 192], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d240.s0_BioInfer.d240.s0.p3", "text": "Here we demonstrate that type XIII collagen is concentrated in cultured skin fibroblasts and several other human mesenchymal cell lines in the focal adhesions at the ends of actin stress fibers, co-localizing with the known focal adhesion components talin and vinculin.", "text_with_entity_marker": "Here we demonstrate that type XIII collagen is concentrated in cultured skin fibroblasts and several other human mesenchymal cell lines in the focal adhesions at the ends of actin stress fibers, co-localizing with the known focal adhesion components [E1]talin[/E1] and [E2]vinculin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "talin", "entity_1_idx": [[250, 255]], "entity_1_idx_in_text_with_entity_marker": [254, 259], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vinculin", "entity_2_idx": [[260, 268]], "entity_2_idx_in_text_with_entity_marker": [273, 281], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d240.s0_BioInfer.d240.s0.p4", "text": "Here we demonstrate that type XIII collagen is concentrated in cultured skin fibroblasts and several other human mesenchymal cell lines in the focal adhesions at the ends of actin stress fibers, co-localizing with the known focal adhesion components talin and vinculin.", "text_with_entity_marker": "Here we demonstrate that type XIII collagen is concentrated in cultured skin fibroblasts and several other human mesenchymal cell lines in the focal adhesions at the ends of [E1]actin[/E1] stress fibers, co-localizing with the known focal adhesion components [E2]talin[/E2] and vinculin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[174, 179]], "entity_1_idx_in_text_with_entity_marker": [178, 183], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[250, 255]], "entity_2_idx_in_text_with_entity_marker": [263, 268], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d240.s0_BioInfer.d240.s0.p5", "text": "Here we demonstrate that type XIII collagen is concentrated in cultured skin fibroblasts and several other human mesenchymal cell lines in the focal adhesions at the ends of actin stress fibers, co-localizing with the known focal adhesion components talin and vinculin.", "text_with_entity_marker": "Here we demonstrate that type XIII collagen is concentrated in cultured skin fibroblasts and several other human mesenchymal cell lines in the focal adhesions at the ends of [E1]actin[/E1] stress fibers, co-localizing with the known focal adhesion components talin and [E2]vinculin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[174, 179]], "entity_1_idx_in_text_with_entity_marker": [178, 183], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vinculin", "entity_2_idx": [[260, 268]], "entity_2_idx_in_text_with_entity_marker": [273, 281], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d586.s0_BioInfer.d586.s0.p0", "text": "The RAD54 and RAD51 genes are involved in genetic recombination and double-strand break repair in the yeast Saccharomyces cerevisiae.", "text_with_entity_marker": "The [E1]RAD54[/E1] and [E2]RAD51[/E2] genes are involved in genetic recombination and double-strand break repair in the yeast Saccharomyces cerevisiae.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD54", "entity_1_idx": [[4, 9]], "entity_1_idx_in_text_with_entity_marker": [8, 13], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD51", "entity_2_idx": [[14, 19]], "entity_2_idx_in_text_with_entity_marker": [27, 32], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d210.s0_BioInfer.d210.s0.p30", "text": "Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.", "text_with_entity_marker": "Finally, we evaluated the acetylation of three putative [E1]PCAF[/E1] substrates, histones H3 and [E2]H4[/E2] and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "PCAF", "entity_1_idx": [[56, 60]], "entity_1_idx_in_text_with_entity_marker": [60, 64], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H4", "entity_2_idx": [[89, 91]], "entity_2_idx_in_text_with_entity_marker": [102, 104], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d210.s0_BioInfer.d210.s0.p31", "text": "Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.", "text_with_entity_marker": "Finally, we evaluated the acetylation of three putative PCAF substrates, histones [E1]H3[/E1] and [E2]H4[/E2] and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H3", "entity_1_idx": [[82, 84]], "entity_1_idx_in_text_with_entity_marker": [86, 88], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H4", "entity_2_idx": [[89, 91]], "entity_2_idx_in_text_with_entity_marker": [102, 104], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d210.s0_BioInfer.d210.s0.p32", "text": "Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.", "text_with_entity_marker": "Finally, we evaluated the acetylation of three putative PCAF substrates, [E1]histones[/E1] H3 and [E2]H4[/E2] and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "histones", "entity_1_idx": [[73, 81]], "entity_1_idx_in_text_with_entity_marker": [77, 85], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H4", "entity_2_idx": [[89, 91]], "entity_2_idx_in_text_with_entity_marker": [102, 104], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d210.s0_BioInfer.d210.s0.p33", "text": "Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.", "text_with_entity_marker": "Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and [E1]H4[/E1] and the transcription factor p53, and have determined that histone H3 is significantly preferred over the [E2]histone[/E2] H4 and p53 substrates.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H4", "entity_1_idx": [[89, 91]], "entity_1_idx_in_text_with_entity_marker": [93, 95], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[198, 205]], "entity_2_idx_in_text_with_entity_marker": [211, 218], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d210.s0_BioInfer.d210.s0.p34", "text": "Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.", "text_with_entity_marker": "Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and [E1]H4[/E1] and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and [E2]p53[/E2] substrates.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H4", "entity_1_idx": [[89, 91]], "entity_1_idx_in_text_with_entity_marker": [93, 95], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p53", "entity_2_idx": [[213, 216]], "entity_2_idx_in_text_with_entity_marker": [226, 229], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d210.s0_BioInfer.d210.s0.p35", "text": "Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.", "text_with_entity_marker": "Finally, we evaluated the acetylation of three putative [E1]PCAF[/E1] substrates, histones [E2]H3[/E2] and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "PCAF", "entity_1_idx": [[56, 60]], "entity_1_idx_in_text_with_entity_marker": [60, 64], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H3", "entity_2_idx": [[82, 84]], "entity_2_idx_in_text_with_entity_marker": [95, 97], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d210.s0_BioInfer.d210.s0.p36", "text": "Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.", "text_with_entity_marker": "Finally, we evaluated the acetylation of three putative [E1]PCAF[/E1] substrates, [E2]histones[/E2] H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PCAF", "entity_1_idx": [[56, 60]], "entity_1_idx_in_text_with_entity_marker": [60, 64], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histones", "entity_2_idx": [[73, 81]], "entity_2_idx_in_text_with_entity_marker": [86, 94], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d210.s0_BioInfer.d210.s0.p37", "text": "Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.", "text_with_entity_marker": "Finally, we evaluated the acetylation of three putative [E1]PCAF[/E1] substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the [E2]histone[/E2] H4 and p53 substrates.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PCAF", "entity_1_idx": [[56, 60]], "entity_1_idx_in_text_with_entity_marker": [60, 64], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[198, 205]], "entity_2_idx_in_text_with_entity_marker": [211, 218], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d210.s0_BioInfer.d210.s0.p38", "text": "Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.", "text_with_entity_marker": "Finally, we evaluated the acetylation of three putative [E1]PCAF[/E1] substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and [E2]p53[/E2] substrates.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PCAF", "entity_1_idx": [[56, 60]], "entity_1_idx_in_text_with_entity_marker": [60, 64], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p53", "entity_2_idx": [[213, 216]], "entity_2_idx_in_text_with_entity_marker": [226, 229], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d210.s0_BioInfer.d210.s0.p39", "text": "Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.", "text_with_entity_marker": "Finally, we evaluated the acetylation of three putative PCAF substrates, [E1]histones[/E1] [E2]H3[/E2] and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "histones", "entity_1_idx": [[73, 81]], "entity_1_idx_in_text_with_entity_marker": [77, 85], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H3", "entity_2_idx": [[82, 84]], "entity_2_idx_in_text_with_entity_marker": [95, 97], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d119.s0_BioInfer.d119.s0.p0", "text": "By site-directed mutagenesis of profilin II from Dictyostelium discoideum the point mutations K114E and W3N were generated by PCR thus changing actin and poly-(L)-proline-binding activity respectively.", "text_with_entity_marker": "By site-directed mutagenesis of [E1]profilin II[/E1] from Dictyostelium discoideum the point mutations K114E and W3N were generated by PCR thus changing [E2]actin[/E2] and poly-(L)-proline-binding activity respectively.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin II", "entity_1_idx": [[32, 43]], "entity_1_idx_in_text_with_entity_marker": [36, 47], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[144, 149]], "entity_2_idx_in_text_with_entity_marker": [157, 162], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d119.s1_BioInfer.d119.s1.p0", "text": "The K114E profilin exhibited a profound decrease in its ability to interact with actin, whereas binding to poly-(L)-proline was essentially unchanged.", "text_with_entity_marker": "The [E1]K114E profilin[/E1] exhibited a profound decrease in its ability to interact with [E2]actin[/E2], whereas binding to poly-(L)-proline was essentially unchanged.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "K114E profilin", "entity_1_idx": [[4, 18]], "entity_1_idx_in_text_with_entity_marker": [8, 22], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[81, 86]], "entity_2_idx_in_text_with_entity_marker": [94, 99], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d274.s0_BioInfer.d274.s0.p0", "text": "However, similar to utrophin, alpha-syntrophin is only present at the neuromuscular junction in mdx mouse muscle in which dystrophin is absent.", "text_with_entity_marker": "However, similar to utrophin, [E1]alpha-syntrophin[/E1] is only present at the neuromuscular junction in mdx mouse muscle in which [E2]dystrophin[/E2] is absent.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-syntrophin", "entity_1_idx": [[30, 46]], "entity_1_idx_in_text_with_entity_marker": [34, 50], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "dystrophin", "entity_2_idx": [[122, 132]], "entity_2_idx_in_text_with_entity_marker": [135, 145], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d274.s0_BioInfer.d274.s0.p1", "text": "However, similar to utrophin, alpha-syntrophin is only present at the neuromuscular junction in mdx mouse muscle in which dystrophin is absent.", "text_with_entity_marker": "However, similar to [E1]utrophin[/E1], [E2]alpha-syntrophin[/E2] is only present at the neuromuscular junction in mdx mouse muscle in which dystrophin is absent.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "utrophin", "entity_1_idx": [[20, 28]], "entity_1_idx_in_text_with_entity_marker": [24, 32], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-syntrophin", "entity_2_idx": [[30, 46]], "entity_2_idx_in_text_with_entity_marker": [43, 59], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d274.s0_BioInfer.d274.s0.p2", "text": "However, similar to utrophin, alpha-syntrophin is only present at the neuromuscular junction in mdx mouse muscle in which dystrophin is absent.", "text_with_entity_marker": "However, similar to [E1]utrophin[/E1], alpha-syntrophin is only present at the neuromuscular junction in mdx mouse muscle in which [E2]dystrophin[/E2] is absent.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "utrophin", "entity_1_idx": [[20, 28]], "entity_1_idx_in_text_with_entity_marker": [24, 32], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "dystrophin", "entity_2_idx": [[122, 132]], "entity_2_idx_in_text_with_entity_marker": [135, 145], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d274.s1_BioInfer.d274.s1.p0", "text": "Identification of alpha-syntrophin binding to syntrophin triplet, dystrophin, and utrophin.", "text_with_entity_marker": "Identification of [E1]alpha-syntrophin[/E1] binding to syntrophin triplet, [E2]dystrophin[/E2], and utrophin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-syntrophin", "entity_1_idx": [[18, 34]], "entity_1_idx_in_text_with_entity_marker": [22, 38], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "dystrophin", "entity_2_idx": [[66, 76]], "entity_2_idx_in_text_with_entity_marker": [79, 89], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d274.s1_BioInfer.d274.s1.p1", "text": "Identification of alpha-syntrophin binding to syntrophin triplet, dystrophin, and utrophin.", "text_with_entity_marker": "Identification of [E1]alpha-syntrophin[/E1] binding to [E2]syntrophin triplet[/E2], dystrophin, and utrophin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-syntrophin", "entity_1_idx": [[18, 34]], "entity_1_idx_in_text_with_entity_marker": [22, 38], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "syntrophin triplet", "entity_2_idx": [[46, 64]], "entity_2_idx_in_text_with_entity_marker": [59, 77], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d274.s1_BioInfer.d274.s1.p2", "text": "Identification of alpha-syntrophin binding to syntrophin triplet, dystrophin, and utrophin.", "text_with_entity_marker": "Identification of [E1]alpha-syntrophin[/E1] binding to syntrophin triplet, dystrophin, and [E2]utrophin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-syntrophin", "entity_1_idx": [[18, 34]], "entity_1_idx_in_text_with_entity_marker": [22, 38], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "utrophin", "entity_2_idx": [[82, 90]], "entity_2_idx_in_text_with_entity_marker": [95, 103], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d274.s1_BioInfer.d274.s1.p3", "text": "Identification of alpha-syntrophin binding to syntrophin triplet, dystrophin, and utrophin.", "text_with_entity_marker": "Identification of alpha-syntrophin binding to [E1]syntrophin triplet[/E1], [E2]dystrophin[/E2], and utrophin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "syntrophin triplet", "entity_1_idx": [[46, 64]], "entity_1_idx_in_text_with_entity_marker": [50, 68], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "dystrophin", "entity_2_idx": [[66, 76]], "entity_2_idx_in_text_with_entity_marker": [79, 89], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d274.s1_BioInfer.d274.s1.p4", "text": "Identification of alpha-syntrophin binding to syntrophin triplet, dystrophin, and utrophin.", "text_with_entity_marker": "Identification of alpha-syntrophin binding to syntrophin triplet, [E1]dystrophin[/E1], and [E2]utrophin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "dystrophin", "entity_1_idx": [[66, 76]], "entity_1_idx_in_text_with_entity_marker": [70, 80], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "utrophin", "entity_2_idx": [[82, 90]], "entity_2_idx_in_text_with_entity_marker": [95, 103], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d274.s1_BioInfer.d274.s1.p5", "text": "Identification of alpha-syntrophin binding to syntrophin triplet, dystrophin, and utrophin.", "text_with_entity_marker": "Identification of alpha-syntrophin binding to [E1]syntrophin triplet[/E1], dystrophin, and [E2]utrophin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "syntrophin triplet", "entity_1_idx": [[46, 64]], "entity_1_idx_in_text_with_entity_marker": [50, 68], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "utrophin", "entity_2_idx": [[82, 90]], "entity_2_idx_in_text_with_entity_marker": [95, 103], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d833.s0_BioInfer.d833.s0.p10", "text": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "text_with_entity_marker": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, [E1]alpha-catenin[/E1], beta-catenin, [E2]plakoglobin[/E2], vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-catenin", "entity_1_idx": [[82, 95]], "entity_1_idx_in_text_with_entity_marker": [86, 99], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[111, 122]], "entity_2_idx_in_text_with_entity_marker": [124, 135], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d833.s0_BioInfer.d833.s0.p11", "text": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "text_with_entity_marker": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, [E1]alpha-catenin[/E1], beta-catenin, plakoglobin, vinculin and [E2]alpha-actinin[/E2] appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-catenin", "entity_1_idx": [[82, 95]], "entity_1_idx_in_text_with_entity_marker": [86, 99], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-actinin", "entity_2_idx": [[137, 150]], "entity_2_idx_in_text_with_entity_marker": [150, 163], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d833.s0_BioInfer.d833.s0.p12", "text": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "text_with_entity_marker": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, [E1]alpha-catenin[/E1], beta-catenin, plakoglobin, [E2]vinculin[/E2] and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-catenin", "entity_1_idx": [[82, 95]], "entity_1_idx_in_text_with_entity_marker": [86, 99], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vinculin", "entity_2_idx": [[124, 132]], "entity_2_idx_in_text_with_entity_marker": [137, 145], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d833.s0_BioInfer.d833.s0.p13", "text": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "text_with_entity_marker": "Within 1 hour of raising the concentration of calcium ions, integrins, [E1]cadherins[/E1], [E2]alpha-catenin[/E2], beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cadherins", "entity_1_idx": [[71, 80]], "entity_1_idx_in_text_with_entity_marker": [75, 84], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[82, 95]], "entity_2_idx_in_text_with_entity_marker": [95, 108], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d833.s0_BioInfer.d833.s0.p14", "text": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "text_with_entity_marker": "Within 1 hour of raising the concentration of calcium ions, [E1]integrins[/E1], cadherins, [E2]alpha-catenin[/E2], beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "integrins", "entity_1_idx": [[60, 69]], "entity_1_idx_in_text_with_entity_marker": [64, 73], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[82, 95]], "entity_2_idx_in_text_with_entity_marker": [95, 108], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d833.s0_BioInfer.d833.s0.p15", "text": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "text_with_entity_marker": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, [E1]paxillin[/E1] and [E2]talin[/E2], did not.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "paxillin", "entity_1_idx": [[232, 240]], "entity_1_idx_in_text_with_entity_marker": [236, 244], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[245, 250]], "entity_2_idx_in_text_with_entity_marker": [258, 263], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d833.s0_BioInfer.d833.s0.p16", "text": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "text_with_entity_marker": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, [E1]plakoglobin[/E1], vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, [E2]paxillin[/E2] and talin, did not.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "plakoglobin", "entity_1_idx": [[111, 122]], "entity_1_idx_in_text_with_entity_marker": [115, 126], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "paxillin", "entity_2_idx": [[232, 240]], "entity_2_idx_in_text_with_entity_marker": [245, 253], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d833.s0_BioInfer.d833.s0.p17", "text": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "text_with_entity_marker": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and [E1]alpha-actinin[/E1] appeared to accumulate at cell-cell borders, whereas the focal contact proteins, [E2]paxillin[/E2] and talin, did not.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-actinin", "entity_1_idx": [[137, 150]], "entity_1_idx_in_text_with_entity_marker": [141, 154], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "paxillin", "entity_2_idx": [[232, 240]], "entity_2_idx_in_text_with_entity_marker": [245, 253], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d833.s0_BioInfer.d833.s0.p18", "text": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "text_with_entity_marker": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, [E1]vinculin[/E1] and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, [E2]paxillin[/E2] and talin, did not.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "vinculin", "entity_1_idx": [[124, 132]], "entity_1_idx_in_text_with_entity_marker": [128, 136], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "paxillin", "entity_2_idx": [[232, 240]], "entity_2_idx_in_text_with_entity_marker": [245, 253], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d833.s0_BioInfer.d833.s0.p19", "text": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "text_with_entity_marker": "Within 1 hour of raising the concentration of calcium ions, integrins, [E1]cadherins[/E1], alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, [E2]paxillin[/E2] and talin, did not.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cadherins", "entity_1_idx": [[71, 80]], "entity_1_idx_in_text_with_entity_marker": [75, 84], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "paxillin", "entity_2_idx": [[232, 240]], "entity_2_idx_in_text_with_entity_marker": [245, 253], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d491.s0_BioInfer.d491.s0.p0", "text": "Porcine arterial SMCs in culture not only express high levels of alpha-smooth muscle (SM) actin but, contrary to rodent SMCs, also maintain an appreciable expression of SM myosin heavy chain isoforms 1 and 2, desmin, and smoothelin, a recently described late differentiation marker of vascular SMCs.", "text_with_entity_marker": "Porcine arterial SMCs in culture not only express high levels of alpha-smooth muscle (SM) actin but, contrary to rodent SMCs, also maintain an appreciable expression of SM myosin heavy chain isoforms 1 and 2, [E1]desmin[/E1], and [E2]smoothelin[/E2], a recently described late differentiation marker of vascular SMCs.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "desmin", "entity_1_idx": [[209, 215]], "entity_1_idx_in_text_with_entity_marker": [213, 219], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "smoothelin", "entity_2_idx": [[221, 231]], "entity_2_idx_in_text_with_entity_marker": [234, 244], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d491.s0_BioInfer.d491.s0.p1", "text": "Porcine arterial SMCs in culture not only express high levels of alpha-smooth muscle (SM) actin but, contrary to rodent SMCs, also maintain an appreciable expression of SM myosin heavy chain isoforms 1 and 2, desmin, and smoothelin, a recently described late differentiation marker of vascular SMCs.", "text_with_entity_marker": "Porcine arterial SMCs in culture not only express high levels of alpha-smooth muscle (SM) actin but, contrary to rodent SMCs, also maintain an appreciable expression of [E1]SM myosin heavy chain[/E1] isoforms 1 and 2, [E2]desmin[/E2], and smoothelin, a recently described late differentiation marker of vascular SMCs.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SM myosin heavy chain", "entity_1_idx": [[169, 190], [200, 201]], "entity_1_idx_in_text_with_entity_marker": [173, 194], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "desmin", "entity_2_idx": [[209, 215]], "entity_2_idx_in_text_with_entity_marker": [222, 228], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d491.s0_BioInfer.d491.s0.p2", "text": "Porcine arterial SMCs in culture not only express high levels of alpha-smooth muscle (SM) actin but, contrary to rodent SMCs, also maintain an appreciable expression of SM myosin heavy chain isoforms 1 and 2, desmin, and smoothelin, a recently described late differentiation marker of vascular SMCs.", "text_with_entity_marker": "Porcine arterial SMCs in culture not only express high levels of alpha-smooth muscle (SM) actin but, contrary to rodent SMCs, also maintain an appreciable expression of [E1]SM myosin heavy chain[/E1] isoforms 1 and 2, [E2]desmin[/E2], and smoothelin, a recently described late differentiation marker of vascular SMCs.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SM myosin heavy chain", "entity_1_idx": [[169, 190], [206, 207]], "entity_1_idx_in_text_with_entity_marker": [173, 194], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "desmin", "entity_2_idx": [[209, 215]], "entity_2_idx_in_text_with_entity_marker": [222, 228], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d491.s0_BioInfer.d491.s0.p3", "text": "Porcine arterial SMCs in culture not only express high levels of alpha-smooth muscle (SM) actin but, contrary to rodent SMCs, also maintain an appreciable expression of SM myosin heavy chain isoforms 1 and 2, desmin, and smoothelin, a recently described late differentiation marker of vascular SMCs.", "text_with_entity_marker": "Porcine arterial SMCs in culture not only express high levels of [E1]alpha-smooth muscle[/E1] (SM) actin but, contrary to rodent SMCs, also maintain an appreciable expression of SM myosin heavy chain isoforms 1 and 2, [E2]desmin[/E2], and smoothelin, a recently described late differentiation marker of vascular SMCs.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-smooth muscle", "entity_1_idx": [[65, 84], [90, 95]], "entity_1_idx_in_text_with_entity_marker": [69, 88], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "desmin", "entity_2_idx": [[209, 215]], "entity_2_idx_in_text_with_entity_marker": [222, 228], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d491.s0_BioInfer.d491.s0.p4", "text": "Porcine arterial SMCs in culture not only express high levels of alpha-smooth muscle (SM) actin but, contrary to rodent SMCs, also maintain an appreciable expression of SM myosin heavy chain isoforms 1 and 2, desmin, and smoothelin, a recently described late differentiation marker of vascular SMCs.", "text_with_entity_marker": "Porcine arterial SMCs in culture not only express high levels of alpha-smooth muscle (SM) actin but, contrary to rodent SMCs, also maintain an appreciable expression of [E1]SM myosin heavy chain[/E1] isoforms 1 and 2, desmin, and [E2]smoothelin[/E2], a recently described late differentiation marker of vascular SMCs.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SM myosin heavy chain", "entity_1_idx": [[169, 190], [200, 201]], "entity_1_idx_in_text_with_entity_marker": [173, 194], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "smoothelin", "entity_2_idx": [[221, 231]], "entity_2_idx_in_text_with_entity_marker": [234, 244], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d491.s0_BioInfer.d491.s0.p5", "text": "Porcine arterial SMCs in culture not only express high levels of alpha-smooth muscle (SM) actin but, contrary to rodent SMCs, also maintain an appreciable expression of SM myosin heavy chain isoforms 1 and 2, desmin, and smoothelin, a recently described late differentiation marker of vascular SMCs.", "text_with_entity_marker": "Porcine arterial SMCs in culture not only express high levels of alpha-smooth muscle (SM) actin but, contrary to rodent SMCs, also maintain an appreciable expression of [E1]SM myosin heavy chain[/E1] isoforms 1 and 2, desmin, and [E2]smoothelin[/E2], a recently described late differentiation marker of vascular SMCs.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SM myosin heavy chain", "entity_1_idx": [[169, 190], [206, 207]], "entity_1_idx_in_text_with_entity_marker": [173, 194], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "smoothelin", "entity_2_idx": [[221, 231]], "entity_2_idx_in_text_with_entity_marker": [234, 244], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d491.s0_BioInfer.d491.s0.p6", "text": "Porcine arterial SMCs in culture not only express high levels of alpha-smooth muscle (SM) actin but, contrary to rodent SMCs, also maintain an appreciable expression of SM myosin heavy chain isoforms 1 and 2, desmin, and smoothelin, a recently described late differentiation marker of vascular SMCs.", "text_with_entity_marker": "Porcine arterial SMCs in culture not only express high levels of [E1]alpha-smooth muscle[/E1] (SM) actin but, contrary to rodent SMCs, also maintain an appreciable expression of SM myosin heavy chain isoforms 1 and 2, desmin, and [E2]smoothelin[/E2], a recently described late differentiation marker of vascular SMCs.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-smooth muscle", "entity_1_idx": [[65, 84], [90, 95]], "entity_1_idx_in_text_with_entity_marker": [69, 88], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "smoothelin", "entity_2_idx": [[221, 231]], "entity_2_idx_in_text_with_entity_marker": [234, 244], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d491.s0_BioInfer.d491.s0.p7", "text": "Porcine arterial SMCs in culture not only express high levels of alpha-smooth muscle (SM) actin but, contrary to rodent SMCs, also maintain an appreciable expression of SM myosin heavy chain isoforms 1 and 2, desmin, and smoothelin, a recently described late differentiation marker of vascular SMCs.", "text_with_entity_marker": "Porcine arterial SMCs in culture not only express high levels of alpha-smooth muscle (SM) actin but, contrary to rodent SMCs, also maintain an appreciable expression of [E1-E2]SM myosin heavy chain[/E1-E2] isoforms 1 and 2, desmin, and smoothelin, a recently described late differentiation marker of vascular SMCs.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SM myosin heavy chain", "entity_1_idx": [[169, 190], [206, 207]], "entity_1_idx_in_text_with_entity_marker": [176, 197], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "SM myosin heavy chain", "entity_2_idx": [[169, 190], [200, 201]], "entity_2_idx_in_text_with_entity_marker": [176, 197], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d491.s0_BioInfer.d491.s0.p8", "text": "Porcine arterial SMCs in culture not only express high levels of alpha-smooth muscle (SM) actin but, contrary to rodent SMCs, also maintain an appreciable expression of SM myosin heavy chain isoforms 1 and 2, desmin, and smoothelin, a recently described late differentiation marker of vascular SMCs.", "text_with_entity_marker": "Porcine arterial SMCs in culture not only express high levels of [E1]alpha-smooth muscle[/E1] (SM) actin but, contrary to rodent SMCs, also maintain an appreciable expression of [E2]SM myosin heavy chain[/E2] isoforms 1 and 2, desmin, and smoothelin, a recently described late differentiation marker of vascular SMCs.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-smooth muscle", "entity_1_idx": [[65, 84], [90, 95]], "entity_1_idx_in_text_with_entity_marker": [69, 88], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "SM myosin heavy chain", "entity_2_idx": [[169, 190], [200, 201]], "entity_2_idx_in_text_with_entity_marker": [182, 203], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d491.s0_BioInfer.d491.s0.p9", "text": "Porcine arterial SMCs in culture not only express high levels of alpha-smooth muscle (SM) actin but, contrary to rodent SMCs, also maintain an appreciable expression of SM myosin heavy chain isoforms 1 and 2, desmin, and smoothelin, a recently described late differentiation marker of vascular SMCs.", "text_with_entity_marker": "Porcine arterial SMCs in culture not only express high levels of [E1]alpha-smooth muscle[/E1] (SM) actin but, contrary to rodent SMCs, also maintain an appreciable expression of [E2]SM myosin heavy chain[/E2] isoforms 1 and 2, desmin, and smoothelin, a recently described late differentiation marker of vascular SMCs.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-smooth muscle", "entity_1_idx": [[65, 84], [90, 95]], "entity_1_idx_in_text_with_entity_marker": [69, 88], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "SM myosin heavy chain", "entity_2_idx": [[169, 190], [206, 207]], "entity_2_idx_in_text_with_entity_marker": [182, 203], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d112.s0_BioInfer.d112.s0.p0", "text": "Both types of beads induced the recruitment of N-cadherin, beta-catenin, alpha-catenin and p120, by lateral mobilization of preexisting cell membrane complexes.", "text_with_entity_marker": "Both types of beads induced the recruitment of [E1]N-cadherin[/E1], beta-catenin, [E2]alpha-catenin[/E2] and p120, by lateral mobilization of preexisting cell membrane complexes.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "N-cadherin", "entity_1_idx": [[47, 57]], "entity_1_idx_in_text_with_entity_marker": [51, 61], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[73, 86]], "entity_2_idx_in_text_with_entity_marker": [86, 99], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d112.s0_BioInfer.d112.s0.p1", "text": "Both types of beads induced the recruitment of N-cadherin, beta-catenin, alpha-catenin and p120, by lateral mobilization of preexisting cell membrane complexes.", "text_with_entity_marker": "Both types of beads induced the recruitment of [E1]N-cadherin[/E1], [E2]beta-catenin[/E2], alpha-catenin and p120, by lateral mobilization of preexisting cell membrane complexes.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "N-cadherin", "entity_1_idx": [[47, 57]], "entity_1_idx_in_text_with_entity_marker": [51, 61], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[59, 71]], "entity_2_idx_in_text_with_entity_marker": [72, 84], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d112.s0_BioInfer.d112.s0.p2", "text": "Both types of beads induced the recruitment of N-cadherin, beta-catenin, alpha-catenin and p120, by lateral mobilization of preexisting cell membrane complexes.", "text_with_entity_marker": "Both types of beads induced the recruitment of [E1]N-cadherin[/E1], beta-catenin, alpha-catenin and [E2]p120[/E2], by lateral mobilization of preexisting cell membrane complexes.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "N-cadherin", "entity_1_idx": [[47, 57]], "entity_1_idx_in_text_with_entity_marker": [51, 61], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "p120", "entity_2_idx": [[91, 95]], "entity_2_idx_in_text_with_entity_marker": [104, 108], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d112.s0_BioInfer.d112.s0.p3", "text": "Both types of beads induced the recruitment of N-cadherin, beta-catenin, alpha-catenin and p120, by lateral mobilization of preexisting cell membrane complexes.", "text_with_entity_marker": "Both types of beads induced the recruitment of N-cadherin, [E1]beta-catenin[/E1], [E2]alpha-catenin[/E2] and p120, by lateral mobilization of preexisting cell membrane complexes.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[59, 71]], "entity_1_idx_in_text_with_entity_marker": [63, 75], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[73, 86]], "entity_2_idx_in_text_with_entity_marker": [86, 99], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d112.s0_BioInfer.d112.s0.p4", "text": "Both types of beads induced the recruitment of N-cadherin, beta-catenin, alpha-catenin and p120, by lateral mobilization of preexisting cell membrane complexes.", "text_with_entity_marker": "Both types of beads induced the recruitment of N-cadherin, beta-catenin, [E1]alpha-catenin[/E1] and [E2]p120[/E2], by lateral mobilization of preexisting cell membrane complexes.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[73, 86]], "entity_1_idx_in_text_with_entity_marker": [77, 90], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "p120", "entity_2_idx": [[91, 95]], "entity_2_idx_in_text_with_entity_marker": [104, 108], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d112.s0_BioInfer.d112.s0.p5", "text": "Both types of beads induced the recruitment of N-cadherin, beta-catenin, alpha-catenin and p120, by lateral mobilization of preexisting cell membrane complexes.", "text_with_entity_marker": "Both types of beads induced the recruitment of N-cadherin, [E1]beta-catenin[/E1], alpha-catenin and [E2]p120[/E2], by lateral mobilization of preexisting cell membrane complexes.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[59, 71]], "entity_1_idx_in_text_with_entity_marker": [63, 75], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "p120", "entity_2_idx": [[91, 95]], "entity_2_idx_in_text_with_entity_marker": [104, 108], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d39.s0_BioInfer.d39.s0.p0", "text": "Although binding patterns of different sera were not identical, almost all sera caused IgG binding to platelet components of 87-90 kD, 140 kD (identified as vinculin) and 220-240 kD (tentatively identified as talin and actin-binding protein).", "text_with_entity_marker": "Although binding patterns of different sera were not identical, almost all sera caused [E1]IgG[/E1] binding to platelet components of 87-90 kD, 140 kD (identified as vinculin) and 220-240 kD (tentatively identified as talin and [E2]actin-binding protein[/E2]).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "IgG", "entity_1_idx": [[87, 90]], "entity_1_idx_in_text_with_entity_marker": [91, 94], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin-binding protein", "entity_2_idx": [[219, 240]], "entity_2_idx_in_text_with_entity_marker": [232, 253], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d39.s0_BioInfer.d39.s0.p1", "text": "Although binding patterns of different sera were not identical, almost all sera caused IgG binding to platelet components of 87-90 kD, 140 kD (identified as vinculin) and 220-240 kD (tentatively identified as talin and actin-binding protein).", "text_with_entity_marker": "Although binding patterns of different sera were not identical, almost all sera caused [E1]IgG[/E1] binding to platelet components of 87-90 kD, 140 kD (identified as vinculin) and 220-240 kD (tentatively identified as [E2]talin[/E2] and actin-binding protein).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "IgG", "entity_1_idx": [[87, 90]], "entity_1_idx_in_text_with_entity_marker": [91, 94], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[209, 214]], "entity_2_idx_in_text_with_entity_marker": [222, 227], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d39.s0_BioInfer.d39.s0.p2", "text": "Although binding patterns of different sera were not identical, almost all sera caused IgG binding to platelet components of 87-90 kD, 140 kD (identified as vinculin) and 220-240 kD (tentatively identified as talin and actin-binding protein).", "text_with_entity_marker": "Although binding patterns of different sera were not identical, almost all sera caused [E1]IgG[/E1] binding to platelet components of 87-90 kD, 140 kD (identified as [E2]vinculin[/E2]) and 220-240 kD (tentatively identified as talin and actin-binding protein).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "IgG", "entity_1_idx": [[87, 90]], "entity_1_idx_in_text_with_entity_marker": [91, 94], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vinculin", "entity_2_idx": [[157, 165]], "entity_2_idx_in_text_with_entity_marker": [170, 178], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d39.s0_BioInfer.d39.s0.p3", "text": "Although binding patterns of different sera were not identical, almost all sera caused IgG binding to platelet components of 87-90 kD, 140 kD (identified as vinculin) and 220-240 kD (tentatively identified as talin and actin-binding protein).", "text_with_entity_marker": "Although binding patterns of different sera were not identical, almost all sera caused IgG binding to platelet components of 87-90 kD, 140 kD (identified as vinculin) and 220-240 kD (tentatively identified as [E1]talin[/E1] and [E2]actin-binding protein[/E2]).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "talin", "entity_1_idx": [[209, 214]], "entity_1_idx_in_text_with_entity_marker": [213, 218], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin-binding protein", "entity_2_idx": [[219, 240]], "entity_2_idx_in_text_with_entity_marker": [232, 253], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d39.s0_BioInfer.d39.s0.p4", "text": "Although binding patterns of different sera were not identical, almost all sera caused IgG binding to platelet components of 87-90 kD, 140 kD (identified as vinculin) and 220-240 kD (tentatively identified as talin and actin-binding protein).", "text_with_entity_marker": "Although binding patterns of different sera were not identical, almost all sera caused IgG binding to platelet components of 87-90 kD, 140 kD (identified as [E1]vinculin[/E1]) and 220-240 kD (tentatively identified as talin and [E2]actin-binding protein[/E2]).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "vinculin", "entity_1_idx": [[157, 165]], "entity_1_idx_in_text_with_entity_marker": [161, 169], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin-binding protein", "entity_2_idx": [[219, 240]], "entity_2_idx_in_text_with_entity_marker": [232, 253], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d39.s0_BioInfer.d39.s0.p5", "text": "Although binding patterns of different sera were not identical, almost all sera caused IgG binding to platelet components of 87-90 kD, 140 kD (identified as vinculin) and 220-240 kD (tentatively identified as talin and actin-binding protein).", "text_with_entity_marker": "Although binding patterns of different sera were not identical, almost all sera caused IgG binding to platelet components of 87-90 kD, 140 kD (identified as [E1]vinculin[/E1]) and 220-240 kD (tentatively identified as [E2]talin[/E2] and actin-binding protein).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "vinculin", "entity_1_idx": [[157, 165]], "entity_1_idx_in_text_with_entity_marker": [161, 169], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[209, 214]], "entity_2_idx_in_text_with_entity_marker": [222, 227], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d513.s0_BioInfer.d513.s0.p0", "text": "Reduced expression of E-cadherin, alpha-catenin, and beta-catenin was observed in 64% (87 of 135), 50% (43 of 86), and 58% (50 of 86) of the specimens tested, respectively.", "text_with_entity_marker": "Reduced expression of [E1]E-cadherin[/E1], alpha-catenin, and [E2]beta-catenin[/E2] was observed in 64% (87 of 135), 50% (43 of 86), and 58% (50 of 86) of the specimens tested, respectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[22, 32]], "entity_1_idx_in_text_with_entity_marker": [26, 36], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[53, 65]], "entity_2_idx_in_text_with_entity_marker": [66, 78], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d513.s0_BioInfer.d513.s0.p1", "text": "Reduced expression of E-cadherin, alpha-catenin, and beta-catenin was observed in 64% (87 of 135), 50% (43 of 86), and 58% (50 of 86) of the specimens tested, respectively.", "text_with_entity_marker": "Reduced expression of [E1]E-cadherin[/E1], [E2]alpha-catenin[/E2], and beta-catenin was observed in 64% (87 of 135), 50% (43 of 86), and 58% (50 of 86) of the specimens tested, respectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[22, 32]], "entity_1_idx_in_text_with_entity_marker": [26, 36], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[34, 47]], "entity_2_idx_in_text_with_entity_marker": [47, 60], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d513.s0_BioInfer.d513.s0.p2", "text": "Reduced expression of E-cadherin, alpha-catenin, and beta-catenin was observed in 64% (87 of 135), 50% (43 of 86), and 58% (50 of 86) of the specimens tested, respectively.", "text_with_entity_marker": "Reduced expression of E-cadherin, [E1]alpha-catenin[/E1], and [E2]beta-catenin[/E2] was observed in 64% (87 of 135), 50% (43 of 86), and 58% (50 of 86) of the specimens tested, respectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[34, 47]], "entity_1_idx_in_text_with_entity_marker": [38, 51], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[53, 65]], "entity_2_idx_in_text_with_entity_marker": [66, 78], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d308.s0_BioInfer.d308.s0.p0", "text": "In Acanthamoeba, the two isoforms of profilin may have specialized functions on the basis of their identical (approximately 10 microM) affinities for actin monomers and different affinities for PIP2.", "text_with_entity_marker": "In Acanthamoeba, the two isoforms of [E1]profilin[/E1] may have specialized functions on the basis of their identical (approximately 10 microM) affinities for [E2]actin[/E2] monomers and different affinities for PIP2.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[37, 45]], "entity_1_idx_in_text_with_entity_marker": [41, 49], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[150, 155]], "entity_2_idx_in_text_with_entity_marker": [163, 168], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d98.s0_BioInfer.d98.s0.p0", "text": "Binding to human dipeptidyl peptidase IV by adenosine deaminase and antibodies that inhibit ligand binding involves overlapping, discontinuous sites on a predicted beta propeller domain.", "text_with_entity_marker": "Binding to human [E1]dipeptidyl peptidase IV[/E1] by [E2]adenosine deaminase[/E2] and antibodies that inhibit ligand binding involves overlapping, discontinuous sites on a predicted beta propeller domain.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "dipeptidyl peptidase IV", "entity_1_idx": [[17, 40]], "entity_1_idx_in_text_with_entity_marker": [21, 44], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "adenosine deaminase", "entity_2_idx": [[44, 63]], "entity_2_idx_in_text_with_entity_marker": [57, 76], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d454.s0_BioInfer.d454.s0.p0", "text": "No significant changes in glomerular vinculin, talin, beta 1-integrin, or total actin expression occurred at any time point during disease development.", "text_with_entity_marker": "No significant changes in glomerular [E1]vinculin[/E1], talin, [E2]beta 1-integrin[/E2], or total actin expression occurred at any time point during disease development.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "vinculin", "entity_1_idx": [[37, 45]], "entity_1_idx_in_text_with_entity_marker": [41, 49], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta 1-integrin", "entity_2_idx": [[54, 69]], "entity_2_idx_in_text_with_entity_marker": [67, 82], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d454.s0_BioInfer.d454.s0.p1", "text": "No significant changes in glomerular vinculin, talin, beta 1-integrin, or total actin expression occurred at any time point during disease development.", "text_with_entity_marker": "No significant changes in glomerular vinculin, talin, [E1]beta 1-integrin[/E1], or total [E2]actin[/E2] expression occurred at any time point during disease development.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta 1-integrin", "entity_1_idx": [[54, 69]], "entity_1_idx_in_text_with_entity_marker": [58, 73], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[80, 85]], "entity_2_idx_in_text_with_entity_marker": [93, 98], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d454.s0_BioInfer.d454.s0.p2", "text": "No significant changes in glomerular vinculin, talin, beta 1-integrin, or total actin expression occurred at any time point during disease development.", "text_with_entity_marker": "No significant changes in glomerular vinculin, [E1]talin[/E1], [E2]beta 1-integrin[/E2], or total actin expression occurred at any time point during disease development.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "talin", "entity_1_idx": [[47, 52]], "entity_1_idx_in_text_with_entity_marker": [51, 56], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta 1-integrin", "entity_2_idx": [[54, 69]], "entity_2_idx_in_text_with_entity_marker": [67, 82], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d454.s0_BioInfer.d454.s0.p3", "text": "No significant changes in glomerular vinculin, talin, beta 1-integrin, or total actin expression occurred at any time point during disease development.", "text_with_entity_marker": "No significant changes in glomerular [E1]vinculin[/E1], talin, beta 1-integrin, or total [E2]actin[/E2] expression occurred at any time point during disease development.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "vinculin", "entity_1_idx": [[37, 45]], "entity_1_idx_in_text_with_entity_marker": [41, 49], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[80, 85]], "entity_2_idx_in_text_with_entity_marker": [93, 98], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d454.s0_BioInfer.d454.s0.p4", "text": "No significant changes in glomerular vinculin, talin, beta 1-integrin, or total actin expression occurred at any time point during disease development.", "text_with_entity_marker": "No significant changes in glomerular [E1]vinculin[/E1], [E2]talin[/E2], beta 1-integrin, or total actin expression occurred at any time point during disease development.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "vinculin", "entity_1_idx": [[37, 45]], "entity_1_idx_in_text_with_entity_marker": [41, 49], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "talin", "entity_2_idx": [[47, 52]], "entity_2_idx_in_text_with_entity_marker": [60, 65], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d454.s0_BioInfer.d454.s0.p5", "text": "No significant changes in glomerular vinculin, talin, beta 1-integrin, or total actin expression occurred at any time point during disease development.", "text_with_entity_marker": "No significant changes in glomerular vinculin, [E1]talin[/E1], beta 1-integrin, or total [E2]actin[/E2] expression occurred at any time point during disease development.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "talin", "entity_1_idx": [[47, 52]], "entity_1_idx_in_text_with_entity_marker": [51, 56], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[80, 85]], "entity_2_idx_in_text_with_entity_marker": [93, 98], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d737.s0_BioInfer.d737.s0.p0", "text": "This arrest can be suppressed by mutations in RAD51, RAD52, and RAD57, suggesting that the cell cycle defect in sgs1 srs2 mutants results from inappropriate homologous recombination.", "text_with_entity_marker": "This arrest can be suppressed by mutations in RAD51, RAD52, and RAD57, suggesting that the cell cycle defect in [E1]sgs1[/E1] [E2]srs2[/E2] mutants results from inappropriate homologous recombination.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "sgs1", "entity_1_idx": [[112, 116]], "entity_1_idx_in_text_with_entity_marker": [116, 120], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "srs2", "entity_2_idx": [[117, 121]], "entity_2_idx_in_text_with_entity_marker": [130, 134], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d737.s0_BioInfer.d737.s0.p1", "text": "This arrest can be suppressed by mutations in RAD51, RAD52, and RAD57, suggesting that the cell cycle defect in sgs1 srs2 mutants results from inappropriate homologous recombination.", "text_with_entity_marker": "This arrest can be suppressed by mutations in RAD51, [E1]RAD52[/E1], and RAD57, suggesting that the cell cycle defect in [E2]sgs1[/E2] srs2 mutants results from inappropriate homologous recombination.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD52", "entity_1_idx": [[53, 58]], "entity_1_idx_in_text_with_entity_marker": [57, 62], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "sgs1", "entity_2_idx": [[112, 116]], "entity_2_idx_in_text_with_entity_marker": [125, 129], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d737.s0_BioInfer.d737.s0.p2", "text": "This arrest can be suppressed by mutations in RAD51, RAD52, and RAD57, suggesting that the cell cycle defect in sgs1 srs2 mutants results from inappropriate homologous recombination.", "text_with_entity_marker": "This arrest can be suppressed by mutations in RAD51, RAD52, and [E1]RAD57[/E1], suggesting that the cell cycle defect in [E2]sgs1[/E2] srs2 mutants results from inappropriate homologous recombination.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD57", "entity_1_idx": [[64, 69]], "entity_1_idx_in_text_with_entity_marker": [68, 73], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "sgs1", "entity_2_idx": [[112, 116]], "entity_2_idx_in_text_with_entity_marker": [125, 129], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d737.s0_BioInfer.d737.s0.p3", "text": "This arrest can be suppressed by mutations in RAD51, RAD52, and RAD57, suggesting that the cell cycle defect in sgs1 srs2 mutants results from inappropriate homologous recombination.", "text_with_entity_marker": "This arrest can be suppressed by mutations in [E1]RAD51[/E1], RAD52, and RAD57, suggesting that the cell cycle defect in [E2]sgs1[/E2] srs2 mutants results from inappropriate homologous recombination.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD51", "entity_1_idx": [[46, 51]], "entity_1_idx_in_text_with_entity_marker": [50, 55], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "sgs1", "entity_2_idx": [[112, 116]], "entity_2_idx_in_text_with_entity_marker": [125, 129], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d737.s0_BioInfer.d737.s0.p4", "text": "This arrest can be suppressed by mutations in RAD51, RAD52, and RAD57, suggesting that the cell cycle defect in sgs1 srs2 mutants results from inappropriate homologous recombination.", "text_with_entity_marker": "This arrest can be suppressed by mutations in RAD51, [E1]RAD52[/E1], and RAD57, suggesting that the cell cycle defect in sgs1 [E2]srs2[/E2] mutants results from inappropriate homologous recombination.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD52", "entity_1_idx": [[53, 58]], "entity_1_idx_in_text_with_entity_marker": [57, 62], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "srs2", "entity_2_idx": [[117, 121]], "entity_2_idx_in_text_with_entity_marker": [130, 134], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d737.s0_BioInfer.d737.s0.p5", "text": "This arrest can be suppressed by mutations in RAD51, RAD52, and RAD57, suggesting that the cell cycle defect in sgs1 srs2 mutants results from inappropriate homologous recombination.", "text_with_entity_marker": "This arrest can be suppressed by mutations in RAD51, RAD52, and [E1]RAD57[/E1], suggesting that the cell cycle defect in sgs1 [E2]srs2[/E2] mutants results from inappropriate homologous recombination.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD57", "entity_1_idx": [[64, 69]], "entity_1_idx_in_text_with_entity_marker": [68, 73], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "srs2", "entity_2_idx": [[117, 121]], "entity_2_idx_in_text_with_entity_marker": [130, 134], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d737.s0_BioInfer.d737.s0.p6", "text": "This arrest can be suppressed by mutations in RAD51, RAD52, and RAD57, suggesting that the cell cycle defect in sgs1 srs2 mutants results from inappropriate homologous recombination.", "text_with_entity_marker": "This arrest can be suppressed by mutations in [E1]RAD51[/E1], RAD52, and RAD57, suggesting that the cell cycle defect in sgs1 [E2]srs2[/E2] mutants results from inappropriate homologous recombination.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD51", "entity_1_idx": [[46, 51]], "entity_1_idx_in_text_with_entity_marker": [50, 55], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "srs2", "entity_2_idx": [[117, 121]], "entity_2_idx_in_text_with_entity_marker": [130, 134], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d737.s0_BioInfer.d737.s0.p7", "text": "This arrest can be suppressed by mutations in RAD51, RAD52, and RAD57, suggesting that the cell cycle defect in sgs1 srs2 mutants results from inappropriate homologous recombination.", "text_with_entity_marker": "This arrest can be suppressed by mutations in RAD51, [E1]RAD52[/E1], and [E2]RAD57[/E2], suggesting that the cell cycle defect in sgs1 srs2 mutants results from inappropriate homologous recombination.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD52", "entity_1_idx": [[53, 58]], "entity_1_idx_in_text_with_entity_marker": [57, 62], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD57", "entity_2_idx": [[64, 69]], "entity_2_idx_in_text_with_entity_marker": [77, 82], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d737.s0_BioInfer.d737.s0.p8", "text": "This arrest can be suppressed by mutations in RAD51, RAD52, and RAD57, suggesting that the cell cycle defect in sgs1 srs2 mutants results from inappropriate homologous recombination.", "text_with_entity_marker": "This arrest can be suppressed by mutations in [E1]RAD51[/E1], [E2]RAD52[/E2], and RAD57, suggesting that the cell cycle defect in sgs1 srs2 mutants results from inappropriate homologous recombination.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD51", "entity_1_idx": [[46, 51]], "entity_1_idx_in_text_with_entity_marker": [50, 55], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD52", "entity_2_idx": [[53, 58]], "entity_2_idx_in_text_with_entity_marker": [66, 71], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d737.s0_BioInfer.d737.s0.p9", "text": "This arrest can be suppressed by mutations in RAD51, RAD52, and RAD57, suggesting that the cell cycle defect in sgs1 srs2 mutants results from inappropriate homologous recombination.", "text_with_entity_marker": "This arrest can be suppressed by mutations in [E1]RAD51[/E1], RAD52, and [E2]RAD57[/E2], suggesting that the cell cycle defect in sgs1 srs2 mutants results from inappropriate homologous recombination.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD51", "entity_1_idx": [[46, 51]], "entity_1_idx_in_text_with_entity_marker": [50, 55], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD57", "entity_2_idx": [[64, 69]], "entity_2_idx_in_text_with_entity_marker": [77, 82], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d575.s1_BioInfer.d575.s1.p0", "text": "The APC protein and E-cadherin form similar but independent complexes with alpha-catenin, beta-catenin, and plakoglobin.", "text_with_entity_marker": "The [E1]APC[/E1] protein and [E2]E-cadherin[/E2] form similar but independent complexes with alpha-catenin, beta-catenin, and plakoglobin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "APC", "entity_1_idx": [[4, 7]], "entity_1_idx_in_text_with_entity_marker": [8, 11], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "E-cadherin", "entity_2_idx": [[20, 30]], "entity_2_idx_in_text_with_entity_marker": [33, 43], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d575.s1_BioInfer.d575.s1.p1", "text": "The APC protein and E-cadherin form similar but independent complexes with alpha-catenin, beta-catenin, and plakoglobin.", "text_with_entity_marker": "The APC protein and [E1]E-cadherin[/E1] form similar but independent complexes with alpha-catenin, beta-catenin, and [E2]plakoglobin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "E-cadherin", "entity_1_idx": [[20, 30]], "entity_1_idx_in_text_with_entity_marker": [24, 34], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[108, 119]], "entity_2_idx_in_text_with_entity_marker": [121, 132], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d575.s1_BioInfer.d575.s1.p2", "text": "The APC protein and E-cadherin form similar but independent complexes with alpha-catenin, beta-catenin, and plakoglobin.", "text_with_entity_marker": "The APC protein and [E1]E-cadherin[/E1] form similar but independent complexes with [E2]alpha-catenin[/E2], beta-catenin, and plakoglobin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "E-cadherin", "entity_1_idx": [[20, 30]], "entity_1_idx_in_text_with_entity_marker": [24, 34], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[75, 88]], "entity_2_idx_in_text_with_entity_marker": [88, 101], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d575.s1_BioInfer.d575.s1.p3", "text": "The APC protein and E-cadherin form similar but independent complexes with alpha-catenin, beta-catenin, and plakoglobin.", "text_with_entity_marker": "The APC protein and [E1]E-cadherin[/E1] form similar but independent complexes with alpha-catenin, [E2]beta-catenin[/E2], and plakoglobin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "E-cadherin", "entity_1_idx": [[20, 30]], "entity_1_idx_in_text_with_entity_marker": [24, 34], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[90, 102]], "entity_2_idx_in_text_with_entity_marker": [103, 115], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d575.s1_BioInfer.d575.s1.p4", "text": "The APC protein and E-cadherin form similar but independent complexes with alpha-catenin, beta-catenin, and plakoglobin.", "text_with_entity_marker": "The [E1]APC[/E1] protein and E-cadherin form similar but independent complexes with alpha-catenin, beta-catenin, and [E2]plakoglobin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "APC", "entity_1_idx": [[4, 7]], "entity_1_idx_in_text_with_entity_marker": [8, 11], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[108, 119]], "entity_2_idx_in_text_with_entity_marker": [121, 132], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d575.s1_BioInfer.d575.s1.p5", "text": "The APC protein and E-cadherin form similar but independent complexes with alpha-catenin, beta-catenin, and plakoglobin.", "text_with_entity_marker": "The [E1]APC[/E1] protein and E-cadherin form similar but independent complexes with [E2]alpha-catenin[/E2], beta-catenin, and plakoglobin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "APC", "entity_1_idx": [[4, 7]], "entity_1_idx_in_text_with_entity_marker": [8, 11], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[75, 88]], "entity_2_idx_in_text_with_entity_marker": [88, 101], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d575.s1_BioInfer.d575.s1.p6", "text": "The APC protein and E-cadherin form similar but independent complexes with alpha-catenin, beta-catenin, and plakoglobin.", "text_with_entity_marker": "The [E1]APC[/E1] protein and E-cadherin form similar but independent complexes with alpha-catenin, [E2]beta-catenin[/E2], and plakoglobin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "APC", "entity_1_idx": [[4, 7]], "entity_1_idx_in_text_with_entity_marker": [8, 11], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[90, 102]], "entity_2_idx_in_text_with_entity_marker": [103, 115], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d575.s1_BioInfer.d575.s1.p7", "text": "The APC protein and E-cadherin form similar but independent complexes with alpha-catenin, beta-catenin, and plakoglobin.", "text_with_entity_marker": "The APC protein and E-cadherin form similar but independent complexes with [E1]alpha-catenin[/E1], beta-catenin, and [E2]plakoglobin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-catenin", "entity_1_idx": [[75, 88]], "entity_1_idx_in_text_with_entity_marker": [79, 92], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[108, 119]], "entity_2_idx_in_text_with_entity_marker": [121, 132], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d575.s1_BioInfer.d575.s1.p8", "text": "The APC protein and E-cadherin form similar but independent complexes with alpha-catenin, beta-catenin, and plakoglobin.", "text_with_entity_marker": "The APC protein and E-cadherin form similar but independent complexes with alpha-catenin, [E1]beta-catenin[/E1], and [E2]plakoglobin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "beta-catenin", "entity_1_idx": [[90, 102]], "entity_1_idx_in_text_with_entity_marker": [94, 106], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[108, 119]], "entity_2_idx_in_text_with_entity_marker": [121, 132], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d575.s1_BioInfer.d575.s1.p9", "text": "The APC protein and E-cadherin form similar but independent complexes with alpha-catenin, beta-catenin, and plakoglobin.", "text_with_entity_marker": "The APC protein and E-cadherin form similar but independent complexes with [E1]alpha-catenin[/E1], [E2]beta-catenin[/E2], and plakoglobin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-catenin", "entity_1_idx": [[75, 88]], "entity_1_idx_in_text_with_entity_marker": [79, 92], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[90, 102]], "entity_2_idx_in_text_with_entity_marker": [103, 115], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d443.s0_BioInfer.d443.s0.p0", "text": "Mutations in BUD3, BUD4, and AXL1 cause a and alpha cells to exhibit the bipolar pattern, indicating that these genes are necessary to specify the axial budding pattern (Chant, J., and I. Herskowitz. 1991. Cell. 65:1203-1212; Fujita, A., C. Oka, Y. Arikawa, T. Katagi, A. Tonouchi, S. Kuhara, and Y. Misumi. 1994. Nature (Lond.). 372:567-570).", "text_with_entity_marker": "Mutations in BUD3, [E1]BUD4[/E1], and [E2]AXL1[/E2] cause a and alpha cells to exhibit the bipolar pattern, indicating that these genes are necessary to specify the axial budding pattern (Chant, J., and I. Herskowitz. 1991. Cell. 65:1203-1212; Fujita, A., C. Oka, Y. Arikawa, T. Katagi, A. Tonouchi, S. Kuhara, and Y. Misumi. 1994. Nature (Lond.). 372:567-570).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "BUD4", "entity_1_idx": [[19, 23]], "entity_1_idx_in_text_with_entity_marker": [23, 27], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "AXL1", "entity_2_idx": [[29, 33]], "entity_2_idx_in_text_with_entity_marker": [42, 46], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d443.s0_BioInfer.d443.s0.p1", "text": "Mutations in BUD3, BUD4, and AXL1 cause a and alpha cells to exhibit the bipolar pattern, indicating that these genes are necessary to specify the axial budding pattern (Chant, J., and I. Herskowitz. 1991. Cell. 65:1203-1212; Fujita, A., C. Oka, Y. Arikawa, T. Katagi, A. Tonouchi, S. Kuhara, and Y. Misumi. 1994. Nature (Lond.). 372:567-570).", "text_with_entity_marker": "Mutations in [E1]BUD3[/E1], [E2]BUD4[/E2], and AXL1 cause a and alpha cells to exhibit the bipolar pattern, indicating that these genes are necessary to specify the axial budding pattern (Chant, J., and I. Herskowitz. 1991. Cell. 65:1203-1212; Fujita, A., C. Oka, Y. Arikawa, T. Katagi, A. Tonouchi, S. Kuhara, and Y. Misumi. 1994. Nature (Lond.). 372:567-570).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "BUD3", "entity_1_idx": [[13, 17]], "entity_1_idx_in_text_with_entity_marker": [17, 21], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "BUD4", "entity_2_idx": [[19, 23]], "entity_2_idx_in_text_with_entity_marker": [32, 36], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d443.s0_BioInfer.d443.s0.p2", "text": "Mutations in BUD3, BUD4, and AXL1 cause a and alpha cells to exhibit the bipolar pattern, indicating that these genes are necessary to specify the axial budding pattern (Chant, J., and I. Herskowitz. 1991. Cell. 65:1203-1212; Fujita, A., C. Oka, Y. Arikawa, T. Katagi, A. Tonouchi, S. Kuhara, and Y. Misumi. 1994. Nature (Lond.). 372:567-570).", "text_with_entity_marker": "Mutations in [E1]BUD3[/E1], BUD4, and [E2]AXL1[/E2] cause a and alpha cells to exhibit the bipolar pattern, indicating that these genes are necessary to specify the axial budding pattern (Chant, J., and I. Herskowitz. 1991. Cell. 65:1203-1212; Fujita, A., C. Oka, Y. Arikawa, T. Katagi, A. Tonouchi, S. Kuhara, and Y. Misumi. 1994. Nature (Lond.). 372:567-570).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "BUD3", "entity_1_idx": [[13, 17]], "entity_1_idx_in_text_with_entity_marker": [17, 21], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "AXL1", "entity_2_idx": [[29, 33]], "entity_2_idx_in_text_with_entity_marker": [42, 46], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d374.s0_BioInfer.d374.s0.p0", "text": "In this case, efficient repair does not require RAD1 and MSH2, consistent with our previous observations.", "text_with_entity_marker": "In this case, efficient repair does not require [E1]RAD1[/E1] and [E2]MSH2[/E2], consistent with our previous observations.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD1", "entity_1_idx": [[48, 52]], "entity_1_idx_in_text_with_entity_marker": [52, 56], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MSH2", "entity_2_idx": [[57, 61]], "entity_2_idx_in_text_with_entity_marker": [70, 74], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d409.s0_BioInfer.d409.s0.p0", "text": "Location of profilin at presynaptic sites in the cerebellar cortex; implication for the regulation of the actin-polymerization state during axonal elongation and synaptogenesis.", "text_with_entity_marker": "Location of [E1]profilin[/E1] at presynaptic sites in the cerebellar cortex; implication for the regulation of the [E2]actin[/E2]-polymerization state during axonal elongation and synaptogenesis.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[12, 20]], "entity_1_idx_in_text_with_entity_marker": [16, 24], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[106, 111]], "entity_2_idx_in_text_with_entity_marker": [119, 124], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d566.s0_BioInfer.d566.s0.p0", "text": "The ability of WIP to replace verprolin is dependent on its WH2 actin binding domain and a putative profilin binding domain.", "text_with_entity_marker": "The ability of WIP to replace verprolin is dependent on its WH2 [E1]actin[/E1] binding domain and a putative [E2]profilin[/E2] binding domain.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[64, 69]], "entity_1_idx_in_text_with_entity_marker": [68, 73], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[100, 108]], "entity_2_idx_in_text_with_entity_marker": [113, 121], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d566.s0_BioInfer.d566.s0.p1", "text": "The ability of WIP to replace verprolin is dependent on its WH2 actin binding domain and a putative profilin binding domain.", "text_with_entity_marker": "The ability of [E1]WIP[/E1] to replace verprolin is dependent on its WH2 actin binding domain and a putative [E2]profilin[/E2] binding domain.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "WIP", "entity_1_idx": [[15, 18]], "entity_1_idx_in_text_with_entity_marker": [19, 22], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[100, 108]], "entity_2_idx_in_text_with_entity_marker": [113, 121], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d566.s0_BioInfer.d566.s0.p2", "text": "The ability of WIP to replace verprolin is dependent on its WH2 actin binding domain and a putative profilin binding domain.", "text_with_entity_marker": "The ability of WIP to replace [E1]verprolin[/E1] is dependent on its WH2 actin binding domain and a putative [E2]profilin[/E2] binding domain.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "verprolin", "entity_1_idx": [[30, 39]], "entity_1_idx_in_text_with_entity_marker": [34, 43], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[100, 108]], "entity_2_idx_in_text_with_entity_marker": [113, 121], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d566.s0_BioInfer.d566.s0.p3", "text": "The ability of WIP to replace verprolin is dependent on its WH2 actin binding domain and a putative profilin binding domain.", "text_with_entity_marker": "The ability of [E1]WIP[/E1] to replace verprolin is dependent on its WH2 [E2]actin[/E2] binding domain and a putative profilin binding domain.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "WIP", "entity_1_idx": [[15, 18]], "entity_1_idx_in_text_with_entity_marker": [19, 22], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[64, 69]], "entity_2_idx_in_text_with_entity_marker": [77, 82], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d566.s0_BioInfer.d566.s0.p4", "text": "The ability of WIP to replace verprolin is dependent on its WH2 actin binding domain and a putative profilin binding domain.", "text_with_entity_marker": "The ability of WIP to replace [E1]verprolin[/E1] is dependent on its WH2 [E2]actin[/E2] binding domain and a putative profilin binding domain.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "verprolin", "entity_1_idx": [[30, 39]], "entity_1_idx_in_text_with_entity_marker": [34, 43], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[64, 69]], "entity_2_idx_in_text_with_entity_marker": [77, 82], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d566.s0_BioInfer.d566.s0.p5", "text": "The ability of WIP to replace verprolin is dependent on its WH2 actin binding domain and a putative profilin binding domain.", "text_with_entity_marker": "The ability of [E1]WIP[/E1] to replace [E2]verprolin[/E2] is dependent on its WH2 actin binding domain and a putative profilin binding domain.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "WIP", "entity_1_idx": [[15, 18]], "entity_1_idx_in_text_with_entity_marker": [19, 22], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "verprolin", "entity_2_idx": [[30, 39]], "entity_2_idx_in_text_with_entity_marker": [43, 52], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d566.s1_BioInfer.d566.s1.p0", "text": "Thus, like verprolin, WIP functions in yeast to link the polarity development pathway and the actin cytoskeleton to generate cytoskeletal asymmetry.", "text_with_entity_marker": "Thus, like [E1]verprolin[/E1], WIP functions in yeast to link the polarity development pathway and the [E2]actin[/E2] cytoskeleton to generate cytoskeletal asymmetry.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "verprolin", "entity_1_idx": [[11, 20]], "entity_1_idx_in_text_with_entity_marker": [15, 24], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[94, 99]], "entity_2_idx_in_text_with_entity_marker": [107, 112], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d566.s1_BioInfer.d566.s1.p1", "text": "Thus, like verprolin, WIP functions in yeast to link the polarity development pathway and the actin cytoskeleton to generate cytoskeletal asymmetry.", "text_with_entity_marker": "Thus, like [E1]verprolin[/E1], [E2]WIP[/E2] functions in yeast to link the polarity development pathway and the actin cytoskeleton to generate cytoskeletal asymmetry.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "verprolin", "entity_1_idx": [[11, 20]], "entity_1_idx_in_text_with_entity_marker": [15, 24], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "WIP", "entity_2_idx": [[22, 25]], "entity_2_idx_in_text_with_entity_marker": [35, 38], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d566.s1_BioInfer.d566.s1.p2", "text": "Thus, like verprolin, WIP functions in yeast to link the polarity development pathway and the actin cytoskeleton to generate cytoskeletal asymmetry.", "text_with_entity_marker": "Thus, like verprolin, [E1]WIP[/E1] functions in yeast to link the polarity development pathway and the [E2]actin[/E2] cytoskeleton to generate cytoskeletal asymmetry.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "WIP", "entity_1_idx": [[22, 25]], "entity_1_idx_in_text_with_entity_marker": [26, 29], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[94, 99]], "entity_2_idx_in_text_with_entity_marker": [107, 112], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d239.s0_BioInfer.d239.s0.p0", "text": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).", "text_with_entity_marker": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor [E1]p27[/E1], enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/[E2]CDK4[/E2]).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p27", "entity_1_idx": [[161, 164]], "entity_1_idx_in_text_with_entity_marker": [165, 168], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CDK4", "entity_2_idx": [[308, 312]], "entity_2_idx_in_text_with_entity_marker": [321, 325], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d239.s0_BioInfer.d239.s0.p1", "text": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).", "text_with_entity_marker": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/[E1]CDK2[/E1] (but not to cyclin D3/[E2]CDK4[/E2]).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CDK2", "entity_1_idx": [[281, 285]], "entity_1_idx_in_text_with_entity_marker": [285, 289], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CDK4", "entity_2_idx": [[308, 312]], "entity_2_idx_in_text_with_entity_marker": [321, 325], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d239.s0_BioInfer.d239.s0.p2", "text": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).", "text_with_entity_marker": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the [E1]cyclin-dependent kinase inhibitor[/E1] p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/[E2]CDK4[/E2]).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin-dependent kinase inhibitor", "entity_1_idx": [[127, 160]], "entity_1_idx_in_text_with_entity_marker": [131, 164], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "CDK4", "entity_2_idx": [[308, 312]], "entity_2_idx_in_text_with_entity_marker": [321, 325], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d239.s0_BioInfer.d239.s0.p3", "text": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).", "text_with_entity_marker": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to [E1]cyclin E[/E1]/CDK2 (but not to cyclin D3/[E2]CDK4[/E2]).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin E", "entity_1_idx": [[272, 280]], "entity_1_idx_in_text_with_entity_marker": [276, 284], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CDK4", "entity_2_idx": [[308, 312]], "entity_2_idx_in_text_with_entity_marker": [321, 325], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d239.s0_BioInfer.d239.s0.p4", "text": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).", "text_with_entity_marker": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/[E1]CDK2[/E1] complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/[E2]CDK4[/E2]).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CDK2", "entity_1_idx": [[208, 212]], "entity_1_idx_in_text_with_entity_marker": [212, 216], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CDK4", "entity_2_idx": [[308, 312]], "entity_2_idx_in_text_with_entity_marker": [321, 325], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d239.s0_BioInfer.d239.s0.p5", "text": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).", "text_with_entity_marker": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to [E1]cyclin D3[/E1]/[E2]CDK4[/E2]).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cyclin D3", "entity_1_idx": [[298, 307]], "entity_1_idx_in_text_with_entity_marker": [302, 311], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CDK4", "entity_2_idx": [[308, 312]], "entity_2_idx_in_text_with_entity_marker": [321, 325], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d239.s0_BioInfer.d239.s0.p6", "text": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).", "text_with_entity_marker": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with [E1]cyclin E[/E1]/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/[E2]CDK4[/E2]).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin E", "entity_1_idx": [[199, 207]], "entity_1_idx_in_text_with_entity_marker": [203, 211], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CDK4", "entity_2_idx": [[308, 312]], "entity_2_idx_in_text_with_entity_marker": [321, 325], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d239.s0_BioInfer.d239.s0.p7", "text": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).", "text_with_entity_marker": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of [E1]p27[/E1] with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/[E2]CDK4[/E2]).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p27", "entity_1_idx": [[190, 193]], "entity_1_idx_in_text_with_entity_marker": [194, 197], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CDK4", "entity_2_idx": [[308, 312]], "entity_2_idx_in_text_with_entity_marker": [321, 325], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d239.s0_BioInfer.d239.s0.p8", "text": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).", "text_with_entity_marker": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of [E1]kinase[/E1] activity associated to cyclin E/CDK2 (but not to cyclin D3/[E2]CDK4[/E2]).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "kinase", "entity_1_idx": [[242, 248]], "entity_1_idx_in_text_with_entity_marker": [246, 252], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "CDK4", "entity_2_idx": [[308, 312]], "entity_2_idx_in_text_with_entity_marker": [321, 325], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d239.s0_BioInfer.d239.s0.p9", "text": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).", "text_with_entity_marker": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor [E1]p27[/E1], enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/[E2]CDK2[/E2] (but not to cyclin D3/CDK4).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p27", "entity_1_idx": [[161, 164]], "entity_1_idx_in_text_with_entity_marker": [165, 168], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CDK2", "entity_2_idx": [[281, 285]], "entity_2_idx_in_text_with_entity_marker": [294, 298], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d3.s0_BioInfer.d3.s0.p0", "text": "Absence of alpha-syntrophin leads to structurally aberrant neuromuscular synapses deficient in utrophin.", "text_with_entity_marker": "Absence of [E1]alpha-syntrophin[/E1] leads to structurally aberrant neuromuscular synapses deficient in [E2]utrophin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-syntrophin", "entity_1_idx": [[11, 27]], "entity_1_idx_in_text_with_entity_marker": [15, 31], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "utrophin", "entity_2_idx": [[95, 103]], "entity_2_idx_in_text_with_entity_marker": [108, 116], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d3.s1_BioInfer.d3.s1.p0", "text": "Thus, alpha-syntrophin has an important role in synapse formation and in the organization of utrophin, acetylcholine receptor, and acetylcholinesterase at the neuromuscular synapse.", "text_with_entity_marker": "Thus, alpha-syntrophin has an important role in synapse formation and in the organization of utrophin, [E1]acetylcholine receptor[/E1], and [E2]acetylcholinesterase[/E2] at the neuromuscular synapse.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "acetylcholine receptor", "entity_1_idx": [[103, 125]], "entity_1_idx_in_text_with_entity_marker": [107, 129], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "acetylcholinesterase", "entity_2_idx": [[131, 151]], "entity_2_idx_in_text_with_entity_marker": [144, 164], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d3.s1_BioInfer.d3.s1.p1", "text": "Thus, alpha-syntrophin has an important role in synapse formation and in the organization of utrophin, acetylcholine receptor, and acetylcholinesterase at the neuromuscular synapse.", "text_with_entity_marker": "Thus, alpha-syntrophin has an important role in synapse formation and in the organization of [E1]utrophin[/E1], [E2]acetylcholine receptor[/E2], and acetylcholinesterase at the neuromuscular synapse.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "utrophin", "entity_1_idx": [[93, 101]], "entity_1_idx_in_text_with_entity_marker": [97, 105], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "acetylcholine receptor", "entity_2_idx": [[103, 125]], "entity_2_idx_in_text_with_entity_marker": [116, 138], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d3.s1_BioInfer.d3.s1.p2", "text": "Thus, alpha-syntrophin has an important role in synapse formation and in the organization of utrophin, acetylcholine receptor, and acetylcholinesterase at the neuromuscular synapse.", "text_with_entity_marker": "Thus, [E1]alpha-syntrophin[/E1] has an important role in synapse formation and in the organization of utrophin, [E2]acetylcholine receptor[/E2], and acetylcholinesterase at the neuromuscular synapse.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-syntrophin", "entity_1_idx": [[6, 22]], "entity_1_idx_in_text_with_entity_marker": [10, 26], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "acetylcholine receptor", "entity_2_idx": [[103, 125]], "entity_2_idx_in_text_with_entity_marker": [116, 138], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d3.s1_BioInfer.d3.s1.p3", "text": "Thus, alpha-syntrophin has an important role in synapse formation and in the organization of utrophin, acetylcholine receptor, and acetylcholinesterase at the neuromuscular synapse.", "text_with_entity_marker": "Thus, alpha-syntrophin has an important role in synapse formation and in the organization of [E1]utrophin[/E1], acetylcholine receptor, and [E2]acetylcholinesterase[/E2] at the neuromuscular synapse.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "utrophin", "entity_1_idx": [[93, 101]], "entity_1_idx_in_text_with_entity_marker": [97, 105], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "acetylcholinesterase", "entity_2_idx": [[131, 151]], "entity_2_idx_in_text_with_entity_marker": [144, 164], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d3.s1_BioInfer.d3.s1.p4", "text": "Thus, alpha-syntrophin has an important role in synapse formation and in the organization of utrophin, acetylcholine receptor, and acetylcholinesterase at the neuromuscular synapse.", "text_with_entity_marker": "Thus, [E1]alpha-syntrophin[/E1] has an important role in synapse formation and in the organization of utrophin, acetylcholine receptor, and [E2]acetylcholinesterase[/E2] at the neuromuscular synapse.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-syntrophin", "entity_1_idx": [[6, 22]], "entity_1_idx_in_text_with_entity_marker": [10, 26], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "acetylcholinesterase", "entity_2_idx": [[131, 151]], "entity_2_idx_in_text_with_entity_marker": [144, 164], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d3.s1_BioInfer.d3.s1.p5", "text": "Thus, alpha-syntrophin has an important role in synapse formation and in the organization of utrophin, acetylcholine receptor, and acetylcholinesterase at the neuromuscular synapse.", "text_with_entity_marker": "Thus, [E1]alpha-syntrophin[/E1] has an important role in synapse formation and in the organization of [E2]utrophin[/E2], acetylcholine receptor, and acetylcholinesterase at the neuromuscular synapse.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-syntrophin", "entity_1_idx": [[6, 22]], "entity_1_idx_in_text_with_entity_marker": [10, 26], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "utrophin", "entity_2_idx": [[93, 101]], "entity_2_idx_in_text_with_entity_marker": [106, 114], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d723.s0_BioInfer.d723.s0.p0", "text": "The structural homology between cofilin and gelsolin segment-1 binding to actin was confirmed experimentally by two types of competitive binding assays.", "text_with_entity_marker": "The structural homology between cofilin and [E1]gelsolin[/E1] segment-1 binding to [E2]actin[/E2] was confirmed experimentally by two types of competitive binding assays.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "gelsolin", "entity_1_idx": [[44, 52]], "entity_1_idx_in_text_with_entity_marker": [48, 56], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[74, 79]], "entity_2_idx_in_text_with_entity_marker": [87, 92], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d723.s0_BioInfer.d723.s0.p1", "text": "The structural homology between cofilin and gelsolin segment-1 binding to actin was confirmed experimentally by two types of competitive binding assays.", "text_with_entity_marker": "The structural homology between [E1]cofilin[/E1] and gelsolin segment-1 binding to [E2]actin[/E2] was confirmed experimentally by two types of competitive binding assays.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cofilin", "entity_1_idx": [[32, 39]], "entity_1_idx_in_text_with_entity_marker": [36, 43], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[74, 79]], "entity_2_idx_in_text_with_entity_marker": [87, 92], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d723.s0_BioInfer.d723.s0.p2", "text": "The structural homology between cofilin and gelsolin segment-1 binding to actin was confirmed experimentally by two types of competitive binding assays.", "text_with_entity_marker": "The structural homology between [E1]cofilin[/E1] and [E2]gelsolin[/E2] segment-1 binding to actin was confirmed experimentally by two types of competitive binding assays.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cofilin", "entity_1_idx": [[32, 39]], "entity_1_idx_in_text_with_entity_marker": [36, 43], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "gelsolin", "entity_2_idx": [[44, 52]], "entity_2_idx_in_text_with_entity_marker": [57, 65], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d600.s0_BioInfer.d600.s0.p0", "text": "The core, isolated in the absence of free Ca2+, contains five major proteins: the actin (Mr 43 000) that makes up the filaments, the villin (Mr 95 000) and fimbrin (Mr 68 000) that cross-link the filaments together, and the 110 000 Mr polypeptide-calmodulin complex that makes up cross-filaments which project laterally from the core and link it to the inner surface of the microvillus membrane.", "text_with_entity_marker": "The core, isolated in the absence of free Ca2+, contains five major proteins: the [E1]actin[/E1] (Mr 43 000) that makes up the filaments, the villin (Mr 95 000) and [E2]fimbrin[/E2] (Mr 68 000) that cross-link the filaments together, and the 110 000 Mr polypeptide-calmodulin complex that makes up cross-filaments which project laterally from the core and link it to the inner surface of the microvillus membrane.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[82, 87]], "entity_1_idx_in_text_with_entity_marker": [86, 91], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "fimbrin", "entity_2_idx": [[156, 163]], "entity_2_idx_in_text_with_entity_marker": [169, 176], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d600.s0_BioInfer.d600.s0.p1", "text": "The core, isolated in the absence of free Ca2+, contains five major proteins: the actin (Mr 43 000) that makes up the filaments, the villin (Mr 95 000) and fimbrin (Mr 68 000) that cross-link the filaments together, and the 110 000 Mr polypeptide-calmodulin complex that makes up cross-filaments which project laterally from the core and link it to the inner surface of the microvillus membrane.", "text_with_entity_marker": "The core, isolated in the absence of free Ca2+, contains five major proteins: the [E1]actin[/E1] (Mr 43 000) that makes up the filaments, the [E2]villin[/E2] (Mr 95 000) and fimbrin (Mr 68 000) that cross-link the filaments together, and the 110 000 Mr polypeptide-calmodulin complex that makes up cross-filaments which project laterally from the core and link it to the inner surface of the microvillus membrane.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[82, 87]], "entity_1_idx_in_text_with_entity_marker": [86, 91], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "villin", "entity_2_idx": [[133, 139]], "entity_2_idx_in_text_with_entity_marker": [146, 152], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d600.s0_BioInfer.d600.s0.p2", "text": "The core, isolated in the absence of free Ca2+, contains five major proteins: the actin (Mr 43 000) that makes up the filaments, the villin (Mr 95 000) and fimbrin (Mr 68 000) that cross-link the filaments together, and the 110 000 Mr polypeptide-calmodulin complex that makes up cross-filaments which project laterally from the core and link it to the inner surface of the microvillus membrane.", "text_with_entity_marker": "The core, isolated in the absence of free Ca2+, contains five major proteins: the [E1]actin[/E1] (Mr 43 000) that makes up the filaments, the villin (Mr 95 000) and fimbrin (Mr 68 000) that cross-link the filaments together, and the 110 000 Mr polypeptide-[E2]calmodulin[/E2] complex that makes up cross-filaments which project laterally from the core and link it to the inner surface of the microvillus membrane.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[82, 87]], "entity_1_idx_in_text_with_entity_marker": [86, 91], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "calmodulin", "entity_2_idx": [[247, 257]], "entity_2_idx_in_text_with_entity_marker": [260, 270], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d600.s0_BioInfer.d600.s0.p3", "text": "The core, isolated in the absence of free Ca2+, contains five major proteins: the actin (Mr 43 000) that makes up the filaments, the villin (Mr 95 000) and fimbrin (Mr 68 000) that cross-link the filaments together, and the 110 000 Mr polypeptide-calmodulin complex that makes up cross-filaments which project laterally from the core and link it to the inner surface of the microvillus membrane.", "text_with_entity_marker": "The core, isolated in the absence of free Ca2+, contains five major proteins: the actin (Mr 43 000) that makes up the filaments, the [E1]villin[/E1] (Mr 95 000) and [E2]fimbrin[/E2] (Mr 68 000) that cross-link the filaments together, and the 110 000 Mr polypeptide-calmodulin complex that makes up cross-filaments which project laterally from the core and link it to the inner surface of the microvillus membrane.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "villin", "entity_1_idx": [[133, 139]], "entity_1_idx_in_text_with_entity_marker": [137, 143], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "fimbrin", "entity_2_idx": [[156, 163]], "entity_2_idx_in_text_with_entity_marker": [169, 176], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d600.s0_BioInfer.d600.s0.p4", "text": "The core, isolated in the absence of free Ca2+, contains five major proteins: the actin (Mr 43 000) that makes up the filaments, the villin (Mr 95 000) and fimbrin (Mr 68 000) that cross-link the filaments together, and the 110 000 Mr polypeptide-calmodulin complex that makes up cross-filaments which project laterally from the core and link it to the inner surface of the microvillus membrane.", "text_with_entity_marker": "The core, isolated in the absence of free Ca2+, contains five major proteins: the actin (Mr 43 000) that makes up the filaments, the villin (Mr 95 000) and [E1]fimbrin[/E1] (Mr 68 000) that cross-link the filaments together, and the 110 000 Mr polypeptide-[E2]calmodulin[/E2] complex that makes up cross-filaments which project laterally from the core and link it to the inner surface of the microvillus membrane.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "fimbrin", "entity_1_idx": [[156, 163]], "entity_1_idx_in_text_with_entity_marker": [160, 167], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "calmodulin", "entity_2_idx": [[247, 257]], "entity_2_idx_in_text_with_entity_marker": [260, 270], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d600.s0_BioInfer.d600.s0.p5", "text": "The core, isolated in the absence of free Ca2+, contains five major proteins: the actin (Mr 43 000) that makes up the filaments, the villin (Mr 95 000) and fimbrin (Mr 68 000) that cross-link the filaments together, and the 110 000 Mr polypeptide-calmodulin complex that makes up cross-filaments which project laterally from the core and link it to the inner surface of the microvillus membrane.", "text_with_entity_marker": "The core, isolated in the absence of free Ca2+, contains five major proteins: the actin (Mr 43 000) that makes up the filaments, the [E1]villin[/E1] (Mr 95 000) and fimbrin (Mr 68 000) that cross-link the filaments together, and the 110 000 Mr polypeptide-[E2]calmodulin[/E2] complex that makes up cross-filaments which project laterally from the core and link it to the inner surface of the microvillus membrane.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "villin", "entity_1_idx": [[133, 139]], "entity_1_idx_in_text_with_entity_marker": [137, 143], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "calmodulin", "entity_2_idx": [[247, 257]], "entity_2_idx_in_text_with_entity_marker": [260, 270], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d66.s0_BioInfer.d66.s0.p0", "text": "Another cyclin-dependent kinase inhibitor, p27KIP1, and cyclin D increased slightly, whereas proliferating cell nuclear antigen and p130 remained unchanged.", "text_with_entity_marker": "Another [E1]cyclin-dependent kinase inhibitor[/E1], p27KIP1, and cyclin D increased slightly, whereas [E2]proliferating cell nuclear antigen[/E2] and p130 remained unchanged.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin-dependent kinase inhibitor", "entity_1_idx": [[8, 41]], "entity_1_idx_in_text_with_entity_marker": [12, 45], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "proliferating cell nuclear antigen", "entity_2_idx": [[93, 127]], "entity_2_idx_in_text_with_entity_marker": [106, 140], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d66.s0_BioInfer.d66.s0.p1", "text": "Another cyclin-dependent kinase inhibitor, p27KIP1, and cyclin D increased slightly, whereas proliferating cell nuclear antigen and p130 remained unchanged.", "text_with_entity_marker": "Another cyclin-dependent kinase inhibitor, p27KIP1, and cyclin D increased slightly, whereas [E1]proliferating cell nuclear antigen[/E1] and [E2]p130[/E2] remained unchanged.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "proliferating cell nuclear antigen", "entity_1_idx": [[93, 127]], "entity_1_idx_in_text_with_entity_marker": [97, 131], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "p130", "entity_2_idx": [[132, 136]], "entity_2_idx_in_text_with_entity_marker": [145, 149], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d66.s0_BioInfer.d66.s0.p2", "text": "Another cyclin-dependent kinase inhibitor, p27KIP1, and cyclin D increased slightly, whereas proliferating cell nuclear antigen and p130 remained unchanged.", "text_with_entity_marker": "Another cyclin-dependent kinase inhibitor, [E1]p27KIP1[/E1], and cyclin D increased slightly, whereas [E2]proliferating cell nuclear antigen[/E2] and p130 remained unchanged.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p27KIP1", "entity_1_idx": [[43, 50]], "entity_1_idx_in_text_with_entity_marker": [47, 54], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "proliferating cell nuclear antigen", "entity_2_idx": [[93, 127]], "entity_2_idx_in_text_with_entity_marker": [106, 140], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d66.s0_BioInfer.d66.s0.p3", "text": "Another cyclin-dependent kinase inhibitor, p27KIP1, and cyclin D increased slightly, whereas proliferating cell nuclear antigen and p130 remained unchanged.", "text_with_entity_marker": "Another cyclin-dependent kinase inhibitor, p27KIP1, and [E1]cyclin D[/E1] increased slightly, whereas [E2]proliferating cell nuclear antigen[/E2] and p130 remained unchanged.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin D", "entity_1_idx": [[56, 64]], "entity_1_idx_in_text_with_entity_marker": [60, 68], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "proliferating cell nuclear antigen", "entity_2_idx": [[93, 127]], "entity_2_idx_in_text_with_entity_marker": [106, 140], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d66.s0_BioInfer.d66.s0.p4", "text": "Another cyclin-dependent kinase inhibitor, p27KIP1, and cyclin D increased slightly, whereas proliferating cell nuclear antigen and p130 remained unchanged.", "text_with_entity_marker": "Another [E1]cyclin-dependent kinase inhibitor[/E1], p27KIP1, and cyclin D increased slightly, whereas proliferating cell nuclear antigen and [E2]p130[/E2] remained unchanged.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin-dependent kinase inhibitor", "entity_1_idx": [[8, 41]], "entity_1_idx_in_text_with_entity_marker": [12, 45], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "p130", "entity_2_idx": [[132, 136]], "entity_2_idx_in_text_with_entity_marker": [145, 149], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d66.s0_BioInfer.d66.s0.p5", "text": "Another cyclin-dependent kinase inhibitor, p27KIP1, and cyclin D increased slightly, whereas proliferating cell nuclear antigen and p130 remained unchanged.", "text_with_entity_marker": "Another [E1]cyclin-dependent kinase inhibitor[/E1], [E2]p27KIP1[/E2], and cyclin D increased slightly, whereas proliferating cell nuclear antigen and p130 remained unchanged.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cyclin-dependent kinase inhibitor", "entity_1_idx": [[8, 41]], "entity_1_idx_in_text_with_entity_marker": [12, 45], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "p27KIP1", "entity_2_idx": [[43, 50]], "entity_2_idx_in_text_with_entity_marker": [56, 63], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d66.s0_BioInfer.d66.s0.p6", "text": "Another cyclin-dependent kinase inhibitor, p27KIP1, and cyclin D increased slightly, whereas proliferating cell nuclear antigen and p130 remained unchanged.", "text_with_entity_marker": "Another [E1]cyclin-dependent kinase inhibitor[/E1], p27KIP1, and [E2]cyclin D[/E2] increased slightly, whereas proliferating cell nuclear antigen and p130 remained unchanged.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin-dependent kinase inhibitor", "entity_1_idx": [[8, 41]], "entity_1_idx_in_text_with_entity_marker": [12, 45], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "cyclin D", "entity_2_idx": [[56, 64]], "entity_2_idx_in_text_with_entity_marker": [69, 77], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d66.s0_BioInfer.d66.s0.p7", "text": "Another cyclin-dependent kinase inhibitor, p27KIP1, and cyclin D increased slightly, whereas proliferating cell nuclear antigen and p130 remained unchanged.", "text_with_entity_marker": "Another cyclin-dependent kinase inhibitor, [E1]p27KIP1[/E1], and cyclin D increased slightly, whereas proliferating cell nuclear antigen and [E2]p130[/E2] remained unchanged.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p27KIP1", "entity_1_idx": [[43, 50]], "entity_1_idx_in_text_with_entity_marker": [47, 54], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p130", "entity_2_idx": [[132, 136]], "entity_2_idx_in_text_with_entity_marker": [145, 149], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d66.s0_BioInfer.d66.s0.p8", "text": "Another cyclin-dependent kinase inhibitor, p27KIP1, and cyclin D increased slightly, whereas proliferating cell nuclear antigen and p130 remained unchanged.", "text_with_entity_marker": "Another cyclin-dependent kinase inhibitor, p27KIP1, and [E1]cyclin D[/E1] increased slightly, whereas proliferating cell nuclear antigen and [E2]p130[/E2] remained unchanged.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin D", "entity_1_idx": [[56, 64]], "entity_1_idx_in_text_with_entity_marker": [60, 68], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "p130", "entity_2_idx": [[132, 136]], "entity_2_idx_in_text_with_entity_marker": [145, 149], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d66.s0_BioInfer.d66.s0.p9", "text": "Another cyclin-dependent kinase inhibitor, p27KIP1, and cyclin D increased slightly, whereas proliferating cell nuclear antigen and p130 remained unchanged.", "text_with_entity_marker": "Another cyclin-dependent kinase inhibitor, [E1]p27KIP1[/E1], and [E2]cyclin D[/E2] increased slightly, whereas proliferating cell nuclear antigen and p130 remained unchanged.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p27KIP1", "entity_1_idx": [[43, 50]], "entity_1_idx_in_text_with_entity_marker": [47, 54], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin D", "entity_2_idx": [[56, 64]], "entity_2_idx_in_text_with_entity_marker": [69, 77], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d471.s0_BioInfer.d471.s0.p0", "text": "Other than monomeric actin, no major profilin ligands are detected in crude extracts.", "text_with_entity_marker": "Other than monomeric [E1]actin[/E1], no major [E2]profilin[/E2] ligands are detected in crude extracts.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[21, 26]], "entity_1_idx_in_text_with_entity_marker": [25, 30], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[37, 45]], "entity_2_idx_in_text_with_entity_marker": [50, 58], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d471.s1_BioInfer.d471.s1.p0", "text": "Our results show that the major pool of polymerizable actin monomers is complexed with profilin and spread throughout the cytoplasm.", "text_with_entity_marker": "Our results show that the major pool of polymerizable [E1]actin[/E1] monomers is complexed with [E2]profilin[/E2] and spread throughout the cytoplasm.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[54, 59]], "entity_1_idx_in_text_with_entity_marker": [58, 63], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[87, 95]], "entity_2_idx_in_text_with_entity_marker": [100, 108], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d471.s2_BioInfer.d471.s2.p0", "text": "Selective monoclonal antibodies confirm that most of the profilin is bound to actin: 65% in extract immunoadsorption assays and 74-89% by fluorescent antibody staining.", "text_with_entity_marker": "Selective monoclonal antibodies confirm that most of the [E1]profilin[/E1] is bound to [E2]actin[/E2]: 65% in extract immunoadsorption assays and 74-89% by fluorescent antibody staining.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[57, 65]], "entity_1_idx_in_text_with_entity_marker": [61, 69], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[78, 83]], "entity_2_idx_in_text_with_entity_marker": [91, 96], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d471.s3_BioInfer.d471.s3.p0", "text": "We used biochemical fractionation, immunoassays and microscopy of live and fixed Acanthamoeba to determine how much profilin is bound to its known ligands: actin, membrane PIP(2), Arp2/3 complex and polyproline sequences.", "text_with_entity_marker": "We used biochemical fractionation, immunoassays and microscopy of live and fixed Acanthamoeba to determine how much [E1]profilin[/E1] is bound to its known ligands: actin, membrane PIP(2), [E2]Arp2[/E2]/3 complex and polyproline sequences.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[116, 124]], "entity_1_idx_in_text_with_entity_marker": [120, 128], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Arp2", "entity_2_idx": [[180, 184]], "entity_2_idx_in_text_with_entity_marker": [193, 197], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d471.s3_BioInfer.d471.s3.p1", "text": "We used biochemical fractionation, immunoassays and microscopy of live and fixed Acanthamoeba to determine how much profilin is bound to its known ligands: actin, membrane PIP(2), Arp2/3 complex and polyproline sequences.", "text_with_entity_marker": "We used biochemical fractionation, immunoassays and microscopy of live and fixed Acanthamoeba to determine how much profilin is bound to its known ligands: [E1]actin[/E1], membrane PIP(2), [E2]Arp2[/E2]/3 complex and polyproline sequences.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[156, 161]], "entity_1_idx_in_text_with_entity_marker": [160, 165], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Arp2", "entity_2_idx": [[180, 184]], "entity_2_idx_in_text_with_entity_marker": [193, 197], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d471.s3_BioInfer.d471.s3.p2", "text": "We used biochemical fractionation, immunoassays and microscopy of live and fixed Acanthamoeba to determine how much profilin is bound to its known ligands: actin, membrane PIP(2), Arp2/3 complex and polyproline sequences.", "text_with_entity_marker": "We used biochemical fractionation, immunoassays and microscopy of live and fixed Acanthamoeba to determine how much profilin is bound to its known ligands: actin, membrane PIP(2), [E1-E2]Arp[/E1]2[/E2]/3 complex and polyproline sequences.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Arp", "entity_1_idx": [[180, 183], [185, 186]], "entity_1_idx_in_text_with_entity_marker": [187, 190], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Arp[/E1]2", "entity_2_idx": [[180, 184]], "entity_2_idx_in_text_with_entity_marker": [187, 196], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d471.s3_BioInfer.d471.s3.p3", "text": "We used biochemical fractionation, immunoassays and microscopy of live and fixed Acanthamoeba to determine how much profilin is bound to its known ligands: actin, membrane PIP(2), Arp2/3 complex and polyproline sequences.", "text_with_entity_marker": "We used biochemical fractionation, immunoassays and microscopy of live and fixed Acanthamoeba to determine how much [E1]profilin[/E1] is bound to its known ligands: [E2]actin[/E2], membrane PIP(2), Arp2/3 complex and polyproline sequences.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[116, 124]], "entity_1_idx_in_text_with_entity_marker": [120, 128], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[156, 161]], "entity_2_idx_in_text_with_entity_marker": [169, 174], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d471.s3_BioInfer.d471.s3.p4", "text": "We used biochemical fractionation, immunoassays and microscopy of live and fixed Acanthamoeba to determine how much profilin is bound to its known ligands: actin, membrane PIP(2), Arp2/3 complex and polyproline sequences.", "text_with_entity_marker": "We used biochemical fractionation, immunoassays and microscopy of live and fixed Acanthamoeba to determine how much [E1]profilin[/E1] is bound to its known ligands: actin, membrane PIP(2), [E2]Arp[/E2]2/3 complex and polyproline sequences.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[116, 124]], "entity_1_idx_in_text_with_entity_marker": [120, 128], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Arp", "entity_2_idx": [[180, 183], [185, 186]], "entity_2_idx_in_text_with_entity_marker": [193, 196], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d471.s3_BioInfer.d471.s3.p5", "text": "We used biochemical fractionation, immunoassays and microscopy of live and fixed Acanthamoeba to determine how much profilin is bound to its known ligands: actin, membrane PIP(2), Arp2/3 complex and polyproline sequences.", "text_with_entity_marker": "We used biochemical fractionation, immunoassays and microscopy of live and fixed Acanthamoeba to determine how much profilin is bound to its known ligands: [E1]actin[/E1], membrane PIP(2), [E2]Arp[/E2]2/3 complex and polyproline sequences.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[156, 161]], "entity_1_idx_in_text_with_entity_marker": [160, 165], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Arp", "entity_2_idx": [[180, 183], [185, 186]], "entity_2_idx_in_text_with_entity_marker": [193, 196], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d185.s0_BioInfer.d185.s0.p0", "text": "Effects of macrophage profilin on actin in the presence and absence of acumentin and gelsolin.", "text_with_entity_marker": "Effects of macrophage profilin on [E1]actin[/E1] in the presence and absence of [E2]acumentin[/E2] and gelsolin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[34, 39]], "entity_1_idx_in_text_with_entity_marker": [38, 43], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "acumentin", "entity_2_idx": [[71, 80]], "entity_2_idx_in_text_with_entity_marker": [84, 93], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d185.s0_BioInfer.d185.s0.p1", "text": "Effects of macrophage profilin on actin in the presence and absence of acumentin and gelsolin.", "text_with_entity_marker": "Effects of macrophage profilin on [E1]actin[/E1] in the presence and absence of acumentin and [E2]gelsolin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[34, 39]], "entity_1_idx_in_text_with_entity_marker": [38, 43], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "gelsolin", "entity_2_idx": [[85, 93]], "entity_2_idx_in_text_with_entity_marker": [98, 106], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d185.s0_BioInfer.d185.s0.p2", "text": "Effects of macrophage profilin on actin in the presence and absence of acumentin and gelsolin.", "text_with_entity_marker": "Effects of [E1]macrophage profilin[/E1] on [E2]actin[/E2] in the presence and absence of acumentin and gelsolin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "macrophage profilin", "entity_1_idx": [[11, 30]], "entity_1_idx_in_text_with_entity_marker": [15, 34], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[34, 39]], "entity_2_idx_in_text_with_entity_marker": [47, 52], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d185.s0_BioInfer.d185.s0.p3", "text": "Effects of macrophage profilin on actin in the presence and absence of acumentin and gelsolin.", "text_with_entity_marker": "Effects of macrophage profilin on actin in the presence and absence of [E1]acumentin[/E1] and [E2]gelsolin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "acumentin", "entity_1_idx": [[71, 80]], "entity_1_idx_in_text_with_entity_marker": [75, 84], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "gelsolin", "entity_2_idx": [[85, 93]], "entity_2_idx_in_text_with_entity_marker": [98, 106], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d185.s0_BioInfer.d185.s0.p4", "text": "Effects of macrophage profilin on actin in the presence and absence of acumentin and gelsolin.", "text_with_entity_marker": "Effects of [E1]macrophage profilin[/E1] on actin in the presence and absence of [E2]acumentin[/E2] and gelsolin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "macrophage profilin", "entity_1_idx": [[11, 30]], "entity_1_idx_in_text_with_entity_marker": [15, 34], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "acumentin", "entity_2_idx": [[71, 80]], "entity_2_idx_in_text_with_entity_marker": [84, 93], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d185.s0_BioInfer.d185.s0.p5", "text": "Effects of macrophage profilin on actin in the presence and absence of acumentin and gelsolin.", "text_with_entity_marker": "Effects of [E1]macrophage profilin[/E1] on actin in the presence and absence of acumentin and [E2]gelsolin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "macrophage profilin", "entity_1_idx": [[11, 30]], "entity_1_idx_in_text_with_entity_marker": [15, 34], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "gelsolin", "entity_2_idx": [[85, 93]], "entity_2_idx_in_text_with_entity_marker": [98, 106], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p60", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein ([E1]M[/E1]), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and [E2]large[/E2] (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "M", "entity_1_idx": [[118, 119]], "entity_1_idx_in_text_with_entity_marker": [122, 123], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "large", "entity_2_idx": [[220, 225], [230, 237]], "entity_2_idx_in_text_with_entity_marker": [233, 238], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p61", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase ([E1]HN[/E1]) protein and [E2]large[/E2] (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "HN", "entity_1_idx": [[204, 206]], "entity_1_idx_in_text_with_entity_marker": [208, 210], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "large", "entity_2_idx": [[220, 225], [230, 237]], "entity_2_idx_in_text_with_entity_marker": [233, 238], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p62", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein ([E1]NP[/E1]), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and [E2]large[/E2] (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "NP", "entity_1_idx": [[66, 68]], "entity_1_idx_in_text_with_entity_marker": [70, 72], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "large", "entity_2_idx": [[220, 225], [230, 237]], "entity_2_idx_in_text_with_entity_marker": [233, 238], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p63", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, [E1]matrix protein[/E1] (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and [E2]large[/E2] (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "matrix protein", "entity_1_idx": [[102, 116]], "entity_1_idx_in_text_with_entity_marker": [106, 120], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "large", "entity_2_idx": [[220, 225], [230, 237]], "entity_2_idx_in_text_with_entity_marker": [233, 238], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p64", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, [E1]haemagglutinin-neuraminidase[/E1] (HN) protein and [E2]large[/E2] (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "haemagglutinin-neuraminidase", "entity_1_idx": [[174, 202], [208, 215]], "entity_1_idx_in_text_with_entity_marker": [178, 206], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "large", "entity_2_idx": [[220, 225], [230, 237]], "entity_2_idx_in_text_with_entity_marker": [233, 238], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p65", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein ([E1]P[/E1]), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and [E2]large[/E2] (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "P", "entity_1_idx": [[87, 88]], "entity_1_idx_in_text_with_entity_marker": [91, 92], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "large", "entity_2_idx": [[220, 225], [230, 237]], "entity_2_idx_in_text_with_entity_marker": [233, 238], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p66", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic ([E1]SH[/E1]) protein, haemagglutinin-neuraminidase (HN) protein and [E2]large[/E2] (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SH", "entity_1_idx": [[161, 163]], "entity_1_idx_in_text_with_entity_marker": [165, 167], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "large", "entity_2_idx": [[220, 225], [230, 237]], "entity_2_idx_in_text_with_entity_marker": [233, 238], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p67", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein ([E1]F[/E1]), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and [E2]large[/E2] (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "F", "entity_1_idx": [[138, 139]], "entity_1_idx_in_text_with_entity_marker": [142, 143], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "large", "entity_2_idx": [[220, 225], [230, 237]], "entity_2_idx_in_text_with_entity_marker": [233, 238], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p68", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and [E1]large[/E1] ([E2]L[/E2]) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "large", "entity_1_idx": [[220, 225], [230, 237]], "entity_1_idx_in_text_with_entity_marker": [224, 229], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "L", "entity_2_idx": [[227, 228]], "entity_2_idx_in_text_with_entity_marker": [240, 241], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p69", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein ([E1]M[/E1]), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase ([E2]HN[/E2]) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "M", "entity_1_idx": [[118, 119]], "entity_1_idx_in_text_with_entity_marker": [122, 123], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "HN", "entity_2_idx": [[204, 206]], "entity_2_idx_in_text_with_entity_marker": [217, 219], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d363.s0_BioInfer.d363.s0.p0", "text": "Interestingly, two major actin-binding proteins found in brain, gelsolin and profilin, specifically interact with phosphatidylinositol 4,5-bisphosphate, and may themselves play a role in regulating phosphoinositide turnover.", "text_with_entity_marker": "Interestingly, two major [E1]actin-binding proteins[/E1] found in brain, gelsolin and [E2]profilin[/E2], specifically interact with phosphatidylinositol 4,5-bisphosphate, and may themselves play a role in regulating phosphoinositide turnover.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin-binding proteins", "entity_1_idx": [[25, 47]], "entity_1_idx_in_text_with_entity_marker": [29, 51], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "profilin", "entity_2_idx": [[77, 85]], "entity_2_idx_in_text_with_entity_marker": [90, 98], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d363.s0_BioInfer.d363.s0.p1", "text": "Interestingly, two major actin-binding proteins found in brain, gelsolin and profilin, specifically interact with phosphatidylinositol 4,5-bisphosphate, and may themselves play a role in regulating phosphoinositide turnover.", "text_with_entity_marker": "Interestingly, two major [E1]actin-binding proteins[/E1] found in brain, [E2]gelsolin[/E2] and profilin, specifically interact with phosphatidylinositol 4,5-bisphosphate, and may themselves play a role in regulating phosphoinositide turnover.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin-binding proteins", "entity_1_idx": [[25, 47]], "entity_1_idx_in_text_with_entity_marker": [29, 51], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "gelsolin", "entity_2_idx": [[64, 72]], "entity_2_idx_in_text_with_entity_marker": [77, 85], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d363.s0_BioInfer.d363.s0.p2", "text": "Interestingly, two major actin-binding proteins found in brain, gelsolin and profilin, specifically interact with phosphatidylinositol 4,5-bisphosphate, and may themselves play a role in regulating phosphoinositide turnover.", "text_with_entity_marker": "Interestingly, two major actin-binding proteins found in brain, [E1]gelsolin[/E1] and [E2]profilin[/E2], specifically interact with phosphatidylinositol 4,5-bisphosphate, and may themselves play a role in regulating phosphoinositide turnover.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "gelsolin", "entity_1_idx": [[64, 72]], "entity_1_idx_in_text_with_entity_marker": [68, 76], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[77, 85]], "entity_2_idx_in_text_with_entity_marker": [90, 98], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d713.s1_BioInfer.d713.s1.p10", "text": "We report here that LIMK1 and LIMK2 phosphorylate both cofilin and actin-depolymerizing factor (ADF) specifically at Ser-3 and exhibit partially distinct substrate specificity when tested using site-directed cofilin mutants as substrates.", "text_with_entity_marker": "We report here that [E1]LIMK1[/E1] and LIMK2 phosphorylate both [E2]cofilin[/E2] and actin-depolymerizing factor (ADF) specifically at Ser-3 and exhibit partially distinct substrate specificity when tested using site-directed cofilin mutants as substrates.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "LIMK1", "entity_1_idx": [[20, 25]], "entity_1_idx_in_text_with_entity_marker": [24, 29], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[55, 62]], "entity_2_idx_in_text_with_entity_marker": [68, 75], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d713.s1_BioInfer.d713.s1.p11", "text": "We report here that LIMK1 and LIMK2 phosphorylate both cofilin and actin-depolymerizing factor (ADF) specifically at Ser-3 and exhibit partially distinct substrate specificity when tested using site-directed cofilin mutants as substrates.", "text_with_entity_marker": "We report here that [E1]LIMK1[/E1] and LIMK2 phosphorylate both cofilin and [E2]actin-depolymerizing factor[/E2] (ADF) specifically at Ser-3 and exhibit partially distinct substrate specificity when tested using site-directed cofilin mutants as substrates.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "LIMK1", "entity_1_idx": [[20, 25]], "entity_1_idx_in_text_with_entity_marker": [24, 29], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin-depolymerizing factor", "entity_2_idx": [[67, 94]], "entity_2_idx_in_text_with_entity_marker": [80, 107], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d713.s1_BioInfer.d713.s1.p12", "text": "We report here that LIMK1 and LIMK2 phosphorylate both cofilin and actin-depolymerizing factor (ADF) specifically at Ser-3 and exhibit partially distinct substrate specificity when tested using site-directed cofilin mutants as substrates.", "text_with_entity_marker": "We report here that LIMK1 and LIMK2 phosphorylate both [E1]cofilin[/E1] and actin-depolymerizing factor ([E2]ADF[/E2]) specifically at Ser-3 and exhibit partially distinct substrate specificity when tested using site-directed cofilin mutants as substrates.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[55, 62]], "entity_1_idx_in_text_with_entity_marker": [59, 66], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "ADF", "entity_2_idx": [[96, 99]], "entity_2_idx_in_text_with_entity_marker": [109, 112], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d713.s1_BioInfer.d713.s1.p13", "text": "We report here that LIMK1 and LIMK2 phosphorylate both cofilin and actin-depolymerizing factor (ADF) specifically at Ser-3 and exhibit partially distinct substrate specificity when tested using site-directed cofilin mutants as substrates.", "text_with_entity_marker": "We report here that LIMK1 and LIMK2 phosphorylate both cofilin and [E1]actin-depolymerizing factor[/E1] ([E2]ADF[/E2]) specifically at Ser-3 and exhibit partially distinct substrate specificity when tested using site-directed cofilin mutants as substrates.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin-depolymerizing factor", "entity_1_idx": [[67, 94]], "entity_1_idx_in_text_with_entity_marker": [71, 98], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "ADF", "entity_2_idx": [[96, 99]], "entity_2_idx_in_text_with_entity_marker": [109, 112], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d713.s1_BioInfer.d713.s1.p14", "text": "We report here that LIMK1 and LIMK2 phosphorylate both cofilin and actin-depolymerizing factor (ADF) specifically at Ser-3 and exhibit partially distinct substrate specificity when tested using site-directed cofilin mutants as substrates.", "text_with_entity_marker": "We report here that LIMK1 and LIMK2 phosphorylate both [E1]cofilin[/E1] and [E2]actin-depolymerizing factor[/E2] (ADF) specifically at Ser-3 and exhibit partially distinct substrate specificity when tested using site-directed cofilin mutants as substrates.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[55, 62]], "entity_1_idx_in_text_with_entity_marker": [59, 66], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin-depolymerizing factor", "entity_2_idx": [[67, 94]], "entity_2_idx_in_text_with_entity_marker": [80, 107], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d517.s0_BioInfer.d517.s0.p0", "text": "Removal of one nonhomologous DNA end during gene conversion by a RAD1- and MSH2-independent pathway.", "text_with_entity_marker": "Removal of one nonhomologous DNA end during gene conversion by a [E1]RAD1[/E1]- and [E2]MSH2[/E2]-independent pathway.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD1", "entity_1_idx": [[65, 69]], "entity_1_idx_in_text_with_entity_marker": [69, 73], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MSH2", "entity_2_idx": [[75, 79]], "entity_2_idx_in_text_with_entity_marker": [88, 92], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d688.s0_BioInfer.d688.s0.p20", "text": "The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.", "text_with_entity_marker": "The results indicate that (a) plakoglobin and [E1]beta-catenin[/E1] differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and [E2]alpha-catenin[/E2], can sequester it to the cytoplasm and inhibit its transcriptional activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[46, 58]], "entity_1_idx_in_text_with_entity_marker": [50, 62], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[278, 291]], "entity_2_idx_in_text_with_entity_marker": [291, 304], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d688.s0_BioInfer.d688.s0.p21", "text": "The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.", "text_with_entity_marker": "The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and [E1]vinculin[/E1]; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of [E2]beta-catenin[/E2], cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "vinculin", "entity_1_idx": [[127, 135]], "entity_1_idx_in_text_with_entity_marker": [131, 139], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[251, 263]], "entity_2_idx_in_text_with_entity_marker": [264, 276], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d688.s0_BioInfer.d688.s0.p22", "text": "The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.", "text_with_entity_marker": "The results indicate that (a) [E1]plakoglobin[/E1] and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of [E2]beta-catenin[/E2], cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "plakoglobin", "entity_1_idx": [[30, 41]], "entity_1_idx_in_text_with_entity_marker": [34, 45], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[251, 263]], "entity_2_idx_in_text_with_entity_marker": [264, 276], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d688.s0_BioInfer.d688.s0.p23", "text": "The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.", "text_with_entity_marker": "The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of [E1]beta-catenin[/E1], [E2]cadherin[/E2] and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "beta-catenin", "entity_1_idx": [[251, 263]], "entity_1_idx_in_text_with_entity_marker": [255, 267], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cadherin", "entity_2_idx": [[265, 273]], "entity_2_idx_in_text_with_entity_marker": [278, 286], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d688.s0_BioInfer.d688.s0.p24", "text": "The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.", "text_with_entity_marker": "The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by [E1]beta-catenin[/E1]; and (c) the cytoplasmic partners of [E2]beta-catenin[/E2], cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[201, 213]], "entity_1_idx_in_text_with_entity_marker": [205, 217], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[251, 263]], "entity_2_idx_in_text_with_entity_marker": [264, 276], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d688.s0_BioInfer.d688.s0.p25", "text": "The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.", "text_with_entity_marker": "The results indicate that (a) plakoglobin and [E1]beta-catenin[/E1] differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of [E2]beta-catenin[/E2], cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[46, 58]], "entity_1_idx_in_text_with_entity_marker": [50, 62], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[251, 263]], "entity_2_idx_in_text_with_entity_marker": [264, 276], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d688.s0_BioInfer.d688.s0.p26", "text": "The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.", "text_with_entity_marker": "The results indicate that (a) [E1]plakoglobin[/E1] and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and [E2]vinculin[/E2]; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "plakoglobin", "entity_1_idx": [[30, 41]], "entity_1_idx_in_text_with_entity_marker": [34, 45], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vinculin", "entity_2_idx": [[127, 135]], "entity_2_idx_in_text_with_entity_marker": [140, 148], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d688.s0_BioInfer.d688.s0.p27", "text": "The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.", "text_with_entity_marker": "The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and [E1]vinculin[/E1]; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, [E2]cadherin[/E2] and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "vinculin", "entity_1_idx": [[127, 135]], "entity_1_idx_in_text_with_entity_marker": [131, 139], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cadherin", "entity_2_idx": [[265, 273]], "entity_2_idx_in_text_with_entity_marker": [278, 286], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d688.s0_BioInfer.d688.s0.p28", "text": "The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.", "text_with_entity_marker": "The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and [E1]vinculin[/E1]; (b) LEF-1-dependent transactivation is preferentially driven by [E2]beta-catenin[/E2]; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "vinculin", "entity_1_idx": [[127, 135]], "entity_1_idx_in_text_with_entity_marker": [131, 139], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[201, 213]], "entity_2_idx_in_text_with_entity_marker": [214, 226], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d688.s0_BioInfer.d688.s0.p29", "text": "The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.", "text_with_entity_marker": "The results indicate that (a) plakoglobin and [E1]beta-catenin[/E1] differ in their nuclear translocation and complexing with LEF-1 and [E2]vinculin[/E2]; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "beta-catenin", "entity_1_idx": [[46, 58]], "entity_1_idx_in_text_with_entity_marker": [50, 62], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vinculin", "entity_2_idx": [[127, 135]], "entity_2_idx_in_text_with_entity_marker": [140, 148], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d650.s0_BioInfer.d650.s0.p0", "text": "The mutants ranged in affinity, from those that only weakly affected polymerization of actin to one that bound actin more strongly than wild-type profilin.", "text_with_entity_marker": "The mutants ranged in affinity, from those that only weakly affected polymerization of [E1]actin[/E1] to one that bound actin more strongly than wild-type [E2]profilin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[87, 92]], "entity_1_idx_in_text_with_entity_marker": [91, 96], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "profilin", "entity_2_idx": [[146, 154]], "entity_2_idx_in_text_with_entity_marker": [159, 167], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d650.s0_BioInfer.d650.s0.p1", "text": "The mutants ranged in affinity, from those that only weakly affected polymerization of actin to one that bound actin more strongly than wild-type profilin.", "text_with_entity_marker": "The mutants ranged in affinity, from those that only weakly affected polymerization of actin to one that bound [E1]actin[/E1] more strongly than wild-type [E2]profilin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[111, 116]], "entity_1_idx_in_text_with_entity_marker": [115, 120], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[146, 154]], "entity_2_idx_in_text_with_entity_marker": [159, 167], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d650.s0_BioInfer.d650.s0.p2", "text": "The mutants ranged in affinity, from those that only weakly affected polymerization of actin to one that bound actin more strongly than wild-type profilin.", "text_with_entity_marker": "The mutants ranged in affinity, from those that only weakly affected polymerization of [E1]actin[/E1] to one that bound [E2]actin[/E2] more strongly than wild-type profilin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[87, 92]], "entity_1_idx_in_text_with_entity_marker": [91, 96], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[111, 116]], "entity_2_idx_in_text_with_entity_marker": [124, 129], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d650.s1_BioInfer.d650.s1.p0", "text": "The role of profilin in actin polymerization and nucleotide exchange.", "text_with_entity_marker": "The role of [E1]profilin[/E1] in [E2]actin[/E2] polymerization and nucleotide exchange.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[12, 20]], "entity_1_idx_in_text_with_entity_marker": [16, 24], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[24, 29]], "entity_2_idx_in_text_with_entity_marker": [37, 42], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d650.s2_BioInfer.d650.s2.p0", "text": "With profilins, whose sequestering activity was low, the concentration of free actin monomers observed at steady-state of polymerization [Afree], was close to that seen with actin alone ([Acc], critical concentration of polymerization).", "text_with_entity_marker": "With [E1]profilins[/E1], whose sequestering activity was low, the concentration of free actin monomers observed at steady-state of polymerization [Afree], was close to that seen with [E2]actin[/E2] alone ([Acc], critical concentration of polymerization).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilins", "entity_1_idx": [[5, 14]], "entity_1_idx_in_text_with_entity_marker": [9, 18], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[174, 179]], "entity_2_idx_in_text_with_entity_marker": [187, 192], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d650.s2_BioInfer.d650.s2.p1", "text": "With profilins, whose sequestering activity was low, the concentration of free actin monomers observed at steady-state of polymerization [Afree], was close to that seen with actin alone ([Acc], critical concentration of polymerization).", "text_with_entity_marker": "With [E1]profilins[/E1], whose sequestering activity was low, the concentration of free [E2]actin[/E2] monomers observed at steady-state of polymerization [Afree], was close to that seen with actin alone ([Acc], critical concentration of polymerization).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilins", "entity_1_idx": [[5, 14]], "entity_1_idx_in_text_with_entity_marker": [9, 18], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[79, 84]], "entity_2_idx_in_text_with_entity_marker": [92, 97], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d650.s2_BioInfer.d650.s2.p2", "text": "With profilins, whose sequestering activity was low, the concentration of free actin monomers observed at steady-state of polymerization [Afree], was close to that seen with actin alone ([Acc], critical concentration of polymerization).", "text_with_entity_marker": "With profilins, whose sequestering activity was low, the concentration of free [E1]actin[/E1] monomers observed at steady-state of polymerization [Afree], was close to that seen with [E2]actin[/E2] alone ([Acc], critical concentration of polymerization).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[79, 84]], "entity_1_idx_in_text_with_entity_marker": [83, 88], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[174, 179]], "entity_2_idx_in_text_with_entity_marker": [187, 192], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d830.s0_BioInfer.d830.s0.p0", "text": "When the actin monomer pool in untransfected myoblasts is increased 70% by treatment with latrunculin A, synthesis of ADF and actin are down-regulated compared with cofilin and 19 other proteins selected at random.", "text_with_entity_marker": "When the actin monomer pool in untransfected myoblasts is increased 70% by treatment with latrunculin A, synthesis of [E1]ADF[/E1] and actin are down-regulated compared with [E2]cofilin[/E2] and 19 other proteins selected at random.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ADF", "entity_1_idx": [[118, 121]], "entity_1_idx_in_text_with_entity_marker": [122, 125], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "cofilin", "entity_2_idx": [[165, 172]], "entity_2_idx_in_text_with_entity_marker": [178, 185], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d830.s0_BioInfer.d830.s0.p1", "text": "When the actin monomer pool in untransfected myoblasts is increased 70% by treatment with latrunculin A, synthesis of ADF and actin are down-regulated compared with cofilin and 19 other proteins selected at random.", "text_with_entity_marker": "When the [E1]actin[/E1] monomer pool in untransfected myoblasts is increased 70% by treatment with latrunculin A, synthesis of [E2]ADF[/E2] and actin are down-regulated compared with cofilin and 19 other proteins selected at random.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[9, 14]], "entity_1_idx_in_text_with_entity_marker": [13, 18], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "ADF", "entity_2_idx": [[118, 121]], "entity_2_idx_in_text_with_entity_marker": [131, 134], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d830.s0_BioInfer.d830.s0.p2", "text": "When the actin monomer pool in untransfected myoblasts is increased 70% by treatment with latrunculin A, synthesis of ADF and actin are down-regulated compared with cofilin and 19 other proteins selected at random.", "text_with_entity_marker": "When the actin monomer pool in untransfected myoblasts is increased 70% by treatment with latrunculin A, synthesis of [E1]ADF[/E1] and [E2]actin[/E2] are down-regulated compared with cofilin and 19 other proteins selected at random.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ADF", "entity_1_idx": [[118, 121]], "entity_1_idx_in_text_with_entity_marker": [122, 125], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[126, 131]], "entity_2_idx_in_text_with_entity_marker": [139, 144], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d830.s0_BioInfer.d830.s0.p3", "text": "When the actin monomer pool in untransfected myoblasts is increased 70% by treatment with latrunculin A, synthesis of ADF and actin are down-regulated compared with cofilin and 19 other proteins selected at random.", "text_with_entity_marker": "When the [E1]actin[/E1] monomer pool in untransfected myoblasts is increased 70% by treatment with latrunculin A, synthesis of ADF and actin are down-regulated compared with [E2]cofilin[/E2] and 19 other proteins selected at random.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[9, 14]], "entity_1_idx_in_text_with_entity_marker": [13, 18], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "cofilin", "entity_2_idx": [[165, 172]], "entity_2_idx_in_text_with_entity_marker": [178, 185], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d830.s0_BioInfer.d830.s0.p4", "text": "When the actin monomer pool in untransfected myoblasts is increased 70% by treatment with latrunculin A, synthesis of ADF and actin are down-regulated compared with cofilin and 19 other proteins selected at random.", "text_with_entity_marker": "When the actin monomer pool in untransfected myoblasts is increased 70% by treatment with latrunculin A, synthesis of ADF and [E1]actin[/E1] are down-regulated compared with [E2]cofilin[/E2] and 19 other proteins selected at random.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[126, 131]], "entity_1_idx_in_text_with_entity_marker": [130, 135], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "cofilin", "entity_2_idx": [[165, 172]], "entity_2_idx_in_text_with_entity_marker": [178, 185], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d830.s0_BioInfer.d830.s0.p5", "text": "When the actin monomer pool in untransfected myoblasts is increased 70% by treatment with latrunculin A, synthesis of ADF and actin are down-regulated compared with cofilin and 19 other proteins selected at random.", "text_with_entity_marker": "When the [E1]actin[/E1] monomer pool in untransfected myoblasts is increased 70% by treatment with latrunculin A, synthesis of ADF and [E2]actin[/E2] are down-regulated compared with cofilin and 19 other proteins selected at random.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[9, 14]], "entity_1_idx_in_text_with_entity_marker": [13, 18], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[126, 131]], "entity_2_idx_in_text_with_entity_marker": [139, 144], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d379.s0_BioInfer.d379.s0.p20", "text": "In this study the role of MSH2, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and MSH6 proteins.", "text_with_entity_marker": "In this study the role of MSH2, [E1]MSH3[/E1], and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the [E2]MSH3[/E2] and MSH6 proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MSH3", "entity_1_idx": [[32, 36]], "entity_1_idx_in_text_with_entity_marker": [36, 40], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MSH3", "entity_2_idx": [[307, 311]], "entity_2_idx_in_text_with_entity_marker": [320, 324], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d379.s0_BioInfer.d379.s0.p21", "text": "In this study the role of MSH2, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and MSH6 proteins.", "text_with_entity_marker": "In this study the role of MSH2, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of [E1]msh2[/E1], [E2]msh3[/E2], and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and MSH6 proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "msh2", "entity_1_idx": [[202, 206]], "entity_1_idx_in_text_with_entity_marker": [206, 210], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "msh3", "entity_2_idx": [[208, 212]], "entity_2_idx_in_text_with_entity_marker": [221, 225], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d379.s0_BioInfer.d379.s0.p22", "text": "In this study the role of MSH2, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and MSH6 proteins.", "text_with_entity_marker": "In this study the role of MSH2, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, [E1]msh3[/E1], and [E2]msh6[/E2] mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and MSH6 proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "msh3", "entity_1_idx": [[208, 212]], "entity_1_idx_in_text_with_entity_marker": [212, 216], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "msh6", "entity_2_idx": [[218, 222]], "entity_2_idx_in_text_with_entity_marker": [231, 235], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d379.s0_BioInfer.d379.s0.p23", "text": "In this study the role of MSH2, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and MSH6 proteins.", "text_with_entity_marker": "In this study the role of [E1]MSH2[/E1], MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, [E2]msh3[/E2], and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and MSH6 proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MSH2", "entity_1_idx": [[26, 30]], "entity_1_idx_in_text_with_entity_marker": [30, 34], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "msh3", "entity_2_idx": [[208, 212]], "entity_2_idx_in_text_with_entity_marker": [221, 225], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d379.s0_BioInfer.d379.s0.p24", "text": "In this study the role of MSH2, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and MSH6 proteins.", "text_with_entity_marker": "In this study the role of MSH2, MSH3, and [E1]MSH6[/E1] in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, [E2]msh3[/E2], and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and MSH6 proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MSH6", "entity_1_idx": [[42, 46]], "entity_1_idx_in_text_with_entity_marker": [46, 50], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "msh3", "entity_2_idx": [[208, 212]], "entity_2_idx_in_text_with_entity_marker": [221, 225], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d379.s0_BioInfer.d379.s0.p25", "text": "In this study the role of MSH2, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and MSH6 proteins.", "text_with_entity_marker": "In this study the role of MSH2, [E1]MSH3[/E1], and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, [E2]msh3[/E2], and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and MSH6 proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MSH3", "entity_1_idx": [[32, 36]], "entity_1_idx_in_text_with_entity_marker": [36, 40], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "msh3", "entity_2_idx": [[208, 212]], "entity_2_idx_in_text_with_entity_marker": [221, 225], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d379.s0_BioInfer.d379.s0.p26", "text": "In this study the role of MSH2, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and MSH6 proteins.", "text_with_entity_marker": "In this study the role of MSH2, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of [E1]msh2[/E1], msh3, and [E2]msh6[/E2] mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and MSH6 proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "msh2", "entity_1_idx": [[202, 206]], "entity_1_idx_in_text_with_entity_marker": [206, 210], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "msh6", "entity_2_idx": [[218, 222]], "entity_2_idx_in_text_with_entity_marker": [231, 235], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d379.s0_BioInfer.d379.s0.p27", "text": "In this study the role of MSH2, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and MSH6 proteins.", "text_with_entity_marker": "In this study the role of [E1]MSH2[/E1], MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of [E2]msh2[/E2], msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and MSH6 proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MSH2", "entity_1_idx": [[26, 30]], "entity_1_idx_in_text_with_entity_marker": [30, 34], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "msh2", "entity_2_idx": [[202, 206]], "entity_2_idx_in_text_with_entity_marker": [215, 219], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d379.s0_BioInfer.d379.s0.p28", "text": "In this study the role of MSH2, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and MSH6 proteins.", "text_with_entity_marker": "In this study the role of MSH2, MSH3, and [E1]MSH6[/E1] in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of [E2]msh2[/E2], msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and MSH6 proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MSH6", "entity_1_idx": [[42, 46]], "entity_1_idx_in_text_with_entity_marker": [46, 50], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "msh2", "entity_2_idx": [[202, 206]], "entity_2_idx_in_text_with_entity_marker": [215, 219], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d379.s0_BioInfer.d379.s0.p29", "text": "In this study the role of MSH2, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and MSH6 proteins.", "text_with_entity_marker": "In this study the role of MSH2, [E1]MSH3[/E1], and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of [E2]msh2[/E2], msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and MSH6 proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MSH3", "entity_1_idx": [[32, 36]], "entity_1_idx_in_text_with_entity_marker": [36, 40], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "msh2", "entity_2_idx": [[202, 206]], "entity_2_idx_in_text_with_entity_marker": [215, 219], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d111.s0_BioInfer.d111.s0.p0", "text": "Both pathway cells and superior tarsal smooth muscle cells expressed alpha-smooth muscle actin and smooth muscle myosin heavy chain throughout development.", "text_with_entity_marker": "Both pathway cells and superior tarsal smooth muscle cells expressed [E1]alpha-smooth muscle actin[/E1] and [E2]smooth muscle myosin heavy chain[/E2] throughout development.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-smooth muscle actin", "entity_1_idx": [[69, 94]], "entity_1_idx_in_text_with_entity_marker": [73, 98], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "smooth muscle myosin heavy chain", "entity_2_idx": [[99, 131]], "entity_2_idx_in_text_with_entity_marker": [112, 144], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d131.s0_BioInfer.d131.s0.p0", "text": "CD26 is a T cell activation antigen that contains dipeptidyl peptidase IV activity and is known to bind adenosine deaminase.", "text_with_entity_marker": "CD26 is a T cell activation antigen that contains [E1]dipeptidyl peptidase IV[/E1] activity and is known to bind [E2]adenosine deaminase[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "dipeptidyl peptidase IV", "entity_1_idx": [[50, 73]], "entity_1_idx_in_text_with_entity_marker": [54, 77], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "adenosine deaminase", "entity_2_idx": [[104, 123]], "entity_2_idx_in_text_with_entity_marker": [117, 136], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d131.s0_BioInfer.d131.s0.p1", "text": "CD26 is a T cell activation antigen that contains dipeptidyl peptidase IV activity and is known to bind adenosine deaminase.", "text_with_entity_marker": "[E1]CD26[/E1] is a T cell activation antigen that contains [E2]dipeptidyl peptidase IV[/E2] activity and is known to bind adenosine deaminase.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "CD26", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "dipeptidyl peptidase IV", "entity_2_idx": [[50, 73]], "entity_2_idx_in_text_with_entity_marker": [63, 86], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d131.s0_BioInfer.d131.s0.p2", "text": "CD26 is a T cell activation antigen that contains dipeptidyl peptidase IV activity and is known to bind adenosine deaminase.", "text_with_entity_marker": "[E1]CD26[/E1] is a T cell activation antigen that contains dipeptidyl peptidase IV activity and is known to bind [E2]adenosine deaminase[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "CD26", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "adenosine deaminase", "entity_2_idx": [[104, 123]], "entity_2_idx_in_text_with_entity_marker": [117, 136], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d394.s0_BioInfer.d394.s0.p0", "text": "It is also possible that PtdIns-4,5-P2 has other roles, such as promoting the release of G actin from profilin or promoting the cross-linking of actin or its anchorage to the plasma membrane.", "text_with_entity_marker": "It is also possible that PtdIns-4,5-P2 has other roles, such as promoting the release of G actin from [E1]profilin[/E1] or promoting the cross-linking of [E2]actin[/E2] or its anchorage to the plasma membrane.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[102, 110]], "entity_1_idx_in_text_with_entity_marker": [106, 114], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[145, 150]], "entity_2_idx_in_text_with_entity_marker": [158, 163], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d394.s0_BioInfer.d394.s0.p1", "text": "It is also possible that PtdIns-4,5-P2 has other roles, such as promoting the release of G actin from profilin or promoting the cross-linking of actin or its anchorage to the plasma membrane.", "text_with_entity_marker": "It is also possible that PtdIns-4,5-P2 has other roles, such as promoting the release of G [E1]actin[/E1] from [E2]profilin[/E2] or promoting the cross-linking of actin or its anchorage to the plasma membrane.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[91, 96]], "entity_1_idx_in_text_with_entity_marker": [95, 100], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[102, 110]], "entity_2_idx_in_text_with_entity_marker": [115, 123], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d394.s0_BioInfer.d394.s0.p2", "text": "It is also possible that PtdIns-4,5-P2 has other roles, such as promoting the release of G actin from profilin or promoting the cross-linking of actin or its anchorage to the plasma membrane.", "text_with_entity_marker": "It is also possible that PtdIns-4,5-P2 has other roles, such as promoting the release of G [E1]actin[/E1] from profilin or promoting the cross-linking of [E2]actin[/E2] or its anchorage to the plasma membrane.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[91, 96]], "entity_1_idx_in_text_with_entity_marker": [95, 100], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[145, 150]], "entity_2_idx_in_text_with_entity_marker": [158, 163], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p60", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase ([E1]HN[/E1]; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural ([E2]V[/E2]; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "HN", "entity_1_idx": [[213, 215]], "entity_1_idx_in_text_with_entity_marker": [217, 219], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "V", "entity_2_idx": [[340, 341]], "entity_2_idx_in_text_with_entity_marker": [353, 354], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p61", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase ([E1]HN[/E1]; 74 kDa), nucleocapsid ([E2]N[/E2]; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "HN", "entity_1_idx": [[213, 215]], "entity_1_idx_in_text_with_entity_marker": [217, 219], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "N", "entity_2_idx": [[240, 241]], "entity_2_idx_in_text_with_entity_marker": [253, 254], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p62", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase ([E1]HN[/E1]; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix ([E2]M[/E2]; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "HN", "entity_1_idx": [[213, 215]], "entity_1_idx_in_text_with_entity_marker": [217, 219], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "M", "entity_2_idx": [[309, 310]], "entity_2_idx_in_text_with_entity_marker": [322, 323], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p63", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the [E1]large[/E1] (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), [E2]nucleocapsid[/E2] (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "large", "entity_1_idx": [[163, 168], [351, 359]], "entity_1_idx_in_text_with_entity_marker": [167, 172], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "nucleocapsid", "entity_2_idx": [[226, 238], [351, 359]], "entity_2_idx_in_text_with_entity_marker": [239, 251], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p64", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the [E1]large[/E1] (L; 190 kDa), [E2]haemagglutinin neuraminidase[/E2] (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "large", "entity_1_idx": [[163, 168], [351, 359]], "entity_1_idx_in_text_with_entity_marker": [167, 172], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "haemagglutinin neuraminidase", "entity_2_idx": [[183, 211], [351, 359]], "entity_2_idx_in_text_with_entity_marker": [196, 224], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p65", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the [E1]large[/E1] (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), [E2]phosphoprotein[/E2] (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "large", "entity_1_idx": [[163, 168], [351, 359]], "entity_1_idx_in_text_with_entity_marker": [167, 172], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "phosphoprotein", "entity_2_idx": [[273, 287], [351, 359]], "entity_2_idx_in_text_with_entity_marker": [286, 300], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p66", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the [E1]large[/E1] (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein ([E2]P[/E2]; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "large", "entity_1_idx": [[163, 168], [351, 359]], "entity_1_idx_in_text_with_entity_marker": [167, 172], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P", "entity_2_idx": [[289, 290]], "entity_2_idx_in_text_with_entity_marker": [302, 303], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p67", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the [E1]large[/E1] (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural ([E2]V[/E2]; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "large", "entity_1_idx": [[163, 168], [351, 359]], "entity_1_idx_in_text_with_entity_marker": [167, 172], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "V", "entity_2_idx": [[340, 341]], "entity_2_idx_in_text_with_entity_marker": [353, 354], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p68", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the [E1]large[/E1] (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid ([E2]N[/E2]; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "large", "entity_1_idx": [[163, 168], [351, 359]], "entity_1_idx_in_text_with_entity_marker": [167, 172], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "N", "entity_2_idx": [[240, 241]], "entity_2_idx_in_text_with_entity_marker": [253, 254], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p69", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the [E1]large[/E1] (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix ([E2]M[/E2]; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "large", "entity_1_idx": [[163, 168], [351, 359]], "entity_1_idx_in_text_with_entity_marker": [167, 172], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "M", "entity_2_idx": [[309, 310]], "entity_2_idx_in_text_with_entity_marker": [322, 323], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p80", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), [E1]haemagglutinin neuraminidase[/E1] (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix ([E2]M[/E2]; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "haemagglutinin neuraminidase", "entity_1_idx": [[183, 211], [351, 359]], "entity_1_idx_in_text_with_entity_marker": [187, 215], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "M", "entity_2_idx": [[309, 310]], "entity_2_idx_in_text_with_entity_marker": [322, 323], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p81", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), [E1]phosphoprotein[/E1] ([E2]P[/E2]; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "phosphoprotein", "entity_1_idx": [[273, 287], [351, 359]], "entity_1_idx_in_text_with_entity_marker": [277, 291], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P", "entity_2_idx": [[289, 290]], "entity_2_idx_in_text_with_entity_marker": [302, 303], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p82", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), [E1]phosphoprotein[/E1] (P; 49 kDa), matrix (M; 43 kDa) and non-structural ([E2]V[/E2]; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "phosphoprotein", "entity_1_idx": [[273, 287], [351, 359]], "entity_1_idx_in_text_with_entity_marker": [277, 291], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "V", "entity_2_idx": [[340, 341]], "entity_2_idx_in_text_with_entity_marker": [353, 354], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p83", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid ([E1]N[/E1]; 66 kDa), fusion (F0; 63 kDa), [E2]phosphoprotein[/E2] (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "N", "entity_1_idx": [[240, 241]], "entity_1_idx_in_text_with_entity_marker": [244, 245], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "phosphoprotein", "entity_2_idx": [[273, 287], [351, 359]], "entity_2_idx_in_text_with_entity_marker": [286, 300], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p84", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), [E1]phosphoprotein[/E1] (P; 49 kDa), matrix ([E2]M[/E2]; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "phosphoprotein", "entity_1_idx": [[273, 287], [351, 359]], "entity_1_idx_in_text_with_entity_marker": [277, 291], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "M", "entity_2_idx": [[309, 310]], "entity_2_idx_in_text_with_entity_marker": [322, 323], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p85", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein ([E1]P[/E1]; 49 kDa), matrix (M; 43 kDa) and non-structural ([E2]V[/E2]; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "P", "entity_1_idx": [[289, 290]], "entity_1_idx_in_text_with_entity_marker": [293, 294], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "V", "entity_2_idx": [[340, 341]], "entity_2_idx_in_text_with_entity_marker": [353, 354], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p86", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid ([E1]N[/E1]; 66 kDa), fusion (F0; 63 kDa), phosphoprotein ([E2]P[/E2]; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "N", "entity_1_idx": [[240, 241]], "entity_1_idx_in_text_with_entity_marker": [244, 245], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P", "entity_2_idx": [[289, 290]], "entity_2_idx_in_text_with_entity_marker": [302, 303], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p87", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein ([E1]P[/E1]; 49 kDa), matrix ([E2]M[/E2]; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "P", "entity_1_idx": [[289, 290]], "entity_1_idx_in_text_with_entity_marker": [293, 294], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "M", "entity_2_idx": [[309, 310]], "entity_2_idx_in_text_with_entity_marker": [322, 323], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p88", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid ([E1]N[/E1]; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural ([E2]V[/E2]; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "N", "entity_1_idx": [[240, 241]], "entity_1_idx_in_text_with_entity_marker": [244, 245], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "V", "entity_2_idx": [[340, 341]], "entity_2_idx_in_text_with_entity_marker": [353, 354], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p89", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix ([E1]M[/E1]; 43 kDa) and non-structural ([E2]V[/E2]; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "M", "entity_1_idx": [[309, 310]], "entity_1_idx_in_text_with_entity_marker": [313, 314], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "V", "entity_2_idx": [[340, 341]], "entity_2_idx_in_text_with_entity_marker": [353, 354], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d208.s0_BioInfer.d208.s0.p0", "text": "Finally, both receptors can interact with FADD, TRADD, and RIP.", "text_with_entity_marker": "Finally, both receptors can interact with FADD, [E1]TRADD[/E1], and [E2]RIP[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TRADD", "entity_1_idx": [[48, 53]], "entity_1_idx_in_text_with_entity_marker": [52, 57], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RIP", "entity_2_idx": [[59, 62]], "entity_2_idx_in_text_with_entity_marker": [72, 75], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d208.s0_BioInfer.d208.s0.p1", "text": "Finally, both receptors can interact with FADD, TRADD, and RIP.", "text_with_entity_marker": "Finally, both receptors can interact with [E1]FADD[/E1], [E2]TRADD[/E2], and RIP.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "FADD", "entity_1_idx": [[42, 46]], "entity_1_idx_in_text_with_entity_marker": [46, 50], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "TRADD", "entity_2_idx": [[48, 53]], "entity_2_idx_in_text_with_entity_marker": [61, 66], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d208.s0_BioInfer.d208.s0.p2", "text": "Finally, both receptors can interact with FADD, TRADD, and RIP.", "text_with_entity_marker": "Finally, both receptors can interact with [E1]FADD[/E1], TRADD, and [E2]RIP[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "FADD", "entity_1_idx": [[42, 46]], "entity_1_idx_in_text_with_entity_marker": [46, 50], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RIP", "entity_2_idx": [[59, 62]], "entity_2_idx_in_text_with_entity_marker": [72, 75], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d208.s1_BioInfer.d208.s1.p0", "text": "Thus, both DR5 and DR4 use FADD, TRADD, and RIP in their signal transduction pathways, and FADD is the common mediator of apoptosis by all known death domain-containing receptors.", "text_with_entity_marker": "Thus, both DR5 and [E1]DR4[/E1] use FADD, TRADD, and [E2]RIP[/E2] in their signal transduction pathways, and FADD is the common mediator of apoptosis by all known death domain-containing receptors.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "DR4", "entity_1_idx": [[19, 22]], "entity_1_idx_in_text_with_entity_marker": [23, 26], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RIP", "entity_2_idx": [[44, 47]], "entity_2_idx_in_text_with_entity_marker": [57, 60], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d208.s1_BioInfer.d208.s1.p1", "text": "Thus, both DR5 and DR4 use FADD, TRADD, and RIP in their signal transduction pathways, and FADD is the common mediator of apoptosis by all known death domain-containing receptors.", "text_with_entity_marker": "Thus, both DR5 and [E1]DR4[/E1] use FADD, [E2]TRADD[/E2], and RIP in their signal transduction pathways, and FADD is the common mediator of apoptosis by all known death domain-containing receptors.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "DR4", "entity_1_idx": [[19, 22]], "entity_1_idx_in_text_with_entity_marker": [23, 26], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TRADD", "entity_2_idx": [[33, 38]], "entity_2_idx_in_text_with_entity_marker": [46, 51], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d208.s1_BioInfer.d208.s1.p2", "text": "Thus, both DR5 and DR4 use FADD, TRADD, and RIP in their signal transduction pathways, and FADD is the common mediator of apoptosis by all known death domain-containing receptors.", "text_with_entity_marker": "Thus, both [E1]DR5[/E1] and [E2]DR4[/E2] use FADD, TRADD, and RIP in their signal transduction pathways, and FADD is the common mediator of apoptosis by all known death domain-containing receptors.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "DR5", "entity_1_idx": [[11, 14]], "entity_1_idx_in_text_with_entity_marker": [15, 18], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "DR4", "entity_2_idx": [[19, 22]], "entity_2_idx_in_text_with_entity_marker": [32, 35], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d208.s1_BioInfer.d208.s1.p3", "text": "Thus, both DR5 and DR4 use FADD, TRADD, and RIP in their signal transduction pathways, and FADD is the common mediator of apoptosis by all known death domain-containing receptors.", "text_with_entity_marker": "Thus, both DR5 and [E1]DR4[/E1] use [E2]FADD[/E2], TRADD, and RIP in their signal transduction pathways, and FADD is the common mediator of apoptosis by all known death domain-containing receptors.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "DR4", "entity_1_idx": [[19, 22]], "entity_1_idx_in_text_with_entity_marker": [23, 26], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "FADD", "entity_2_idx": [[27, 31]], "entity_2_idx_in_text_with_entity_marker": [40, 44], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d208.s1_BioInfer.d208.s1.p4", "text": "Thus, both DR5 and DR4 use FADD, TRADD, and RIP in their signal transduction pathways, and FADD is the common mediator of apoptosis by all known death domain-containing receptors.", "text_with_entity_marker": "Thus, both DR5 and [E1]DR4[/E1] use FADD, TRADD, and RIP in their signal transduction pathways, and [E2]FADD[/E2] is the common mediator of apoptosis by all known death domain-containing receptors.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "DR4", "entity_1_idx": [[19, 22]], "entity_1_idx_in_text_with_entity_marker": [23, 26], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "FADD", "entity_2_idx": [[91, 95]], "entity_2_idx_in_text_with_entity_marker": [104, 108], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d208.s1_BioInfer.d208.s1.p5", "text": "Thus, both DR5 and DR4 use FADD, TRADD, and RIP in their signal transduction pathways, and FADD is the common mediator of apoptosis by all known death domain-containing receptors.", "text_with_entity_marker": "Thus, both DR5 and DR4 use FADD, [E1]TRADD[/E1], and [E2]RIP[/E2] in their signal transduction pathways, and FADD is the common mediator of apoptosis by all known death domain-containing receptors.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TRADD", "entity_1_idx": [[33, 38]], "entity_1_idx_in_text_with_entity_marker": [37, 42], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RIP", "entity_2_idx": [[44, 47]], "entity_2_idx_in_text_with_entity_marker": [57, 60], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d208.s1_BioInfer.d208.s1.p6", "text": "Thus, both DR5 and DR4 use FADD, TRADD, and RIP in their signal transduction pathways, and FADD is the common mediator of apoptosis by all known death domain-containing receptors.", "text_with_entity_marker": "Thus, both [E1]DR5[/E1] and DR4 use FADD, TRADD, and [E2]RIP[/E2] in their signal transduction pathways, and FADD is the common mediator of apoptosis by all known death domain-containing receptors.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "DR5", "entity_1_idx": [[11, 14]], "entity_1_idx_in_text_with_entity_marker": [15, 18], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RIP", "entity_2_idx": [[44, 47]], "entity_2_idx_in_text_with_entity_marker": [57, 60], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d208.s1_BioInfer.d208.s1.p7", "text": "Thus, both DR5 and DR4 use FADD, TRADD, and RIP in their signal transduction pathways, and FADD is the common mediator of apoptosis by all known death domain-containing receptors.", "text_with_entity_marker": "Thus, both DR5 and DR4 use [E1]FADD[/E1], TRADD, and [E2]RIP[/E2] in their signal transduction pathways, and FADD is the common mediator of apoptosis by all known death domain-containing receptors.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "FADD", "entity_1_idx": [[27, 31]], "entity_1_idx_in_text_with_entity_marker": [31, 35], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RIP", "entity_2_idx": [[44, 47]], "entity_2_idx_in_text_with_entity_marker": [57, 60], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d208.s1_BioInfer.d208.s1.p8", "text": "Thus, both DR5 and DR4 use FADD, TRADD, and RIP in their signal transduction pathways, and FADD is the common mediator of apoptosis by all known death domain-containing receptors.", "text_with_entity_marker": "Thus, both DR5 and DR4 use FADD, TRADD, and [E1]RIP[/E1] in their signal transduction pathways, and [E2]FADD[/E2] is the common mediator of apoptosis by all known death domain-containing receptors.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RIP", "entity_1_idx": [[44, 47]], "entity_1_idx_in_text_with_entity_marker": [48, 51], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "FADD", "entity_2_idx": [[91, 95]], "entity_2_idx_in_text_with_entity_marker": [104, 108], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d208.s1_BioInfer.d208.s1.p9", "text": "Thus, both DR5 and DR4 use FADD, TRADD, and RIP in their signal transduction pathways, and FADD is the common mediator of apoptosis by all known death domain-containing receptors.", "text_with_entity_marker": "Thus, both [E1]DR5[/E1] and DR4 use FADD, [E2]TRADD[/E2], and RIP in their signal transduction pathways, and FADD is the common mediator of apoptosis by all known death domain-containing receptors.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "DR5", "entity_1_idx": [[11, 14]], "entity_1_idx_in_text_with_entity_marker": [15, 18], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TRADD", "entity_2_idx": [[33, 38]], "entity_2_idx_in_text_with_entity_marker": [46, 51], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d208.s1_BioInfer.d208.s1.p10", "text": "Thus, both DR5 and DR4 use FADD, TRADD, and RIP in their signal transduction pathways, and FADD is the common mediator of apoptosis by all known death domain-containing receptors.", "text_with_entity_marker": "Thus, both DR5 and DR4 use [E1]FADD[/E1], [E2]TRADD[/E2], and RIP in their signal transduction pathways, and FADD is the common mediator of apoptosis by all known death domain-containing receptors.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "FADD", "entity_1_idx": [[27, 31]], "entity_1_idx_in_text_with_entity_marker": [31, 35], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TRADD", "entity_2_idx": [[33, 38]], "entity_2_idx_in_text_with_entity_marker": [46, 51], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d208.s1_BioInfer.d208.s1.p11", "text": "Thus, both DR5 and DR4 use FADD, TRADD, and RIP in their signal transduction pathways, and FADD is the common mediator of apoptosis by all known death domain-containing receptors.", "text_with_entity_marker": "Thus, both DR5 and DR4 use FADD, [E1]TRADD[/E1], and RIP in their signal transduction pathways, and [E2]FADD[/E2] is the common mediator of apoptosis by all known death domain-containing receptors.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TRADD", "entity_1_idx": [[33, 38]], "entity_1_idx_in_text_with_entity_marker": [37, 42], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "FADD", "entity_2_idx": [[91, 95]], "entity_2_idx_in_text_with_entity_marker": [104, 108], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d208.s1_BioInfer.d208.s1.p12", "text": "Thus, both DR5 and DR4 use FADD, TRADD, and RIP in their signal transduction pathways, and FADD is the common mediator of apoptosis by all known death domain-containing receptors.", "text_with_entity_marker": "Thus, both [E1]DR5[/E1] and DR4 use [E2]FADD[/E2], TRADD, and RIP in their signal transduction pathways, and FADD is the common mediator of apoptosis by all known death domain-containing receptors.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "DR5", "entity_1_idx": [[11, 14]], "entity_1_idx_in_text_with_entity_marker": [15, 18], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "FADD", "entity_2_idx": [[27, 31]], "entity_2_idx_in_text_with_entity_marker": [40, 44], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d208.s1_BioInfer.d208.s1.p13", "text": "Thus, both DR5 and DR4 use FADD, TRADD, and RIP in their signal transduction pathways, and FADD is the common mediator of apoptosis by all known death domain-containing receptors.", "text_with_entity_marker": "Thus, both [E1]DR5[/E1] and DR4 use FADD, TRADD, and RIP in their signal transduction pathways, and [E2]FADD[/E2] is the common mediator of apoptosis by all known death domain-containing receptors.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "DR5", "entity_1_idx": [[11, 14]], "entity_1_idx_in_text_with_entity_marker": [15, 18], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "FADD", "entity_2_idx": [[91, 95]], "entity_2_idx_in_text_with_entity_marker": [104, 108], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d208.s1_BioInfer.d208.s1.p14", "text": "Thus, both DR5 and DR4 use FADD, TRADD, and RIP in their signal transduction pathways, and FADD is the common mediator of apoptosis by all known death domain-containing receptors.", "text_with_entity_marker": "Thus, both DR5 and DR4 use [E1]FADD[/E1], TRADD, and RIP in their signal transduction pathways, and [E2]FADD[/E2] is the common mediator of apoptosis by all known death domain-containing receptors.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "FADD", "entity_1_idx": [[27, 31]], "entity_1_idx_in_text_with_entity_marker": [31, 35], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "FADD", "entity_2_idx": [[91, 95]], "entity_2_idx_in_text_with_entity_marker": [104, 108], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d269.s0_BioInfer.d269.s0.p0", "text": "However, immunofluorescence staining revealed a similar organisation of actin microfilaments, talin and phosphotyrosyl-containing proteins on both substrates.", "text_with_entity_marker": "However, immunofluorescence staining revealed a similar organisation of [E1]actin[/E1] microfilaments, [E2]talin[/E2] and phosphotyrosyl-containing proteins on both substrates.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[72, 77]], "entity_1_idx_in_text_with_entity_marker": [76, 81], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "talin", "entity_2_idx": [[94, 99]], "entity_2_idx_in_text_with_entity_marker": [107, 112], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d298.s0_BioInfer.d298.s0.p0", "text": "Immunoprecipitation of metabolically labeled proteins with HECD-1 revealed three bands corresponding to E-cadherin, alpha-catenin, and gamma-catenin and a 79-kDa band which was apparently smaller than that of normal beta-catenin, indicating truncated beta-catenin.", "text_with_entity_marker": "Immunoprecipitation of metabolically labeled proteins with HECD-1 revealed three bands corresponding to E-cadherin, alpha-catenin, and gamma-catenin and a 79-kDa band which was apparently smaller than that of normal [E1]beta-catenin[/E1], indicating truncated [E2]beta-catenin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[216, 228]], "entity_1_idx_in_text_with_entity_marker": [220, 232], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[251, 263]], "entity_2_idx_in_text_with_entity_marker": [264, 276], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d298.s0_BioInfer.d298.s0.p1", "text": "Immunoprecipitation of metabolically labeled proteins with HECD-1 revealed three bands corresponding to E-cadherin, alpha-catenin, and gamma-catenin and a 79-kDa band which was apparently smaller than that of normal beta-catenin, indicating truncated beta-catenin.", "text_with_entity_marker": "Immunoprecipitation of metabolically labeled proteins with [E1]HECD-1[/E1] revealed three bands corresponding to E-cadherin, alpha-catenin, and gamma-catenin and a 79-kDa band which was apparently smaller than that of normal beta-catenin, indicating truncated [E2]beta-catenin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "HECD-1", "entity_1_idx": [[59, 65]], "entity_1_idx_in_text_with_entity_marker": [63, 69], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[251, 263]], "entity_2_idx_in_text_with_entity_marker": [264, 276], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d298.s0_BioInfer.d298.s0.p2", "text": "Immunoprecipitation of metabolically labeled proteins with HECD-1 revealed three bands corresponding to E-cadherin, alpha-catenin, and gamma-catenin and a 79-kDa band which was apparently smaller than that of normal beta-catenin, indicating truncated beta-catenin.", "text_with_entity_marker": "Immunoprecipitation of metabolically labeled proteins with HECD-1 revealed three bands corresponding to [E1]E-cadherin[/E1], alpha-catenin, and gamma-catenin and a 79-kDa band which was apparently smaller than that of normal beta-catenin, indicating truncated [E2]beta-catenin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[104, 114]], "entity_1_idx_in_text_with_entity_marker": [108, 118], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[251, 263]], "entity_2_idx_in_text_with_entity_marker": [264, 276], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d298.s0_BioInfer.d298.s0.p3", "text": "Immunoprecipitation of metabolically labeled proteins with HECD-1 revealed three bands corresponding to E-cadherin, alpha-catenin, and gamma-catenin and a 79-kDa band which was apparently smaller than that of normal beta-catenin, indicating truncated beta-catenin.", "text_with_entity_marker": "Immunoprecipitation of metabolically labeled proteins with HECD-1 revealed three bands corresponding to E-cadherin, [E1]alpha-catenin[/E1], and gamma-catenin and a 79-kDa band which was apparently smaller than that of normal beta-catenin, indicating truncated [E2]beta-catenin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[116, 129]], "entity_1_idx_in_text_with_entity_marker": [120, 133], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[251, 263]], "entity_2_idx_in_text_with_entity_marker": [264, 276], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d298.s0_BioInfer.d298.s0.p4", "text": "Immunoprecipitation of metabolically labeled proteins with HECD-1 revealed three bands corresponding to E-cadherin, alpha-catenin, and gamma-catenin and a 79-kDa band which was apparently smaller than that of normal beta-catenin, indicating truncated beta-catenin.", "text_with_entity_marker": "Immunoprecipitation of metabolically labeled proteins with HECD-1 revealed three bands corresponding to E-cadherin, alpha-catenin, and [E1]gamma-catenin[/E1] and a 79-kDa band which was apparently smaller than that of normal beta-catenin, indicating truncated [E2]beta-catenin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "gamma-catenin", "entity_1_idx": [[135, 148]], "entity_1_idx_in_text_with_entity_marker": [139, 152], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[251, 263]], "entity_2_idx_in_text_with_entity_marker": [264, 276], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d298.s0_BioInfer.d298.s0.p5", "text": "Immunoprecipitation of metabolically labeled proteins with HECD-1 revealed three bands corresponding to E-cadherin, alpha-catenin, and gamma-catenin and a 79-kDa band which was apparently smaller than that of normal beta-catenin, indicating truncated beta-catenin.", "text_with_entity_marker": "Immunoprecipitation of metabolically labeled proteins with [E1]HECD-1[/E1] revealed three bands corresponding to E-cadherin, alpha-catenin, and gamma-catenin and a 79-kDa band which was apparently smaller than that of normal [E2]beta-catenin[/E2], indicating truncated beta-catenin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "HECD-1", "entity_1_idx": [[59, 65]], "entity_1_idx_in_text_with_entity_marker": [63, 69], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[216, 228]], "entity_2_idx_in_text_with_entity_marker": [229, 241], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d298.s0_BioInfer.d298.s0.p6", "text": "Immunoprecipitation of metabolically labeled proteins with HECD-1 revealed three bands corresponding to E-cadherin, alpha-catenin, and gamma-catenin and a 79-kDa band which was apparently smaller than that of normal beta-catenin, indicating truncated beta-catenin.", "text_with_entity_marker": "Immunoprecipitation of metabolically labeled proteins with HECD-1 revealed three bands corresponding to [E1]E-cadherin[/E1], alpha-catenin, and gamma-catenin and a 79-kDa band which was apparently smaller than that of normal [E2]beta-catenin[/E2], indicating truncated beta-catenin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[104, 114]], "entity_1_idx_in_text_with_entity_marker": [108, 118], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[216, 228]], "entity_2_idx_in_text_with_entity_marker": [229, 241], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d298.s0_BioInfer.d298.s0.p7", "text": "Immunoprecipitation of metabolically labeled proteins with HECD-1 revealed three bands corresponding to E-cadherin, alpha-catenin, and gamma-catenin and a 79-kDa band which was apparently smaller than that of normal beta-catenin, indicating truncated beta-catenin.", "text_with_entity_marker": "Immunoprecipitation of metabolically labeled proteins with HECD-1 revealed three bands corresponding to E-cadherin, [E1]alpha-catenin[/E1], and gamma-catenin and a 79-kDa band which was apparently smaller than that of normal [E2]beta-catenin[/E2], indicating truncated beta-catenin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[116, 129]], "entity_1_idx_in_text_with_entity_marker": [120, 133], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[216, 228]], "entity_2_idx_in_text_with_entity_marker": [229, 241], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d298.s0_BioInfer.d298.s0.p8", "text": "Immunoprecipitation of metabolically labeled proteins with HECD-1 revealed three bands corresponding to E-cadherin, alpha-catenin, and gamma-catenin and a 79-kDa band which was apparently smaller than that of normal beta-catenin, indicating truncated beta-catenin.", "text_with_entity_marker": "Immunoprecipitation of metabolically labeled proteins with HECD-1 revealed three bands corresponding to E-cadherin, alpha-catenin, and [E1]gamma-catenin[/E1] and a 79-kDa band which was apparently smaller than that of normal [E2]beta-catenin[/E2], indicating truncated beta-catenin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "gamma-catenin", "entity_1_idx": [[135, 148]], "entity_1_idx_in_text_with_entity_marker": [139, 152], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[216, 228]], "entity_2_idx_in_text_with_entity_marker": [229, 241], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d298.s0_BioInfer.d298.s0.p9", "text": "Immunoprecipitation of metabolically labeled proteins with HECD-1 revealed three bands corresponding to E-cadherin, alpha-catenin, and gamma-catenin and a 79-kDa band which was apparently smaller than that of normal beta-catenin, indicating truncated beta-catenin.", "text_with_entity_marker": "Immunoprecipitation of metabolically labeled proteins with [E1]HECD-1[/E1] revealed three bands corresponding to [E2]E-cadherin[/E2], alpha-catenin, and gamma-catenin and a 79-kDa band which was apparently smaller than that of normal beta-catenin, indicating truncated beta-catenin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "HECD-1", "entity_1_idx": [[59, 65]], "entity_1_idx_in_text_with_entity_marker": [63, 69], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "E-cadherin", "entity_2_idx": [[104, 114]], "entity_2_idx_in_text_with_entity_marker": [117, 127], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d298.s0_BioInfer.d298.s0.p10", "text": "Immunoprecipitation of metabolically labeled proteins with HECD-1 revealed three bands corresponding to E-cadherin, alpha-catenin, and gamma-catenin and a 79-kDa band which was apparently smaller than that of normal beta-catenin, indicating truncated beta-catenin.", "text_with_entity_marker": "Immunoprecipitation of metabolically labeled proteins with [E1]HECD-1[/E1] revealed three bands corresponding to E-cadherin, [E2]alpha-catenin[/E2], and gamma-catenin and a 79-kDa band which was apparently smaller than that of normal beta-catenin, indicating truncated beta-catenin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "HECD-1", "entity_1_idx": [[59, 65]], "entity_1_idx_in_text_with_entity_marker": [63, 69], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[116, 129]], "entity_2_idx_in_text_with_entity_marker": [129, 142], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d298.s0_BioInfer.d298.s0.p11", "text": "Immunoprecipitation of metabolically labeled proteins with HECD-1 revealed three bands corresponding to E-cadherin, alpha-catenin, and gamma-catenin and a 79-kDa band which was apparently smaller than that of normal beta-catenin, indicating truncated beta-catenin.", "text_with_entity_marker": "Immunoprecipitation of metabolically labeled proteins with [E1]HECD-1[/E1] revealed three bands corresponding to E-cadherin, alpha-catenin, and [E2]gamma-catenin[/E2] and a 79-kDa band which was apparently smaller than that of normal beta-catenin, indicating truncated beta-catenin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "HECD-1", "entity_1_idx": [[59, 65]], "entity_1_idx_in_text_with_entity_marker": [63, 69], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "gamma-catenin", "entity_2_idx": [[135, 148]], "entity_2_idx_in_text_with_entity_marker": [148, 161], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d298.s0_BioInfer.d298.s0.p12", "text": "Immunoprecipitation of metabolically labeled proteins with HECD-1 revealed three bands corresponding to E-cadherin, alpha-catenin, and gamma-catenin and a 79-kDa band which was apparently smaller than that of normal beta-catenin, indicating truncated beta-catenin.", "text_with_entity_marker": "Immunoprecipitation of metabolically labeled proteins with HECD-1 revealed three bands corresponding to [E1]E-cadherin[/E1], [E2]alpha-catenin[/E2], and gamma-catenin and a 79-kDa band which was apparently smaller than that of normal beta-catenin, indicating truncated beta-catenin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[104, 114]], "entity_1_idx_in_text_with_entity_marker": [108, 118], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[116, 129]], "entity_2_idx_in_text_with_entity_marker": [129, 142], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d298.s0_BioInfer.d298.s0.p13", "text": "Immunoprecipitation of metabolically labeled proteins with HECD-1 revealed three bands corresponding to E-cadherin, alpha-catenin, and gamma-catenin and a 79-kDa band which was apparently smaller than that of normal beta-catenin, indicating truncated beta-catenin.", "text_with_entity_marker": "Immunoprecipitation of metabolically labeled proteins with HECD-1 revealed three bands corresponding to [E1]E-cadherin[/E1], alpha-catenin, and [E2]gamma-catenin[/E2] and a 79-kDa band which was apparently smaller than that of normal beta-catenin, indicating truncated beta-catenin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[104, 114]], "entity_1_idx_in_text_with_entity_marker": [108, 118], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "gamma-catenin", "entity_2_idx": [[135, 148]], "entity_2_idx_in_text_with_entity_marker": [148, 161], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d298.s0_BioInfer.d298.s0.p14", "text": "Immunoprecipitation of metabolically labeled proteins with HECD-1 revealed three bands corresponding to E-cadherin, alpha-catenin, and gamma-catenin and a 79-kDa band which was apparently smaller than that of normal beta-catenin, indicating truncated beta-catenin.", "text_with_entity_marker": "Immunoprecipitation of metabolically labeled proteins with HECD-1 revealed three bands corresponding to E-cadherin, [E1]alpha-catenin[/E1], and [E2]gamma-catenin[/E2] and a 79-kDa band which was apparently smaller than that of normal beta-catenin, indicating truncated beta-catenin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[116, 129]], "entity_1_idx_in_text_with_entity_marker": [120, 133], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "gamma-catenin", "entity_2_idx": [[135, 148]], "entity_2_idx_in_text_with_entity_marker": [148, 161], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p50", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as [E1]ROM2[/E1], RHO2, [E2]HCS77[/E2]/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ROM2", "entity_1_idx": [[258, 262]], "entity_1_idx_in_text_with_entity_marker": [262, 266], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "HCS77", "entity_2_idx": [[270, 275]], "entity_2_idx_in_text_with_entity_marker": [283, 288], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p51", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, [E1]HCS77[/E1]/WSC1/SLG1 and MID2 also suppressed [E2]glc7-10[/E2] effectively.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "HCS77", "entity_1_idx": [[270, 275]], "entity_1_idx_in_text_with_entity_marker": [274, 279], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "glc7-10", "entity_2_idx": [[311, 318]], "entity_2_idx_in_text_with_entity_marker": [324, 331], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p52", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a [E1]glc7-10[/E1] dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, [E2]HCS77[/E2]/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "glc7-10", "entity_1_idx": [[151, 158]], "entity_1_idx_in_text_with_entity_marker": [155, 162], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "HCS77", "entity_2_idx": [[270, 275]], "entity_2_idx_in_text_with_entity_marker": [283, 288], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p53", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked [E1]PKC1[/E1] as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, [E2]HCS77[/E2]/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PKC1", "entity_1_idx": [[141, 145]], "entity_1_idx_in_text_with_entity_marker": [145, 149], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "HCS77", "entity_2_idx": [[270, 275]], "entity_2_idx_in_text_with_entity_marker": [283, 288], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p54", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, [E1]HCS77[/E1]/WSC1/[E2]SLG1[/E2] and MID2 also suppressed glc7-10 effectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "HCS77", "entity_1_idx": [[270, 275]], "entity_1_idx_in_text_with_entity_marker": [274, 279], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "SLG1", "entity_2_idx": [[281, 285]], "entity_2_idx_in_text_with_entity_marker": [294, 298], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p55", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 ([E1]MEKK[/E1]) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, [E2]HCS77[/E2]/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MEKK", "entity_1_idx": [[37, 41]], "entity_1_idx_in_text_with_entity_marker": [41, 45], "entity_1_type": "DNA_family_or_group", "entity_1_type_id": 4, "entity_2": "HCS77", "entity_2_idx": [[270, 275]], "entity_2_idx_in_text_with_entity_marker": [283, 288], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p56", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 ([E1]MEK[/E1]) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, [E2]HCS77[/E2]/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MEK", "entity_1_idx": [[106, 109]], "entity_1_idx_in_text_with_entity_marker": [110, 113], "entity_1_type": "DNA_family_or_group", "entity_1_type_id": 4, "entity_2": "HCS77", "entity_2_idx": [[270, 275]], "entity_2_idx_in_text_with_entity_marker": [283, 288], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p57", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 ([E1]MAP kinase[/E1]) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, [E2]HCS77[/E2]/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MAP kinase", "entity_1_idx": [[120, 130]], "entity_1_idx_in_text_with_entity_marker": [124, 134], "entity_1_type": "DNA_family_or_group", "entity_1_type_id": 4, "entity_2": "HCS77", "entity_2_idx": [[270, 275]], "entity_2_idx_in_text_with_entity_marker": [283, 288], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p58", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the [E1]Pkc1p[/E1] pathway such as ROM2, RHO2, HCS77/[E2]WSC1[/E2]/SLG1 and MID2 also suppressed glc7-10 effectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Pkc1p", "entity_1_idx": [[236, 241]], "entity_1_idx_in_text_with_entity_marker": [240, 245], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "WSC1", "entity_2_idx": [[276, 280]], "entity_2_idx_in_text_with_entity_marker": [289, 293], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p59", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the [E1]Pkc1p[/E1] pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and [E2]MID2[/E2] also suppressed glc7-10 effectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Pkc1p", "entity_1_idx": [[236, 241]], "entity_1_idx_in_text_with_entity_marker": [240, 245], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "MID2", "entity_2_idx": [[290, 294]], "entity_2_idx_in_text_with_entity_marker": [303, 307], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d428.s0_BioInfer.d428.s0.p0", "text": "Modifying preselected sites on proteins: the stretch of residues 633-642 of the myosin heavy chain is part of the actin-binding site.", "text_with_entity_marker": "Modifying preselected sites on proteins: the stretch of residues 633-642 of the [E1]myosin heavy chain[/E1] is part of the [E2]actin[/E2]-binding site.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "myosin heavy chain", "entity_1_idx": [[80, 98]], "entity_1_idx_in_text_with_entity_marker": [84, 102], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[114, 119]], "entity_2_idx_in_text_with_entity_marker": [127, 132], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d565.s0_BioInfer.d565.s0.p0", "text": "The ability of these three mutant UL5 proteins to form specific interactions with other members of the helicase-primase complex, UL8 and UL52, indicates that the functional domains required for replication activity of UL5 are separable from domains responsible for protein-protein interactions.", "text_with_entity_marker": "The ability of these three mutant UL5 proteins to form specific interactions with other members of the helicase-primase complex, [E1]UL8[/E1] and [E2]UL52[/E2], indicates that the functional domains required for replication activity of UL5 are separable from domains responsible for protein-protein interactions.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "UL8", "entity_1_idx": [[129, 132]], "entity_1_idx_in_text_with_entity_marker": [133, 136], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "UL52", "entity_2_idx": [[137, 141]], "entity_2_idx_in_text_with_entity_marker": [150, 154], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d565.s0_BioInfer.d565.s0.p1", "text": "The ability of these three mutant UL5 proteins to form specific interactions with other members of the helicase-primase complex, UL8 and UL52, indicates that the functional domains required for replication activity of UL5 are separable from domains responsible for protein-protein interactions.", "text_with_entity_marker": "The ability of these three mutant [E1]UL5[/E1] proteins to form specific interactions with other members of the helicase-primase complex, UL8 and [E2]UL52[/E2], indicates that the functional domains required for replication activity of UL5 are separable from domains responsible for protein-protein interactions.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "UL5", "entity_1_idx": [[34, 37]], "entity_1_idx_in_text_with_entity_marker": [38, 41], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "UL52", "entity_2_idx": [[137, 141]], "entity_2_idx_in_text_with_entity_marker": [150, 154], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d565.s0_BioInfer.d565.s0.p2", "text": "The ability of these three mutant UL5 proteins to form specific interactions with other members of the helicase-primase complex, UL8 and UL52, indicates that the functional domains required for replication activity of UL5 are separable from domains responsible for protein-protein interactions.", "text_with_entity_marker": "The ability of these three mutant UL5 proteins to form specific interactions with other members of the [E1]helicase-primase[/E1] complex, UL8 and [E2]UL52[/E2], indicates that the functional domains required for replication activity of UL5 are separable from domains responsible for protein-protein interactions.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "helicase-primase", "entity_1_idx": [[103, 119]], "entity_1_idx_in_text_with_entity_marker": [107, 123], "entity_1_type": "Protein_complex", "entity_1_type_id": 5, "entity_2": "UL52", "entity_2_idx": [[137, 141]], "entity_2_idx_in_text_with_entity_marker": [150, 154], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d565.s0_BioInfer.d565.s0.p3", "text": "The ability of these three mutant UL5 proteins to form specific interactions with other members of the helicase-primase complex, UL8 and UL52, indicates that the functional domains required for replication activity of UL5 are separable from domains responsible for protein-protein interactions.", "text_with_entity_marker": "The ability of these three mutant UL5 proteins to form specific interactions with other members of the helicase-primase complex, UL8 and [E1]UL52[/E1], indicates that the functional domains required for replication activity of [E2]UL5[/E2] are separable from domains responsible for protein-protein interactions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL52", "entity_1_idx": [[137, 141]], "entity_1_idx_in_text_with_entity_marker": [141, 145], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "UL5", "entity_2_idx": [[218, 221]], "entity_2_idx_in_text_with_entity_marker": [231, 234], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d565.s0_BioInfer.d565.s0.p4", "text": "The ability of these three mutant UL5 proteins to form specific interactions with other members of the helicase-primase complex, UL8 and UL52, indicates that the functional domains required for replication activity of UL5 are separable from domains responsible for protein-protein interactions.", "text_with_entity_marker": "The ability of these three mutant [E1]UL5[/E1] proteins to form specific interactions with other members of the helicase-primase complex, [E2]UL8[/E2] and UL52, indicates that the functional domains required for replication activity of UL5 are separable from domains responsible for protein-protein interactions.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "UL5", "entity_1_idx": [[34, 37]], "entity_1_idx_in_text_with_entity_marker": [38, 41], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "UL8", "entity_2_idx": [[129, 132]], "entity_2_idx_in_text_with_entity_marker": [142, 145], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d565.s0_BioInfer.d565.s0.p5", "text": "The ability of these three mutant UL5 proteins to form specific interactions with other members of the helicase-primase complex, UL8 and UL52, indicates that the functional domains required for replication activity of UL5 are separable from domains responsible for protein-protein interactions.", "text_with_entity_marker": "The ability of these three mutant UL5 proteins to form specific interactions with other members of the [E1]helicase-primase[/E1] complex, [E2]UL8[/E2] and UL52, indicates that the functional domains required for replication activity of UL5 are separable from domains responsible for protein-protein interactions.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "helicase-primase", "entity_1_idx": [[103, 119]], "entity_1_idx_in_text_with_entity_marker": [107, 123], "entity_1_type": "Protein_complex", "entity_1_type_id": 5, "entity_2": "UL8", "entity_2_idx": [[129, 132]], "entity_2_idx_in_text_with_entity_marker": [142, 145], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d565.s0_BioInfer.d565.s0.p6", "text": "The ability of these three mutant UL5 proteins to form specific interactions with other members of the helicase-primase complex, UL8 and UL52, indicates that the functional domains required for replication activity of UL5 are separable from domains responsible for protein-protein interactions.", "text_with_entity_marker": "The ability of these three mutant UL5 proteins to form specific interactions with other members of the helicase-primase complex, [E1]UL8[/E1] and UL52, indicates that the functional domains required for replication activity of [E2]UL5[/E2] are separable from domains responsible for protein-protein interactions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL8", "entity_1_idx": [[129, 132]], "entity_1_idx_in_text_with_entity_marker": [133, 136], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "UL5", "entity_2_idx": [[218, 221]], "entity_2_idx_in_text_with_entity_marker": [231, 234], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d565.s0_BioInfer.d565.s0.p7", "text": "The ability of these three mutant UL5 proteins to form specific interactions with other members of the helicase-primase complex, UL8 and UL52, indicates that the functional domains required for replication activity of UL5 are separable from domains responsible for protein-protein interactions.", "text_with_entity_marker": "The ability of these three mutant [E1]UL5[/E1] proteins to form specific interactions with other members of the [E2]helicase-primase[/E2] complex, UL8 and UL52, indicates that the functional domains required for replication activity of UL5 are separable from domains responsible for protein-protein interactions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL5", "entity_1_idx": [[34, 37]], "entity_1_idx_in_text_with_entity_marker": [38, 41], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "helicase-primase", "entity_2_idx": [[103, 119]], "entity_2_idx_in_text_with_entity_marker": [116, 132], "entity_2_type": "Protein_complex", "entity_2_type_id": 5}], "directed": false, "reverse": false}
{"id": "BioInfer.d565.s0_BioInfer.d565.s0.p8", "text": "The ability of these three mutant UL5 proteins to form specific interactions with other members of the helicase-primase complex, UL8 and UL52, indicates that the functional domains required for replication activity of UL5 are separable from domains responsible for protein-protein interactions.", "text_with_entity_marker": "The ability of these three mutant [E1]UL5[/E1] proteins to form specific interactions with other members of the helicase-primase complex, UL8 and UL52, indicates that the functional domains required for replication activity of [E2]UL5[/E2] are separable from domains responsible for protein-protein interactions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL5", "entity_1_idx": [[34, 37]], "entity_1_idx_in_text_with_entity_marker": [38, 41], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "UL5", "entity_2_idx": [[218, 221]], "entity_2_idx_in_text_with_entity_marker": [231, 234], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d565.s0_BioInfer.d565.s0.p9", "text": "The ability of these three mutant UL5 proteins to form specific interactions with other members of the helicase-primase complex, UL8 and UL52, indicates that the functional domains required for replication activity of UL5 are separable from domains responsible for protein-protein interactions.", "text_with_entity_marker": "The ability of these three mutant UL5 proteins to form specific interactions with other members of the [E1]helicase-primase[/E1] complex, UL8 and UL52, indicates that the functional domains required for replication activity of [E2]UL5[/E2] are separable from domains responsible for protein-protein interactions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "helicase-primase", "entity_1_idx": [[103, 119]], "entity_1_idx_in_text_with_entity_marker": [107, 123], "entity_1_type": "Protein_complex", "entity_1_type_id": 5, "entity_2": "UL5", "entity_2_idx": [[218, 221]], "entity_2_idx_in_text_with_entity_marker": [231, 234], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d485.s0_BioInfer.d485.s0.p10", "text": "PF4-dependent downregulation of cyclin E-cdk2 activity was associated with increased binding of the cyclin-dependent kinase inhibitor, p21(Cip1/WAF1), to the cyclin E-cdk2 complex.", "text_with_entity_marker": "PF4-dependent downregulation of cyclin E-cdk2 activity was associated with increased binding of the cyclin-dependent kinase inhibitor, p21([E1]Cip1[/E1]/[E2]WAF1[/E2]), to the cyclin E-cdk2 complex.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Cip1", "entity_1_idx": [[139, 143]], "entity_1_idx_in_text_with_entity_marker": [143, 147], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "WAF1", "entity_2_idx": [[144, 148]], "entity_2_idx_in_text_with_entity_marker": [157, 161], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d485.s0_BioInfer.d485.s0.p11", "text": "PF4-dependent downregulation of cyclin E-cdk2 activity was associated with increased binding of the cyclin-dependent kinase inhibitor, p21(Cip1/WAF1), to the cyclin E-cdk2 complex.", "text_with_entity_marker": "PF4-dependent downregulation of cyclin E-cdk2 activity was associated with increased binding of the cyclin-dependent kinase inhibitor, p21([E1]Cip1[/E1]/WAF1), to the cyclin E-[E2]cdk2[/E2] complex.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Cip1", "entity_1_idx": [[139, 143]], "entity_1_idx_in_text_with_entity_marker": [143, 147], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cdk2", "entity_2_idx": [[167, 171]], "entity_2_idx_in_text_with_entity_marker": [180, 184], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d485.s0_BioInfer.d485.s0.p12", "text": "PF4-dependent downregulation of cyclin E-cdk2 activity was associated with increased binding of the cyclin-dependent kinase inhibitor, p21(Cip1/WAF1), to the cyclin E-cdk2 complex.", "text_with_entity_marker": "[E1]PF4[/E1]-dependent downregulation of cyclin E-cdk2 activity was associated with increased binding of the cyclin-dependent kinase inhibitor, p21([E2]Cip1[/E2]/WAF1), to the cyclin E-cdk2 complex.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PF4", "entity_1_idx": [[0, 3]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Cip1", "entity_2_idx": [[139, 143]], "entity_2_idx_in_text_with_entity_marker": [152, 156], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d485.s0_BioInfer.d485.s0.p13", "text": "PF4-dependent downregulation of cyclin E-cdk2 activity was associated with increased binding of the cyclin-dependent kinase inhibitor, p21(Cip1/WAF1), to the cyclin E-cdk2 complex.", "text_with_entity_marker": "PF4-dependent downregulation of [E1]cyclin E[/E1]-cdk2 activity was associated with increased binding of the cyclin-dependent kinase inhibitor, p21([E2]Cip1[/E2]/WAF1), to the cyclin E-cdk2 complex.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cyclin E", "entity_1_idx": [[32, 40]], "entity_1_idx_in_text_with_entity_marker": [36, 44], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Cip1", "entity_2_idx": [[139, 143]], "entity_2_idx_in_text_with_entity_marker": [152, 156], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d485.s0_BioInfer.d485.s0.p14", "text": "PF4-dependent downregulation of cyclin E-cdk2 activity was associated with increased binding of the cyclin-dependent kinase inhibitor, p21(Cip1/WAF1), to the cyclin E-cdk2 complex.", "text_with_entity_marker": "PF4-dependent downregulation of cyclin E-cdk2 activity was associated with increased binding of the cyclin-dependent kinase inhibitor, [E1]p21[/E1]([E2]Cip1[/E2]/WAF1), to the cyclin E-cdk2 complex.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p21", "entity_1_idx": [[135, 138]], "entity_1_idx_in_text_with_entity_marker": [139, 142], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Cip1", "entity_2_idx": [[139, 143]], "entity_2_idx_in_text_with_entity_marker": [152, 156], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d485.s0_BioInfer.d485.s0.p15", "text": "PF4-dependent downregulation of cyclin E-cdk2 activity was associated with increased binding of the cyclin-dependent kinase inhibitor, p21(Cip1/WAF1), to the cyclin E-cdk2 complex.", "text_with_entity_marker": "PF4-dependent downregulation of cyclin E-[E1]cdk2[/E1] activity was associated with increased binding of the cyclin-dependent kinase inhibitor, p21(Cip1/WAF1), to the [E2]cyclin E[/E2]-cdk2 complex.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cdk2", "entity_1_idx": [[41, 45]], "entity_1_idx_in_text_with_entity_marker": [45, 49], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin E", "entity_2_idx": [[158, 166]], "entity_2_idx_in_text_with_entity_marker": [171, 179], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d485.s0_BioInfer.d485.s0.p16", "text": "PF4-dependent downregulation of cyclin E-cdk2 activity was associated with increased binding of the cyclin-dependent kinase inhibitor, p21(Cip1/WAF1), to the cyclin E-cdk2 complex.", "text_with_entity_marker": "PF4-dependent downregulation of cyclin E-[E1]cdk2[/E1] activity was associated with increased binding of the cyclin-dependent kinase inhibitor, p21(Cip1/[E2]WAF1[/E2]), to the cyclin E-cdk2 complex.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cdk2", "entity_1_idx": [[41, 45]], "entity_1_idx_in_text_with_entity_marker": [45, 49], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "WAF1", "entity_2_idx": [[144, 148]], "entity_2_idx_in_text_with_entity_marker": [157, 161], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d485.s0_BioInfer.d485.s0.p17", "text": "PF4-dependent downregulation of cyclin E-cdk2 activity was associated with increased binding of the cyclin-dependent kinase inhibitor, p21(Cip1/WAF1), to the cyclin E-cdk2 complex.", "text_with_entity_marker": "PF4-dependent downregulation of cyclin E-[E1]cdk2[/E1] activity was associated with increased binding of the cyclin-dependent kinase inhibitor, p21(Cip1/WAF1), to the cyclin E-[E2]cdk2[/E2] complex.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cdk2", "entity_1_idx": [[41, 45]], "entity_1_idx_in_text_with_entity_marker": [45, 49], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cdk2", "entity_2_idx": [[167, 171]], "entity_2_idx_in_text_with_entity_marker": [180, 184], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d485.s0_BioInfer.d485.s0.p18", "text": "PF4-dependent downregulation of cyclin E-cdk2 activity was associated with increased binding of the cyclin-dependent kinase inhibitor, p21(Cip1/WAF1), to the cyclin E-cdk2 complex.", "text_with_entity_marker": "[E1]PF4[/E1]-dependent downregulation of cyclin E-[E2]cdk2[/E2] activity was associated with increased binding of the cyclin-dependent kinase inhibitor, p21(Cip1/WAF1), to the cyclin E-cdk2 complex.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "PF4", "entity_1_idx": [[0, 3]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cdk2", "entity_2_idx": [[41, 45]], "entity_2_idx_in_text_with_entity_marker": [54, 58], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d485.s0_BioInfer.d485.s0.p19", "text": "PF4-dependent downregulation of cyclin E-cdk2 activity was associated with increased binding of the cyclin-dependent kinase inhibitor, p21(Cip1/WAF1), to the cyclin E-cdk2 complex.", "text_with_entity_marker": "PF4-dependent downregulation of [E1]cyclin E[/E1]-[E2]cdk2[/E2] activity was associated with increased binding of the cyclin-dependent kinase inhibitor, p21(Cip1/WAF1), to the cyclin E-cdk2 complex.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cyclin E", "entity_1_idx": [[32, 40]], "entity_1_idx_in_text_with_entity_marker": [36, 44], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cdk2", "entity_2_idx": [[41, 45]], "entity_2_idx_in_text_with_entity_marker": [54, 58], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d804.s0_BioInfer.d804.s0.p0", "text": "We find that profilin contributes in several ways to Cdc42-induced nucleation of actin filaments in high speed supernatant of lysed neutrophils.", "text_with_entity_marker": "We find that [E1]profilin[/E1] contributes in several ways to Cdc42-induced nucleation of [E2]actin[/E2] filaments in high speed supernatant of lysed neutrophils.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[13, 21]], "entity_1_idx_in_text_with_entity_marker": [17, 25], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[81, 86]], "entity_2_idx_in_text_with_entity_marker": [94, 99], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d804.s0_BioInfer.d804.s0.p1", "text": "We find that profilin contributes in several ways to Cdc42-induced nucleation of actin filaments in high speed supernatant of lysed neutrophils.", "text_with_entity_marker": "We find that [E1]profilin[/E1] contributes in several ways to [E2]Cdc42[/E2]-induced nucleation of actin filaments in high speed supernatant of lysed neutrophils.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[13, 21]], "entity_1_idx_in_text_with_entity_marker": [17, 25], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Cdc42", "entity_2_idx": [[53, 58]], "entity_2_idx_in_text_with_entity_marker": [66, 71], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d804.s0_BioInfer.d804.s0.p2", "text": "We find that profilin contributes in several ways to Cdc42-induced nucleation of actin filaments in high speed supernatant of lysed neutrophils.", "text_with_entity_marker": "We find that profilin contributes in several ways to [E1]Cdc42[/E1]-induced nucleation of [E2]actin[/E2] filaments in high speed supernatant of lysed neutrophils.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Cdc42", "entity_1_idx": [[53, 58]], "entity_1_idx_in_text_with_entity_marker": [57, 62], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[81, 86]], "entity_2_idx_in_text_with_entity_marker": [94, 99], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d596.s0_BioInfer.d596.s0.p0", "text": "The comparison of E-CD proteins synthesized by E62 and E24 cell lines revealed no structural or functional differences because both localized at cell-cell contacts and associated with alpha-catenin, beta-catenin, and plakoglobin.", "text_with_entity_marker": "The comparison of [E1]E-CD[/E1] proteins synthesized by E62 and E24 cell lines revealed no structural or functional differences because both localized at cell-cell contacts and associated with alpha-catenin, beta-catenin, and [E2]plakoglobin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "E-CD", "entity_1_idx": [[18, 22]], "entity_1_idx_in_text_with_entity_marker": [22, 26], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[217, 228]], "entity_2_idx_in_text_with_entity_marker": [230, 241], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d596.s0_BioInfer.d596.s0.p1", "text": "The comparison of E-CD proteins synthesized by E62 and E24 cell lines revealed no structural or functional differences because both localized at cell-cell contacts and associated with alpha-catenin, beta-catenin, and plakoglobin.", "text_with_entity_marker": "The comparison of [E1]E-CD[/E1] proteins synthesized by E62 and E24 cell lines revealed no structural or functional differences because both localized at cell-cell contacts and associated with alpha-catenin, [E2]beta-catenin[/E2], and plakoglobin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "E-CD", "entity_1_idx": [[18, 22]], "entity_1_idx_in_text_with_entity_marker": [22, 26], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[199, 211]], "entity_2_idx_in_text_with_entity_marker": [212, 224], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d596.s0_BioInfer.d596.s0.p2", "text": "The comparison of E-CD proteins synthesized by E62 and E24 cell lines revealed no structural or functional differences because both localized at cell-cell contacts and associated with alpha-catenin, beta-catenin, and plakoglobin.", "text_with_entity_marker": "The comparison of [E1]E-CD[/E1] proteins synthesized by E62 and E24 cell lines revealed no structural or functional differences because both localized at cell-cell contacts and associated with [E2]alpha-catenin[/E2], beta-catenin, and plakoglobin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "E-CD", "entity_1_idx": [[18, 22]], "entity_1_idx_in_text_with_entity_marker": [22, 26], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[184, 197]], "entity_2_idx_in_text_with_entity_marker": [197, 210], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d596.s0_BioInfer.d596.s0.p3", "text": "The comparison of E-CD proteins synthesized by E62 and E24 cell lines revealed no structural or functional differences because both localized at cell-cell contacts and associated with alpha-catenin, beta-catenin, and plakoglobin.", "text_with_entity_marker": "The comparison of E-CD proteins synthesized by E62 and E24 cell lines revealed no structural or functional differences because both localized at cell-cell contacts and associated with alpha-catenin, [E1]beta-catenin[/E1], and [E2]plakoglobin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[199, 211]], "entity_1_idx_in_text_with_entity_marker": [203, 215], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[217, 228]], "entity_2_idx_in_text_with_entity_marker": [230, 241], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d596.s0_BioInfer.d596.s0.p4", "text": "The comparison of E-CD proteins synthesized by E62 and E24 cell lines revealed no structural or functional differences because both localized at cell-cell contacts and associated with alpha-catenin, beta-catenin, and plakoglobin.", "text_with_entity_marker": "The comparison of E-CD proteins synthesized by E62 and E24 cell lines revealed no structural or functional differences because both localized at cell-cell contacts and associated with [E1]alpha-catenin[/E1], beta-catenin, and [E2]plakoglobin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[184, 197]], "entity_1_idx_in_text_with_entity_marker": [188, 201], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[217, 228]], "entity_2_idx_in_text_with_entity_marker": [230, 241], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d596.s0_BioInfer.d596.s0.p5", "text": "The comparison of E-CD proteins synthesized by E62 and E24 cell lines revealed no structural or functional differences because both localized at cell-cell contacts and associated with alpha-catenin, beta-catenin, and plakoglobin.", "text_with_entity_marker": "The comparison of E-CD proteins synthesized by E62 and E24 cell lines revealed no structural or functional differences because both localized at cell-cell contacts and associated with [E1]alpha-catenin[/E1], [E2]beta-catenin[/E2], and plakoglobin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[184, 197]], "entity_1_idx_in_text_with_entity_marker": [188, 201], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[199, 211]], "entity_2_idx_in_text_with_entity_marker": [212, 224], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d666.s0_BioInfer.d666.s0.p0", "text": "The present study was designed to determine if cholesterol feeding results in alterations in the isoforms of actin and/or myosin heavy chain in gallbladder smooth muscle.", "text_with_entity_marker": "The present study was designed to determine if cholesterol feeding results in alterations in the isoforms of [E1]actin[/E1] and/or [E2]myosin heavy chain[/E2] in gallbladder smooth muscle.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[109, 114]], "entity_1_idx_in_text_with_entity_marker": [113, 118], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin heavy chain", "entity_2_idx": [[122, 140]], "entity_2_idx_in_text_with_entity_marker": [135, 153], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d322.s0_BioInfer.d322.s0.p0", "text": "In cell extracts, we found that complementary strand synthesis was inhibited by the cyclin-dependent kinase inhibitor p21(WAF1/CIP1) and rescued by the addition of proliferating cell nuclear antigen, arguing for the involvement of DNA polymerase (Pol) delta in the conversion reaction.", "text_with_entity_marker": "In cell extracts, we found that complementary strand synthesis was inhibited by the [E1]cyclin-dependent kinase inhibitor[/E1] p21([E2]WAF1[/E2]/CIP1) and rescued by the addition of proliferating cell nuclear antigen, arguing for the involvement of DNA polymerase (Pol) delta in the conversion reaction.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cyclin-dependent kinase inhibitor", "entity_1_idx": [[84, 117]], "entity_1_idx_in_text_with_entity_marker": [88, 121], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "WAF1", "entity_2_idx": [[122, 126]], "entity_2_idx_in_text_with_entity_marker": [135, 139], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d322.s0_BioInfer.d322.s0.p1", "text": "In cell extracts, we found that complementary strand synthesis was inhibited by the cyclin-dependent kinase inhibitor p21(WAF1/CIP1) and rescued by the addition of proliferating cell nuclear antigen, arguing for the involvement of DNA polymerase (Pol) delta in the conversion reaction.", "text_with_entity_marker": "In cell extracts, we found that complementary strand synthesis was inhibited by the [E1]cyclin-dependent kinase inhibitor[/E1] p21(WAF1/CIP1) and rescued by the addition of [E2]proliferating cell nuclear antigen[/E2], arguing for the involvement of DNA polymerase (Pol) delta in the conversion reaction.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin-dependent kinase inhibitor", "entity_1_idx": [[84, 117]], "entity_1_idx_in_text_with_entity_marker": [88, 121], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "proliferating cell nuclear antigen", "entity_2_idx": [[164, 198]], "entity_2_idx_in_text_with_entity_marker": [177, 211], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d322.s0_BioInfer.d322.s0.p2", "text": "In cell extracts, we found that complementary strand synthesis was inhibited by the cyclin-dependent kinase inhibitor p21(WAF1/CIP1) and rescued by the addition of proliferating cell nuclear antigen, arguing for the involvement of DNA polymerase (Pol) delta in the conversion reaction.", "text_with_entity_marker": "In cell extracts, we found that complementary strand synthesis was inhibited by the [E1]cyclin-dependent kinase inhibitor[/E1] p21(WAF1/[E2]CIP1[/E2]) and rescued by the addition of proliferating cell nuclear antigen, arguing for the involvement of DNA polymerase (Pol) delta in the conversion reaction.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cyclin-dependent kinase inhibitor", "entity_1_idx": [[84, 117]], "entity_1_idx_in_text_with_entity_marker": [88, 121], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "CIP1", "entity_2_idx": [[127, 131]], "entity_2_idx_in_text_with_entity_marker": [140, 144], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d322.s0_BioInfer.d322.s0.p3", "text": "In cell extracts, we found that complementary strand synthesis was inhibited by the cyclin-dependent kinase inhibitor p21(WAF1/CIP1) and rescued by the addition of proliferating cell nuclear antigen, arguing for the involvement of DNA polymerase (Pol) delta in the conversion reaction.", "text_with_entity_marker": "In cell extracts, we found that complementary strand synthesis was inhibited by the [E1]cyclin-dependent kinase inhibitor[/E1] [E2]p21[/E2](WAF1/CIP1) and rescued by the addition of proliferating cell nuclear antigen, arguing for the involvement of DNA polymerase (Pol) delta in the conversion reaction.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cyclin-dependent kinase inhibitor", "entity_1_idx": [[84, 117]], "entity_1_idx_in_text_with_entity_marker": [88, 121], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "p21", "entity_2_idx": [[118, 121]], "entity_2_idx_in_text_with_entity_marker": [131, 134], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d322.s0_BioInfer.d322.s0.p4", "text": "In cell extracts, we found that complementary strand synthesis was inhibited by the cyclin-dependent kinase inhibitor p21(WAF1/CIP1) and rescued by the addition of proliferating cell nuclear antigen, arguing for the involvement of DNA polymerase (Pol) delta in the conversion reaction.", "text_with_entity_marker": "In cell extracts, we found that complementary strand synthesis was inhibited by the [E1]cyclin-dependent kinase inhibitor[/E1] p21(WAF1/CIP1) and rescued by the addition of proliferating cell nuclear antigen, arguing for the involvement of [E2]DNA polymerase[/E2] (Pol) delta in the conversion reaction.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin-dependent kinase inhibitor", "entity_1_idx": [[84, 117]], "entity_1_idx_in_text_with_entity_marker": [88, 121], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "DNA polymerase", "entity_2_idx": [[231, 245], [252, 257]], "entity_2_idx_in_text_with_entity_marker": [244, 258], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d322.s0_BioInfer.d322.s0.p5", "text": "In cell extracts, we found that complementary strand synthesis was inhibited by the cyclin-dependent kinase inhibitor p21(WAF1/CIP1) and rescued by the addition of proliferating cell nuclear antigen, arguing for the involvement of DNA polymerase (Pol) delta in the conversion reaction.", "text_with_entity_marker": "In cell extracts, we found that complementary strand synthesis was inhibited by the [E1]cyclin-dependent kinase inhibitor[/E1] p21(WAF1/CIP1) and rescued by the addition of proliferating cell nuclear antigen, arguing for the involvement of DNA polymerase ([E2]Pol[/E2]) delta in the conversion reaction.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin-dependent kinase inhibitor", "entity_1_idx": [[84, 117]], "entity_1_idx_in_text_with_entity_marker": [88, 121], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "Pol", "entity_2_idx": [[247, 250]], "entity_2_idx_in_text_with_entity_marker": [260, 263], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d322.s0_BioInfer.d322.s0.p6", "text": "In cell extracts, we found that complementary strand synthesis was inhibited by the cyclin-dependent kinase inhibitor p21(WAF1/CIP1) and rescued by the addition of proliferating cell nuclear antigen, arguing for the involvement of DNA polymerase (Pol) delta in the conversion reaction.", "text_with_entity_marker": "In cell extracts, we found that complementary strand synthesis was inhibited by the cyclin-dependent kinase inhibitor p21([E1]WAF1[/E1]/CIP1) and rescued by the addition of [E2]proliferating cell nuclear antigen[/E2], arguing for the involvement of DNA polymerase (Pol) delta in the conversion reaction.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "WAF1", "entity_1_idx": [[122, 126]], "entity_1_idx_in_text_with_entity_marker": [126, 130], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "proliferating cell nuclear antigen", "entity_2_idx": [[164, 198]], "entity_2_idx_in_text_with_entity_marker": [177, 211], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d322.s0_BioInfer.d322.s0.p7", "text": "In cell extracts, we found that complementary strand synthesis was inhibited by the cyclin-dependent kinase inhibitor p21(WAF1/CIP1) and rescued by the addition of proliferating cell nuclear antigen, arguing for the involvement of DNA polymerase (Pol) delta in the conversion reaction.", "text_with_entity_marker": "In cell extracts, we found that complementary strand synthesis was inhibited by the cyclin-dependent kinase inhibitor p21([E1]WAF1[/E1]/[E2]CIP1[/E2]) and rescued by the addition of proliferating cell nuclear antigen, arguing for the involvement of DNA polymerase (Pol) delta in the conversion reaction.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "WAF1", "entity_1_idx": [[122, 126]], "entity_1_idx_in_text_with_entity_marker": [126, 130], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CIP1", "entity_2_idx": [[127, 131]], "entity_2_idx_in_text_with_entity_marker": [140, 144], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d322.s0_BioInfer.d322.s0.p8", "text": "In cell extracts, we found that complementary strand synthesis was inhibited by the cyclin-dependent kinase inhibitor p21(WAF1/CIP1) and rescued by the addition of proliferating cell nuclear antigen, arguing for the involvement of DNA polymerase (Pol) delta in the conversion reaction.", "text_with_entity_marker": "In cell extracts, we found that complementary strand synthesis was inhibited by the cyclin-dependent kinase inhibitor [E1]p21[/E1]([E2]WAF1[/E2]/CIP1) and rescued by the addition of proliferating cell nuclear antigen, arguing for the involvement of DNA polymerase (Pol) delta in the conversion reaction.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p21", "entity_1_idx": [[118, 121]], "entity_1_idx_in_text_with_entity_marker": [122, 125], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "WAF1", "entity_2_idx": [[122, 126]], "entity_2_idx_in_text_with_entity_marker": [135, 139], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d322.s0_BioInfer.d322.s0.p9", "text": "In cell extracts, we found that complementary strand synthesis was inhibited by the cyclin-dependent kinase inhibitor p21(WAF1/CIP1) and rescued by the addition of proliferating cell nuclear antigen, arguing for the involvement of DNA polymerase (Pol) delta in the conversion reaction.", "text_with_entity_marker": "In cell extracts, we found that complementary strand synthesis was inhibited by the cyclin-dependent kinase inhibitor p21([E1]WAF1[/E1]/CIP1) and rescued by the addition of proliferating cell nuclear antigen, arguing for the involvement of [E2]DNA polymerase[/E2] (Pol) delta in the conversion reaction.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "WAF1", "entity_1_idx": [[122, 126]], "entity_1_idx_in_text_with_entity_marker": [126, 130], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "DNA polymerase", "entity_2_idx": [[231, 245], [252, 257]], "entity_2_idx_in_text_with_entity_marker": [244, 258], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d322.s0_BioInfer.d322.s0.p10", "text": "In cell extracts, we found that complementary strand synthesis was inhibited by the cyclin-dependent kinase inhibitor p21(WAF1/CIP1) and rescued by the addition of proliferating cell nuclear antigen, arguing for the involvement of DNA polymerase (Pol) delta in the conversion reaction.", "text_with_entity_marker": "In cell extracts, we found that complementary strand synthesis was inhibited by the cyclin-dependent kinase inhibitor p21([E1]WAF1[/E1]/CIP1) and rescued by the addition of proliferating cell nuclear antigen, arguing for the involvement of DNA polymerase ([E2]Pol[/E2]) delta in the conversion reaction.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "WAF1", "entity_1_idx": [[122, 126]], "entity_1_idx_in_text_with_entity_marker": [126, 130], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Pol", "entity_2_idx": [[247, 250]], "entity_2_idx_in_text_with_entity_marker": [260, 263], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d322.s0_BioInfer.d322.s0.p11", "text": "In cell extracts, we found that complementary strand synthesis was inhibited by the cyclin-dependent kinase inhibitor p21(WAF1/CIP1) and rescued by the addition of proliferating cell nuclear antigen, arguing for the involvement of DNA polymerase (Pol) delta in the conversion reaction.", "text_with_entity_marker": "In cell extracts, we found that complementary strand synthesis was inhibited by the cyclin-dependent kinase inhibitor p21(WAF1/[E1]CIP1[/E1]) and rescued by the addition of [E2]proliferating cell nuclear antigen[/E2], arguing for the involvement of DNA polymerase (Pol) delta in the conversion reaction.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CIP1", "entity_1_idx": [[127, 131]], "entity_1_idx_in_text_with_entity_marker": [131, 135], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "proliferating cell nuclear antigen", "entity_2_idx": [[164, 198]], "entity_2_idx_in_text_with_entity_marker": [177, 211], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d322.s0_BioInfer.d322.s0.p12", "text": "In cell extracts, we found that complementary strand synthesis was inhibited by the cyclin-dependent kinase inhibitor p21(WAF1/CIP1) and rescued by the addition of proliferating cell nuclear antigen, arguing for the involvement of DNA polymerase (Pol) delta in the conversion reaction.", "text_with_entity_marker": "In cell extracts, we found that complementary strand synthesis was inhibited by the cyclin-dependent kinase inhibitor [E1]p21[/E1](WAF1/CIP1) and rescued by the addition of [E2]proliferating cell nuclear antigen[/E2], arguing for the involvement of DNA polymerase (Pol) delta in the conversion reaction.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p21", "entity_1_idx": [[118, 121]], "entity_1_idx_in_text_with_entity_marker": [122, 125], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "proliferating cell nuclear antigen", "entity_2_idx": [[164, 198]], "entity_2_idx_in_text_with_entity_marker": [177, 211], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d322.s0_BioInfer.d322.s0.p13", "text": "In cell extracts, we found that complementary strand synthesis was inhibited by the cyclin-dependent kinase inhibitor p21(WAF1/CIP1) and rescued by the addition of proliferating cell nuclear antigen, arguing for the involvement of DNA polymerase (Pol) delta in the conversion reaction.", "text_with_entity_marker": "In cell extracts, we found that complementary strand synthesis was inhibited by the cyclin-dependent kinase inhibitor p21(WAF1/CIP1) and rescued by the addition of [E1]proliferating cell nuclear antigen[/E1], arguing for the involvement of [E2]DNA polymerase[/E2] (Pol) delta in the conversion reaction.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "proliferating cell nuclear antigen", "entity_1_idx": [[164, 198]], "entity_1_idx_in_text_with_entity_marker": [168, 202], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "DNA polymerase", "entity_2_idx": [[231, 245], [252, 257]], "entity_2_idx_in_text_with_entity_marker": [244, 258], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d322.s0_BioInfer.d322.s0.p14", "text": "In cell extracts, we found that complementary strand synthesis was inhibited by the cyclin-dependent kinase inhibitor p21(WAF1/CIP1) and rescued by the addition of proliferating cell nuclear antigen, arguing for the involvement of DNA polymerase (Pol) delta in the conversion reaction.", "text_with_entity_marker": "In cell extracts, we found that complementary strand synthesis was inhibited by the cyclin-dependent kinase inhibitor p21(WAF1/CIP1) and rescued by the addition of [E1]proliferating cell nuclear antigen[/E1], arguing for the involvement of DNA polymerase ([E2]Pol[/E2]) delta in the conversion reaction.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "proliferating cell nuclear antigen", "entity_1_idx": [[164, 198]], "entity_1_idx_in_text_with_entity_marker": [168, 202], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "Pol", "entity_2_idx": [[247, 250]], "entity_2_idx_in_text_with_entity_marker": [260, 263], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d322.s0_BioInfer.d322.s0.p15", "text": "In cell extracts, we found that complementary strand synthesis was inhibited by the cyclin-dependent kinase inhibitor p21(WAF1/CIP1) and rescued by the addition of proliferating cell nuclear antigen, arguing for the involvement of DNA polymerase (Pol) delta in the conversion reaction.", "text_with_entity_marker": "In cell extracts, we found that complementary strand synthesis was inhibited by the cyclin-dependent kinase inhibitor [E1]p21[/E1](WAF1/[E2]CIP1[/E2]) and rescued by the addition of proliferating cell nuclear antigen, arguing for the involvement of DNA polymerase (Pol) delta in the conversion reaction.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p21", "entity_1_idx": [[118, 121]], "entity_1_idx_in_text_with_entity_marker": [122, 125], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CIP1", "entity_2_idx": [[127, 131]], "entity_2_idx_in_text_with_entity_marker": [140, 144], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d322.s0_BioInfer.d322.s0.p16", "text": "In cell extracts, we found that complementary strand synthesis was inhibited by the cyclin-dependent kinase inhibitor p21(WAF1/CIP1) and rescued by the addition of proliferating cell nuclear antigen, arguing for the involvement of DNA polymerase (Pol) delta in the conversion reaction.", "text_with_entity_marker": "In cell extracts, we found that complementary strand synthesis was inhibited by the cyclin-dependent kinase inhibitor p21(WAF1/[E1]CIP1[/E1]) and rescued by the addition of proliferating cell nuclear antigen, arguing for the involvement of [E2]DNA polymerase[/E2] (Pol) delta in the conversion reaction.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CIP1", "entity_1_idx": [[127, 131]], "entity_1_idx_in_text_with_entity_marker": [131, 135], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "DNA polymerase", "entity_2_idx": [[231, 245], [252, 257]], "entity_2_idx_in_text_with_entity_marker": [244, 258], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d322.s0_BioInfer.d322.s0.p17", "text": "In cell extracts, we found that complementary strand synthesis was inhibited by the cyclin-dependent kinase inhibitor p21(WAF1/CIP1) and rescued by the addition of proliferating cell nuclear antigen, arguing for the involvement of DNA polymerase (Pol) delta in the conversion reaction.", "text_with_entity_marker": "In cell extracts, we found that complementary strand synthesis was inhibited by the cyclin-dependent kinase inhibitor p21(WAF1/[E1]CIP1[/E1]) and rescued by the addition of proliferating cell nuclear antigen, arguing for the involvement of DNA polymerase ([E2]Pol[/E2]) delta in the conversion reaction.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CIP1", "entity_1_idx": [[127, 131]], "entity_1_idx_in_text_with_entity_marker": [131, 135], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Pol", "entity_2_idx": [[247, 250]], "entity_2_idx_in_text_with_entity_marker": [260, 263], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d322.s0_BioInfer.d322.s0.p18", "text": "In cell extracts, we found that complementary strand synthesis was inhibited by the cyclin-dependent kinase inhibitor p21(WAF1/CIP1) and rescued by the addition of proliferating cell nuclear antigen, arguing for the involvement of DNA polymerase (Pol) delta in the conversion reaction.", "text_with_entity_marker": "In cell extracts, we found that complementary strand synthesis was inhibited by the cyclin-dependent kinase inhibitor [E1]p21[/E1](WAF1/CIP1) and rescued by the addition of proliferating cell nuclear antigen, arguing for the involvement of [E2]DNA polymerase[/E2] (Pol) delta in the conversion reaction.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p21", "entity_1_idx": [[118, 121]], "entity_1_idx_in_text_with_entity_marker": [122, 125], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "DNA polymerase", "entity_2_idx": [[231, 245], [252, 257]], "entity_2_idx_in_text_with_entity_marker": [244, 258], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d322.s0_BioInfer.d322.s0.p19", "text": "In cell extracts, we found that complementary strand synthesis was inhibited by the cyclin-dependent kinase inhibitor p21(WAF1/CIP1) and rescued by the addition of proliferating cell nuclear antigen, arguing for the involvement of DNA polymerase (Pol) delta in the conversion reaction.", "text_with_entity_marker": "In cell extracts, we found that complementary strand synthesis was inhibited by the cyclin-dependent kinase inhibitor [E1]p21[/E1](WAF1/CIP1) and rescued by the addition of proliferating cell nuclear antigen, arguing for the involvement of DNA polymerase ([E2]Pol[/E2]) delta in the conversion reaction.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p21", "entity_1_idx": [[118, 121]], "entity_1_idx_in_text_with_entity_marker": [122, 125], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Pol", "entity_2_idx": [[247, 250]], "entity_2_idx_in_text_with_entity_marker": [260, 263], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d322.s0_BioInfer.d322.s0.p20", "text": "In cell extracts, we found that complementary strand synthesis was inhibited by the cyclin-dependent kinase inhibitor p21(WAF1/CIP1) and rescued by the addition of proliferating cell nuclear antigen, arguing for the involvement of DNA polymerase (Pol) delta in the conversion reaction.", "text_with_entity_marker": "In cell extracts, we found that complementary strand synthesis was inhibited by the cyclin-dependent kinase inhibitor p21(WAF1/CIP1) and rescued by the addition of proliferating cell nuclear antigen, arguing for the involvement of [E1]DNA polymerase[/E1] ([E2]Pol[/E2]) delta in the conversion reaction.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "DNA polymerase", "entity_1_idx": [[231, 245], [252, 257]], "entity_1_idx_in_text_with_entity_marker": [235, 249], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "Pol", "entity_2_idx": [[247, 250]], "entity_2_idx_in_text_with_entity_marker": [260, 263], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p30", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase ([E1]TS[/E1]), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone [E2]H3[/E2], and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TS", "entity_1_idx": [[81, 83]], "entity_1_idx_in_text_with_entity_marker": [85, 87], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H3", "entity_2_idx": [[231, 233]], "entity_2_idx_in_text_with_entity_marker": [244, 246], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p31", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen ([E1]PCNA[/E1]), histone H1, [E2]histone[/E2] H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PCNA", "entity_1_idx": [[186, 190]], "entity_1_idx_in_text_with_entity_marker": [190, 194], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[205, 212]], "entity_2_idx_in_text_with_entity_marker": [218, 225], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p32", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen ([E1]PCNA[/E1]), [E2]histone[/E2] H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PCNA", "entity_1_idx": [[186, 190]], "entity_1_idx_in_text_with_entity_marker": [190, 194], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[193, 200]], "entity_2_idx_in_text_with_entity_marker": [206, 213], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p33", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen ([E1]PCNA[/E1]), histone H1, histone H2A + 2B, histone H3, and [E2]histone[/E2] H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PCNA", "entity_1_idx": [[186, 190]], "entity_1_idx_in_text_with_entity_marker": [190, 194], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[239, 246]], "entity_2_idx_in_text_with_entity_marker": [252, 259], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p34", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen ([E1]PCNA[/E1]), histone H1, histone H2A + 2B, [E2]histone[/E2] H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PCNA", "entity_1_idx": [[186, 190]], "entity_1_idx_in_text_with_entity_marker": [190, 194], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[223, 230]], "entity_2_idx_in_text_with_entity_marker": [236, 243], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p35", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen ([E1]PCNA[/E1]), histone H1, histone [E2]H[/E2]2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PCNA", "entity_1_idx": [[186, 190]], "entity_1_idx_in_text_with_entity_marker": [190, 194], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H", "entity_2_idx": [[213, 214], [219, 221]], "entity_2_idx_in_text_with_entity_marker": [226, 227], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p36", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen ([E1]PCNA[/E1]), histone H1, histone H2A + 2B, histone H3, and histone [E2]H4[/E2], was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PCNA", "entity_1_idx": [[186, 190]], "entity_1_idx_in_text_with_entity_marker": [190, 194], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H4", "entity_2_idx": [[247, 249]], "entity_2_idx_in_text_with_entity_marker": [260, 262], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p37", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase ([E1]PNR[/E1]), proliferating cell nuclear antigen ([E2]PCNA[/E2]), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PNR", "entity_1_idx": [[144, 147]], "entity_1_idx_in_text_with_entity_marker": [148, 151], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "PCNA", "entity_2_idx": [[186, 190]], "entity_2_idx_in_text_with_entity_marker": [199, 203], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p38", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including [E1]thymidylate synthase[/E1] (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen ([E2]PCNA[/E2]), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "thymidylate synthase", "entity_1_idx": [[59, 79]], "entity_1_idx_in_text_with_entity_marker": [63, 83], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "PCNA", "entity_2_idx": [[186, 190]], "entity_2_idx_in_text_with_entity_marker": [199, 203], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p39", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), [E1]dihydrofolate reductase[/E1] (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen ([E2]PCNA[/E2]), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "dihydrofolate reductase", "entity_1_idx": [[86, 109]], "entity_1_idx_in_text_with_entity_marker": [90, 113], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "PCNA", "entity_2_idx": [[186, 190]], "entity_2_idx_in_text_with_entity_marker": [199, 203], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d687.s0_BioInfer.d687.s0.p0", "text": "The results indicate increased fractional synthesis and degradation of myosin heavy chain and light chains, but not actin, in the left compared to the right ventricular free wall.", "text_with_entity_marker": "The results indicate increased fractional synthesis and degradation of [E1-E2]myosin[/E1] heavy chain[/E2] and light chains, but not actin, in the left compared to the right ventricular free wall.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin", "entity_1_idx": [[71, 77], [94, 106]], "entity_1_idx_in_text_with_entity_marker": [78, 84], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin[/E1] heavy chain", "entity_2_idx": [[71, 89]], "entity_2_idx_in_text_with_entity_marker": [78, 101], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d687.s0_BioInfer.d687.s0.p1", "text": "The results indicate increased fractional synthesis and degradation of myosin heavy chain and light chains, but not actin, in the left compared to the right ventricular free wall.", "text_with_entity_marker": "The results indicate increased fractional synthesis and degradation of [E1]myosin[/E1] heavy chain and light chains, but not [E2]actin[/E2], in the left compared to the right ventricular free wall.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin", "entity_1_idx": [[71, 77], [94, 106]], "entity_1_idx_in_text_with_entity_marker": [75, 81], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[116, 121]], "entity_2_idx_in_text_with_entity_marker": [129, 134], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d687.s0_BioInfer.d687.s0.p2", "text": "The results indicate increased fractional synthesis and degradation of myosin heavy chain and light chains, but not actin, in the left compared to the right ventricular free wall.", "text_with_entity_marker": "The results indicate increased fractional synthesis and degradation of [E1]myosin heavy chain[/E1] and light chains, but not [E2]actin[/E2], in the left compared to the right ventricular free wall.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin heavy chain", "entity_1_idx": [[71, 89]], "entity_1_idx_in_text_with_entity_marker": [75, 93], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[116, 121]], "entity_2_idx_in_text_with_entity_marker": [129, 134], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d687.s1_BioInfer.d687.s1.p0", "text": "To test for regional differences in the rates of synthesis and degradation of contractile proteins during normal physiological growth of the heart in vivo, fractional rates of protein accumulation and synthesis were assessed for total protein, myosin heavy chain, myosin light chain, phosphorylatable myosin light chain, and actin in the right and left ventricular free walls of growing, New Zealand White rabbits.", "text_with_entity_marker": "To test for regional differences in the rates of synthesis and degradation of contractile proteins during normal physiological growth of the heart in vivo, fractional rates of protein accumulation and synthesis were assessed for total protein, myosin heavy chain, [E1]myosin light chain[/E1], phosphorylatable myosin light chain, and [E2]actin[/E2] in the right and left ventricular free walls of growing, New Zealand White rabbits.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin light chain", "entity_1_idx": [[264, 282]], "entity_1_idx_in_text_with_entity_marker": [268, 286], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[325, 330]], "entity_2_idx_in_text_with_entity_marker": [338, 343], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d687.s1_BioInfer.d687.s1.p1", "text": "To test for regional differences in the rates of synthesis and degradation of contractile proteins during normal physiological growth of the heart in vivo, fractional rates of protein accumulation and synthesis were assessed for total protein, myosin heavy chain, myosin light chain, phosphorylatable myosin light chain, and actin in the right and left ventricular free walls of growing, New Zealand White rabbits.", "text_with_entity_marker": "To test for regional differences in the rates of synthesis and degradation of contractile proteins during normal physiological growth of the heart in vivo, fractional rates of protein accumulation and synthesis were assessed for total protein, [E1]myosin heavy chain[/E1], [E2]myosin light chain[/E2], phosphorylatable myosin light chain, and actin in the right and left ventricular free walls of growing, New Zealand White rabbits.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin heavy chain", "entity_1_idx": [[244, 262]], "entity_1_idx_in_text_with_entity_marker": [248, 266], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin light chain", "entity_2_idx": [[264, 282]], "entity_2_idx_in_text_with_entity_marker": [277, 295], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d687.s1_BioInfer.d687.s1.p2", "text": "To test for regional differences in the rates of synthesis and degradation of contractile proteins during normal physiological growth of the heart in vivo, fractional rates of protein accumulation and synthesis were assessed for total protein, myosin heavy chain, myosin light chain, phosphorylatable myosin light chain, and actin in the right and left ventricular free walls of growing, New Zealand White rabbits.", "text_with_entity_marker": "To test for regional differences in the rates of synthesis and degradation of contractile proteins during normal physiological growth of the heart in vivo, fractional rates of protein accumulation and synthesis were assessed for total protein, myosin heavy chain, [E1]myosin light chain[/E1], [E2]phosphorylatable myosin light chain[/E2], and actin in the right and left ventricular free walls of growing, New Zealand White rabbits.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin light chain", "entity_1_idx": [[264, 282]], "entity_1_idx_in_text_with_entity_marker": [268, 286], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "phosphorylatable myosin light chain", "entity_2_idx": [[284, 319]], "entity_2_idx_in_text_with_entity_marker": [297, 332], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d687.s1_BioInfer.d687.s1.p3", "text": "To test for regional differences in the rates of synthesis and degradation of contractile proteins during normal physiological growth of the heart in vivo, fractional rates of protein accumulation and synthesis were assessed for total protein, myosin heavy chain, myosin light chain, phosphorylatable myosin light chain, and actin in the right and left ventricular free walls of growing, New Zealand White rabbits.", "text_with_entity_marker": "To test for regional differences in the rates of synthesis and degradation of contractile proteins during normal physiological growth of the heart in vivo, fractional rates of protein accumulation and synthesis were assessed for total protein, [E1]myosin heavy chain[/E1], myosin light chain, phosphorylatable myosin light chain, and [E2]actin[/E2] in the right and left ventricular free walls of growing, New Zealand White rabbits.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin heavy chain", "entity_1_idx": [[244, 262]], "entity_1_idx_in_text_with_entity_marker": [248, 266], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[325, 330]], "entity_2_idx_in_text_with_entity_marker": [338, 343], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d687.s1_BioInfer.d687.s1.p4", "text": "To test for regional differences in the rates of synthesis and degradation of contractile proteins during normal physiological growth of the heart in vivo, fractional rates of protein accumulation and synthesis were assessed for total protein, myosin heavy chain, myosin light chain, phosphorylatable myosin light chain, and actin in the right and left ventricular free walls of growing, New Zealand White rabbits.", "text_with_entity_marker": "To test for regional differences in the rates of synthesis and degradation of contractile proteins during normal physiological growth of the heart in vivo, fractional rates of protein accumulation and synthesis were assessed for total protein, myosin heavy chain, myosin light chain, [E1]phosphorylatable myosin light chain[/E1], and [E2]actin[/E2] in the right and left ventricular free walls of growing, New Zealand White rabbits.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "phosphorylatable myosin light chain", "entity_1_idx": [[284, 319]], "entity_1_idx_in_text_with_entity_marker": [288, 323], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[325, 330]], "entity_2_idx_in_text_with_entity_marker": [338, 343], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d687.s1_BioInfer.d687.s1.p5", "text": "To test for regional differences in the rates of synthesis and degradation of contractile proteins during normal physiological growth of the heart in vivo, fractional rates of protein accumulation and synthesis were assessed for total protein, myosin heavy chain, myosin light chain, phosphorylatable myosin light chain, and actin in the right and left ventricular free walls of growing, New Zealand White rabbits.", "text_with_entity_marker": "To test for regional differences in the rates of synthesis and degradation of contractile proteins during normal physiological growth of the heart in vivo, fractional rates of protein accumulation and synthesis were assessed for total protein, [E1]myosin heavy chain[/E1], myosin light chain, [E2]phosphorylatable myosin light chain[/E2], and actin in the right and left ventricular free walls of growing, New Zealand White rabbits.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin heavy chain", "entity_1_idx": [[244, 262]], "entity_1_idx_in_text_with_entity_marker": [248, 266], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "phosphorylatable myosin light chain", "entity_2_idx": [[284, 319]], "entity_2_idx_in_text_with_entity_marker": [297, 332], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d436.s0_BioInfer.d436.s0.p0", "text": "Moreover, ectopic expression of cyclin D1 and Cdk4 can stimulate the Brca1 promoter in an E2F-dependent manner, and this is inhibited by coexpression of the p16(INK4a) cyclin-dependent kinase inhibitor.", "text_with_entity_marker": "Moreover, ectopic expression of cyclin D1 and Cdk4 can stimulate the Brca1 promoter in an [E1]E2F[/E1]-dependent manner, and this is inhibited by coexpression of the p16(INK4a) [E2]cyclin-dependent kinase inhibitor[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E2F", "entity_1_idx": [[90, 93]], "entity_1_idx_in_text_with_entity_marker": [94, 97], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin-dependent kinase inhibitor", "entity_2_idx": [[168, 201]], "entity_2_idx_in_text_with_entity_marker": [181, 214], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d436.s0_BioInfer.d436.s0.p1", "text": "Moreover, ectopic expression of cyclin D1 and Cdk4 can stimulate the Brca1 promoter in an E2F-dependent manner, and this is inhibited by coexpression of the p16(INK4a) cyclin-dependent kinase inhibitor.", "text_with_entity_marker": "Moreover, ectopic expression of cyclin D1 and Cdk4 can stimulate the Brca1 promoter in an [E1]E2F[/E1]-dependent manner, and this is inhibited by coexpression of the [E2]p16[/E2](INK4a) cyclin-dependent kinase inhibitor.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E2F", "entity_1_idx": [[90, 93]], "entity_1_idx_in_text_with_entity_marker": [94, 97], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p16", "entity_2_idx": [[157, 160]], "entity_2_idx_in_text_with_entity_marker": [170, 173], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d436.s0_BioInfer.d436.s0.p2", "text": "Moreover, ectopic expression of cyclin D1 and Cdk4 can stimulate the Brca1 promoter in an E2F-dependent manner, and this is inhibited by coexpression of the p16(INK4a) cyclin-dependent kinase inhibitor.", "text_with_entity_marker": "Moreover, ectopic expression of cyclin D1 and [E1]Cdk4[/E1] can stimulate the Brca1 promoter in an [E2]E2F[/E2]-dependent manner, and this is inhibited by coexpression of the p16(INK4a) cyclin-dependent kinase inhibitor.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Cdk4", "entity_1_idx": [[46, 50]], "entity_1_idx_in_text_with_entity_marker": [50, 54], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "E2F", "entity_2_idx": [[90, 93]], "entity_2_idx_in_text_with_entity_marker": [103, 106], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d436.s0_BioInfer.d436.s0.p3", "text": "Moreover, ectopic expression of cyclin D1 and Cdk4 can stimulate the Brca1 promoter in an E2F-dependent manner, and this is inhibited by coexpression of the p16(INK4a) cyclin-dependent kinase inhibitor.", "text_with_entity_marker": "Moreover, ectopic expression of cyclin D1 and Cdk4 can stimulate the [E1]Brca1[/E1] promoter in an [E2]E2F[/E2]-dependent manner, and this is inhibited by coexpression of the p16(INK4a) cyclin-dependent kinase inhibitor.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Brca1", "entity_1_idx": [[69, 74]], "entity_1_idx_in_text_with_entity_marker": [73, 78], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "E2F", "entity_2_idx": [[90, 93]], "entity_2_idx_in_text_with_entity_marker": [103, 106], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d436.s0_BioInfer.d436.s0.p4", "text": "Moreover, ectopic expression of cyclin D1 and Cdk4 can stimulate the Brca1 promoter in an E2F-dependent manner, and this is inhibited by coexpression of the p16(INK4a) cyclin-dependent kinase inhibitor.", "text_with_entity_marker": "Moreover, ectopic expression of cyclin D1 and Cdk4 can stimulate the Brca1 promoter in an [E1]E2F[/E1]-dependent manner, and this is inhibited by coexpression of the p16([E2]INK4a[/E2]) cyclin-dependent kinase inhibitor.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E2F", "entity_1_idx": [[90, 93]], "entity_1_idx_in_text_with_entity_marker": [94, 97], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "INK4a", "entity_2_idx": [[161, 166]], "entity_2_idx_in_text_with_entity_marker": [174, 179], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d436.s0_BioInfer.d436.s0.p5", "text": "Moreover, ectopic expression of cyclin D1 and Cdk4 can stimulate the Brca1 promoter in an E2F-dependent manner, and this is inhibited by coexpression of the p16(INK4a) cyclin-dependent kinase inhibitor.", "text_with_entity_marker": "Moreover, ectopic expression of [E1]cyclin D1[/E1] and Cdk4 can stimulate the Brca1 promoter in an [E2]E2F[/E2]-dependent manner, and this is inhibited by coexpression of the p16(INK4a) cyclin-dependent kinase inhibitor.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin D1", "entity_1_idx": [[32, 41]], "entity_1_idx_in_text_with_entity_marker": [36, 45], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "E2F", "entity_2_idx": [[90, 93]], "entity_2_idx_in_text_with_entity_marker": [103, 106], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d436.s0_BioInfer.d436.s0.p6", "text": "Moreover, ectopic expression of cyclin D1 and Cdk4 can stimulate the Brca1 promoter in an E2F-dependent manner, and this is inhibited by coexpression of the p16(INK4a) cyclin-dependent kinase inhibitor.", "text_with_entity_marker": "Moreover, ectopic expression of cyclin D1 and Cdk4 can stimulate the Brca1 promoter in an E2F-dependent manner, and this is inhibited by coexpression of the [E1]p16[/E1](INK4a) [E2]cyclin-dependent kinase inhibitor[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "p16", "entity_1_idx": [[157, 160]], "entity_1_idx_in_text_with_entity_marker": [161, 164], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin-dependent kinase inhibitor", "entity_2_idx": [[168, 201]], "entity_2_idx_in_text_with_entity_marker": [181, 214], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d436.s0_BioInfer.d436.s0.p7", "text": "Moreover, ectopic expression of cyclin D1 and Cdk4 can stimulate the Brca1 promoter in an E2F-dependent manner, and this is inhibited by coexpression of the p16(INK4a) cyclin-dependent kinase inhibitor.", "text_with_entity_marker": "Moreover, ectopic expression of cyclin D1 and [E1]Cdk4[/E1] can stimulate the Brca1 promoter in an E2F-dependent manner, and this is inhibited by coexpression of the p16(INK4a) [E2]cyclin-dependent kinase inhibitor[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Cdk4", "entity_1_idx": [[46, 50]], "entity_1_idx_in_text_with_entity_marker": [50, 54], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin-dependent kinase inhibitor", "entity_2_idx": [[168, 201]], "entity_2_idx_in_text_with_entity_marker": [181, 214], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d436.s0_BioInfer.d436.s0.p8", "text": "Moreover, ectopic expression of cyclin D1 and Cdk4 can stimulate the Brca1 promoter in an E2F-dependent manner, and this is inhibited by coexpression of the p16(INK4a) cyclin-dependent kinase inhibitor.", "text_with_entity_marker": "Moreover, ectopic expression of cyclin D1 and Cdk4 can stimulate the [E1]Brca1[/E1] promoter in an E2F-dependent manner, and this is inhibited by coexpression of the p16(INK4a) [E2]cyclin-dependent kinase inhibitor[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Brca1", "entity_1_idx": [[69, 74]], "entity_1_idx_in_text_with_entity_marker": [73, 78], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "cyclin-dependent kinase inhibitor", "entity_2_idx": [[168, 201]], "entity_2_idx_in_text_with_entity_marker": [181, 214], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d436.s0_BioInfer.d436.s0.p9", "text": "Moreover, ectopic expression of cyclin D1 and Cdk4 can stimulate the Brca1 promoter in an E2F-dependent manner, and this is inhibited by coexpression of the p16(INK4a) cyclin-dependent kinase inhibitor.", "text_with_entity_marker": "Moreover, ectopic expression of cyclin D1 and Cdk4 can stimulate the Brca1 promoter in an E2F-dependent manner, and this is inhibited by coexpression of the p16([E1]INK4a[/E1]) [E2]cyclin-dependent kinase inhibitor[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "INK4a", "entity_1_idx": [[161, 166]], "entity_1_idx_in_text_with_entity_marker": [165, 170], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin-dependent kinase inhibitor", "entity_2_idx": [[168, 201]], "entity_2_idx_in_text_with_entity_marker": [181, 214], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d436.s0_BioInfer.d436.s0.p10", "text": "Moreover, ectopic expression of cyclin D1 and Cdk4 can stimulate the Brca1 promoter in an E2F-dependent manner, and this is inhibited by coexpression of the p16(INK4a) cyclin-dependent kinase inhibitor.", "text_with_entity_marker": "Moreover, ectopic expression of [E1]cyclin D1[/E1] and Cdk4 can stimulate the Brca1 promoter in an E2F-dependent manner, and this is inhibited by coexpression of the p16(INK4a) [E2]cyclin-dependent kinase inhibitor[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin D1", "entity_1_idx": [[32, 41]], "entity_1_idx_in_text_with_entity_marker": [36, 45], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin-dependent kinase inhibitor", "entity_2_idx": [[168, 201]], "entity_2_idx_in_text_with_entity_marker": [181, 214], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d436.s0_BioInfer.d436.s0.p11", "text": "Moreover, ectopic expression of cyclin D1 and Cdk4 can stimulate the Brca1 promoter in an E2F-dependent manner, and this is inhibited by coexpression of the p16(INK4a) cyclin-dependent kinase inhibitor.", "text_with_entity_marker": "Moreover, ectopic expression of cyclin D1 and [E1]Cdk4[/E1] can stimulate the Brca1 promoter in an E2F-dependent manner, and this is inhibited by coexpression of the [E2]p16[/E2](INK4a) cyclin-dependent kinase inhibitor.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Cdk4", "entity_1_idx": [[46, 50]], "entity_1_idx_in_text_with_entity_marker": [50, 54], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p16", "entity_2_idx": [[157, 160]], "entity_2_idx_in_text_with_entity_marker": [170, 173], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d436.s0_BioInfer.d436.s0.p12", "text": "Moreover, ectopic expression of cyclin D1 and Cdk4 can stimulate the Brca1 promoter in an E2F-dependent manner, and this is inhibited by coexpression of the p16(INK4a) cyclin-dependent kinase inhibitor.", "text_with_entity_marker": "Moreover, ectopic expression of cyclin D1 and Cdk4 can stimulate the [E1]Brca1[/E1] promoter in an E2F-dependent manner, and this is inhibited by coexpression of the [E2]p16[/E2](INK4a) cyclin-dependent kinase inhibitor.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Brca1", "entity_1_idx": [[69, 74]], "entity_1_idx_in_text_with_entity_marker": [73, 78], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "p16", "entity_2_idx": [[157, 160]], "entity_2_idx_in_text_with_entity_marker": [170, 173], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d436.s0_BioInfer.d436.s0.p13", "text": "Moreover, ectopic expression of cyclin D1 and Cdk4 can stimulate the Brca1 promoter in an E2F-dependent manner, and this is inhibited by coexpression of the p16(INK4a) cyclin-dependent kinase inhibitor.", "text_with_entity_marker": "Moreover, ectopic expression of cyclin D1 and Cdk4 can stimulate the Brca1 promoter in an E2F-dependent manner, and this is inhibited by coexpression of the [E1]p16[/E1]([E2]INK4a[/E2]) cyclin-dependent kinase inhibitor.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p16", "entity_1_idx": [[157, 160]], "entity_1_idx_in_text_with_entity_marker": [161, 164], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "INK4a", "entity_2_idx": [[161, 166]], "entity_2_idx_in_text_with_entity_marker": [174, 179], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d436.s0_BioInfer.d436.s0.p14", "text": "Moreover, ectopic expression of cyclin D1 and Cdk4 can stimulate the Brca1 promoter in an E2F-dependent manner, and this is inhibited by coexpression of the p16(INK4a) cyclin-dependent kinase inhibitor.", "text_with_entity_marker": "Moreover, ectopic expression of [E1]cyclin D1[/E1] and Cdk4 can stimulate the Brca1 promoter in an E2F-dependent manner, and this is inhibited by coexpression of the [E2]p16[/E2](INK4a) cyclin-dependent kinase inhibitor.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cyclin D1", "entity_1_idx": [[32, 41]], "entity_1_idx_in_text_with_entity_marker": [36, 45], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p16", "entity_2_idx": [[157, 160]], "entity_2_idx_in_text_with_entity_marker": [170, 173], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d436.s0_BioInfer.d436.s0.p15", "text": "Moreover, ectopic expression of cyclin D1 and Cdk4 can stimulate the Brca1 promoter in an E2F-dependent manner, and this is inhibited by coexpression of the p16(INK4a) cyclin-dependent kinase inhibitor.", "text_with_entity_marker": "Moreover, ectopic expression of cyclin D1 and [E1]Cdk4[/E1] can stimulate the [E2]Brca1[/E2] promoter in an E2F-dependent manner, and this is inhibited by coexpression of the p16(INK4a) cyclin-dependent kinase inhibitor.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Cdk4", "entity_1_idx": [[46, 50]], "entity_1_idx_in_text_with_entity_marker": [50, 54], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Brca1", "entity_2_idx": [[69, 74]], "entity_2_idx_in_text_with_entity_marker": [82, 87], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d436.s0_BioInfer.d436.s0.p16", "text": "Moreover, ectopic expression of cyclin D1 and Cdk4 can stimulate the Brca1 promoter in an E2F-dependent manner, and this is inhibited by coexpression of the p16(INK4a) cyclin-dependent kinase inhibitor.", "text_with_entity_marker": "Moreover, ectopic expression of cyclin D1 and [E1]Cdk4[/E1] can stimulate the Brca1 promoter in an E2F-dependent manner, and this is inhibited by coexpression of the p16([E2]INK4a[/E2]) cyclin-dependent kinase inhibitor.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Cdk4", "entity_1_idx": [[46, 50]], "entity_1_idx_in_text_with_entity_marker": [50, 54], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "INK4a", "entity_2_idx": [[161, 166]], "entity_2_idx_in_text_with_entity_marker": [174, 179], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d436.s0_BioInfer.d436.s0.p17", "text": "Moreover, ectopic expression of cyclin D1 and Cdk4 can stimulate the Brca1 promoter in an E2F-dependent manner, and this is inhibited by coexpression of the p16(INK4a) cyclin-dependent kinase inhibitor.", "text_with_entity_marker": "Moreover, ectopic expression of [E1]cyclin D1[/E1] and [E2]Cdk4[/E2] can stimulate the Brca1 promoter in an E2F-dependent manner, and this is inhibited by coexpression of the p16(INK4a) cyclin-dependent kinase inhibitor.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin D1", "entity_1_idx": [[32, 41]], "entity_1_idx_in_text_with_entity_marker": [36, 45], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Cdk4", "entity_2_idx": [[46, 50]], "entity_2_idx_in_text_with_entity_marker": [59, 63], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d436.s0_BioInfer.d436.s0.p18", "text": "Moreover, ectopic expression of cyclin D1 and Cdk4 can stimulate the Brca1 promoter in an E2F-dependent manner, and this is inhibited by coexpression of the p16(INK4a) cyclin-dependent kinase inhibitor.", "text_with_entity_marker": "Moreover, ectopic expression of cyclin D1 and Cdk4 can stimulate the [E1]Brca1[/E1] promoter in an E2F-dependent manner, and this is inhibited by coexpression of the p16([E2]INK4a[/E2]) cyclin-dependent kinase inhibitor.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Brca1", "entity_1_idx": [[69, 74]], "entity_1_idx_in_text_with_entity_marker": [73, 78], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "INK4a", "entity_2_idx": [[161, 166]], "entity_2_idx_in_text_with_entity_marker": [174, 179], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d436.s0_BioInfer.d436.s0.p19", "text": "Moreover, ectopic expression of cyclin D1 and Cdk4 can stimulate the Brca1 promoter in an E2F-dependent manner, and this is inhibited by coexpression of the p16(INK4a) cyclin-dependent kinase inhibitor.", "text_with_entity_marker": "Moreover, ectopic expression of [E1]cyclin D1[/E1] and Cdk4 can stimulate the [E2]Brca1[/E2] promoter in an E2F-dependent manner, and this is inhibited by coexpression of the p16(INK4a) cyclin-dependent kinase inhibitor.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cyclin D1", "entity_1_idx": [[32, 41]], "entity_1_idx_in_text_with_entity_marker": [36, 45], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Brca1", "entity_2_idx": [[69, 74]], "entity_2_idx_in_text_with_entity_marker": [82, 87], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d436.s0_BioInfer.d436.s0.p20", "text": "Moreover, ectopic expression of cyclin D1 and Cdk4 can stimulate the Brca1 promoter in an E2F-dependent manner, and this is inhibited by coexpression of the p16(INK4a) cyclin-dependent kinase inhibitor.", "text_with_entity_marker": "Moreover, ectopic expression of [E1]cyclin D1[/E1] and Cdk4 can stimulate the Brca1 promoter in an E2F-dependent manner, and this is inhibited by coexpression of the p16([E2]INK4a[/E2]) cyclin-dependent kinase inhibitor.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cyclin D1", "entity_1_idx": [[32, 41]], "entity_1_idx_in_text_with_entity_marker": [36, 45], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "INK4a", "entity_2_idx": [[161, 166]], "entity_2_idx_in_text_with_entity_marker": [174, 179], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d720.s0_BioInfer.d720.s0.p0", "text": "The sites on the myosin heavy chain that interact with actin and are responsible for force generation are ill-defined: crosslinking and experiments with isolated domains of the myosin head implicate regions in both the 50K and 20K (molecular weights in thousands) domains of the myosin head (subfragment 1, S1) in this process.", "text_with_entity_marker": "The sites on the myosin heavy chain that interact with actin and are responsible for force generation are ill-defined: crosslinking and experiments with isolated domains of the [E1]myosin[/E1] head implicate regions in both the 50K and 20K (molecular weights in thousands) domains of the [E2]myosin[/E2] head (subfragment 1, S1) in this process.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin", "entity_1_idx": [[177, 183]], "entity_1_idx_in_text_with_entity_marker": [181, 187], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin", "entity_2_idx": [[279, 285]], "entity_2_idx_in_text_with_entity_marker": [292, 298], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d720.s0_BioInfer.d720.s0.p1", "text": "The sites on the myosin heavy chain that interact with actin and are responsible for force generation are ill-defined: crosslinking and experiments with isolated domains of the myosin head implicate regions in both the 50K and 20K (molecular weights in thousands) domains of the myosin head (subfragment 1, S1) in this process.", "text_with_entity_marker": "The sites on the myosin heavy chain that interact with [E1]actin[/E1] and are responsible for force generation are ill-defined: crosslinking and experiments with isolated domains of the [E2]myosin[/E2] head implicate regions in both the 50K and 20K (molecular weights in thousands) domains of the myosin head (subfragment 1, S1) in this process.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[55, 60]], "entity_1_idx_in_text_with_entity_marker": [59, 64], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "myosin", "entity_2_idx": [[177, 183]], "entity_2_idx_in_text_with_entity_marker": [190, 196], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d720.s0_BioInfer.d720.s0.p2", "text": "The sites on the myosin heavy chain that interact with actin and are responsible for force generation are ill-defined: crosslinking and experiments with isolated domains of the myosin head implicate regions in both the 50K and 20K (molecular weights in thousands) domains of the myosin head (subfragment 1, S1) in this process.", "text_with_entity_marker": "The sites on the [E1]myosin heavy chain[/E1] that interact with actin and are responsible for force generation are ill-defined: crosslinking and experiments with isolated domains of the [E2]myosin[/E2] head implicate regions in both the 50K and 20K (molecular weights in thousands) domains of the myosin head (subfragment 1, S1) in this process.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin heavy chain", "entity_1_idx": [[17, 35]], "entity_1_idx_in_text_with_entity_marker": [21, 39], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "myosin", "entity_2_idx": [[177, 183]], "entity_2_idx_in_text_with_entity_marker": [190, 196], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d720.s0_BioInfer.d720.s0.p3", "text": "The sites on the myosin heavy chain that interact with actin and are responsible for force generation are ill-defined: crosslinking and experiments with isolated domains of the myosin head implicate regions in both the 50K and 20K (molecular weights in thousands) domains of the myosin head (subfragment 1, S1) in this process.", "text_with_entity_marker": "The sites on the myosin heavy chain that interact with [E1]actin[/E1] and are responsible for force generation are ill-defined: crosslinking and experiments with isolated domains of the myosin head implicate regions in both the 50K and 20K (molecular weights in thousands) domains of the [E2]myosin[/E2] head (subfragment 1, S1) in this process.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[55, 60]], "entity_1_idx_in_text_with_entity_marker": [59, 64], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "myosin", "entity_2_idx": [[279, 285]], "entity_2_idx_in_text_with_entity_marker": [292, 298], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d720.s0_BioInfer.d720.s0.p4", "text": "The sites on the myosin heavy chain that interact with actin and are responsible for force generation are ill-defined: crosslinking and experiments with isolated domains of the myosin head implicate regions in both the 50K and 20K (molecular weights in thousands) domains of the myosin head (subfragment 1, S1) in this process.", "text_with_entity_marker": "The sites on the [E1]myosin heavy chain[/E1] that interact with actin and are responsible for force generation are ill-defined: crosslinking and experiments with isolated domains of the myosin head implicate regions in both the 50K and 20K (molecular weights in thousands) domains of the [E2]myosin[/E2] head (subfragment 1, S1) in this process.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin heavy chain", "entity_1_idx": [[17, 35]], "entity_1_idx_in_text_with_entity_marker": [21, 39], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "myosin", "entity_2_idx": [[279, 285]], "entity_2_idx_in_text_with_entity_marker": [292, 298], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d720.s0_BioInfer.d720.s0.p5", "text": "The sites on the myosin heavy chain that interact with actin and are responsible for force generation are ill-defined: crosslinking and experiments with isolated domains of the myosin head implicate regions in both the 50K and 20K (molecular weights in thousands) domains of the myosin head (subfragment 1, S1) in this process.", "text_with_entity_marker": "The sites on the [E1]myosin heavy chain[/E1] that interact with [E2]actin[/E2] and are responsible for force generation are ill-defined: crosslinking and experiments with isolated domains of the myosin head implicate regions in both the 50K and 20K (molecular weights in thousands) domains of the myosin head (subfragment 1, S1) in this process.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "myosin heavy chain", "entity_1_idx": [[17, 35]], "entity_1_idx_in_text_with_entity_marker": [21, 39], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[55, 60]], "entity_2_idx_in_text_with_entity_marker": [68, 73], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d221.s0_BioInfer.d221.s0.p0", "text": "Further deletion analysis demonstrated that this fragment contains three regions, which are important for nucleation and share functional and/or limited sequence similarity with host WASP family proteins: an acidic stretch, an actin monomer-binding region, and a cofilin homology sequence.", "text_with_entity_marker": "Further deletion analysis demonstrated that this fragment contains three regions, which are important for nucleation and share functional and/or limited sequence similarity with host WASP family proteins: an acidic stretch, an [E1]actin[/E1] monomer-binding region, and a [E2]cofilin[/E2] homology sequence.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[227, 232]], "entity_1_idx_in_text_with_entity_marker": [231, 236], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[263, 270]], "entity_2_idx_in_text_with_entity_marker": [276, 283], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d221.s0_BioInfer.d221.s0.p1", "text": "Further deletion analysis demonstrated that this fragment contains three regions, which are important for nucleation and share functional and/or limited sequence similarity with host WASP family proteins: an acidic stretch, an actin monomer-binding region, and a cofilin homology sequence.", "text_with_entity_marker": "Further deletion analysis demonstrated that this fragment contains three regions, which are important for nucleation and share functional and/or limited sequence similarity with host [E1]WASP[/E1] family proteins: an acidic stretch, an actin monomer-binding region, and a [E2]cofilin[/E2] homology sequence.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "WASP", "entity_1_idx": [[183, 187]], "entity_1_idx_in_text_with_entity_marker": [187, 191], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[263, 270]], "entity_2_idx_in_text_with_entity_marker": [276, 283], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d221.s0_BioInfer.d221.s0.p2", "text": "Further deletion analysis demonstrated that this fragment contains three regions, which are important for nucleation and share functional and/or limited sequence similarity with host WASP family proteins: an acidic stretch, an actin monomer-binding region, and a cofilin homology sequence.", "text_with_entity_marker": "Further deletion analysis demonstrated that this fragment contains three regions, which are important for nucleation and share functional and/or limited sequence similarity with host [E1]WASP[/E1] family proteins: an acidic stretch, an [E2]actin[/E2] monomer-binding region, and a cofilin homology sequence.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "WASP", "entity_1_idx": [[183, 187]], "entity_1_idx_in_text_with_entity_marker": [187, 191], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[227, 232]], "entity_2_idx_in_text_with_entity_marker": [240, 245], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d221.s1_BioInfer.d221.s1.p0", "text": "The cofilin homology sequence is critical for stimulating actin nucleation with the Arp2/3 complex in vitro, and is essential for actin polymerization and motility in cells.", "text_with_entity_marker": "The cofilin homology sequence is critical for stimulating actin nucleation with the [E1]Arp2[/E1]/3 complex in vitro, and is essential for [E2]actin[/E2] polymerization and motility in cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Arp2", "entity_1_idx": [[84, 88]], "entity_1_idx_in_text_with_entity_marker": [88, 92], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[130, 135]], "entity_2_idx_in_text_with_entity_marker": [143, 148], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d221.s1_BioInfer.d221.s1.p1", "text": "The cofilin homology sequence is critical for stimulating actin nucleation with the Arp2/3 complex in vitro, and is essential for actin polymerization and motility in cells.", "text_with_entity_marker": "The cofilin homology sequence is critical for stimulating actin nucleation with the [E1-E2]Arp[/E1]2[/E2]/3 complex in vitro, and is essential for actin polymerization and motility in cells.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Arp", "entity_1_idx": [[84, 87], [89, 90]], "entity_1_idx_in_text_with_entity_marker": [91, 94], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Arp[/E1]2", "entity_2_idx": [[84, 88]], "entity_2_idx_in_text_with_entity_marker": [91, 100], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d221.s1_BioInfer.d221.s1.p2", "text": "The cofilin homology sequence is critical for stimulating actin nucleation with the Arp2/3 complex in vitro, and is essential for actin polymerization and motility in cells.", "text_with_entity_marker": "The [E1]cofilin[/E1] homology sequence is critical for stimulating actin nucleation with the [E2]Arp2[/E2]/3 complex in vitro, and is essential for actin polymerization and motility in cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[4, 11]], "entity_1_idx_in_text_with_entity_marker": [8, 15], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Arp2", "entity_2_idx": [[84, 88]], "entity_2_idx_in_text_with_entity_marker": [97, 101], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d221.s1_BioInfer.d221.s1.p3", "text": "The cofilin homology sequence is critical for stimulating actin nucleation with the Arp2/3 complex in vitro, and is essential for actin polymerization and motility in cells.", "text_with_entity_marker": "The cofilin homology sequence is critical for stimulating [E1]actin[/E1] nucleation with the [E2]Arp2[/E2]/3 complex in vitro, and is essential for actin polymerization and motility in cells.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[58, 63]], "entity_1_idx_in_text_with_entity_marker": [62, 67], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Arp2", "entity_2_idx": [[84, 88]], "entity_2_idx_in_text_with_entity_marker": [97, 101], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d221.s1_BioInfer.d221.s1.p4", "text": "The cofilin homology sequence is critical for stimulating actin nucleation with the Arp2/3 complex in vitro, and is essential for actin polymerization and motility in cells.", "text_with_entity_marker": "The cofilin homology sequence is critical for stimulating actin nucleation with the [E1]Arp[/E1]2/3 complex in vitro, and is essential for [E2]actin[/E2] polymerization and motility in cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Arp", "entity_1_idx": [[84, 87], [89, 90]], "entity_1_idx_in_text_with_entity_marker": [88, 91], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[130, 135]], "entity_2_idx_in_text_with_entity_marker": [143, 148], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d221.s1_BioInfer.d221.s1.p5", "text": "The cofilin homology sequence is critical for stimulating actin nucleation with the Arp2/3 complex in vitro, and is essential for actin polymerization and motility in cells.", "text_with_entity_marker": "The [E1]cofilin[/E1] homology sequence is critical for stimulating actin nucleation with the Arp2/3 complex in vitro, and is essential for [E2]actin[/E2] polymerization and motility in cells.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cofilin", "entity_1_idx": [[4, 11]], "entity_1_idx_in_text_with_entity_marker": [8, 15], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[130, 135]], "entity_2_idx_in_text_with_entity_marker": [143, 148], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d221.s1_BioInfer.d221.s1.p6", "text": "The cofilin homology sequence is critical for stimulating actin nucleation with the Arp2/3 complex in vitro, and is essential for actin polymerization and motility in cells.", "text_with_entity_marker": "The cofilin homology sequence is critical for stimulating [E1]actin[/E1] nucleation with the Arp2/3 complex in vitro, and is essential for [E2]actin[/E2] polymerization and motility in cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[58, 63]], "entity_1_idx_in_text_with_entity_marker": [62, 67], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[130, 135]], "entity_2_idx_in_text_with_entity_marker": [143, 148], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d221.s1_BioInfer.d221.s1.p7", "text": "The cofilin homology sequence is critical for stimulating actin nucleation with the Arp2/3 complex in vitro, and is essential for actin polymerization and motility in cells.", "text_with_entity_marker": "The [E1]cofilin[/E1] homology sequence is critical for stimulating actin nucleation with the [E2]Arp[/E2]2/3 complex in vitro, and is essential for actin polymerization and motility in cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[4, 11]], "entity_1_idx_in_text_with_entity_marker": [8, 15], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Arp", "entity_2_idx": [[84, 87], [89, 90]], "entity_2_idx_in_text_with_entity_marker": [97, 100], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d221.s1_BioInfer.d221.s1.p8", "text": "The cofilin homology sequence is critical for stimulating actin nucleation with the Arp2/3 complex in vitro, and is essential for actin polymerization and motility in cells.", "text_with_entity_marker": "The cofilin homology sequence is critical for stimulating [E1]actin[/E1] nucleation with the [E2]Arp[/E2]2/3 complex in vitro, and is essential for actin polymerization and motility in cells.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[58, 63]], "entity_1_idx_in_text_with_entity_marker": [62, 67], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Arp", "entity_2_idx": [[84, 87], [89, 90]], "entity_2_idx_in_text_with_entity_marker": [97, 100], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d221.s1_BioInfer.d221.s1.p9", "text": "The cofilin homology sequence is critical for stimulating actin nucleation with the Arp2/3 complex in vitro, and is essential for actin polymerization and motility in cells.", "text_with_entity_marker": "The [E1]cofilin[/E1] homology sequence is critical for stimulating [E2]actin[/E2] nucleation with the Arp2/3 complex in vitro, and is essential for actin polymerization and motility in cells.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cofilin", "entity_1_idx": [[4, 11]], "entity_1_idx_in_text_with_entity_marker": [8, 15], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[58, 63]], "entity_2_idx_in_text_with_entity_marker": [71, 76], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d792.s0_BioInfer.d792.s0.p0", "text": "VASP, in turn, provides the ABM-2 sequences [XPPPPP, X = G, P, L, S, A] for binding profilin, an actin-regulatory protein that stimulates actin filament assembly.", "text_with_entity_marker": "[E1]VASP[/E1], in turn, provides the ABM-2 sequences [XPPPPP, X = G, P, L, S, A] for binding [E2]profilin[/E2], an actin-regulatory protein that stimulates actin filament assembly.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "VASP", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[84, 92]], "entity_2_idx_in_text_with_entity_marker": [97, 105], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d792.s0_BioInfer.d792.s0.p1", "text": "VASP, in turn, provides the ABM-2 sequences [XPPPPP, X = G, P, L, S, A] for binding profilin, an actin-regulatory protein that stimulates actin filament assembly.", "text_with_entity_marker": "VASP, in turn, provides the ABM-2 sequences [XPPPPP, X = G, P, L, S, A] for binding [E1]profilin[/E1], an [E2]actin[/E2]-regulatory protein that stimulates actin filament assembly.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[84, 92]], "entity_1_idx_in_text_with_entity_marker": [88, 96], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[97, 102]], "entity_2_idx_in_text_with_entity_marker": [110, 115], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d792.s0_BioInfer.d792.s0.p2", "text": "VASP, in turn, provides the ABM-2 sequences [XPPPPP, X = G, P, L, S, A] for binding profilin, an actin-regulatory protein that stimulates actin filament assembly.", "text_with_entity_marker": "VASP, in turn, provides the ABM-2 sequences [XPPPPP, X = G, P, L, S, A] for binding [E1]profilin[/E1], an actin-regulatory protein that stimulates [E2]actin[/E2] filament assembly.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[84, 92]], "entity_1_idx_in_text_with_entity_marker": [88, 96], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[138, 143]], "entity_2_idx_in_text_with_entity_marker": [151, 156], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d792.s0_BioInfer.d792.s0.p3", "text": "VASP, in turn, provides the ABM-2 sequences [XPPPPP, X = G, P, L, S, A] for binding profilin, an actin-regulatory protein that stimulates actin filament assembly.", "text_with_entity_marker": "[E1]VASP[/E1], in turn, provides the ABM-2 sequences [XPPPPP, X = G, P, L, S, A] for binding profilin, an [E2]actin[/E2]-regulatory protein that stimulates actin filament assembly.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "VASP", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[97, 102]], "entity_2_idx_in_text_with_entity_marker": [110, 115], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d792.s0_BioInfer.d792.s0.p4", "text": "VASP, in turn, provides the ABM-2 sequences [XPPPPP, X = G, P, L, S, A] for binding profilin, an actin-regulatory protein that stimulates actin filament assembly.", "text_with_entity_marker": "[E1]VASP[/E1], in turn, provides the ABM-2 sequences [XPPPPP, X = G, P, L, S, A] for binding profilin, an actin-regulatory protein that stimulates [E2]actin[/E2] filament assembly.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "VASP", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[138, 143]], "entity_2_idx_in_text_with_entity_marker": [151, 156], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d792.s0_BioInfer.d792.s0.p5", "text": "VASP, in turn, provides the ABM-2 sequences [XPPPPP, X = G, P, L, S, A] for binding profilin, an actin-regulatory protein that stimulates actin filament assembly.", "text_with_entity_marker": "VASP, in turn, provides the ABM-2 sequences [XPPPPP, X = G, P, L, S, A] for binding profilin, an [E1]actin[/E1]-regulatory protein that stimulates [E2]actin[/E2] filament assembly.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[97, 102]], "entity_1_idx_in_text_with_entity_marker": [101, 106], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[138, 143]], "entity_2_idx_in_text_with_entity_marker": [151, 156], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d360.s0_BioInfer.d360.s0.p0", "text": "Interaction of Munc-18-2 with syntaxin 3 controls the association of apical SNAREs in epithelial cells.", "text_with_entity_marker": "Interaction of [E1]Munc-18-2[/E1] with [E2]syntaxin 3[/E2] controls the association of apical SNAREs in epithelial cells.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Munc-18-2", "entity_1_idx": [[15, 24]], "entity_1_idx_in_text_with_entity_marker": [19, 28], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "syntaxin 3", "entity_2_idx": [[30, 40]], "entity_2_idx_in_text_with_entity_marker": [43, 53], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d360.s0_BioInfer.d360.s0.p1", "text": "Interaction of Munc-18-2 with syntaxin 3 controls the association of apical SNAREs in epithelial cells.", "text_with_entity_marker": "Interaction of [E1]Munc-18-2[/E1] with syntaxin 3 controls the association of apical [E2]SNAREs[/E2] in epithelial cells.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Munc-18-2", "entity_1_idx": [[15, 24]], "entity_1_idx_in_text_with_entity_marker": [19, 28], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "SNAREs", "entity_2_idx": [[76, 82]], "entity_2_idx_in_text_with_entity_marker": [89, 95], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d360.s0_BioInfer.d360.s0.p2", "text": "Interaction of Munc-18-2 with syntaxin 3 controls the association of apical SNAREs in epithelial cells.", "text_with_entity_marker": "Interaction of Munc-18-2 with [E1]syntaxin 3[/E1] controls the association of apical [E2]SNAREs[/E2] in epithelial cells.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "syntaxin 3", "entity_1_idx": [[30, 40]], "entity_1_idx_in_text_with_entity_marker": [34, 44], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "SNAREs", "entity_2_idx": [[76, 82]], "entity_2_idx_in_text_with_entity_marker": [89, 95], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d360.s1_BioInfer.d360.s1.p0", "text": "The quantity of the complex is reduced by treatment of Caco-2 cells with the alkylating agent N-ethylmaleimide which also has an inhibitory effect on the ability of Munc-18-2 to associate with syntaxin 3 in vitro.", "text_with_entity_marker": "The quantity of the complex is reduced by treatment of Caco-2 cells with the alkylating agent N-ethylmaleimide which also has an inhibitory effect on the ability of [E1]Munc-18-2[/E1] to associate with [E2]syntaxin 3[/E2] in vitro.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Munc-18-2", "entity_1_idx": [[165, 174]], "entity_1_idx_in_text_with_entity_marker": [169, 178], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "syntaxin 3", "entity_2_idx": [[193, 203]], "entity_2_idx_in_text_with_entity_marker": [206, 216], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d483.s0_BioInfer.d483.s0.p20", "text": "PDGF treatment had no effect on talin, vimentin, or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml epidermal growth factor (EGF), 30 ng/ml somatomedin C, or 10 microM insulin also had no effect on vinculin or actin distribution.", "text_with_entity_marker": "PDGF treatment had no effect on [E1]talin[/E1], vimentin, or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml [E2]epidermal growth factor[/E2] (EGF), 30 ng/ml somatomedin C, or 10 microM insulin also had no effect on vinculin or actin distribution.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "talin", "entity_1_idx": [[32, 37]], "entity_1_idx_in_text_with_entity_marker": [36, 41], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "epidermal growth factor", "entity_2_idx": [[182, 205]], "entity_2_idx_in_text_with_entity_marker": [195, 218], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d483.s0_BioInfer.d483.s0.p21", "text": "PDGF treatment had no effect on talin, vimentin, or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml epidermal growth factor (EGF), 30 ng/ml somatomedin C, or 10 microM insulin also had no effect on vinculin or actin distribution.", "text_with_entity_marker": "PDGF treatment had no effect on talin, vimentin, or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml epidermal growth factor (EGF), 30 ng/ml somatomedin C, or 10 microM [E1]insulin[/E1] also had no effect on vinculin or [E2]actin[/E2] distribution.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "insulin", "entity_1_idx": [[250, 257]], "entity_1_idx_in_text_with_entity_marker": [254, 261], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[292, 297]], "entity_2_idx_in_text_with_entity_marker": [305, 310], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d483.s0_BioInfer.d483.s0.p22", "text": "PDGF treatment had no effect on talin, vimentin, or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml epidermal growth factor (EGF), 30 ng/ml somatomedin C, or 10 microM insulin also had no effect on vinculin or actin distribution.", "text_with_entity_marker": "PDGF treatment had no effect on talin, vimentin, or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml epidermal growth factor (EGF), 30 ng/ml [E1]somatomedin C[/E1], or 10 microM insulin also had no effect on vinculin or [E2]actin[/E2] distribution.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "somatomedin C", "entity_1_idx": [[222, 235]], "entity_1_idx_in_text_with_entity_marker": [226, 239], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[292, 297]], "entity_2_idx_in_text_with_entity_marker": [305, 310], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d483.s0_BioInfer.d483.s0.p23", "text": "PDGF treatment had no effect on talin, vimentin, or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml epidermal growth factor (EGF), 30 ng/ml somatomedin C, or 10 microM insulin also had no effect on vinculin or actin distribution.", "text_with_entity_marker": "PDGF treatment had no effect on talin, vimentin, or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml epidermal growth factor ([E1]EGF[/E1]), 30 ng/ml somatomedin C, or 10 microM insulin also had no effect on vinculin or [E2]actin[/E2] distribution.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "EGF", "entity_1_idx": [[207, 210]], "entity_1_idx_in_text_with_entity_marker": [211, 214], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[292, 297]], "entity_2_idx_in_text_with_entity_marker": [305, 310], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d483.s0_BioInfer.d483.s0.p24", "text": "PDGF treatment had no effect on talin, vimentin, or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml epidermal growth factor (EGF), 30 ng/ml somatomedin C, or 10 microM insulin also had no effect on vinculin or actin distribution.", "text_with_entity_marker": "[E1]PDGF[/E1] treatment had no effect on talin, vimentin, or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml epidermal growth factor (EGF), 30 ng/ml somatomedin C, or 10 microM insulin also had no effect on vinculin or [E2]actin[/E2] distribution.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PDGF", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[292, 297]], "entity_2_idx_in_text_with_entity_marker": [305, 310], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d483.s0_BioInfer.d483.s0.p25", "text": "PDGF treatment had no effect on talin, vimentin, or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml epidermal growth factor (EGF), 30 ng/ml somatomedin C, or 10 microM insulin also had no effect on vinculin or actin distribution.", "text_with_entity_marker": "PDGF treatment had no effect on talin, vimentin, or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml [E1]epidermal growth factor[/E1] (EGF), 30 ng/ml somatomedin C, or 10 microM insulin also had no effect on vinculin or [E2]actin[/E2] distribution.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "epidermal growth factor", "entity_1_idx": [[182, 205]], "entity_1_idx_in_text_with_entity_marker": [186, 209], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[292, 297]], "entity_2_idx_in_text_with_entity_marker": [305, 310], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d483.s0_BioInfer.d483.s0.p26", "text": "PDGF treatment had no effect on talin, vimentin, or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml epidermal growth factor (EGF), 30 ng/ml somatomedin C, or 10 microM insulin also had no effect on vinculin or actin distribution.", "text_with_entity_marker": "PDGF treatment had no effect on talin, vimentin, or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml epidermal growth factor (EGF), 30 ng/ml [E1]somatomedin C[/E1], or 10 microM [E2]insulin[/E2] also had no effect on vinculin or actin distribution.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "somatomedin C", "entity_1_idx": [[222, 235]], "entity_1_idx_in_text_with_entity_marker": [226, 239], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[250, 257]], "entity_2_idx_in_text_with_entity_marker": [263, 270], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d483.s0_BioInfer.d483.s0.p27", "text": "PDGF treatment had no effect on talin, vimentin, or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml epidermal growth factor (EGF), 30 ng/ml somatomedin C, or 10 microM insulin also had no effect on vinculin or actin distribution.", "text_with_entity_marker": "PDGF treatment had no effect on talin, vimentin, or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml epidermal growth factor ([E1]EGF[/E1]), 30 ng/ml somatomedin C, or 10 microM [E2]insulin[/E2] also had no effect on vinculin or actin distribution.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "EGF", "entity_1_idx": [[207, 210]], "entity_1_idx_in_text_with_entity_marker": [211, 214], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[250, 257]], "entity_2_idx_in_text_with_entity_marker": [263, 270], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d483.s0_BioInfer.d483.s0.p28", "text": "PDGF treatment had no effect on talin, vimentin, or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml epidermal growth factor (EGF), 30 ng/ml somatomedin C, or 10 microM insulin also had no effect on vinculin or actin distribution.", "text_with_entity_marker": "[E1]PDGF[/E1] treatment had no effect on talin, vimentin, or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml epidermal growth factor (EGF), 30 ng/ml somatomedin C, or 10 microM [E2]insulin[/E2] also had no effect on vinculin or actin distribution.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PDGF", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[250, 257]], "entity_2_idx_in_text_with_entity_marker": [263, 270], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d483.s0_BioInfer.d483.s0.p29", "text": "PDGF treatment had no effect on talin, vimentin, or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml epidermal growth factor (EGF), 30 ng/ml somatomedin C, or 10 microM insulin also had no effect on vinculin or actin distribution.", "text_with_entity_marker": "PDGF treatment had no effect on talin, vimentin, or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml [E1]epidermal growth factor[/E1] (EGF), 30 ng/ml somatomedin C, or 10 microM [E2]insulin[/E2] also had no effect on vinculin or actin distribution.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "epidermal growth factor", "entity_1_idx": [[182, 205]], "entity_1_idx_in_text_with_entity_marker": [186, 209], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[250, 257]], "entity_2_idx_in_text_with_entity_marker": [263, 270], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
